---
date: 2022-08-02 07:27:34
---



# 期刊题录 -- 2022 Critical Care Medicine.

<Badge text="Atman 机器翻译，未校对" vertical="middle"/>


## Stability of Spo2/Fio2 and Respiratory Rate-Oxygenation Indexes in Critical Respiratory Disorders.

8:e694-e695. DOI:10.1097/CCM.0000000000005559

## 严重呼吸疾病中Spo2/Fio2和呼吸频率-氧合指数的稳定性。

--------
--------

## Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial., Kula, Roman

8:e693-e694. DOI:10.1097/CCM.0000000000005555

## 治疗性高热与发热危重症脓毒症患者的生存率改善相关：一项初探性随机化试验。

--------
--------

## The authors reply.

8:e691-e693. DOI:10.1097/CCM.0000000000005573

## 作者回复。

--------
--------

## Fragility Index and Trial Sequential Analysis for Randomized Controlled Studies Testing IV Vitamin C in Critically Ill Patients.

8:e690-e691. DOI:10.1097/CCM.0000000000005562

## 在危重病患者中评估IV维生素C的随机对照研究的脆性指数和试验序列分析。

--------
--------

## The authors reply.

8:e689-e690. DOI:10.1097/CCM.0000000000005574

## 作者回复。

--------
--------

## Cerebral Tissue Oxygenation Monitoring for Guiding RBC Transfusion in Neurocritical Patients.

8:e688-e689. DOI:10.1097/CCM.0000000000005561

## 神经重症患者指导 RBC 输注的脑组织氧合监测。

--------
--------

## The authors reply.

8:e687-e688. DOI:10.1097/CCM.0000000000005576

## 作者回复。

--------
--------

## Hyperbaric Oxygenation Therapy Alone for Carbon Monoxide Poisoning: Time for Reinforcements?

8:e686-e687. DOI:10.1097/CCM.0000000000005553

## 一氧化碳中毒的单独高压氧合治疗：强化时间？

--------
--------

## The authors reply., Rass, Verena

8:e684-e685. DOI:10.1097/CCM.0000000000005577

## 作者回复。

--------
--------

## Factors Associated With Prolonged Mechanical Ventilation in Nontraumatic Subarachnoid Hemorrhage., Siddiqui, Suhail Sarwar

8:e683-e684. DOI:10.1097/CCM.0000000000005541

## 非创伤性蛛网膜下腔出血机械通气延长的相关因素。

--------
--------

## Home-Ward Bound?, Rampon, Garrett

8:1285-1287. DOI:10.1097/CCM.0000000000005560

## 家庭病房界限？

--------
--------

## Is "Set It and Forget It" Bad Medicine for Sedation and Analgesia for Intubated Emergency Department Patients?, Winkle, Julie

8:1283-1285. DOI:10.1097/CCM.0000000000005566

## “设置它，遗忘它”是否有损急诊插管患者的镇静和镇痛的良药？

--------
--------

## A Call for a Consensus Approach to the Design, Implementation, and Evaluation of Early Warning Systems., Bhavani, Sivasubramanium V.

8:1280-1282. DOI:10.1097/CCM.0000000000005568

## 呼吁对预警系统的设计、实施和评估采取共识方法。

--------
--------

## Sepsis Awareness Is Good, Please Do Not Let It Be Misunderstood.

8:1277-1279. DOI:10.1097/CCM.0000000000005569

## 败血症意识良好，请不要误解。

--------
--------

## Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

8:1175-1186. DOI:10.1097/CCM.0000000000005580

Abstract: 

OBJECTIVES: To determine the safety and efficacy of probiotics or synbiotics on morbidity and mortality in critically ill adults and children. 

DATA SOURCES: We searched MEDLINE, EMBASE, CENTRAL, and unpublished sources from inception to May 4, 2021. 

STUDY SELECTION: We performed a systematic search for randomized controlled trials (RCTs) that compared enteral probiotics or synbiotics to placebo or no treatment in critically ill patients. We screened studies independently and in duplicate. 

DATA EXTRACTION: Independent reviewers extracted data in duplicate. A random-effects model was used to pool data. We assessed the overall certainty of evidence for each outcome using the Grading Recommendations Assessment, Development, and Evaluation approach. 

DATA SYNTHESIS: Sixty-five RCTs enrolled 8,483 patients. Probiotics may reduce ventilator-associated pneumonia (VAP) (relative risk [RR], 0.72; 95% CI, 0.59 to 0.89 and risk difference [RD], 6.9% reduction; 95% CI, 2.7-10.2% fewer; low certainty), healthcare-associated pneumonia (HAP) (RR, 0.70; 95% CI, 0.55-0.89; RD, 5.5% reduction; 95% CI, 8.2-2.0% fewer; low certainty), ICU length of stay (LOS) (mean difference [MD], 1.38 days fewer; 95% CI, 0.57-2.19 d fewer; low certainty), hospital LOS (MD, 2.21 d fewer; 95% CI, 1.18-3.24 d fewer; low certainty), and duration of invasive mechanical ventilation (MD, 2.53 d fewer; 95% CI, 1.31-3.74 d fewer; low certainty). Probiotics probably have no effect on mortality (RR, 0.95; 95% CI, 0.87-1.04 and RD, 1.1% reduction; 95% CI, 2.8% reduction to 0.8% increase; moderate certainty). Post hoc sensitivity analyses without high risk of bias studies negated the effect of probiotics on VAP, HAP, and hospital LOS. 

CONCLUSIONS: Low certainty RCT evidence suggests that probiotics or synbiotics during critical illness may reduce VAP, HAP, ICU and hospital LOS but probably have no effect on mortality.

## 益生菌在危重症中的应用：一项随机对照试验的系统评价和荟萃分析。

摘要：

目的：确定益生菌或合生元对危重成人和儿童发病率和死亡率的安全性和有效性。

数据来源：我们检索了MEDLINE、EMBASE、CENTRAL和未发表的数据库，时间范围为从建库至2021年5月4日。

研究选择：我们对比较肠内益生菌或合生元与安慰剂或不治疗重症患者的随机对照试验(RCT)进行了系统检索。我们对研究进行了独立和重复筛选。

数据提取：独立审查者重复提取数据。使用随机效应模型汇总数据。我们使用分级推荐评估、开发和评价方法评估了每项结局证据的总体确定性。

数据综合：65项RCT入组了8483例患者。益生菌可减少呼吸机相关性肺炎(VAP)（相对风险[RR]，0.72；95%CI，0.59-0.89，风险差异[RD]，减少6.9%；95%CI，减少2.7-10.2%；低确定性）、医疗相关性肺炎(HAP)（RR，0.70；95%CI，0.55-0.89；RD，减少5.5%；95%CI，减少8.2-2.0%；低确定性），ICU住院时间(LOS)（平均差异[MD]少1.38天；95%CI少0.57-2.19天；低确定性）、住院LOS（MD少2.21天；95%CI少1.18-3.24天；低确定性）和有创机械通气持续时间（MD少2.53天；95%CI少1.31-3.74天；低确定性）。益生菌很可能对死亡率没有影响（RR，0.95；95%CI，0.87-1.04；RD，1.1%下降；95%CI，2.8%下降至0.8%增加；中度确定）。没有高偏倚风险研究的事后敏感性分析否定了益生菌对VAP、HAP和医院LOS的影响。

结论：低确定性RCT证据表明，危重症期间益生菌或合生菌可降低VAP、HAP、ICU和医院LOS，但可能对死亡率无影响。

--------
--------

## Electrical Impedance Tomography in Acute Respiratory Distress Syndrome Management.

8:1210-1223. DOI:10.1097/CCM.0000000000005582

Abstract: 

OBJECTIVE: To describe, through a narrative review, the physiologic principles underlying electrical impedance tomography, and its potential applications in managing acute respiratory distress syndrome (ARDS). To address the current evidence supporting its use in different clinical scenarios along the ARDS management continuum. 

DATA SOURCES: We performed an online search in Pubmed to review articles. We searched MEDLINE, Cochrane Central Register, and clinicaltrials.gov for controlled trials databases. 

STUDY SELECTION: Selected publications included case series, pilot-physiologic studies, observational cohorts, and randomized controlled trials. To describe the rationale underlying physiologic principles, we included experimental studies. 

DATA EXTRACTION: Data from relevant publications were reviewed, analyzed, and its content summarized. 

DATA SYNTHESIS: Electrical impedance tomography is an imaging technique that has aided in understanding the mechanisms underlying multiple interventions used in ARDS management. It has the potential to monitor and predict the response to prone positioning, aid in the dosage of flow rate in high-flow nasal cannula, and guide the titration of positive-end expiratory pressure during invasive mechanical ventilation. The latter has been demonstrated to improve physiologic and mechanical parameters correlating with lung recruitment. Similarly, its use in detecting pneumothorax and harmful patient-ventilator interactions such as pendelluft has been proven effective. Nonetheless, its impact on clinically meaningful outcomes remains to be determined. 

CONCLUSIONS: Electrical impedance tomography is a potential tool for the individualized management of ARDS throughout its different stages. Clinical trials should aim to determine whether a specific approach can improve clinical outcomes in ARDS management.

## 急性呼吸窘迫综合征管理中的电阻抗断层成像。

摘要：
目的：通过叙述性回顾，描述电阻抗断层成像的生理学原理及其在管理急性呼吸窘迫综合征(ARDS)中的潜在应用。阐述支持其在ARDS管理连续体不同临床情况下使用的当前证据。

数据来源：我们在Pubmed中进行了在线检索，以对文章进行综述。我们检索了MEDLINE、Cochrane Central Register和clinicaltrials.gov对照试验数据库。

研究选择：选定的出版物包括病例系列、初步生理学研究、观察性队列和随机对照试验。为了描述潜在的生理学原理，我们纳入了实验性研究。

数据提取：对相关出版物中的数据进行审查、分析，并对其内容进行总结。

数据综合：电阻抗断层扫描是一种成像技术，有助于了解多种干预措施在ARDS管理中的作用机制。它可在有创机械通气期间监测和预测对俯卧位的反应，帮助高流量鼻插管的流速剂量，并指导对呼气末正压的滴定。已证实后者可改善与肺复张相关的生理和机械参数。同样，已证实其用于检测气胸和有害的患者-呼吸机相互作用（如pendelluft）有效。尽管如此，其对有临床意义结局的影响仍有待确定。

结论：电阻抗断层扫描是ARDS不同阶段个体化管理的潜在工具。临床试验的目的应是确定特定方法是否能改善ARDS管理的临床结局。n死亡率。

--------
--------

## Patient, Public, and Healthcare Professionals' Sepsis Awareness, Knowledge, and Information Seeking Behaviors: A Scoping Review., Fiest, Kirsten M.

8:1187-1197. DOI:10.1097/CCM.0000000000005564

Abstract: 

OBJECTIVES: Sepsis awareness and understanding are important aspects of prevention, recognition, and clinical management of sepsis. We conducted a scoping review to identify and map the literature related to sepsis awareness, general knowledge, and information-seeking behaviors with a goal to inform future sepsis research and knowledge translation campaigns. 

DESIGN: Scoping review. 

SETTING: Using Arksey and O'Malley's methodological framework, we conducted a systematic search on May 3, 2021, across four databases (MEDLINE, EMBASE, CINAHL, and Education Research Complete). Title/abstract and full-text screening was done in duplicate. One researcher extracted the data for each included article, and a second researcher checked data accuracy. The protocol was registered on Open Science Framework ( https://doi.org/10.17605/OSF.IO/YX7AU ). 

SUBJECTS: Articles related to sepsis awareness, knowledge, and information seeking behaviors among patients, public, and healthcare professionals. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Of 5,927 unique studies, 80 reported on patient ( n = 13/80;16.3%), public ( n = 15/80;18.8%), or healthcare professional (nurses, physicians, emergency medical technicians) ( n = 48/80; 60%) awareness and knowledge of sepsis. Healthcare professional awareness and knowledge of sepsis is high compared with patients/public. The proportion of patients/public who had heard of the term sepsis ranged from 2% (Japan) to 88.6% (Germany). The proportions of patients/public who correctly identified the definition of sepsis ranged from 4.2% (Singapore) to 92% (Sweden). The results from the included studies appear to suggest that patient/public awareness of sepsis gradually improved over time. We found that the definition of sepsis was inconsistent in the literature and that few studies reported on patient, public, or healthcare professional knowledge of sepsis risk factors. Most patient/public get their sepsis information from the internet, whereas healthcare professionals get it from their role in healthcare through job training or educational training. 

CONCLUSIONS: Patient, public, and healthcare professional awareness and knowledge of sepsis vary globally. Future research may benefit from a consistent definition as well as country-specific data to support targeted public awareness campaigns.

## 患者、公众和医疗保健专业人员的败血症意识、知识和寻求信息的行为：一项应对审查。

摘要

目的：败血症认识和理解是败血症预防、识别和临床管理的重要方面。我们进行了一项范围审查，以确定和映射与败血症意识、一般知识和信息寻求行为相关的文献，目的是告知未来的败血症研究和知识转化项目。

设计：范围审查。

设置：使用Arksey和O'Malley的方法学框架，我们于2021年5月3日在四个数据库（MEDLINE、EMBASE、CINAHL和Education Research Complete）中进行了系统检索。重复进行标题/摘要和全文筛选。一名研究者从每篇纳入的文章中提取数据，另一名研究者检查数据的准确性。该方案已在Open Science Framework（https://doi.org/10.17605/OSF.IO/YX7AU ).

受试者：与患者、公众和医疗保健专业人员的败血症意识、知识和信息寻求行为相关的文章。

干预：无。

测量值和主要结果：在5,927项独特的研究中，80项报告了患者(n = 13/80；16.3%)、公众(n = 15/80；18.8%)或医疗保健专业人员（护士、医生、急救医疗技术人员）(n = 48/80；60%)对败血症的认识和了解。与患者/公众相比，医疗保健专业人士对败血症的认识和知识较高。听说过术语“脓毒症”的患者/公众比例范围是2%（日本）至88.6%（德国）。正确识别败血症定义的患者/公众比例范围为4.2%（新加坡）至92%（瑞典）。纳入的研究结果似乎表明，随着时间的推移，患者/公众对败血症的认识逐渐改善。我们发现文献中败血症的定义不一致，且仅有少数研究报告了败血症风险因素的患者、公共或医疗保健专业人士知识。大多数患者/公众通过网络获得其败血症信息，而医疗保健专业人员通过工作培训或教育培训从其在医疗保健中的角色获得这些信息。

结论：败血症的患者、公众和医疗保健专业人员意识和知识在全球各不相同。未来的研究可能受益于一致的定义以及特定国家的数据，以支持目标公众意识活动。

--------
--------

## The Impact of Health Information Technology for Early Detection of Patient Deterioration on Mortality and Length of Stay in the Hospital Acute Care Setting: Systematic Review and Meta-Analysis.

8:1198-1209. DOI:10.1097/CCM.0000000000005554

Abstract: 

OBJECTIVE: To evaluate the impact of health information technology (HIT) for early detection of patient deterioration on patient mortality and length of stay (LOS) in acute care hospital settings. 

DATA SOURCES: We searched MEDLINE and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus from 1990 to January 19, 2021. 

STUDY SELECTION: We included studies that enrolled patients hospitalized on the floor, in the ICU, or admitted through the emergency department. 

Eligible studies compared HIT for early detection of patient deterioration with usual care and reported at least one end point of interest: hospital or ICU LOS or mortality at any time point. 

DATA EXTRACTION: Study data were abstracted by two independent reviewers using a standardized data extraction form. 

DATA SYNTHESIS: Random-effects meta-analysis was used to pool data. Among the 30 eligible studies, seven were randomized controlled trials (RCTs) and 23 were pre-post studies. Compared with usual care, HIT for early detection of patient deterioration was not associated with a reduction in hospital mortality or LOS in the meta-analyses of RCTs. In the meta-analyses of pre-post studies, HIT interventions demonstrated a significant association with improved hospital mortality for the entire study cohort (odds ratio, 0.78 [95% CI, 0.70-0.87]) and reduced hospital LOS overall. 

CONCLUSIONS: HIT for early detection of patient deterioration in acute care settings was not significantly associated with improved mortality or LOS in the meta-analyses of RCTs. In the meta-analyses of pre-post studies, HIT was associated with improved hospital mortality and LOS; however, these results should be interpreted with caution. The differences in patient outcomes between the findings of the RCTs and pre-post studies may be secondary to confounding caused by unmeasured improvements in practice and workflow over time.

## 早期检测患者病情恶化的健康信息技术对医院急性护理环境中死亡率和住院时间的影响： 系统评价和荟萃分析。

摘要：

目的：旨在评价健康信息技术(HIT)对患者恶化的早期检测对急诊医院环境中患者死亡率和住院时间(LOS)的影响。

数据来源：我们检索了1990年至2021年1月19日期间的MEDLINE和Epub Ahead of Print、In-Process&Other Non-Indexed Citations and Daily、Embase、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews和Scopus。

研究选择：我们纳入的研究入组了在地板上住院、在ICU住院或通过急诊科住院的患者。

符合条件的研究比较了HIT与常规护理早期检测患者恶化，并报告了至少一个关注终点：医院或ICU LOS或任何时间点的死亡率。

数据提取：由两名独立的审查员使用标准化的数据提取表提取研究数据。

数据综合：采用随机效应荟萃分析汇总数据。30项合格研究中，7项为随机对照试验(RCT)，23项为前后研究。在RCT的荟萃分析中，与常规护理相比，HIT用于早期检测患者恶化与住院死亡率或LOS的降低无关。在对治疗前-治疗后研究进行的荟萃分析中，HIT干预与整个研究队列中住院死亡率的改善存在显著相关性（比值比，0.78[95%CI，0.70-0.87]），并总体上减少了住院LOS。

结论：在RCT的荟萃分析中，HIT早期检测急症患者恶化与死亡率或LOS改善无显著相关性。在治疗前后研究的荟萃分析中，HIT与住院死亡率和LOS改善相关；然而，这些结果应谨慎解释。RCT结果和治疗前-治疗后研究结果之间的患者结局差异可能是继发于实践和工作流程随时间推移的未测改善所造成的混杂。

--------
--------

## The Feasibility of Implementing Targeted SEDation in Mechanically Ventilated Emergency Department Patients: The ED-SED Pilot Trial.

8:1224-1235. DOI:10.1097/CCM.0000000000005558

Abstract: 

OBJECTIVES: Deep sedation in the emergency department (ED) is common, increases deep sedation in the ICU, and is negatively associated with outcome. Limiting ED deep sedation may, therefore, be a high-yield intervention to improve outcome. However, the feasibility of conducting an adequately powered ED-based clinical sedation trial is unknown. 

Our objectives were to assess trial feasibility in terms of: 1) recruitment, 2) protocol implementation and practice change, and 3) safety. Patient-centered clinical outcomes were assessed to better plan for a future large-scale clinical trial. 

DESIGN: Pragmatic, multicenter ( n = 3), prospective before-after pilot and feasibility trial. 

SETTING: The ED and ICUs at three medical centers. 

PATIENTS: Consecutive, adult mechanically ventilation ED patients. 

INTERVENTIONS: An educational initiative aimed at reliable ED sedation depth documentation and reducing the proportion of deeply sedated patients (primary outcome). 

MEASUREMENTS AND MAIN RESULTS: Sedation-related data in the ED and the first 48 ICU hours were recorded. Deep sedation was defined as a Richmond Agitation-Sedation Scale of -3 to -5 or a Sedation-Agitation Scale of 1-3. One thousand three hundred fifty-six patients were screened; 415 comprised the final population. Lighter ED sedation was achieved in the intervention group, and the proportion of deeply sedated patients was reduced from 60.2% to 38.8% ( p < 0.01). There were no concerning trends in adverse events (i.e., inadvertent extubation, device removal, and awareness with paralysis). Mortality was 10.0% in the intervention group and 20.4% in the preintervention group ( p < 0.01). Compared with preintervention, the intervention group experienced more ventilator-free days [22.0 (9.0) vs 19.9 (10.6)] and ICU-free days [20.8 (8.7) vs 18.1 (10.4)], p < 0.05 for both. 

CONCLUSIONS: This pilot trial confirmed the feasibility of targeting the ED in order to improve sedation practices and reduce deep sedation. These findings justify an appropriately powered clinical trial regarding ED-based sedation to improve clinical outcomes.

## 在机械通气的急诊科患者中实施靶向镇静的可行性：ED-SED初探性试验。
摘要：

目的：急诊科(ED)中深度镇静很常见，增加了ICU中的深度镇静，并且与结局呈负相关。因此，限制ED深度镇静可能是改善结局的一种高收益干预。但是，尚不清楚进行具有足够效能的基于ED的临床镇静试验的可行性。

我们的目的是评估试验在以下方面的可行性：1）招募，2）方案实施和实践变更，以及3）安全性。评估了以患者为中心的临床结局，以更好地计划未来的大规模临床试验。

设计：实用、多中心(n = 3)、前瞻性先导后可行性试验。

单位：三家医疗中心的急诊科(ED)和重症监护室(ICU)。

患者：连续的成人机械通气ED患者。

干预：一项旨在提供可靠的ED镇静深度记录并降低深度镇静患者比例（主要结局）的教育倡议。

测量和主要结果：记录ED和前48小时ICU内的镇静相关数据。深度镇静定义为Richmond躁动-镇静量表为-3至-5或镇静-躁动量表为1-3。共筛选了1356例患者；415例患者组成最终人群。干预组达到了更轻的ED镇静，深度镇静患者的比例从60.2%降至38.8%(p < 0.01)。不良事件（即，意外拔管、器械移除和瘫痪意识）无相关趋势。干预组死亡率为10.0%，干预前组为20.4%(p < 0.01)。与干预前相比，干预组出现更多的无呼吸机天数[22.0(9.0)vs 19.9(10.6)]和无ICU天数[20.8(8.7)vs 18.1(10.4)]，两者均为p < 0.05。

结论：此项初探性试验证实了靶向ED以改善镇静实践和减少深度镇静的可行性。这些结果证明了关于基于ED镇静以改善临床结局的具有适当把握度的临床试验的合理性。

--------
--------

## Outcomes After Direct Discharge Home From Critical Care Units: A Population-Based Cohort Analysis., Martin, Claudio M.

8:1256-1264. DOI:10.1097/CCM.0000000000005533

Abstract: 

OBJECTIVES: To compare health service use and clinical outcomes for patients with and without direct discharge to home (DDH) from ICUs in Ontario. 

DESIGN: Population-based, observational, cohort study using propensity scoring to match patients who were DDH to those not DDH and a preference-based instrumental variable (IV) analysis using ICU-level DDH rate as the IV. 

SETTING: ICUs in Ontario. 

PATIENTS: Patients discharged home from a hospitalization either directly or within 48 hours of care in an ICU between April 1, 2015, and March 31, 2017. 

INTERVENTION: DDH from ICU. 

MEASUREMENTS AND MAIN RESULTS: Among 76,737 patients in our cohort, 46,859 (61%) were DDH from the ICU. In the propensity matched cohort, the odds for our primary outcome of hospital readmission or emergency department (ED) visit within 30 days were not significantly different for patients DDH (odds ratio [OR], 1.00; 95% CI, 0.96-1.04), and there was no difference in mortality at 90 days for patients DDH (OR, 1.08; 95% CI, 0.97-1.21). The effect on hospital readmission or ED visits was similar in the subgroup of patients discharged from level 2 (OR, 0.98; 95% CI, 0.92-1.04) and level 3 ICUs (OR, 1.02; 95% CI, 0.96-1.09) and in the subgroups with cardiac conditions (OR, 1.03; 95% CI, 0.96-1.12) and noncardiac conditions (OR, 0.98; 95% CI, 0.94-1.03). Similar results were obtained in the IV analysis (coefficient for hospital readmission or ED visit within 30 d = -0.03 ?± 0.03 ( se ); p = 0.3). 

CONCLUSIONS: There was no difference in outcomes for patients DDH compared with ward transfer prior to discharge when two approaches were used to minimize confounding within a large health systemwide observational cohort. We did not evaluate how patients are selected for DDH. Our results suggest that with careful patient selection, this practice might be feasible for routine implementation to ensure efficient and safe use of limited healthcare resources.

## 从重症监护室直接出院回家后的结局：基于人群的队列分析。

摘要：

目的：比较安大略省ICUs直接出院患者和未直接出院患者(DDH)的卫生服务使用和临床结局。

设计：基于人群的观察性队列研究，使用倾向评分匹配DDH患者和非DDH患者，使用ICU水平DDH率作为IV的基于偏好的工具变量(IV)分析。

设置：安大略省的ICU。

患者：2015年4月1日至2017年3月31日，患者直接出院或在ICU监护48小时内出院。

干预：ICU的DDH。

测量和主要结果：在我们的队列中76737例患者中，46859例(61%)为ICU DDH。在倾向性匹配队列中，患者DDH 30天内再次入院或急诊(ED)就诊的主要结局的比值比无显著差异（比值比[or]，1.00；95%CI，0.96-1.04），患者DDH 90天死亡率无差异(or，1.08；95%CI，0.97-1.21)。从2级(or，0.98；95%CI，0.92-1.04)和3级ICU(or，1.02；95%CI，0.96-1.09)出院的患者亚组与心脏疾病(or，1.03；95%CI，0.96-1.12)和非心脏疾病(or，0.98；95%CI，0.94-1.03)亚组对再次入院或ED就诊的影响相似。IV分析（30 d内再次入院或急诊就诊系数 =-0.03？±0.03(se)；p = 0.3）。

结论：当在一个大型卫生系统范围观察队列中使用两种方法将混杂最小化时，患者DDH的结局与出院前的病房转入无差异。我们未评估如何选择DDH患者。我们的研究结果表明，通过谨慎选择患者，这种做法可能适合常规实施，以确保有限医疗资源的有效和安全使用。

--------
--------

## Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational Study.

8:1246-1255. DOI:10.1097/CCM.0000000000005467

Abstract: 

OBJECTIVES: Although COVID-19 is associated with high von Willebrand factor (vWF) parameters promoting thrombosis, venovenous extracorporeal membrane oxygenation (vvECMO) is associated with the development of acquired von Willebrand syndrome (AVWS) promoting bleeding. This study was designed to assess both the incidence and severity of AVWS in COVID-19 patients undergoing vvECMO, and the benefit of comprehensive vWF analyses. 

DESIGN: Prospective observational study. 

SETTING: ICU at a tertiary-care center. 

PATIENTS: Twenty-seven consecutive COVID-19 patients with acute respiratory distress syndrome (ARDS) requiring vvECMO. 

MEASUREMENTS AND MAIN RESULTS: Comprehensive vWF analyses (including sodium dodecyl-sulfate polyacrylamide gel electrophoresis) were performed before, during, and after vvECMO. In a subgroup of 12 patients with AVWS, effectiveness of treatment with desmopressin was assessed. The patients' mean age was 53 years (range, 23-73), 70% were male, and all had various comorbidities. Following markedly elevated vwf antigen (vWF: Ag; mean, 546% ( sd , 282]), vWF collagen binding capacity (mean, 469% [ sd , 271]), vWF activity (vWF:A; mean, 383% [ sd , 132]), and factor VIII activity (mean, 302% [ sd , 106]), and only borderline decreases in high-molecular-weight (HMW) vWF multimers before vvECMO, all of these variables decreased and HMW vWF multimers became undetectable within hours following initiation of vvECMO. All variables fully recovered within 3-38 hours after discontinuation of vvECMO. During vvECMO, decreases in the vWF:A/vWF:Ag ratio correlated with absent HMW vWF multimers. Desmopressin did not affect vWF parameters. 

CONCLUSIONS: In patients with COVID-19-associated ARDS, AVWS developed soon after initiation of vvECMO. The vWF:A/vWF:Ag ratio was a suitable screening test for AVWS. As desmopressin was ineffective, bleeding during vvECMO-associated AVWS should preferably be treated with concentrates containing vWF.

## COVID-19患者静脉-静脉体外膜肺氧合期间获得性血管性血友病综合征和去氨加压素抵抗的前瞻性观察研究。

摘要

目的：尽管COVID-19与高血管性血友病因子(vWF)参数促进血栓形成相关，但是静脉-静脉体外膜肺氧合(vvECMO)与获得性血管性血友病综合征(AVWS)促进出血的发生相关。本研究旨在评估接受vvECMO的COVID-19患者中AVWS的发生率和严重程度，以及综合vWF分析的获益。

设计：前瞻性观察性研究。

地点：三级护理中心的ICU。

患者：连续27例需要vvECMO的COVID-19急性呼吸窘迫综合征(ARDS)患者。

测量和主要结果：在vvECMO之前、期间和之后进行综合vWF分析（包括十二烷基硫酸钠聚丙烯酰胺凝胶电泳）。在12例AVWS患者的亚组中，评估了去氨加压素治疗的有效性。患者的平均年龄为53岁（范围为23-73岁），70%为男性，均有各种合并症。vwf抗原（vwf:Ag；平均值，546%(sd,282])、vwf胶原结合能力（平均值，469%[sd,271]）、vwf活性（vwf:A；平均值，383%[sd,132]）和因子VIII活性（平均值，302%[sd,106]）显著升高后，在vvECMO、在开始vvECMO治疗后数小时内，所有这些变量均降低，HMW vWF多聚体无法检出。在停止vvECMO后3-38小时内，所有变量完全恢复。在vvECMO期间，vWF:A/vWF:Ag比率的降低与缺少HMW vWF多聚体相关。去氨加压素不影响vWF参数。

结论：在COVID-19相关ARDS患者中，AVWS在开始vvECMO治疗后不久发生。vWF:A/vWF:Ag比值是AVWS的适当筛选试验。由于去氨加压素无效，vvECMO相关性AVWS期间的出血最好使用含vWF的浓缩液治疗。

--------
--------

## Relative Hypoglycemia and Lower Hemoglobin A1c-Adjusted Time in Band Are Strongly Associated With Increased Mortality in Critically Ill Patients., Krinsley, James S.

8:e664-e673. DOI:10.1097/CCM.0000000000005490

Abstract: 

OBJECTIVES: To determine the associations of relative hypoglycemia and hemoglobin A1c-adjusted time in blood glucose (BG) band (HA-TIB) with mortality in critically ill patients. 

DESIGN: Retrospective cohort investigation. 

SETTING: University-affiliated adult medical-surgical ICU. 

PATIENTS: Three thousand six hundred fifty-five patients with at least four BG tests and hemoglobin A1c (HbA1c) level admitted between September 14, 2014, and November 30, 2019. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Patients were stratified for HbA1c bands of <6.5%; 6.5-7.9%; greater than or equal to 8.0% with optimal affiliated glucose target ranges of 70-140, 140-180, and 180-250 mg/dL, respectively. HA-TIB, a new glycemic metric, defined the HbA1c-adjusted time in band. Relative hypoglycemia was defined as BG 70-110 mg/dL for patients with HbA1c ?‰? 8.0%. Further stratification included diabetes status-no diabetes (NO-DM, n = 2,616) and preadmission treatment with or without insulin (DM-INS, n = 352; DM-No-INS, n = 687, respectively). Severity-adjusted mortality was calculated as the observed:expected mortality ratio (O:EMR), using the Acute Physiology and Chronic Health Evaluation IV prediction of mortality. Among NO-DM, mortality and O:EMR, decreased with higher TIB 70-140 mg/dL ( p < 0.0001) and were lowest with TIB 90-100%. O:EMR was lower for HA-TIB greater than or equal to 50% than less than 50% and among all DM-No-INS but for DM-INS only those with HbA1 greater than or equal to 8.0%.Among all patients with hba1c greater than or equal to 8.0% And no bg less than 70 mg/dl, mortality was 18.0% For patients with relative hypoglycemia (bg, 70-110 mg/dl) ( p < 0.0001) And was 0.0%, 12.9%, 13.0%, And 34.8% For patients with 0, 0.1-2.9, 3.0-11.9, And greater than or equal to 12.0 Hours of relative hypoglycemia ( p < 0.0001). 

CONCLUSIONS: These findings have considerable bearing on interpretation of previous trials of intensive insulin therapy in the critically ill. Moreover, they suggest that BG values in the 70-110 range may be deleterious for patients with HbA1c greater than or equal to 8.0% and that the appropriate target for BG should be individualized to HbA1c levels. These conclusions need to be tested in randomized trials.

## 在危重患者中，相对低血糖和较低的血红蛋白A1c-调整时间与死亡率增加明显相关。

摘要：

目的：确定相对低血糖和经血红蛋白A1c校正的血糖(BG)带时间(HA-TIB)与重症患者死亡率的相关性。

设计：回顾性队列研究。

单位：大学附属成人内科-外科ICU。

患者：2014年9月14日至2019年11月30日期间收治的30655例至少接受4次BG检测和血红蛋白A1c(HbA1c)水平的患者。

干预：无。

测量值和主要结果：根据HbA1c范围 < 6.5%、6.5-7.9%、大于或等于8.0%以及70-140、140-180和180-250 mg/dL的最佳附属葡萄糖目标范围对患者进行分层。HA-TIB是一种新的血糖指标，定义为HbA1c校正的时间带。对于HbA1c患者，相对低血糖定义为BG 70-110 mg/dL？‰?8.0%.进一步分层包括糖尿病状态-无糖尿病(no-DM，n = 2,616)和使用或不使用胰岛素的入院前治疗（分别为DM-INS，n = 352；DM-no-INS，n = 687）。严重程度调整的死亡率计算为观察到的：预期死亡率比(O:EMR)，使用急性生理学和慢性健康状况评估IV预测死亡率。在NO-DM患者中，死亡率和O:EMR随着TIB 70-140 mg/dL升高而降低(p < 0.0001)，TIB 90-100%时最低。O：在所有DM-No-INS中，HA-TIB大于或等于50%的EMR低于50%，但对于DM-INS，只有HbA1大于或等于8.0%的患者。在所有hba1c≥8.0%且bg≤70 mg/dL的患者中，相对低血糖患者(bg，70-110 mg/dL)的死亡率为18.0%(p < 0.0001)，而相对低血糖患者(bg，0-11.9)的死亡率分别为0.0%、12.9%、13.0%和34.8%。且发生相对低血糖的时间≥12.0小时(p < 0.0001)。

结论：这些结果对之前危重患者胰岛素强化治疗试验的解释有相当大的影响。此外，他们表明，对于HbA1c大于或等于8.0%的患者，BG值在70-110范围内可能是有害的，应根据HbA1c水平个体化设定适当的BG目标。这些结论需要在随机试验中进行检验。

--------
--------

## Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation., Jaquet, Pierre

8:e674-e682. DOI:10.1097/CCM.0000000000005500

Abstract: 

OBJECTIVES: To describe 3-6-month neurologic outcomes of survivors of COVID-19-associated acute respiratory distress syndrome, invasively ventilated in the ICU. 

DESIGN: A bicentric prospective study during the two first waves of the pandemic (March to May and September to December, 2020). 

SETTING: Two academic hospital ICUs, Paris, France. 

PATIENTS: Adult COVID-19-associated acute respiratory distress syndrome survivors, invasively ventilated in the ICU, were eligible for a neurologic consultation between 3 and 6 months post ICU discharge. 

INTERVENTIONS: Follow-up by face-to-face neurologic consultation. 

MEASURES AND MAIN RESULTS: The primary endpoint was favorable functional outcome defined by a modified Rankin scale score less than 2, indicating survival with no significant disability. Secondary endpoints included mild cognitive impairment (Montreal Cognitive Assessment score < 26), ICU-acquired weakness (Medical Research Council score < 48), anxiety and depression (Hospital Anxiety and Depression score > 7), and posttraumatic stress disorder (posttraumatic stress disorder checklist for Diagnostic and Statistical Manual of Mental Disorders 5 score > 30). Of 54 eligible survivors, four non-French-speaking patients were excluded, eight patients were lost-to-follow-up, and one died during follow-up. Forty-one patients were included. Time between ICU discharge and neurologic consultation was 3.8 months (3.6-5.9 mo). A favorable functional outcome was observed in 16 patients (39%) and mild cognitive impairment in 17 of 33 patients tested (52%). ICU-acquired weakness, depression or anxiety, and posttraumatic stress disorder were reported in six of 37 cases (16%), eight of 31 cases (26%), and two of 27 cases (7%), respectively. Twenty-nine patients (74%) required rehabilitation (motor, cognitive, or psychologic). ICU and hospital lengths of stay, tracheostomy, and corticosteroids were negatively associated with favorable outcome. By contrast, use of alpha-2 agonists during ICU stay was associated with favorable outcome. 

CONCLUSIONS: COVID-19-associated acute respiratory distress syndrome requiring intubation led to slight-to-severe functional disability in about 60% of survivors 4 months after ICU discharge. Cognitive impairment, muscle weakness, and psychologic symptoms were frequent. A large multicenter study is warranted to allow identification of modifiable factors for improving long-term outcome.

## 需要插管的COVID-19相关急性呼吸窘迫综合征生存者的神经系统结局。

目的：描述在ICU中接受侵入性通气的COVID-19相关急性呼吸窘迫综合征生存者的3个月神经系统结局。

设计：在前两轮大流行期间（2020年3月至5月和9月至12月）进行的一项双中心前瞻性研究。

单位：法国巴黎，两个学术医院ICU。

患者：成年COVID-19相关急性呼吸窘迫综合征幸存者，在ICU侵入性通气，在离开ICU后3-6个月有资格进行神经学会诊。

干预：面对面神经科会诊进行随访。

测量值和主要结果：主要终点是有利的功能结局，定义为改良Rankin量表评分小于2，表示生存期无显著残疾。次要终点包括轻度认知功能障碍（蒙特利尔认知评估量表评分<26）、ICU获得性虚弱（医学研究委员会评分<48）、焦虑和抑郁（医院焦虑和抑郁评分>7），和创伤后应激障碍（精神障碍诊断和统计手册的创伤后应激障碍检查表5分 > 30）。在54例合格存活者中，排除了4例非法语患者，8例患者失访，1例在随访期间死亡。纳入41例患者。从离开ICU到神经科会诊的时间为3.8个月（3.6-5.9个月）。在检测的33例患者中，16例(39%)观察到良好的功能结局，17例(52%)观察到轻度认知功能障碍。37例病例中分别有6例(16%)、31例病例中有8例(26%)和27例病例中有2例(7%)报告ICU获得性虚弱、抑郁或焦虑和创伤后应激障碍。29例患者(74%)需要康复治疗（运动、认知或心理）。ICU和住院时间、气管造口术和皮质类固醇与良好结局呈负相关。相比之下，在ICU住院期间使用α-2激动剂与有利结局相关。

结论：COVID-19相关的需要插管的急性呼吸窘迫综合征在离开ICU 4个月后，导致约60%的存活者出现轻至重度功能残疾。认知障碍、肌无力和心理症状常见。有必要进行一项大型多中心研究，以确定改善长期结局的可调整因素。

--------
--------

## Platelet Phenotype and Function Changes With Increasing Duration of Extracorporeal Membrane Oxygenation.

8:1236-1245. DOI:10.1097/CCM.0000000000005435

Abstract: 

OBJECTIVES: To investigate platelet pathophysiology associated with pediatric extracorporeal membrane oxygenation (ECMO). 

DESIGN: Prospective observational study of neonatal and pediatric ECMO patients from September 1, 2016, to December 31, 2019. 

SETTING: The PICU in a large tertiary referral pediatric ECMO center. 

PATIENTS: Eighty-seven neonates and children (< 18 yr) supported by ECMO. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Arterial blood samples were collected on days 1, 2, and 5 of ECMO and were analyzed by whole blood flow cytometry. Corresponding clinical data for each patient was also recorded. A total of 87 patients were recruited (median age, 65 d; interquartile range [IQR], 7 d to 4 yr). The median duration of ECMO was 5 days (IQR, 3-8 d) with a median length of stay in PICU and hospital of 18 days (IQR, 10-29 d) and 35 days (IQR, 19-75 d), respectively. Forty-two patients (48%) had at least one major bleed according to a priori determined definitions, and 12 patients (14%) had at least one thrombotic event during ECMO. Platelet fibrinogen receptor expression decreased (median fluorescence intensity [MFI], 29,256 vs 26,544; p = 0.0005), while von Willebrand Factor expression increased (MFI: 7,620 vs 8,829; p = 0.0459) from day 2 to day 5 of ECMO. Platelet response to agonist, Thrombin Receptor Activator Peptide 6, also decreased from day 2 to day 5 of ECMO, as measured by binding with anti-P-selectin, PAC-1 (binds activated GPIIb/IIIa), and anti-CD63 monoclonal antibodies (P-selectin area under the curve [AUC]: 63.46 vs 42.82, respectively, p = 0.0022; PAC-1 AUC: 93.75 vs 74.46, p = 0.0191; CD63 AUC: 55.69 vs 41.76, p = 0.0020). 

CONCLUSIONS: The loss of platelet response over time may contribute to bleeding during ECMO. These novel insights may be useful in understanding mechanisms of bleeding in pediatric ECMO and monitoring platelet markers clinically could allow for prediction or early detection of bleeding and thrombosis.

## 血小板表型和功能随着体外膜氧合持续时间的增加而变化。

摘要：

目的：研究儿科体外膜肺氧合(ECMO)相关血小板病理生理学。

设计：2016年9月1日-2019年12月31日新生儿及儿童ECMO患者前瞻性观察研究。

设置：大型三级转诊儿科ECMO中心的PICU。

患者：87名接受ECMO支持的新生儿和儿童（< 18岁）。

干预：无。

测定和主要结果：在ECMO第1、2和5天采集动脉血样，并采用全血流式细胞术进行分析。还记录了每例患者的相应临床数据。共招募87例患者（中位年龄65天；四分位距[IQR]7天至4岁）。ECMO的中位持续时间为5天（IQR，3-8天），PICU和住院的中位住院时间分别为18天（IQR，10-29天）和35天（IQR，19-75天）。根据先前确定的定义，42例患者(48%)至少发生一次大出血，12例患者(14%)在ECMO期间至少发生一次血栓事件。ECMO第2天至第5天，血小板纤维蛋白原受体表达下降（中位荧光强度[MFI]，29,256 vs 26,544；p = 0.0005），而血管性血友病因子表达增加(MFI：7,620 vs 8,829；p = 0.0459)。通过与抗P-选择素、PAC-1（与活化的GPIIb/IIIa结合）和抗CD63单克隆抗体（P-选择素曲线下面积[AUC]：分别为63.46 vs 42.82，P = 0.0022；PAC-1 AUC：分别为93.75 vs 74.46，p = 0.0191；CD63 AUC：55.69 vs 41.76，p = 0.0020）。

结论：ECMO期间，血小板反应随时间的损失可能会导致出血。这些新见解可能有助于了解儿科ECMO的出血机制，临床监测血小板标志物可以预测或早期检测出血和血栓形成。

--------
--------

## Does Interrupting Self-Induced Lung Injury and Respiratory Drive Expedite Early Spontaneous Breathing in the Setting of Early Severe Diffuse Acute Respiratory  Distress Syndrome?, Petitjeans, Fabrice

8:1272-1276. DOI:10.1097/CCM.0000000000005288

## 在早期重度弥漫性急性呼吸系统疾病背景下，阻断自身诱发的肺损伤和呼吸驱动是否会加速早期自主呼吸  窘迫综合征？

--------
--------

## Can We Always Trust the Wisdom of the Body?, Marini, John J.

8:1268-1271. DOI:10.1097/CCM.0000000000005022

## 我们能否始终相信身体的智慧？

--------
--------

## Emergency Department ICUs Add Value.

8:1265-1267. DOI:10.1097/CCM.0000000000004708

## 急诊科ICU附加值。

--------
--------

## Incidence and Outcomes of Cardiopulmonary Resuscitation in ICUs: Retrospective Cohort Analysis.

DOI:10.1097/CCM.0000000000005624

Abstract: 

OBJECTIVES: We aim to describe incidence and outcomes of cardiopulmonary resuscitation (CPR) efforts and their outcomes in ICUs and their changes over time. 

DESIGN: Retrospective cohort analysis. 

SETTING: Patient data documented in the Austrian Center for Documentation and Quality Assurance in Intensive Care database. 

PATIENTS: Adult patients (age ?‰? 18 yr) admitted to Austrian ICUs between 2005 and 2019. 

INTERVENTIONS: None. 

MEASUREMENTS ANDN MAIN RESULTS: Information on CPR was deduced from the Therapeutic Intervention Scoring System. End points were overall occurrence rate of CPR in the ICU and CPR for unexpected cardiac arrest after the first day of ICU stay as well as survival to discharge from the ICU and the hospital. Incidence and outcomes of ICU-CPR were compared between 2005 and 2009, 2010 and 2014, and 2015 and 2019 using chi-square test. A total of 525,518 first admissions and readmissions to ICU of 494,555 individual patients were included; of these, 72,585 patients (14.7%) died in hospital. ICU-CPR was performed in 20,668 (3.9%) admissions at least once; first events occurred on the first day of ICU admission in 15,266 cases (73.9%). ICU-CPR was first performed later during ICU stay in 5,402 admissions (1.0%). The incidence of ICU-CPR decreased slightly from 4.4% between 2005 and 2009, 3.9% between 2010 and 2014, and 3.7% between 2015 and 2019 (p < 0.001). A total of 7,078 (34.5%) of 20,499 patients who received ICU-CPR survived until hospital discharge. Survival rates varied slightly over the observation period; 59,164 (12.0%) of all patients died during hospital stay without ever receiving CPR in the ICU. 

CONCLUSIONS: The incidence of ICU-CPR is approximately 40 in 1,000 admissions overall and approximately 10 in 1,000 admissions after the day of ICU admission. Short-term survival is approximately four out of 10 patients who receive ICU-CPR.

## ICU中心肺复苏的发生率和结局：回顾性队列分析。

摘要：

目的：我们旨在描述心肺复苏术(CPR)的发生率和结局及其在ICU中的结局，以及随时间的变化。

设计：回顾性队列分析。

设置：奥地利文档和质量保证中心重症监护数据库中记录的患者数据。

患者：成年患者（年龄？‰？18岁），2005年至2019年间入住奥地利ICU。

干预：无。

测量和主要结果：CPR信息根据治疗干预评分系统推导得出。终点是入住ICU第1天后在ICU CPR和非预期心脏骤停CPR的总体发生率以及从ICU和医院出院的生存率。使用卡方检验比较2005年和2009年、2010年和2014年、2015年和2019年之间的ICU-CPR发生率和结局。共纳入494,555例个体患者的525,518例首次入院和再次入院至ICU；其中72,585例患者(14.7%)在医院死亡。在20668例(3.9%)至少一次入院的病例中进行了ICU CPR；在15266例(73.9%)病例中首起事件发生在ICU入院的第一天。随后，在5402例入院患者(1.0%)的ICU住院期间首次进行了ICU-CPR。ICU-CPR的发生率从2005年至2009年的4.4%略微下降，2010年至2014年的3.9%，2015年至2019年的3.7%(p < 0.001)。20499例接受ICU-CPR的患者中共7078例(34.5%)存活至出院。观察期间的生存率略有不同；所有患者中有59164例(12.0%)在住院期间死亡，从未在ICU接受过CPR。

结论：总体ICU CPR的发生率约为40/1,000次入院，ICU入院后的发生率约为10/1,000次入院。在接受ICU-CPR的10例患者中，短期存活率约为4例。

--------
--------

## Persistent But Not Transient Acute Kidney Injury Was Associated With Lower Transplant-Free Survival in Patients With Acute Liver Failure: A Multicenter Cohort Study., Cardoso, Filipe S.

7:e661-e662e. DOI:10.1097/CCM.0000000000005563

Abstract: 

OBJECTIVES: Acute liver failure (ALF) is an orphan disease often complicated by acute kidney injury (AKI). We assessed the impact of transient versus persistent AKI on survival in patients with ALF. 

DESIGN: International multicenter retrospective cohort. 

SETTING: U.S. ALF Study Group prospective registry. 

PATIENTS: Patients with greater than or equal to 18 years and ALF in the registry from 1998 to 2016 were included. Patients with less than 3 days of follow-up, without kidney function evaluation on day 3, or with cirrhosis were excluded. 

INTERVENTIONS: AKI was defined by Kidney Disease Improving Global Outcomes guidelines on day 1. Kidney recovery was defined on day 3 as transient AKI, by a return to no-AKI within 48 hours or persistent AKI if no such recovery or renal replacement therapy (RRT) was observed. Primary outcome was transplant-free survival (TFS) at 21 days. 

MEASUREMENTS AND MAIN RESULTS: Among 1,071 patients with ALF, 339 (31.7%) were males, and median (interquartile range) age was 39 years (29-51 yr). Acetaminophen-related ALF was found in 497 patients (46.4%). On day 1, 485 of 1,071 patients (45.3%) had grade 3-4 hepatic encephalopathy (HE), 500 of 1,070 (46.7%) required invasive mechanical ventilation (IMV), 197 of 1,070 (18.4%) were on vasopressors, and 221 of 1,071 (20.6%) received RRT. On day 1, 673 of 1,071 patients (62.8%) had AKI. On day 3, 72 of 1,071 patients (6.7%) had transient AKI, 601 of 1,071 (56.1%) had persistent AKI, 71 of 1,071 (6.6%) had late onset AKI, and 327 of 1,071 (30.5%) remained without AKI. Following adjustment for confounders (age, sex, race, etiology, HE grade, use of IMV and vasopressors, international normalized ratio, and year), although persistent acute kidney injury (adjusted odds ratio [aOR] [95% CI] 0.62 [0.44-0.88]) or late onset AKI (aOR [95% CI] 0.48 [0.26-0.89]) was associated with lower TFS, transient AKI was not (aOR [95% CI] 1.89 [0.99-3.64]). 

CONCLUSIONS: In a multicenter cohort of patients with ALF, persistent but not transient AKI was independently associated with lower short-term TFS.

## 急性肝衰竭患者中持续性但非一过性急性肾损伤与无移植生存率降低相关：一项多中心研究  队列研究。

摘要

目的：急性肝衰竭(ALF)是一种孤儿病，通常会并发急性肾损伤(AKI)。我们评估了一过性与持续性AKI对ALF患者生存率的影响。

设计：国际多中心回顾性队列研究。

设置：美国ALF研究组前瞻性登记研究。

患者：纳入1998年至2016年登记研究中年龄≥18岁的ALF患者。随访小于3天、第3天未进行肾功能评价或患有肝硬化的患者被排除。

干预：AKI根据第1天改善全球肾脏病预后组织指南定义。肾脏恢复第3天定义为短暂性AKI，即48小时内恢复至无AKI水平，或如果未观察到这种恢复或肾脏替代治疗(RRT)则定义为持续性AKI。主要结局为21天的无移植生存率(TFS)。

测量和主要结果：在1,071例ALF患者中，339例(31.7%)为男性，中位（四分位距）年龄为39岁（29-51岁）。497例患者(46.4%)发现对乙酰氨基酚相关ALF。第1天，1,071例患者中有485例(45.3%)发生3-4级肝性脑病(HE)，1,070例患者中有500例(46.7%)需要侵入性机械通气(IMV)，1,070例患者中有197例(18.4%)正在接受血管加压药，1,071例患者中有221例(20.6%)接受RRT。第1天，1,071例患者中有673例(62.8%)发生AKI。在第3天，1,071例患者中有72例(6.7%)发生一过性AKI，1,071例患者中有601例(56.1%)发生持续性AKI，1,071例患者中有71例(6.6%)发生迟发性AKI，1,071例患者中有327例(30.5%)保持无AKI。在校正混杂因素（年龄、性别、人种、病因、HE分级、IMV和血管加压药的使用、国际标准化比值比和年份）后，尽管持续性急性肾损伤（校正比值比[aOR][95%CI]0.62[0.44-0.88]）或迟发性AKI(aOR[95%CI]0.48[0.26-0.89])与较低的TFS相关，一过性AKI不是(aOR[95%CI]1.89[0.99-3.64])。

结论：在ALF患者的多中心队列中，持续性但非一过性AKI与较低的短期TFS独立相关。

--------
--------

## The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis.

Abstract: 

OBJECTIVE: Hepatorenal syndrome (HRS) is associated with high rates of morbidity and mortality. Evidence examining commonly used drug treatments remains uncertain. We assessed the comparative effectiveness of inpatient treatments for HRS by performing a network meta-analysis of randomized clinical trials (RCTs). 

DATA SOURCES: We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Medline In-Process & Other Non-Indexed Citations, Scopus, and Web of Science from inception. 

STUDY SELECTION AND DATA EXTRACTION: Pairs of reviewers independently identified eligible RCTs that enrolled patients with type 1 or 2 HRS. Pairs of reviewers independently extracted data. 

DATA SYNTHESIS: We assessed risk of bias using the Cochrane tool for RCTs and certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluations approach. Our main outcomes are all-cause mortality, HRS reversal, and serious adverse events. Of 3,079 citations, we included 26 RCTs examining 1,736 patients. Based on pooled analysis, terlipressin increases HRS reversal compared with placebo (142 reversals per 1,000 [95% CI, >87.7 to >210.9]; high certainty). Norepinephrine (112.7 reversals per 1,000 [95% CI, 52.6 to >192.3]) may increase HRS reversal compared with placebo (low certainty). The effect of midodrine+octreotide (67.8 reversals per 1,000 [95% CI, <2.8 to >177.4]; very low) on HRS reversal is uncertain. Terlipressin may reduce mortality compared with placebo (93.7 fewer deaths [95% CI, 168.7 to <12.5]; low certainty). Terlipressin probably increases the risk of serious adverse events compared with placebo (20.4 more events per 1,000 [95% CI, <5.1 to >51]; moderate certainty). 

CONCLUSIONS: Terlipressin increases HRS reversal compared with placebo. Terlipressin may reduce mortality. Until access to terlipressin improves, initial norepinephrine administration may be more appropriate than initial trial with midodrine+octreotide. Our review has the potential to inform future guideline and practice in the treatment of HRS.

DOI: 10.1097/CCM.0000000000005595

## 血管活性药物治疗肝肾综合征的有效性比较：一项系统评价和网络荟萃分析。

摘要：

目的：肝肾综合征(HRS)与高发病率和死亡率相关。检查常用药物治疗的证据仍不确定。我们通过对随机临床试验(RCT)进行网络荟萃分析，评估了HRS住院治疗的比较有效性。

数据来源：我们从一开始就检索了MEDLINE、Embase、Cochrane对照试验中心注册数据库、MEDLINE In-Process&Other Non-Indexed Citations、Scopus和Web of Science。

研究选择和数据提取：由成对的审查员独立确定入选1型或2型HRS患者的合格RCT。成对审查员独立提取数据。

数据综合：我们使用RCT的Cochrane工具评估了偏倚风险，使用推荐、评估、开发和评价方法分级评估了证据的确定性。我们的主要结局是全因死亡率、HRS逆转和严重不良事件。在3,079篇引文中，我们纳入了26项RCT，检查了1,736例患者。基于汇总分析，与安慰剂相比，特利加压素增加HRS逆转（142次逆转/1,000[95%CI，> 87.7至 > 210.9]；高度确定性）。与安慰剂相比，去甲肾上腺素（112.7次逆转/1,000[95%CI，52.6至 > 192.3]）可增加HRS逆转（低确定性）。米多君 + 奥曲肽（67.8次逆转/1000[95%CI，<2.8至>177.4]；极低）对HRS逆转的影响尚不确定。特利加压素与安慰剂相比可降低死亡率（死亡减少93.7[95%CI，168.7至 < 12.5]；确定性较低）。特利加压素与安慰剂相比很可能增加严重不良事件的风险（每1000人中20.4起事件增加[95%CI，<5.1至>51]；中度确定性）。

结论：与安慰剂相比，特利加压素增加HRS逆转。特利加压素可能降低死亡率。在特利加压素使用改善之前，初始去甲肾上腺素给药可能比初始米多君 + 奥曲肽试验更合适。我们的审查有可能为未来HRS治疗指南和实践提供信息。

--------
--------

## The authors reply., Kleinpell, Ruth M.
7:e662-e663. DOI:10.1097/CCM.0000000000005545

## 作者回复。

--------
--------

## Omission of Dietitian as Integral Member of Critical Care Team.

7:e661-e662e. DOI: 10.1097/CCM.0000000000005536

## 遗漏营养师作为重症监护团队的成员。

Keyword: Humans; Critical Care; *Nutritionists; Patient Care Team

--------
--------

## The Role of Registered Dietitian Nutritionists on the Critical Care Interdisciplinary Team., Sauer, Kevin L.

7:e659-e660. DOI:10.1097/CCM.0000000000005532

## 注册营养师在重症监护跨学科团队中的作用。

Keyword: Humans; Critical Care; *Nutritionists; Clinical Competence

--------
--------

## Dietitians' Role in Critical Care Interdisciplinary Team Needs Better Recognition.

7:e658-e659. DOI:10.1097/CCM.0000000000005508

## 营养师在重症监护跨学科团队中的角色需要得到更好的认可。

Keyword: Humans; Critical Care; Health Knowledge, Attitudes, Practice; Surveys and Questionnaires; *Nutritionists; Patient Care Team

--------
--------

## The authors reply.

7:e656-e657e. DOI:10.1097/CCM.0000000000005543

## 作者回复。

--------
--------

## "RAISE"ing a Score to Predict Prolonged Mechanical Ventilation Following Subarachnoid Hemorrhage.

7:e655-e656e. DOI:10.1097/CCM.0000000000005507

## 预测蛛网膜下腔出血后机械通气延长的“RAISE”评分。

Keyword: Humans; Respiration, Artificial; Retrospective Studies; *Subarachnoid Hemorrhage/complications/therapy

--------
--------

## The authors reply., Shanahan, Kristen H.

7:e654-e655e. DOI:10.1097/CCM.0000000000005552

## 作者回复。

--------
--------

## Abandon Noninvasive Ventilation in Bronchiolitis? How Unrecognized Bias Can Lead to Problematic Conclusions., Keim, Garrett

7:e653-e654e. DOI:10.1097/CCM.0000000000005531

Keyword: Humans; Respiration, Artificial; Infant; *Bronchiolitis/therapy; *Noninvasive Ventilation

--------
--------

## The authors reply., Seeliger, Benjamin

7:e651-e652. DOI:10.1097/CCM.0000000000005546

## 作者回复。

--------
--------

## Symptomatic and Asymptomatic Intracranial Hemorrhage in Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress  Syndrome: Are We Missing an Opportunity for Early Intervention?, Clarke, Jonathan

7:e650-e651. DOI:10.1097/CCM.0000000000005527

## 接受静脉-静脉体外膜肺氧合治疗急性呼吸窘迫的患者的症状性和无症状性颅内出血  综合征：我们是否错过了早期干预的机会？

Keyword: Humans; Intensive Care Units; Retrospective Studies; *Extracorporeal Membrane Oxygenation/adverse effects; *Respiratory Distress Syndrome/therapy; Intracranial Hemorrhages/therapy

--------
--------

## The authors reply.

7:e649-e650. DOI:10.1097/CCM.0000000000005547

## 作者回复。

--------
--------

## Oversight in Executive Summary of Sepsis Guidelines 2021.

7:e649. DOI:10.1097/CCM.0000000000005522

## 败血症指导原则2021执行摘要的监督。

Keyword: Humans; Critical Care; *Sepsis/therapy

--------
--------

## Catch Me If You Can-How Herpes Simplex Virus Tries to Evade Diagnosis in Viral Encephalitis.

7:1170-1173. DOI:10.1097/CCM.0000000000005501

## 病毒性脑炎单纯疱疹病毒如何逃避诊断请抓住我。

Keyword: Humans; *Encephalitis, Viral/diagnosis; *Herpes Simplex/diagnosis; Simplexvirus

--------
--------

## Lung Ultrasound and Electrical Impedance as Long-Term Monitoring Tools for Acute Respiratory Failure: Sometimes No Numbers Are Better Than Bad (or Confusing)  Numbers.

7:1167-1170. DOI:10.1097/CCM.0000000000005540

## 肺部超声和电阻抗作为急性呼吸衰竭的长期监测工具：有时没有数字比好（或令人困惑）  编号。

Keyword: Humans; Tomography; *Respiratory Distress Syndrome/diagnostic imaging/therapy; *Respiratory Insufficiency/therapy; Electric Impedance; Lung/diagnostic imaging

--------
--------

## Should We Intubate Pediatric Hematopoietic Cell Transplant Patients With Respiratory Failure Sooner?

7:1163-1167. DOI:10.1097/CCM.0000000000005548

## 对有呼吸衰竭的儿童造血细胞移植患者，我们应该更快地插管吗？

Keyword: Humans; Respiration, Artificial; Child; *Hematopoietic Stem Cell Transplantation; *Respiratory Insufficiency/therapy

--------
--------

## Leveraging Robust Mixed Methodologies to Advance Implementation Research and Practice.

7:1159-1161. DOI:10.1097/CCM.0000000000005551

## 利用稳健混合方法推进实施研究和实践。

--------
--------

## REDOX REDUX? Glutamine, Catabolism, and the Urea-to-Creatinine Ratio as a Novel Nutritional Metric.

7:1156-1159. DOI:10.1097/CCM.0000000000005520

## 还原？谷氨酰胺、分解代谢和尿素/肌酐比值作为一种新型营养指标。

Keyword: Liver/metabolism; *Glutamine; *Urea; Creatinine/metabolism; Oxidation-Reduction

--------
--------

## Hey, Community-Acquired Pneumonia Is Back on the Map!

7:1153-1155. DOI:10.1097/CCM.0000000000005525

## 嘿，社区获得性肺炎又回来了！

Keyword: Humans; *Community-Acquired Infections; *Pneumonia

--------
--------

## Predictive Algorithms for a Crisis., Sotillo, Claudia L.

7:1150-1153. DOI:10.1097/CCM.0000000000005550.

## 危机的预测算法。

Keyword: *Algorithms

--------
--------

## A Palace With a Common Tongue or a Multivariate Tower of Babel?

7:1148-1149. DOI:10.1097/CCM.0000000000005549

## 有普通舌头的宫殿还是多变量的巴别塔？

--------
--------

## Society of Critical Care Medicine Presidential Address-51st Annual Congress, April 2022.

7:1035-1039. DOI:10.1097/CCM.0000000000005584.

## 重症监护医学学会主席致辞-第51届年会，2022年4月。

Keyword: Humans; *Critical Care; *Societies, Medical

--------
--------

## Temperature Management in the ICU., Drewry, Anne

Abstract: 

OBJECTIVE: Temperature abnormalities are recognized as a marker of human disease, and the therapeutic value of temperature is an attractive treatment target. The  objective of this synthetic review is to summarize and critically appraise  evidence for active temperature management in critically ill patients. 

DATA  SOURCES: We searched MEDLINE for publications relevant to body temperature  management (including targeted temperature management and antipyretic therapy) in  cardiac arrest, acute ischemic and hemorrhagic stroke, traumatic brain injury,  and sepsis. Bibliographies of included articles were also searched to identify  additional relevant studies. 

STUDY SELECTION: English-language systematic  reviews, meta-analyses, randomized trials, observational studies, and nonhuman  data were reviewed, with a focus on the most recent randomized control trial  evidence. 

DATA EXTRACTION: Data regarding study methodology, patient population,  temperature management strategy, and clinical outcomes were qualitatively  assessed. 

DATA SYNTHESIS: Temperature management is common in critically ill  patients, and multiple large trials have been conducted to elucidate temperature  targets, management strategies, and timing. The strongest data concerning the use  of therapeutic hypothermia exist in comatose survivors of cardiac arrest, and  recent trials suggest that appropriate postarrest temperature targets between  33?°C and 37.5?°C are reasonable. Targeted temperature management in other critical  illnesses, including acute stroke, traumatic brain injury, and sepsis, has not  shown benefit in large clinical trials. Likewise, trials of pharmacologic  antipyretic therapy have not demonstrated improved outcomes, although national  guidelines do recommend treatment of fever in patients with stroke and traumatic  brain injury based on observational evidence associating fever with worse  outcomes. 

CONCLUSIONS: Body temperature management in critically ill patients  remains an appealing therapy for several illnesses, and additional studies are  needed to clarify management strategies and therapeutic pathways.

7:1138-1147: DOI:10.1097/CCM.0000000000005556

## ICU 的温度管理。

目的：温度异常被公认为是人类疾病的标志，温度的治疗价值是一个有吸引力的治疗目标。本综合综述的目的是总结和批判性评价重症患者主动温度管理的证据。

数据来源：我们在 MEDLINE 中检索了与体温管理（包括针对性温度管理和退热治疗）在心脏骤停、急性缺血性和出血性卒中、创伤性脑损伤和败血症中相关的出版物。还检索了纳入文献的参考书目，以识别其他相关研究。

研究选择：对英文系统综述、荟萃分析、随机试验、观察性研究和非人类数据进行综述，重点关注最新的随机对照试验证据。

数据提取：定性评估关于研究方法、患者人群、温度管理策略和临床结局的数据。

数据综合：温度管理在危重患者中很常见，已经进行了多项大型试验来阐明温度目标、管理策略和时间。关于心脏骤停昏迷幸存者使用治疗性低温的最强数据存在，最近的试验表明，适当的骤停后温度目标在33℃-37.5℃是合理的。其他危重疾病（包括急性卒中、创伤性脑损伤和败血症）的靶向温度管理在大型临床试验中未显示获益。同样，药物退热治疗的试验也未显示结局改善，但根据发热与较差结局相关的观察性证据，国家指南确实建议治疗卒中和创伤性脑损伤患者的发热。

结论：重症患者的体温管理仍然是几种疾病的一种有吸引力的疗法，需要额外的研究来阐明管理策略和治疗途径。

Keyword: Humans; *Intensive Care Units; *Temperature

--------
--------

## Early Neuromuscular Electrical Stimulation in Addition to Early Mobilization Improves Functional Status and Decreases Hospitalization Days of Critically Ill Patients.

7:1116-1126. DOI:10.1097/CCM.0000000000005557.

Abstract: 

OBJECTIVES: To evaluate the impact of the additional use of early neuromuscular electrical stimulation (NMES) on an early mobilization (EM) protocol. 

DESIGN:  Randomized controlled trial. 

SETTING: ICU of the Clinical Hospital of Ribeirão Preto, University of São Paulo, Brazil. 

PATIENTS: One hundred and thirty-nine  consecutive mechanically ventilated patients were included in the first 48 hours  of ICU admission. 

INTERVENTIONS: The patients were divided into two groups: EM  and EM+NMES. Both groups received EM daily. In the EM+NMES group, patients  additionally received NMES 5 days a week, for 60 minutes, starting in the first  48 hours of ICU admission until ICU discharge. 

MEASUREMENTS AND MAIN RESULTS:  Functional status, muscle strength, ICU and hospital length of stay (LOS),  frequency of delirium, days on mechanical ventilation, mortality, and quality of  life were assessed. Patients in the EM+NMES group presented a significant higher  score of functional status measured by the Functional Status Score for the ICU  scale when compared with the EM group in the first day awake: 22 (15-26) versus  12 (8-22) (p = 0.019); at ICU discharge: 28 (21-33) versus 18 (11-26) (p =  0.004); and hospital discharge: 33 (27-35) versus 25 (17-33) (p = 0.014),  respectively. They also had better functional status measured by the Physical  Function Test in the ICU scale, took less days to stand up during the ICU stay,  and had a significant shorter hospital LOS, lower frequency of ICU-acquired  weakness, and better global muscle strength. 

CONCLUSIONS: The additional  application of early NMES promoted better functional status outcomes on the first  day awake and at ICU and hospital discharge. The patients in the EM+NMES group  also took fewer days to stand up and had shorter hospital LOS, lower frequency of  ICU-acquired weakness, and better muscle strength. Future studies are still  necessary to clarify the effects of therapies associated with EM, especially to  assess long-term outcomes.

## 早期神经肌肉电刺激联合早期活动可改善危重患者的功能状态并减少住院天数。

目的：评价额外使用早期神经肌肉电刺激(NMES)对早期活动(EM)方案的影响。

设计：随机对照试验。

设置：巴西圣保罗大学里贝朗普雷托临床医院ICU。

患者：在进入ICU的前48小时内，连续纳入139例机械通气患者。

干预：将患者分为两组：EM和EM + NMES。两组均每日接受EM。在EM + NMES组，患者额外接受NMES，每周5天，持续60 min，从进入ICU的前48小时开始，直至离开ICU。

测量和主要结果：评估功能状态、肌力、ICU和住院时间(LOS)、谵妄频率、机械通气天数、死亡率和生活质量。在第1天清醒时，与EM组相比，EM + NMES组患者通过ICU量表的功能状态评分测量的功能状态评分显著较高：22(15-26)vs 12(8-22)(p = 0.019)；在离开ICU时：28(21-33)vs 18(11-26)(p = 0.004)；和出院：分别为33例(27-35)和25例(17-33)(p = 0.014)。通过ICU量表身体功能试验测得他们的功能状态更好，在ICU住院期间站立的天数更少，住院LOS显著更短，ICU获得性虚弱的频率更低，且整体肌肉力量更好。

结论：早期NMES的额外应用在第一天清醒时以及ICU和出院时促进更好的功能状态结局。EM + NMES组的患者站立的天数更少，住院LOS更短，ICU获得性无力的频率更低，肌肉力量更好。未来的研究仍有必要阐明EM相关治疗的作用，尤其是评估长期结局。

Keyword: Humans; Intensive Care Units; Length of Stay; Respiration, Artificial; Quality of Life; Electric Stimulation; *Critical Illness/therapy; *Early Ambulation; Functional Status

--------
--------

## The Global Open Source Severity of Illness Score (GOSSIS).

Abstract: 

OBJECTIVES: To develop and demonstrate the feasibility of a Global Open Source Severity of Illness Score (GOSSIS)-1 for critical care patients, which  generalizes across healthcare systems and countries. 

DESIGN: A merger of several  critical care multicenter cohorts derived from registry and electronic health  record data. Data were split into training (70%) and test (30%) sets, using each  set exclusively for development and evaluation, respectively. Missing data were  imputed when not available. SETTING/PATIENTS: Two large multicenter datasets from  Australia and New Zealand (Australian and New Zealand Intensive Care Society  Adult Patient Database [ANZICS-APD]) and the United States (eICU Collaborative  Research Database [eICU-CRD]) representing 249,229 and 131,051 patients,  respectively. ANZICS-APD and eICU-CRD contributed data from 162 and 204  hospitals, respectively. The cohort included all ICU admissions discharged in  2014-2015, excluding patients less than 16 years old, admissions less than 6  hours, and those with a previous ICU stay. 

INTERVENTIONS: Not applicable.  

MEASUREMENTS AND MAIN RESULTS: GOSSIS-1 uses data collected during the ICU stay's  first 24 hours, including extrema values for vital signs and laboratory results,  admission diagnosis, the Glasgow Coma Scale, chronic comorbidities, and  admission/demographic variables. The datasets showed significant variation in  admission-related variables, case-mix, and average physiologic state. Despite  this heterogeneity, test set discrimination of GOSSIS-1 was high (area under the  receiver operator characteristic curve [AUROC], 0.918; 95% CI, 0.915-0.921) and  calibration was excellent (standardized mortality ratio [SMR], 0.986; 95% CI,  0.966-1.005; Brier score, 0.050). Performance was held within ANZICS-APD (AUROC,  0.925; SMR, 0.982; Brier score, 0.047) and eICU-CRD (AUROC, 0.904; SMR, 0.992;  Brier score, 0.055). Compared with GOSSIS-1, Acute Physiology and Chronic Health  Evaluation (APACHE)-IIIj (ANZICS-APD) and APACHE-IVa (eICU-CRD), had worse  discrimination with AUROCs of 0.904 and 0.869, and poorer calibration with SMRs  of 0.594 and 0.770, and Brier scores of 0.059 and 0.063, respectively.  

CONCLUSIONS: GOSSIS-1 is a modern, free, open-source inhospital mortality  prediction algorithm for critical care patients, achieving excellent  discrimination and calibration across three countries.

7:1040-1050. DOI:10.1097/CCM.0000000000005518

## 全球开源疾病严重程度评分(GOSSIS)。

目的：开发和证明重症监护患者的全球开源疾病严重程度评分(GOSSIS)-1的可行性，该评分在整个卫生保健系统和国家均适用。

设计：从登记研究和电子健康记录数据中得出的几个重症监护多中心队列的合并。将数据分为培训(70%)和测试(30%)集，分别使用每个集专门用于开发和评价。缺失数据在不可用时进行插补。设置/患者：来自澳大利亚和新西兰（澳大利亚和新西兰重症监护协会成人患者数据库[ANZICS-APD]）和美国（eICU合作研究数据库[eICU-CRD]）的两个大型多中心数据集，分别代表249,229例患者和131,051例患者。ANZICS-APD和eICU-CRD分别提供了162家医院和204家医院的数据。该队列纳入了2014-2015年所有ICU出院患者，不包括小于16岁的患者、住院小于6小时的患者和既往留住ICU的患者。

干预：不适用。

测量和主要结果：GOSSIS-1使用在ICU停留的最初24小时收集的数据，包括生命体征和实验室结果的极值、入院诊断、格拉斯哥昏迷量表、慢性合并症和入院/人口统计学变量。数据集显示入院相关变量、病例混合和平均生理状态有显著变化。尽管存在这种异质性，但GOSSIS-1的试验集区分度较高（受试者工作特征曲线下面积[AUROC]，0.918；95%CI，0.915-0.921），并且校准良好（标准化死亡率[SMR]，0.986；95%CI，0.966-1.005；Brier评分，0.050）。性能在ANZICS-APD（AUROC，0.925；SMR，0.982；Brier评分，0.047）和eICU-CRD（AUROC，0.904；SMR，0.992；Brier评分，0.055）范围内。与GOSSIS-1相比，急性生理学和慢性健康状况评分(APACHE)-IIIj(ANZICS-APD)和APACHE?IVa(eICU-CRD)，AUROCs为0.904和0.869时的辨别较差，SMR为0.594和0.770时的校准较差，Brier评分分别为0.059和0.063。

结论：GOSSIS-1是一种现代、免费、开源的危重患者住院死亡率预测算法，在三个国家实现了极好的区分和校准。

Keyword: Humans; APACHE; Adult; Adolescent; Australia; Hospital Mortality; *Intensive Care Units; *Critical Care

--------
--------

## Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S.  Healthcare Systems to Appraise Current Ventilator Triage Algorithms., Keller, Michael B.

7:1051-1062. DOI:10.1097/CCM.0000000000005534.

Abstract: 

OBJECTIVES: Prior research has hypothesized the Sequential Organ Failure Assessment (SOFA) score to be a poor predictor of mortality in mechanically  ventilated patients with COVID-19. Yet, several U.S. states have proposed  SOFA-based algorithms for ventilator triage during crisis standards of care.  Using a large cohort of mechanically ventilated patients with COVID-19, we  externally validated the predictive capacity of the preintubation SOFA score for  mortality prediction with and without other commonly used algorithm elements.  

DESIGN: Multicenter, retrospective cohort study using electronic health record  data. 

SETTING: Eighty-six U.S. health systems. 

PATIENTS: Patients with COVID-19  hospitalized between January 1, 2020, and February 14, 2021, and subsequently  initiated on mechanical ventilation. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN  RESULTS: Among 15,122 mechanically ventilated patients with COVID-19, SOFA score  alone demonstrated poor discriminant accuracy for inhospital mortality in  mechanically ventilated patients using the validation cohort (area under the  receiver operating characteristic curve [AUC], 0.66; 95% CI, 0.65-0.67).  Discriminant accuracy was even poorer using SOFA score categories (AUC, 0.54; 95%  CI, 0.54-0.55). Age alone demonstrated greater discriminant accuracy for  inhospital mortality than SOFA score (AUC, 0.71; 95% CI, 0.69-0.72). Discriminant  accuracy for mortality improved upon addition of age to the continuous SOFA score  (AUC, 0.74; 95% CI, 0.73-0.76) and categorized SOFA score (AUC, 0.72; 95% CI,  0.71-0.73) models, respectively. The addition of comorbidities did not  substantially increase model discrimination. Of 36 U.S. states with crisis  standards of care guidelines containing ventilator triage algorithms, 31 (86%)  feature the SOFA score. Of these, 25 (81%) rely heavily on the SOFA score (12  exclusively propose SOFA; 13 place highest weight on SOFA or propose SOFA with  one other variable). 

CONCLUSIONS: In a U.S. cohort of over 15,000 ventilated  patients with COVID-19, the SOFA score displayed poor predictive accuracy for  short-term mortality. Our findings warrant reappraisal of the SOFA score's  implementation and weightage in existing ventilator triage pathways in current  U.S. crisis standards of care guidelines.

## 插管前序贯器官功能衰竭评分预测COVID-19死亡率：使用美国86家医疗保健系统的电子健康记录评估当前呼吸机分类算法的外部验证。

目的：既往研究假设序贯器官衰竭评估(SOFA)评分是COVID-19机械通气患者死亡率的较差预测因子。但是，几个美国各州已经提出了在危象标准治疗期间基于SOFA的算法来进行呼吸机分类。使用一个大型队列的COVID-19机械通气患者，我们外部验证了插管前SOFA评分对死亡率预测的预测能力，使用和不使用其他常用的算法元素。

设计：采用电子健康记录数据的多中心、回顾性队列研究。

单位：86个美国卫生系统。

患者：COVID-19患者于2020年1月1日至2021年2月14日住院，随后开始机械通气。

干预：无。

测量值和主要结果：在15,122例具有COVID-19的机械通气患者中，使用验证队列（接受者操作特征曲线下面积[AUC]，0.66；95%CI，0.65-0.67），仅SOFA评分对机械通气患者住院死亡率的鉴别准确性较差。使用SOFA评分类别(AUC，0.54；95%CI，0.54-0.55)判别准确性更差。单独年龄对住院死亡率的判别准确性大于SOFA评分(AUC，0.71；95%CI，0.69-0.72)。在连续SOFA评分(AUC，0.74；95%CI，0.73-0.76)和分类SOFA评分(AUC，0.72；95%CI，0.71-0.73)模型中添加年龄后，死亡率的判别准确性得到改善。增加合并症并未显著增加模型鉴别。在36个美国州的危象标准护理指南中包含呼吸机分类算法，31个州(86%)具有SOFA评分。其中，25例(81%)严重依赖于SOFA评分（12例专门提出SOFA；13例在SOFA上放置最高权重或提出SOFA与另一个变量）。

结论：在英国在超过15000例COVID-19通气患者的美国队列中，SOFA评分对短期死亡率的预测准确性较差。我们的研究结果需要重新评估SOFA评分的实施情况和当前美国危象护理标准指南中现有呼吸机分类途径的权重。

Keyword: Humans; Prognosis; Intensive Care Units; Retrospective Studies; Hospital Mortality; ROC Curve; *COVID-19; Algorithms; *Organ Dysfunction Scores; Delivery of Health Care; Electronic Health Records; Triage; Ventilators, Mechanical

--------
--------

## Can Early Electroencephalography Findings Predict Survival and Functional Outcome in Patients With Severe COVID-19 Infection?, Bermeo-Ovalle, Adriana

## 早期脑电图结果能否预测重度COVID-19感染患者的生存和功能结局？

Keyword: Humans; Brain; *COVID-19; Electroencephalography

--------
--------

## The Use and Duration of Preintubation Respiratory Support Is Associated With Increased Mortality in Immunocompromised Children With Acute Respiratory Failure., Lindell, Robert B.

7:1127-1137. DOI:10.1097/CCM.0000000000005535

Abstract: 

OBJECTIVES: To determine the association between preintubation respiratory support and outcomes in patients with acute respiratory failure and to determine  the impact of immunocompromised (IC) diagnoses on outcomes after adjustment for  illness severity. 

DESIGN: Retrospective multicenter cohort study. 

SETTING:  Eighty-two centers in the Virtual Pediatric Systems database. 

PATIENTS: Children  1 month to 17 years old intubated in the PICU who received invasive mechanical  ventilation (IMV) for greater than or equal to 24 hours. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: High-flow nasal cannula (HFNC) or noninvasive  positive-pressure ventilation (NIPPV) or both were used prior to intubation in  1,825 (34%) of 5,348 PICU intubations across 82 centers. When stratified by IC  status, 50% of patients had no IC diagnosis, whereas 41% were IC without prior  hematopoietic cell transplant (HCT) and 9% had prior HCT. Compared with patients  intubated without prior support, preintubation exposure to HFNC (adjusted odds  ratio [aOR], 1.33; 95% CI, 1.10-1.62) or NIPPV (aOR, 1.44; 95% CI, 1.20-1.74) was  associated with increased odds of PICU mortality. Within subgroups of IC status,  preintubation respiratory support was associated with increased odds of PICU  mortality in IC patients (HFNC: aOR, 1.50; 95% CI, 1.11-2.03; NIPPV: aOR, 1.76;  95% CI, 1.31-2.35) and HCT patients (HFNC: aOR, 1.75; 95% CI, 1.07-2.86; NIPPV:  aOR, 1.85; 95% CI, 1.12-3.02) compared with IC/HCT patients intubated without  prior respiratory support. Preintubation exposure to HFNC/NIPPV was not  associated with mortality in patients without an IC diagnosis. Duration of  HFNC/NIPPV greater than 6 hours was associated with increased mortality in IC HCT  patients (HFNC: aOR, 2.41; 95% CI, 1.05-5.55; NIPPV: aOR, 2.53; 95% CI,  1.04-6.15) and patients compared HCT patients with less than 6-hour HFNC/NIPPV  exposure. After adjustment for patient and center characteristics, both  preintubation HFNC/NIPPV use (median, 15%; range, 0-63%) and PICU mortality  varied by center. 

CONCLUSIONS: In IC pediatric patients, preintubation exposure  to HFNC and/or NIPPV is associated with increased odds of PICU mortality,  independent of illness severity. Longer duration of exposure to HFNC/NIPPV prior  to IMV is associated with increased mortality in HCT patients.

## 插管前呼吸支持的使用和持续时间与免疫力受损的急性呼吸衰竭儿童中死亡率增加相关。

目的：确定急性呼吸衰竭患者中插管前呼吸支持与结局之间的相关性，并确定校正疾病严重程度后免疫功能低下(IC)诊断对结局的影响。

设计：回顾性多中心队列研究。

设置：Virtual Pediatric Systems数据库中的82家中心。

患者：在PICU接受插管，接受有创机械通气(IMV)≥24小时的1个月-17岁儿童。

干预：无。

测量和主要结果：在82家中心的5348次PICU插管中，1825次(34%)在插管前采用了高流量鼻插管(HFNC)或非侵入性正压通气(NIPPV)或两者。当按IC状态分层时，50%的患者无IC诊断，而41%为IC而既往未接受造血细胞移植(HCT)，9%为既往HCT。与既往未接受支持治疗的插管患者相比，插管前暴露于HFNC（调整后优势比[aOR]，1.33；95%CI，1.10-1.62）或NIPPV(aOR，1.44；95%CI，1.20-1.74)与PICU死亡率优势增加相关。IC状态亚组内，插管前呼吸支持与IC患者(HFNC：aOR，1.50；95%CI，1.11-2.03；NIPPV：aOR，1.76；95%CI，1.31-2.35)和HCT患者（HFNC：aOR，1.75；95%CI，1.07-2.86；NIPPV：aOR，1.85；95%CI，1.12-3.02），比较既往未接受呼吸支持的插管IC/HCT患者。插管前暴露于HFNC/NIPPV与无IC诊断的患者的死亡率无关。HFNC/NIPPV持续时间大于6小时与IC HCT患者死亡率增加相关(HFNC：aOR，2.41；95%CI，1.05-5.55；NIPPV：aOR，2.53；95%CI，1.04-6.15)，患者比较HFNC/NIPPV暴露小于6小时的HCT患者。调整患者和中心特征后，插管前HFNC/NIPPV使用（中位数，15%；范围，0-63%）和PICU死亡率随中心而变化。

结论：在IC儿科患者中，插管前暴露于HFNC和/或NIPPV与PICU死亡率增加相关，与疾病严重程度无关。在IMV之前暴露于HFNC/NIPPV的时间较长与HCT患者的死亡率增加相关。

Keyword: Humans; Cohort Studies; Retrospective Studies; Child; Oxygen Inhalation Therapy; *Hematopoietic Stem Cell Transplantation; *Noninvasive Ventilation; *Respiratory Distress Syndrome; *Respiratory Insufficiency; Cannula; Intubation, Intratracheal/adverse effects

--------
--------

## Patient Harm and Institutional Avoidability of Out-of-Hours Discharge From Intensive Care: An Analysis Using Mixed Methods.

7:1083-1092. DOI:10.1097/CCM.0000000000005514

Abstract: 

OBJECTIVES: Out-of-hours discharge from ICU to the ward is associated with increased in-hospital mortality and ICU readmission. Little is known about why  this occurs. We map the discharge process and describe the consequences of  out-of-hours discharge to inform practice changes to reduce the impact of  discharge at night. 

DESIGN: This study was part of the REcovery FoLlowing  intensive CarE Treatment mixed methods study. We defined out-of-hours discharge  as 16:00 to 07:59 hours. We undertook 20 in-depth case record reviews where  in-hospital death after ICU discharge had been judged "probably avoidable" in  previous retrospective structured judgment reviews, and 20 where patients  survived. We conducted semistructured interviews with 55 patients, family  members, and staff with experience of ICU discharge processes. These, along with  a stakeholder focus group, informed ICU discharge process mapping using the human  factors-based functional analysis resonance method. 

SETTING: Three U.K. National  Health Service hospitals, chosen to represent different hospital settings.  

SUBJECTS: Patients discharged from ICU, their families, and staff involved in  their care. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Out-of-hours  discharge was common. Patients and staff described out-of-hours discharge as  unsafe due to a reduction in staffing and skill mix at night. Patients discharged  out-of-hours were commonly discharged prematurely, had inadequate handover, were  physiologically unstable, and did not have deterioration recognized or escalated  appropriately. 

We identified five interdependent function keys to facilitating  timely ICU discharge: multidisciplinary team decision for discharge, patient  prepared for discharge, bed meeting, bed manager allocation of beds, and ward bed  made available. 

CONCLUSIONS: We identified significant limitations in  out-of-hours care provision following overnight discharge from ICU. Transfer to  the ward before 16:00 should be facilitated where possible. Our work highlights  changes to help make day time discharge more likely. Where discharge after 16:00  is unavoidable, support systems should be implemented to ensure the safety of  patients discharged from ICU at night.

## 从重症监护中出院的患者损害和机构可避免性：使用混合方法的分析。

目的：离开ICU离开ICU的时间延长与住院死亡率和再次入住ICU相关。目前尚不清楚这种情况的原因。我们绘制了放电过程图，并描述了非工作时间放电的后果，以通知实践变化，减少夜间放电的影响。

设计：本研究是REcovery FoLlowing强化CarE治疗混合方法研究的一部分。我们将非工作时间出院定义为16:00至07:59小时。我们进行了20项深度病例记录审查，其中在既往回顾性结构化判断审查中，ICU出院后的院内死亡被判定为“很可能可以避免”，20例患者存活。我们对55例有ICU出院过程经验的患者、家属和工作人员进行了半结构式访谈。这些人员与利益攸关方小组一起，使用基于人为因素的功能分析共振法绘制知情ICU出院过程图。

背景：选择3家英国国家卫生服务医院代表不同的医院环境。

受试者：从ICU出院的患者及其家属和参与其护理的工作人员。

干预：无。

测量和主要结果：通常在非工作时间出院。由于夜间人员配备和技术组合减少，患者和工作人员描述非工作时间出院不安全。非工作时间出院的患者通常提前出院、交接不充分、生理不稳定，且未发现恶化或适当升级。我们确定了5个相互依赖的功能关键，以促进ICU及时出院：多学科团队决定出院、患者准备出院、床位会议、床位管理者分配床位和提供病床。

结论：我们确定了从ICU过夜出院后非工作时间护理的显著局限性。尽可能在16:00之前转移到病房。我们的工作重点是做出改变，使您更有可能在白天出院。16:00以后不可避免出院的，应实施支持系统，保证夜间离开ICU患者的安全。

Keyword: Humans; Intensive Care Units; Retrospective Studies; Hospital Mortality; Critical Care/methods; *After-Hours Care; *Patient Harm; Patient Discharge; State Medicine

--------
--------

## Catabolism in Critical Illness: A Reanalysis of the REducing Deaths due to OXidative Stress (REDOXS) Trial.

7:1072-1082. DOI:10.1097/CCM.0000000000005499

Abstract: 

OBJECTIVES: Ongoing risk of death and poor functional outcomes are important consequences of prolonged critical illness. Characterizing the catabolic  phenotype of prolonged critical illness could illuminate biological processes and  inform strategies to attenuate catabolism. We aimed to examine if  urea-to-creatinine ratio, a catabolic signature of prolonged critical illness,  was associated with mortality after the first week of ICU stay. 

DESIGN:  Reanalysis of multicenter randomized trial of glutamine supplementation in  critical illness (REducing Deaths due to OXidative Stress [REDOXS]). 

SETTING:  Multiple adult ICUs. 

PATIENTS: Adult patients admitted to ICU with two or more  organ failures related to their acute illness and surviving to day 7.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: The association between  time-varying urea-to-creatinine ratio and 30-day mortality was tested using  Bayesian joint models adjusted for prespecified-covariates (age, kidney  replacement therapy, baseline Sequential Organ Failure Assessment, dietary  protein [g/kg/d], kidney dysfunction, and glutamine-randomization). From 1,021  patients surviving to day 7, 166 (16.3%) died by day 30. After adjustment in a  joint model, a higher time-varying urea-to-creatinine ratio was associated with  increased mortality (hazard ratio [HR], 2.15; 95% credible interval, 1.66-2.82,  for a two-fold greater urea-to-creatinine ratio). This association persisted  throughout the 30-day follow-up. Mediation analysis was performed to explore  urea-to-creatinine ratio as a mediator-variable for the increased risk of death  reported in REDOXS when randomized to glutamine, an exogenous nitrogen load.  Urea-to-creatinine ratio closest to day 7 was estimated to mediate the risk of  death associated with randomization to glutamine supplementation (HR, 1.20; 95%  CI, 1.04-1.38; p = 0.014), with no evidence of a direct effect of glutamine (HR,  0.90; 95% CI, 0.62-1.30; p = 0.566). 

CONCLUSIONS: The catabolic phenotype  measured by increased urea-to-creatinine ratio is associated with increased risk  of death during prolonged ICU stay and signals the deleterious effects of  glutamine administration in the REDOXS study. Urea-to-creatinine ratio is a  promising catabolic signature and potential interventional target.

## 危重症患者中的分解代谢：氧化性应激(REDOXS)试验所致死亡减少的再分析。

目的：持续的死亡风险和不良功能结局是长期危重疾病的重要后果。描述长期危重疾病的分解代谢表型特征可促进生物学过程，并为减弱分解代谢的策略提供信息。我们旨在检查作为长期危重疾病分解代谢标志的尿素肌酐比是否与ICU住院第一周后的死亡率相关。

设计：危重病患者补充谷氨酰胺的多中心随机试验再分析（减少氧化应激导致的死亡[REDOXS]）。

设置：多个成人ICU。

患者：因急性疾病相关的两次或多次器官衰竭入住ICU并存活至第7天的成人患者。

干预：无。

测量值和主要结果：使用Bayesian关节模型检验了经预先指定协变量（年龄、肾脏替代治疗、基线序贯器官衰竭评估、饮食蛋白质[g/kg/d]、肾功能不全和谷氨酰胺随机分组）校正的随时间变化的尿素-肌酐比与30天死亡率之间的相关性。在存活至第7天的1,021例患者中，166例(16.3%)在第30天死亡。在联合模型中校正后，较高的随时间变化的尿素-肌酐比值与死亡率升高相关（风险比[HR]，2.15；95%置信区间，1.66-2.82，尿素-肌酐比值升高2倍）。30天随访期间，这种相关性持续存在。进行了介导分析，以探索当随机分配至谷氨酰胺（外源性氮负荷）时，尿素/肌酐比值作为REDOXS中报告的死亡风险增加的介导变量。估计最接近第7天的尿素/肌酐比值介导了与随机分配至补充谷氨酰胺相关的死亡风险(HR，1.20；95%CI，1.04-1.38；p = 0.014)，没有证据表明谷氨酰胺的直接效应(HR，0.90；95%CI，0.62-1.30；p = 0.566)。

结论：通过尿素与肌酐比值升高测定的分解代谢表型与延长ICU住院期间的死亡风险增加相关，并在REDOXS研究中信号了谷氨酰胺给药的有害作用。尿素肌酐比是一种有前景的分解代谢特征和潜在的干预性靶标。

Keyword: Humans; Oxidative Stress; *Critical Illness/therapy; *Glutamine; Bayes Theorem; Creatinine; Urea

--------
--------

## Lung-Dependent Areas Collapse, Monitored by Electrical Impedance Tomography, May Predict the Oxygenation Response to Prone Ventilation in COVID-19 Acute  Respiratory Distress Syndrome., Cardinale, Michael

7:1093-1102. DOI:10.1097/CCM.0000000000005487

Abstract: 

OBJECTIVES: ICUs have had to deal with a large number of patients with acute respiratory distress syndrome COVID-19, a significant number of whom received  prone ventilation, which is a substantial consumer of care time. The selection of  patients that we have to ventilate in prone position seems interesting. We  evaluate the correlation between the percentage of collapsed dependent lung areas  in the supine position, monitoring by electrical impedance tomography and the  oxygenation response (change in Pao2/Fio2 ratio) to prone position. 

DESIGN: An  observational prospective study. 

SETTING: From October 21, 2020, to 30 March 30,  2021. At the Sainte Anne military teaching Hospital and the Timone University  Hospital. 

PATIENTS: Fifty consecutive patients admitted in our ICUs, with  COVID-19 acute respiratory distress syndrome and required mechanical, were  included. Twenty-four (48%) received prone ventilation. Fifty-eight prone  sessions were investigated. 

INTERVENTIONS: An electrical impedance tomography  recording was made in supine position, daily and repeated just before and just  after the prone session. The daily dependent area collapse was calculated in  relation to the previous electrical impedance tomography recording. Prone  ventilation response was defined as a Pao2/Fio2 ratio improvement greater than  20%. 

MEASUREMENT AND MAIN RESULTS: The main outcome was the correlation between  dependent area collapse and the oxygenation response to prone ventilation.  Dependent area collapse was correlated with oxygenation response to prone  ventilation (R2 = 0.49) and had a satisfactory prediction accuracy of prone  response with an area under the curve of 0.94 (95% CI, 0.87-1.00; p < 0.001).  Best Youden index was obtained for a dependent area collapse greater than 13.5 %.  Sensitivity of 92% (95% CI, 78-97), a specificity of 91% (95% CI, 72-97), a  positive predictive value of 94% (95% CI, 88-100), a negative predictive value of  87% (95% CI, 78-96), and a diagnostic accuracy of 91% (95% CI, 84-98).  

CONCLUSIONS: Dependent lung areas collapse (> 13.5%), monitored by electrical  impedance tomography, has an excellent positive predictive value (94%) of  improved oxygenation during prone ventilation.

## 肺依赖区域塌陷，通过电阻抗断层扫描监测，可预测COVID-19急性呼吸窘迫综合征中对俯卧位通气的氧合反应。

目的：ICU必须处理大量急性呼吸窘迫综合征COVID-19患者，其中相当数量的患者接受俯卧位通气，这是大量的护理时间消耗。选择必须在俯卧位通气的患者似乎很有趣。我们评估了仰卧位时塌陷依赖性肺区的百分比、电阻抗断层扫描监测与俯卧位时氧合反应（Pao2/Fio2比值变化）之间的相关性。

设计：观察性前瞻性研究。

地点：2020年10月21日至2021年3月30日。在Sainte Anne军事教学医院和Timone大学医院。

患者：连续纳入50例在我们ICU住院的COVID-19急性呼吸窘迫综合征且需要机械通气的患者。24例患者(48%)接受俯卧位通气。研究了58次俯卧位治疗。

干预：每天在仰卧位进行电阻抗断层扫描记录，并在俯卧位前后重复。相对于之前的电阻抗断层扫描记录，计算每日依赖区域萎缩。俯卧位通气反应定义为Pao2/Fio2比值改善大于20%。

测量和主要结果：主要结局是依赖区塌陷和俯卧位通气的氧合反应之间的相关性。依赖面积萎缩与俯卧位通气的氧合反应相关(R2 = 0.49)，俯卧位反应的预测准确性令人满意，曲线下面积为0.94(95%CI，0.87-1.00；p < 0.001)。当依赖区塌陷大于13.5%时，约登指数最佳。灵敏度为92%(95%CI，78-97)，特异性为91%(95%CI，72-97)，阳性预测值为94%(95%CI，88-100)，阴性预测值为87%(95%CI，78-96)，诊断准确性为91%(95%CI，84-98)。

结论：依赖性肺区萎缩(> 13.5%)，通过电阻抗断层扫描监测，在俯卧位通气中氧合作用改善具有极好的阳性预测值(94%)。

Keyword: Humans; Prospective Studies; Tomography, X-Ray Computed; Prone Position; *COVID-19/therapy; *Respiratory Distress Syndrome/therapy; Electric Impedance; Lung/diagnostic imaging; *Shock

--------
--------

## Etiology, Treatments, and Outcomes of Patients With Severe Community-Acquired Pneumonia in a Large U.S. Sample., Haessler, Sarah

7:1063-1071. DOI:10.1097/CCM.0000000000005498

Abstract: 

OBJECTIVES: Compare the clinical practice and outcomes in severe community-acquired pneumonia (sCAP) patients to those in non-sCAP patients using  guideline-defined criteria for sCAP. 

DESIGN: Retrospective observational cohort  study. 

SETTING: One hundred seventy-seven U.S. hospitals within the Premier  Healthcare Database. 

PATIENTS: Hospitalized adult (?‰? 18 yr old) patients with  pneumonia. 

MEASUREMENTS AND MAIN RESULTS: Adult patients (?‰? 18 yr old) with a  principal diagnosis of pneumonia or a secondary diagnosis of pneumonia paired  with a principal diagnosis of sepsis or respiratory failure were included.  Patients with at least one guideline-defined major criterion for severe pneumonia  were compared with patients with nonsevere disease. Among 154,799 patients with  pneumonia, 21,805 (14.1%) met criteria for sCAP. They had higher organ failure  scores (1.9 vs 0.63; p < 0.001) and inpatient mortality (22.0 vs 5.0%; p <  0.001), longer lengths of stay (8 vs 5 d; p < 0.001), and higher costs ($20,046  vs $7,543; p < 0.001) than those with nonsevere disease. Patients with sCAP had  twice the rate of positive blood cultures (10.0% vs 4.5%; p < 0.001) and  respiratory cultures (34.2 vs 21.1%; p < 0.001) and more often had isolates  resistant to first-line community-acquired pneumonia antibiotics (10% of severe  vs 3.1% of nonsevere; p < 0.001). Regardless of disease severity, Streptococcus  pneumoniae was the most common pathogen recovered from blood cultures and  Staphylococcus aureus and Pseudomonas species were the most common pathogens  recovered from the respiratory tract. Although few patients with sCAP had  cultures positive for a resistant organism, 65% received vancomycin and 42.8%  received piperacillin-tazobactam. 

CONCLUSIONS: sCAP patients had worse outcomes  and twice the rate of culture positivity. S. aureus and S. pneumoniae were the  most common organisms in respiratory and blood specimens, respectively. Although  only recommended for sCAP patients, nearly all pneumonia patients received blood  cultures, a quarter of nonsevere patients received sputum cultures, and treatment  with broad-spectrum agents was widespread, indicating fertile ground for  antimicrobial and diagnostic stewardship programs.

## 一项大型美国样本研究中严重社区获得性肺炎患者的病因、治疗和结局。

目的：使用指南定义的sCAP标准，比较重度社区获得性肺炎(sCAP)患者与非sCAP患者的临床实践和结果。

设计：回顾性观察性队列研究。

设置：Premier Healthcare数据库中的177家美国医院。

患者：肺炎成年住院患者（ ≥ 18岁）。

测量值和主要结果：主要诊断为肺炎或次要诊断为肺炎同时主要诊断为败血症或呼吸衰竭的成人患者（ ≥ 18岁）被纳入。将具有至少一项指南定义的重度肺炎主要标准的患者与非重度疾病患者进行比较。在154,799例肺炎患者中，21,805例(14.1%)符合sCAP标准。与非重度疾病患者相比，重度疾病患者的器官衰竭评分(1.9 vs 0.63；p < 0.001)和住院死亡率(22.0 vs 5.0%；p < 0.001)更高，住院时间更长（8 vs 5天；p < 0.001），费用更高（20,046美元vs 7,543美元；p < 0.001）。sCAP患者的血培养(10.0%vs 4.5%；p < 0.001)和呼吸道培养(34.2 vs 21.1%；p < 0.001)的阳性率是普通患者的2倍，更常见的分离株对一线社区获得性肺炎抗生素耐药（10%重症vs 3.1%非重症；p < 0.001）。无论疾病的严重程度如何，从血培养中回收的最常见病原体为肺炎链球菌，从呼吸道回收的最常见病原体为金黄色葡萄球菌和假单胞菌属。虽然少数sCAP患者的耐药微生物培养呈阳性，但65%的患者接受万古霉素，42.8%的患者接受哌拉西林-他唑巴坦。

结论：sCAP患者预后更差，培养阳性率是普通人群的2倍。金黄色葡萄球菌和肺炎链球菌分别是呼吸道和血液样本中最常见的微生物。虽然只推荐sCAP患者使用，但是几乎所有的肺炎患者都接受了血培养，四分之一的非重症患者接受了痰培养，并且广谱抗菌药的治疗也很广泛，这表明抗菌和诊断管理方案是有利的。

Keyword: Humans; Adult; Retrospective Studies; Anti-Bacterial Agents/therapeutic use; *Community-Acquired Infections/drug therapy; *Pneumonia/drug therapy/epidemiology/etiology; Staphylococcus aureus

--------
--------

## Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact., de Montmollin, Etienne

7:e643-e648. DOI:10.1097/CCM.0000000000005485

Abstract: 

OBJECTIVES: To describe the prevalence, associated factors, and clinical impact of an initial negative herpes simplex virus (HSV) polymerase chain reaction (PCR)  in critically ill patients with PCR-proven HSV encephalitis. 

DESIGN:  Retrospective multicenter study from 2007 to 2017. 

SETTING: Forty-seven French  ICUs. 

PATIENTS: Critically ill patients admitted to the ICU with  possible/probable acute encephalitis and a positive cerebrospinal fluid (CSF) PCR  for HSV. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: We included 273  patients with a median Glasgow Coma Scale score of 9 (6-12) at ICU admission. CSF  HSV PCR was negative in 11 cases (4%), exclusively in lumbar punctures (LPs)  performed less than 4 days after symptoms onset. Patients with an initial  negative PCR presented with more frequent focal neurologic signs (4/11 [36.4%] vs  35/256 [13.7%]; p = 0.04) and lower CSF leukocytosis (4 cells/mm3 [3-25  cells/mm3] vs 52 cells/mm3 [12-160 cells/mm3]; p < 0.01). An initial negative PCR  was associated with an increased delay between LP and acyclovir treatment (3 d  [2-7 ] vs 0 d [0-0 d]; p < 0.01) and was independently associated with a poor  neurologic outcome at hospital discharge (modified Rankin Scale score ?‰? 4)  (adjusted odds ratio, 9.89; 95% CI, 1.18-82.78). 

CONCLUSIONS: In severe herpes  simplex encephalitis, initial negative CSF HSV PCR occurred in 4% of cases and  was independently associated with worse neurologic outcome at hospital discharge.  In these patients, a systematic multimodal diagnostic approach including early  brain MRI and EEG will help clinicians avoid delayed acyclovir initiation or  early inappropriate discontinuation.

## 脑脊液中聚合酶链反应初始阴性的单纯疱疹病毒性脑炎：患病率、相关因素和临床影响。

目的：描述初次单纯疱疹病毒(HSV)聚合酶链反应(PCR)阴性的重症患者中经PCR证实的HSV脑炎的患病率、相关因素和临床影响。

设计：回顾性多中心研究，2007-2017年。

设置：47个法国ICU。

患者：ICU收治的可能/很可能患有急性脑炎且脑脊液(CSF)PCR检测HSV呈阳性的重症患者。

干预：无。

测量和主要结果：我们纳入了273例入住ICU时中位格拉斯哥昏迷量表评分为9(6-12)的患者。11例病例(4%)的CSF HSV PCR为阴性，仅见于症状发作后不到4天进行的腰椎穿刺(LP)。初始PCR阴性的患者表现出更常见的局灶性神经病学体征(4/11[36.4%]vs 35/256[13.7%]；p = 0.04)和更低的CSF白细胞增多（4个细胞/mm3[3-25个细胞/mm3]vs 52个细胞/mm3[12-160个细胞/mm3]；p < 0.01）。初始阴性PCR与LP和阿昔洛韦治疗之间延迟增加相关（3天[2-7]vs 0天[0-0天]；p < 0.01），并与出院时较差的神经系统结局独立相关（改良Rankin量表评分 ≥ 4）（调整比值比，9.89；95%CI，1.18-82.78）。

结论：在重度单纯疱疹性脑炎中，4%的病例初始CSF HSV PCR阴性，并且与出院时较差的神经系统结局独立相关。在这些患者中，一种包括早期脑部MRI和EEG的系统性多模式诊断方法将帮助临床医生避免延迟阿昔洛韦开始或早期不当停药。

Keyword: Humans; Critical Illness; Prevalence; Polymerase Chain Reaction; *Encephalitis, Herpes Simplex/diagnosis/drug therapy/epidemiology; Acyclovir/therapeutic use; Cerebrospinal Fluid; Simplexvirus/genetics

--------
--------

## Early Clinical and Electrophysiological Brain Dysfunction Is Associated With ICU Outcomes in COVID-19 Critically Ill Patients With Acute Respiratory Distress  Syndrome: A Prospective Bicentric Observational Study.

7:1103-1115. DOI:10.1097/CCM.0000000000005491

Abstract: 

OBJECTIVES: Describe the prevalence of acute cerebral dysfunction and assess the prognostic value of an early clinical and electroencephalography (EEG) assessment  in ICU COVID-19 patients. 

DESIGN: Prospective observational study. 

SETTING: Two  tertiary critical care units in Paris, France, between April and December 2020.  

PATIENTS: Adult critically ill patients with COVID-19 acute respiratory distress  syndrome. 

INTERVENTIONS: Neurologic examination and EEG at two time points during  the ICU stay, first under sedation and second 4-7 days after sedation  discontinuation. 

MEASUREMENTS AND MAIN RESULTS: Association of EEG abnormalities  (background reactivity, continuity, dominant frequency, and presence of  paroxystic discharges) with day-28 mortality and neurologic outcomes (coma and  delirium recovery). Fifty-two patients were included, mostly male (81%), median  (interquartile range) age 68 years (56-74 yr). Delayed awakening was present in  68% of patients (median awakening time of 5 d [2-16 d]) and delirium in 74% of  patients who awoke from coma (62% of mixed delirium, median duration of 5 d [3-8  d]). First, EEG background was slowed in the theta-delta range in 48 (93%)  patients, discontinuous in 25 patients (48%), and nonreactive in 17 patients  (33%). Bifrontal slow waves were observed in 17 patients (33%). Early nonreactive  EEG was associated with lower day-28 ventilator-free days (0 vs 16; p = 0.025),  coma-free days (6 vs 22; p = 0.006), delirium-free days (0 vs 17; p = 0.006), and  higher mortality (41% vs 11%; p = 0.027), whereas discontinuous background was  associated with lower ventilator-free days (0 vs 17; p = 0.010), coma-free days  (1 vs 22; p < 0.001), delirium-free days (0 vs 17; p = 0.001), and higher  mortality (40% vs 4%; p = 0.001), independently of sedation and analgesia.  

CONCLUSIONS: Clinical and neurophysiologic cerebral dysfunction is frequent in  COVID-19 ARDS patients. Early severe EEG abnormalities with nonreactive and/or  discontinuous background activity are associated with delayed awakening,  delirium, and day-28 mortality.

## COVID-19急性呼吸窘迫综合征危重病患者的早期临床和电生理脑功能障碍与ICU预后相关：一项前瞻性双中心观察性研究。

目的：描述急性脑功能障碍的患病率，并评估早期临床和脑电图(EEG)评估在ICU COVID-19患者中的预后价值。

设计：前瞻性观察性研究。

设置：2020年4月至12月，法国巴黎的两个三级重症监护室。

患者：COVID-19急性呼吸窘迫综合征的成年重症患者。

干预：在ICU住院期间的两个时间点进行神经系统检查和EEG检查，第一次是在镇静状态下，第二次是在镇静停止后4-7天。

测量和主要结果：EEG异常（背景反应性、连续性、显性频率和存在阵发性放电）与第28天死亡率和神经系统结局（昏迷和谵妄恢复）的相关性。纳入了52例患者，大多数为男性(81%)，中位（四分位距）年龄为68岁（56-74岁）。68%的患者存在觉醒延迟（中位觉醒时间为5天[2-16天]），74%从昏迷中觉醒的患者存在谵妄（62%为混合型谵妄，中位持续时间为5天[3-8天]）。首先，48例患者(93%)的EEG背景在θ-δ范围内减慢，25例患者(48%)不连续，17例患者(33%)无反应。17例患者(33%)观察到双额慢波。早期无反应性EEG与较低第28天无呼吸机天数(0 vs 16；p = 0.025)、无昏迷天数(6 vs 22；p = 0.006)、无谵妄天数(0 vs 17；p = 0.006)和较高的死亡率(41%vs 11%；p = 0.027)相关，而不连续背景与较低的无呼吸机天数(0 vs 17；p = 0.010)相关，无昏迷天数(1 vs 22；p < 0.001)、无谵妄天数(0 vs 17；p = 0.001)和更高的死亡率(40%vs 4%；p = 0.001)，与镇静和镇痛无关。

结论：COVID-19 ARDS患者临床和神经生理性脑功能障碍常见。早期重度EEG异常伴无反应性和/或不连续背景活动与觉醒延迟、谵妄和第28天死亡率相关。

Keyword: Humans; Female; Male; Prospective Studies; Aged; Critical Illness; Intensive Care Units; Adult; Brain; *Brain Diseases/etiology; *COVID-19/complications; *Delirium/diagnosis/epidemiology/etiology; *Respiratory Distress Syndrome/epidemiology/therapy; Coma/diagnosis/etiology; Respiration, Artificial/adverse effects

--------
--------

## Lung Ultrasound and Electrical Impedance Tomography During Ventilator-Induced Lung Injury.

7:e630-e637. DOI:10.1097/CCM.0000000000005479

Abstract: 

OBJECTIVES: Lung damage during mechanical ventilation involves lung volume and alveolar water content, and lung ultrasound (LUS) and electrical impedance  tomography changes are related to these variables. We investigated whether these  techniques may detect any signal modification during the development of  ventilator-induced lung injury (VILI). 

DESIGN: Experimental animal study.  

SETTING: Experimental Department of a University Hospital. 

SUBJECTS: Forty-two  female pigs (24.2 ?± 2.0 kg). 

INTERVENTIONS: The animals were randomized into  three groups (n = 14): high tidal volume (TV) (mean TV, 803.0 ?± 121.7 mL), high  respiratory rate (RR) (mean RR, 40.3 ?± 1.1 beats/min), and high  positive-end-expiratory pressure (PEEP) (mean PEEP, 24.0 ?± 1.1 cm H2O). The study  lasted 48 hours. At baseline and at 30 minutes, and subsequently every 6 hours,  we recorded extravascular lung water, end-expiratory lung volume, lung strain,  respiratory mechanics, hemodynamics, and gas exchange. At the same time-point,  end-expiratory impedance was recorded relatively to the baseline. LUS was  assessed every 12 hours in 12 fields, each scoring from 0 (presence of A-lines)  to 3 (consolidation). 

MEASUREMENTS AND MAIN RESULTS: In a multiple regression  model, the ratio between extravascular lung water and end-expiratory lung volume  was significantly associated with the LUS total score (p < 0.002; adjusted R2,  0.21). The variables independently associated with the end-expiratory difference  in lung impedance were lung strain (p < 0.001; adjusted R2, 0.18) and  extravascular lung water (p < 0.001; adjusted R2, 0.11). 

CONCLUSIONS: Data  suggest as follows. First, what determines the LUS score is the ratio between  water and gas and not water alone. Therefore, caution is needed when an  improvement of LUS score follows a variation of the lung gas content, as after a  PEEP increase. Second, what determines the end-expiratory difference in lung  impedance is the strain level that may disrupt the intercellular junction,  therefore altering lung impedance. In addition, the increase in extravascular  lung water during VILI development contributed to the observed decrease in  impedance.

## 呼吸机诱导肺损伤期间的肺部超声和电阻抗断层扫描。

目的：机械通气期间的肺损伤涉及肺容量和肺泡水含量，肺超声(LUS)和电阻抗断层扫描变化与这些变量相关。我们研究了这些技术是否可以检测到呼吸机诱导肺损伤(VILI)发展过程中的任何信号改变。

设计：实验动物研究。

单位：某大学医院试验科。

受试者：42头雌性猪(24.2 μm±2.0 kg)。

干预：将动物随机分为3组(n = 14)：高潮气量(TV)（平均TV，803.0?±121.7 mL）、高呼吸频率(RR)（平均RR，40.3?±1.1次/min）和高呼气末正压(PEEP)（平均PEEP，24.0?±1.1 cm H2O）。研究持续48小时。在基线和30 min以及随后每6小时，我们记录了血管外肺水、呼气末肺容量、肺应变、呼吸力学、血液动力学和气体交换。在相同时间点，相对于基线记录呼气末阻抗。每12小时在12个区域中评估LUS，每次评分从0（存在A线）至3（巩固）。

测量值和主要结果：在多元回归模型中，血管外肺水和呼气末肺容量的比值与LUS总分显著相关（p < 0.002；校正的R2，0.21）。与肺阻抗的呼气末差异独立相关的变量为肺应变（p < 0.001；校正的R2，0.18）和血管外肺水（p < 0.001；校正的R2，0.11）。

结论：数据提示如下。首先，决定LUS评分的因素是水和气的比例，而不是水本身。因此，LUS评分的改善伴随肺气体含量的变化时需要谨慎，如PEEP增加后。其次，决定肺阻抗呼气末差异的是可能破坏细胞间连接，从而改变肺阻抗的应变水平。此外，VILI开发过程中血管外肺水增加导致观察到的阻抗降低。

Keyword: Humans; Female; Animals; Swine; Tomography, X-Ray Computed; Tidal Volume; Electric Impedance; Lung/diagnostic imaging; *Lung Injury/diagnostic imaging/etiology; *Ventilator-Induced Lung Injury/diagnostic imaging; Positive-Pressure Respiration/methods

--------
--------

## Validation of Respiratory Rate-Oxygenation Index in Patients With COVID-19-Related Respiratory Failure., Myers, Laura C.

7:e638-e642. DOI:10.1097/CCM.0000000000005474

Abstract: 

OBJECTIVES: The respiratory rate-oxygenation (ROX) index is a fraction of oxygen saturation, Fio2, and respiratory rate that has been validated to predict receipt  of invasive mechanical ventilation in patients receiving high-flow nasal cannula  (HFNC). This study aimed to validate ROX in a cohort of inpatients with  COVID-19-related respiratory failure. 

DESIGN: Retrospective validation of the ROX  index. We calculated sensitivity, specificity, positive predictive value,  negative predictive value, and 95% CIs of ROX for invasive mechanical ventilation  any time during hospitalization. 

SETTING: Twenty-one hospitals of Kaiser  Permanente Northern California, an integrated healthcare delivery system.  

PATIENTS: We identified adults with positive severe acute respiratory syndrome  coronavirus 2 polymerase chain reaction test within 3 weeks of, or during,  hospitalization between February 1, 2020, and December 31, 2020. We calculated  ROX at 12 hours after HFNC initiation. We grouped patients as low (?‰? 4.88),  intermediate (< 4.88 and ?‰? 3.85), or high (< 3.85) risk using previously  published thresholds. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: We  identified 1,847 patients who had no limitation of life support. Of these, 525  (31.7%) received invasive mechanical ventilation any time during hospitalization  and 511 died (27.7%). The sensitivity, specificity, positive predictive value,  and negative predictive value of 12-hour ROX threshold (< 3.85) predicting  invasive mechanical ventilation were 32.3% (95% CI, 28.5-36.3%), 89.8% (95% CI,  88.0-91.4%), 59.4% (95% CI, 53.8-64.9%), and 74.1% (95% CI, 71.8-76.3%),  respectively. 

CONCLUSIONS: The 12-hour ROX index has a positive predictive value  (59.4%) using threshold of less than 3.85 for COVID-19 patients needing invasive  mechanical ventilation. Our health system has embedded ROX into the electronic  health record to prioritize rounding during periods of inpatient surge.

## 在COVID-19相关呼吸衰竭患者中验证呼吸频率-氧合指数。

目的：呼吸频率-氧合(ROX)指数是氧饱和度、Fio2和呼吸频率的分数，已经过验证，可以预测接收  在接受高流量鼻插管的患者中进行有创机械通气  (HFNC).本研究的目的是在住院患者队列中验证ROX  COVID-19相关的呼吸衰竭。

设计：ROX的回顾性验证  指数。我们计算了敏感性、特异性、阳性预测值，  有创机械通气ROX的阴性预测值和95%CI  住院期间的任何时间。

单位：Kaiser的21家医院  Permanente Northern California，一个综合医疗保健服务系统。

患者：我们确定了重度急性呼吸综合征阳性的成人患者  冠状病毒2聚合酶链反应检测，  2020年2月1日至2020年12月31日期间住院。我们计算  开始HFNC后12小时ROX。我们按低风险( ≥ 4.88)对患者进行分组，  既往使用，中等（< 4.88和 ≥ 3.85）或高(< 3.85)风险  公布的阈值。

干预：无。

测量和主要结果：我们  确定了1847例生命支持不受限的患者。其中，525  (31.7%)在住院期间的任何时间接受了有创机械通气  511例死亡(27.7%)。灵敏度、特异性、阳性预测值，  和12小时ROX阈值(< 3.85)预测的阴性预测值  有创机械通气分别为32.3%(95%CI，28.5-36.3%)，89.8%（95%CI，  88.0-91.4%）、59.4%(95%CI，53.8-64.9%)和74.1%(95%CI，71.8-76.3%)，  分别为。

结论：12小时ROX指数具有阳性预测值  (59.4%)对COVID-19需要侵入性治疗的患者采用小于3.85的阈值  机械通气。我们的卫生系统将ROX嵌入电子  在住院患者激增期间优先对健康记录进行四舍五入。

Keyword: Humans; Adult; Retrospective Studies; Oxygen Inhalation Therapy; *COVID-19/therapy; *Noninvasive Ventilation; Cannula; *Respiratory Insufficiency/etiology/therapy; Blood Gas Analysis; Respiratory Rate

--------
--------

## The Effect of Clusters of Double Triggering and Ineffective Efforts in Critically Ill Patients., Magrans, Rudys

7:e619-e629. DOI:10.1097/CCM.0000000000005471

Abstract: 

OBJECTIVES: To characterize clusters of double triggering and ineffective inspiratory efforts throughout mechanical ventilation and investigate their  associations with mortality and duration of ICU stay and mechanical ventilation.  

DESIGN: Registry-based, real-world study. 

BACKGROUND: Asynchronies during  invasive mechanical ventilation can occur as isolated events or in clusters and  might be related to clinical outcomes. 

SUBJECTS: Adults requiring mechanical  ventilation greater than 24 hours for whom greater than or equal to 70% of  ventilator waveforms were available. 

INTERVENTIONS: We identified clusters of  double triggering and ineffective inspiratory efforts and determined their power  and duration. We used Fine-Gray's competing risk model to analyze their effects  on mortality and generalized linear models to analyze their effects on duration  of mechanical ventilation and ICU stay. 

MEASUREMENTS AND MAIN RESULTS: We  analyzed 58,625,796 breaths from 180 patients. All patients had clusters (mean/d,  8.2 [5.4-10.6]; mean power, 54.5 [29.6-111.4]; mean duration, 20.3 min [12.2-34.9  min]). Clusters were less frequent during the first 48 hours (5.5 [2.5-10] vs 7.6  [4.4-9.9] in the remaining period [p = 0.027]). Total number of clusters/d was  positively associated with the probability of being discharged alive considering  the total period of mechanical ventilation (p = 0.001). Power and duration were  similar in the two periods. Power was associated with the probability of being  discharged dead (p = 0.03), longer mechanical ventilation (p < 0.001), and longer  ICU stay (p = 0.035); cluster duration was associated with longer ICU stay (p =  0.027). 

CONCLUSIONS: Clusters of double triggering and ineffective inspiratory  efforts are common. Although higher numbers of clusters might indicate better  chances of survival, clusters with greater power and duration indicate a risk of  worse clinical outcomes.

## 危重患者中双重触发和无效努力集群的影响。

目的：描述整个机械通气期间双重触发和无效吸气努力的集群特征，并研究其  与死亡率、ICU停留时间和机械通气的相关性。

设计：基于注册的现实世界研究。

背景：治疗期间不同步  有创机械通气可能作为孤立事件或聚集性事件发生，并且  可能与临床结局相关。

受试者：需要机械辅助治疗的成人  通气大于24小时，大于或等于70%  呼吸机波形可用。

干预：我们确定了以下事件的集群  双触发和无效的吸气努力并确定其力量  和持续时间。我们使用Fine-Gray竞争风险模型分析了它们的影响  死亡率和广义线性模型，以分析其对持续时间的影响  机械通气和留住ICU。

测量和主要结果：我们  分析了180例患者的58,625,796次呼吸。所有患者均有聚集现象（平均/d，  8.2[5.4-10.6]；平均功率，54.5[29.6-111.4]；平均持续时间，20.3 min[12.2-34.9]  min]）。前48小时内，群集发生率较低（5.5[2.5-10]vs 7.6  [4.4-9.9]）。集群总数/d为  与出院存活概率正相关，考虑  机械通气的总周期(p = 0.001)。把握度和持续时间为  两个阶段相似。

把握度与以下概率相关：  出院时死亡(p = 0.03)、机械通气时间更长(p < 0.001)和时间更长  ICU停留时间(p = 0.035)；集群持续时间与更长的ICU停留时间相关（p =  0.027).结论：双触发和无效吸气的集群  努力是很常见的。尽管聚集数量越多可能表明越好  存活率，把握度和持续时间更高的群组表明存在以下风险  临床结局较差。

Keyword: Humans; Adult; Respiration, Artificial; *Critical Illness/therapy; *Ventilators, Mechanical

--------
--------

## Clinical Benefits of Early Concurrent Use of Cryoprecipitate and Plasma Compared With Plasma Only in Bleeding Trauma Patients.

DOI:10.1097/CCM.0000000000005596

Abstract: 

OBJECTIVES: The effectiveness of cryoprecipitate (Cryo) in trauma has not been well established; the benefits of Cryo might have been overestimated in previous  studies since the difference in the total amount of administered clotting factors  was not considered. We aimed to evaluate the benefits of the concurrent use of  Cryo in combination with fresh frozen plasma (FFP) for bleeding trauma patients.  

DESIGN: Retrospective cohort study. 

SETTING: The American College of Surgeons  Trauma Quality Improvement Program database between 2015 and 2019. 

PATIENTS:  Patients who received greater than or equal to 5 units of packed RBCs and at  least 1 unit of FFP within the first 4 hours after arrival to a hospital were  included and dichotomized according to whether Cryo was used within the first 4  hours of hospital arrival. 

INTERVENTION: None. 

MEASUREMENTS AND MAIN RESULTS: The  outcomes of patients treated with Cryo and FFP were compared with those treated  with FFP only using propensity score-matching analysis. The dose of administered  clotting factors in each group was balanced. The primary outcome was inhospital  mortality, and the secondary outcome was the occurrence rate of adverse events. A  total of 24,002 patients (Cryo+FFP group: 6,018; FFP only group: 17,984) were  eligible for analysis, of whom 4,852 propensity score-matched pairs were  generated. Significantly lower inhospital mortality (1,959 patients [40.4%] in  the Cryo+FFP group vs 2,142 patients [44.1%] in the FFP only group; odds ratio  [OR], 0.86; 95% CI, 0.79-0.93) was observed in the Cryo+FFP group; no significant  difference was observed in the occurrence rate of adverse events (1,857 [38.3%]  vs 1,875 [38.6%]; OR, 1.02; 95% CI, 0.94-1.10). Several sensitivity analyses  showed similar results. 

CONCLUSIONS: Cryo use combined with FFP was significantly  associated with reduced mortality in bleeding trauma patients. Future randomized  controlled trials are warranted to confirm these results.

## 早期联合使用冷沉淀和血浆与仅使用血浆相比在出血性创伤患者中的临床获益。

目的：尚未充分确立冷沉淀(Cryo)在创伤中的有效性；之前可能高估了Cryo的获益  由于给予的凝血因子总量差异的研究  未考虑。我们旨在评价同时使用  冷冻联合新鲜冰冻血浆(FFP)用于创伤出血患者。

设计：回顾性队列研究。

单位：美国外科医师学会  2015年至2019年期间的创伤质量改进项目数据库。

患者：  接受≥5个单位浓缩RBC的患者  到达医院后前4小时内至少1个单位的FFP  根据是否在前4个月内使用Cryo纳入并进行二分类  医院到达的小时数。

干预：无。

测量和主要结果：  将接受冷冻和FFP治疗的患者与接受治疗的患者的结局进行比较  FFP仅使用倾向评分匹配分析。给药剂量  各组的凝血因子平衡。主要结局是住院  死亡率，次要结局是不良事件的发生率。A  共24002例患者（Cryo + FFP组：6018例；仅FFP组：17984例）  符合分析资格，其中4852个倾向评分匹配对  生成。住院死亡率显著降低（1,959例患者[40.4%]  Cryo + FFP组vs仅FFP组的2,142例患者[44.1%]；比值比  [OR]，0.86；95%CI，0.79-0.93），在Cryo + FFP组中观察到；无显著  观察到不良事件发生率存在差异(1,857)[38.3%]  vs 1,875[38.6%]；或者，1.02; 95% CI, 0.94-1.10).多项敏感性分析  显示相似的结果。

结论：冷冻联合FFP使用显著  与出血性创伤患者的死亡率降低相关。未来随机化  有必要进行对照试验来证实这些结果。

--------
--------

## Reexamining the Role of Postoperative ICU Admission for Patients Undergoing Elective Craniotomy: A Systematic Review.

DOI:10.1097/CCM.0000000000005588

Abstract: 

OBJECTIVES: The standard-of-care for postoperative care following elective craniotomy has historically been ICU admission. However, recent literature  interrogating complications and interventions during this postoperative ICU stay  suggests that all patients may not require this level of care. Thus, hospitals  began implementing non-ICU postoperative care pathways for elective craniotomy.  This systematic review aims to summarize and evaluate the existing literature  regarding outcomes and costs for patients receiving non-ICU care after elective  craniotomy. 

DATA SOURCES: A systematic review of the PubMed database was  performed following PRISMA guidelines from database inception to August 2021.  

STUDY SELECTION: Included studies were published in peer-reviewed journals, in  English, and described outcomes for patients undergoing elective craniotomies  without postoperative ICU care. 

DATA EXTRACTION: Data regarding study design,  patient characteristics, and postoperative care pathways were extracted  independently by two authors. Quality and risk of bias were evaluated using the  Oxford Centre for Evidence-Based Medicine Levels of Evidence tool and Risk Of  Bias In Non-Randomized Studies-of Interventions tool, respectively. 

DATA  SYNTHESIS: In total, 1,131 unique articles were identified through the database  search, with 27 meeting inclusion criteria. Included articles were published from  2001 to 2021 and included non-ICU inpatient care and same-day discharge pathways.  Overall, the studies demonstrated that postoperative non-ICU care for elective  craniotomies led to length of stay reduction ranging from 6 hours to 4 days and  notable cost reductions. Across 13 studies, 53 of the 2,469 patients (2.1%)  intended for postoperative management in a non-ICU setting required subsequent  care escalation. 

CONCLUSIONS: Overall, these studies suggest that non-ICU care  pathways for appropriately selected postcraniotomy patients may represent a  meaningful opportunity to improve care value. However, included studies varied  greatly in patient selection, postoperative care protocol, and outcomes  reporting. Standardization and multi-institutional collaboration are needed to  draw definitive conclusions regarding non-ICU postoperative care for elective  craniotomy.

DOI: 10.1097/CCM.0000000000005588

## 系统回顾：对择期开颅手术患者术后ICU住院的作用。

目的：既往择期开颅术后护理的标准治疗是ICU入院。但近期文献  询问术后留住ICU期间的并发症和干预措施  提示所有患者可能不需要该水平的治疗。因此，医院  开始实施非ICU择期开颅手术术后护理路径。本系统综述旨在总结和评价现有文献  关于择期手术后接受非ICU护理患者的结局和费用  开颅手术。

数据来源：对PubMed数据库进行了系统回顾。  从数据库建立至2021年8月，遵循PRISMA指南进行。

研究选择：纳入的研究发表在同行评议期刊上，  英文，并描述了接受择期开颅手术的患者的结局  无术后ICU监护。

数据提取：关于研究设计的数据，  提取患者特征和术后护理路径  由两名作者独立完成。使用  牛津循证医学中心证据分级工具和风险  分别为非随机化研究-干预工具中的偏倚。数据  综合：通过数据库总共确定了1,131篇独特的文章  检索，其中27例符合入选标准。纳入的文章发表于  2001年至2021年，包括非ICU住院护理和当天出院途径。总体而言，研究表明择期手术的术后非ICU护理  开颅术导致住院时间缩短，范围从6小时至4天，和  显著的成本降低。在13项研究中，2,469例患者中的53例(2.1%)  计划在后续需要的非ICU环境中进行术后管理  护理升级。

结论：总体而言，这些研究表明非ICU护理  适当选择的开颅术后患者的路径可能代表  有意义的机会提高护理价值。然而，纳入的研究各不相同  在患者选择、术后护理方案和结局方面发挥了重要作用  报告。需要标准化和多机构合作来  得出关于非ICU择期术后护理的明确结论  开颅手术。

--------
--------

## Right-to-Left Shunts Occur During Cardiopulmonary Resuscitation: Echocardiographic Observations.

Abstract: 

OBJECTIVES: A significant proportion of the population has a patent foramen ovale (PFO). The intracardiac pressure during cardiopulmonary resuscitation (CPR) may  differ from that of normal circulation, which may result in a right-to-left shunt  in the presence of a PFO. In this study, transesophageal echocardiography (TEE)  was conducted to evaluate whether CPR carried out in patients after cardiac  arrest causes right-to-left shunt. 

DESIGN: A retrospective observational study.  

SETTING: One academic medical center from January 2017 to April 2020. 

PATIENTS:  Patients older than 20 years who suffered from nontraumatic out-of-hospital  cardiac arrest (OHCA) and underwent intra-arrest TEE. 

MEASUREMENT AND MAIN  RESULTS: Patients who had microbubbles resulting from fluid injection in the  right atrium, as indicated on TEE imaging, were included in the analysis. The  presence of right-to-left shunt was defined as the appearance of microbubbles in  the systemic circulation, including the left atrium, left ventricle, or aorta. A  total of 97 patients were included in the final analysis. A right-to-left shunt  was observed in 21 patients (21.6%), and no shunt was found in 76 patients  (78.4%). The degree of the right-to-left shunt, determined by the number of  microbubbles, was mild in 11 patients (52.4%), moderate in eight (38.0%), and  severe in two (9.6%). Multivariate analysis showed that no factors were  associated with the presence of right-to-left shunt during CPR. 

CONCLUSIONS:  Right-to-left shunts can be appreciated during CPR in patients who experience  OHCA. Further studies are needed to verify its clinical significance.

DOI: 10.1097/CCM.0000000000005593

## 心肺复苏期间右向左分流：超声心动图观察。

目的：相当大比例的人群有卵圆孔未闭(PFO)。心肺复苏过程中的心内压可能  与正常循环不同，可能导致右向左分流  存在PFO。本研究中，经食管超声心动图(TEE)  评价患者在心脏术后是否进行CPR  心脏停搏引起右向左分流。

设计：回顾性观察性研究。

单位：2017年1月至2020年4月，学术医学中心1家。

患者：  20岁以上非创伤性院外患者  心脏停搏(OHCA)并接受了停搏内TEE。测量和主要  结果：患者体内液体注射产生微气泡  分析中包括TEE成像所示的右心房。事件  存在右向左分流定义为存在微气泡  体循环，包括左心房、左心室或主动脉。A  最终分析共纳入97例患者。右向左分流  21例(21.6%)观察到分流，76例未发现分流  (78.4%).右向左分流的程度，由以下数量决定  微气泡，11例患者(52.4%)为轻度，8例患者(38.0%)为中度，以及  2例(9.6%)为重度。多变量分析显示无因素  与CPR期间出现右向左分流相关。

结论：  在经历CPR的患者中，可以识别右向左分流  OHCA.还需要进一步的研究来验证其临床意义。

--------
--------

## Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen  Complexity-ICU (MRC-ICU)., Sikora, Andrea

Abstract: 

OBJECTIVES: Despite the established role of the critical care pharmacist on the ICU multiprofessional team, critical care pharmacist workloads are likely not  optimized in the ICU. Medication regimen complexity (as measured by the  Medication Regimen Complexity-ICU [MRC-ICU] scoring tool) has been proposed as a  potential metric to optimize critical care pharmacist workload but has lacked  robust external validation. The purpose of this study was to test the hypothesis  that MRC-ICU is related to both patient outcomes and pharmacist interventions in  a diverse ICU population. 

DESIGN: This was a multicenter, observational cohort  study. 

SETTING: Twenty-eight ICUs in the United States. 

PATIENTS: Adult ICU  patients. 

INTERVENTIONS: Critical care pharmacist interventions (quantity and  type) on the medication regimens of critically ill patients over a 4-week period  were prospectively captured. MRC-ICU and patient outcomes (i.e., mortality and  length of stay [LOS]) were recorded retrospectively. 

MEASUREMENTS AND MAIN  RESULTS: A total of 3,908 patients at 28 centers were included. Following  analysis of variance, MRC-ICU was significantly associated with mortality (odds  ratio, 1.09; 95% CI, 1.08-1.11; p < 0.01), ICU LOS (?? coefficient, 0.41; 95% CI,  00.37-0.45; p < 0.01), total pharmacist interventions (?? coefficient, 0.07; 95%  CI, 0.04-0.09; p < 0.01), and a composite intensity score of pharmacist  interventions (?? coefficient, 0.19; 95% CI, 0.11-0.28; p < 0.01). In  multivariable regression analysis, increased patient: pharmacist ratio  (indicating more patients per clinician) was significantly associated with  increased ICU LOS (?? coefficient, 0.02; 0.00-0.04; p = 0.02) and reduced quantity  (?? coefficient, -0.03; 95% CI, -0.04 to -0.02; p < 0.01) and intensity of  interventions (?? coefficient, -0.05; 95% CI, -0.09 to -0.01). 

CONCLUSIONS:  Increased medication regimen complexity, defined by the MRC-ICU, is associated  with increased mortality, LOS, intervention quantity, and intervention intensity.  Further, these results suggest that increased pharmacist workload is associated  with decreased care provided and worsened patient outcomes, which warrants  further exploration into staffing models and patient outcomes.

DOI: 10.1097/CCM.0000000000005585

## 药剂师对改善危重病患者治疗的影响：一项使用有意义的指标及给药方案的大型多中心分析  复杂性-ICU(MRC-ICU)。

目的：尽管重症监护药剂师在ICU多专业团队中的作用已经明确，但是重症监护药剂师的工作量可能不会  在ICU优化。用药方案复杂性（根据  给药方案复杂性-ICU[MRC-ICU]评分工具）被提议作为  优化重症监护药剂师工作负荷的潜在指标，但缺乏  稳健的外部验证。本研究的目的是检验假设  MRC-ICU与患者结局和药剂师干预均相关  不同的ICU人群。

设计：多中心、观察性队列  研究。

设置：美国28间ICU。

患者：成人ICU  患者。

干预：重症监护药剂师干预（数量和  类型），为期4周的重症患者用药方案  前瞻性采集。MRC-ICU和患者结局（即，死亡率和  住院时间[LOS]）进行回顾性记录。测量和主要  结果：共纳入28家研究中心的3,908例患者。方差分析后发现，MRC-ICU与死亡率（比值比，1.09；95%CI，1.08-1.11；p < 0.01）、ICU LOS（β系数，0.41；95%CI，00.37-0.45；p < 0.01）、总药剂师干预（β系数，0.07；95%CI，0.04-0.09；p < 0.01）、和药剂师干预措施的复合强度评分（β系数，0.19；95%CI，0.11-0.28；p < 0.01）。在多变量回归分析中，患者：药剂师比率增加（表明每名临床医生有更多患者）与ICU LOS增加（β系数，0.02；0.00-0.04；p = 0.02）、数量减少（β系数，-0.03；95%CI，-0.04至-0.02；p < 0.01）和干预强度（β系数，-0.05；95%CI，-0.09 to -0.01)。

结论：  MRC-ICU定义的用药方案复杂性增加与  死亡率、LOS、干预量和干预强度增加。此外，这些结果表明增加的药剂师工作量与  提供的护理减少，患者结局变差，需要  进一步探索人员配备模式和患者结局。

--------
--------

## Accuracy of the Initial Rhythm to Predict a Short No-Flow Time in Out-of-Hospital Cardiac Arrest.

Abstract: 

OBJECTIVES: The no-flow time (NFT) can help establish prognosis in out-of-hospital cardiac arrest (OHCA) patients. It is often used as a selection  criterion for extracorporeal resuscitation. In patients with an unwitnessed OHCA  for whom the NFT is unknown, the initial rhythm has been proposed to identify  those more likely to have had a short NFT. Our objective was to determine the  predictive accuracy of an initial shockable rhythm for an NFT of 5 minutes or  less (NFT ?‰¤ 5). 

DESIGN: Retrospective analysis of prospectively collected data.  

SETTING: Prehospital OHCA in eight U.S. and three Canadian sites. 

PATIENTS: A  total of 28,139 adult patients with a witnessed nontraumatic OHCA were included,  of whom 11,228 (39.9%) experienced an emergency medical service-witnessed OHCA  (NFT = 0), 695 (2.7%) had a bystander-witnessed OHCA, and an NFT less than or  equal to 5, and 16,216 (57.6%) with a bystander-witnessed OHCA and an NFT greater  than 5. 

INTERVENTIONS: Sensitivity, specificity, and likelihood ratios of an  initial shockable rhythm to identify patients with an NFT less than or equal to 5  minutes. 

MEASUREMENTS AND MAIN RESULTS: The sensitivity of an initial shockable  rhythm to identify patients with an NFT less than or equal to 5 was poor (25%  [95% CI, 25-26]), but specificity was moderate (70% [95% CI, 69-71]). The  positive and likelihood ratios were inverted (negative accuracy) (positive  likelihood ratio, 0.76 [95% CI, 0.74-0.79]; negative likelihood ratio, 1.12 [95%  CI, 1.10-1.12]). Including only patients with a bystander-witnessed OHCA improved  the sensitivity to 48% (95% CI, 45-52), the positive likelihood ratio to 1.45  (95% CI, 1.33-1.58), and the negative likelihood ratio to 0.77 (95% CI,  0.72-0.83), while slightly lowering the specificity to 67% (95% CI, 66-67).  

CONCLUSIONS: Our analysis demonstrated that the presence of a shockable rhythm at  the time of initial assessment was poorly sensitive and only moderately specific  for OHCA patients with a short NFT. The initial rhythm, therefore, should not be  used as a surrogate for NFT in clinical decision-making.

ONLINE. DOI: 10.1097/CCM.0000000000005594

## 院外心脏骤停中初始节律预测短无流量时间的准确性。

目的：无流量时间(NFT)可帮助建立院外心脏骤停(OHCA)患者的预后。常用作选择  体外复苏标准。在无目击者的OHCA患者中  对于NFT未知的患者，已提出初始节律来确定  更有可能发生短暂NFT的患者。我们的目的是确定  5 min NFT的初始可电击节律的预测准确度或  小于(NFT?‰?5)。

设计：回顾性分析前瞻性收集的数据。

设置：8个美国和3个加拿大研究中心的院前OHCA。

患者：A  共纳入28139例有证据的非创伤性OHCA成年患者，  其中11228例(39.9%)经历了紧急医疗服务见证的OHCA  (NFT = 0)，695例(2.7%)有旁观者察觉的OHCA，且NFT小于或  等于5和16，216例(57.6%)旁观者察觉的OHCA和更高的NFT  > 5.干预：一种干预的敏感性、特异性和似然比  识别NFT≤5患者的初始可电击节律  分钟。

测量和主要结果：初始可电击的灵敏度  识别NFT≤5患者的节律较差(25%)  [95%CI，25-26]），但特异性为中等(70%[95%CI，69-71])。事件  阳性和似然比倒置（阴性准确性）（阳性  似然比，0.76[95%CI，0.74-0.79]；阴性似然比，1.12[95%  CI, 1.10-1.12]).仅包括旁观者见证的OHCA改善的患者  敏感性为48%(95%CI，45-52)，阳性似然比为1.45  (95%CI，1.33-1.58)，阴性似然比0.77（95%CI，  0.72-0.83），同时特异性略微降低至67%(95%CI，66-67)。

结论：我们的分析证明，存在可电击心律  初始评估的时间敏感性较差，仅具有中度特异性  对于NFT较短的OHCA患者。因此，初始节律不应该是  在临床决策中用作NFT的替代指标。

--------
--------

## Immune Profiling Demonstrates a Common Immune Signature of Delayed Acquired Immunodeficiency in Patients With Various Etiologies of Severe Injury: Erratum.

6:e618. DOI:10.1097/CCM.0000000000005565

--------
--------

## The Fundamentals of Hysteresis and Lung Recruitment in Patients With Acute Respiratory Distress Syndrome.

6:e616-e617. doi: 10.1097/CCM.0000000000005473

Keyword: Humans; Lung; *Respiratory Distress Syndrome/therapy

--------
--------

## Sepsis and Resuscitation: The Importance of Time., Feichtinger, Stuart

## 败血症和复苏：时间的重要性。

6:e615-e616. DOI:10.1097/CCM.0000000000005494

Keyword: Humans; Resuscitation; Fluid Therapy; *Sepsis/therapy; *Shock, Septic

--------
--------

## Effects of Moderate Hypothermia on Diastolic Functions of Heart.

6:e613-e614. DOI:10.1097/CCM.0000000000005497

## 中度低温对心脏舒张功能的影响。

Keyword: Humans; Heart; *Hypothermia; *Hypothermia, Induced; Diastole

--------
--------

## The authors reply.

6:e612-e613. DOI:10.1097/CCM.0000000000005544

## 作者回复。

--------
--------

## Wacker et al, Who Conclude That Vitamin C Monotherapy Failed to Significantly Reduce Mortality in Septic Shock Patients: Beware of Potential Confounding  Factors!, Honore, Patrick M.

6:e611-e612. DOI:10.1097/CCM.0000000000005516

## Wacker等人的结论是维生素C单药治疗未能显著降低感染性休克患者的死亡率：需注意潜在的混杂因素  因素！

Keyword: Humans; *Sepsis; *Shock, Septic/drug therapy; Ascorbic Acid/therapeutic use; Vitamins

--------
--------

## The authors reply.

6:e610-e611. DOI:10.1097/CCM.0000000000005528

## 作者回复。

--------
--------

## Benzodiazepine-Based Sedation Did Not Add an Independent Risk of Delirium?, Cai, Xingwei

6:e608-e609. DOI:10.1097/CCM.0000000000005515

## 基于苯二氮卓类的镇静未增加谵妄的独立风险？

Keyword: Humans; Intensive Care Units; *Benzodiazepines/adverse effects; *Delirium/drug therapy; Hypnotics and Sedatives/adverse effects

--------
--------

## The authors reply., Massart, Nicolas

6:e607-e608. DOI:10.1097/CCM.0000000000005542

## 作者回复。

--------
--------

## A Hypothesis-Generating Clinical Study We Should Be Concerned About., Nadeem, Rashid

6:e606-e607. DOI:10.1097/CCM.0000000000005510

## 我们应该关注的假设生成性临床研究。

--------
--------

## The authors reply.

6:e604-e606. DOI:10.1097/CCM.0000000000005529

## 作者回复。

--------
--------

## Further Retractions of Articles by Joachim Boldt., Wiedermann, Christian J.

6:e601-e603. DOI:10.1097/CCM.0000000000005506

## Joachim Boldt进一步撤回文章。

Keyword: Humans; *Biomedical Research; Dyspnea

--------
--------

## The authors reply.

6:e600-e601. DOI:10.1097/CCM.0000000000005521

## 作者回复。

--------
--------

## Is Early Vasopressor Safe in Septic Shock?

6:e599-e600. DOI:10.1097/CCM.0000000000005505

## 感染性休克早期使用血管加压药是否安全？

Keyword: Humans; Retrospective Studies; *Shock, Septic/drug therapy; Vasoconstrictor Agents/adverse effects

--------
--------

## The authors reply., Grim, Chloe C. A.

6:e598-e599. DOI:10.1097/CCM.0000000000005526

## 作者回复。

--------
--------

## What Is the Abnormal Serum Sodium to Be Associated With Mortality in Critically Ill?

6:e596-e597. DOI:10.1097/CCM.0000000000005496

## 危重患者中异常血清钠与死亡率的相关性是什么？
关键词：Humans; *Intensive Care Units; *Critical Illness; Sodium

--------
--------

## The authors reply., L'Her, Erwan

6:e595-e596. DOI:10.1097/CCM.0000000000005523

## 作者回复。

--------
--------

## Noninvasive Method of Measuring of Tidal Volume: A Promising Novel Tool?

6:e594-e595. DOI:10.1097/CCM.0000000000005489

## 潮气量无创测量方法：一种有前景的新型工具？
关键词：Tidal Volume; *Noninvasive Ventilation

--------
--------

## The authors reply., Taran, Shaurya

6:e590. DOI:10.1097/CCM.0000000000005511

## 作者回复。

--------
--------

## Concordance Between Outcomes Associated With Withholding Extubation and Extubation Failure After Successful Spontaneous Breathing Trial.

6:e589. DOI:10.1097/CCM.0000000000005481

## 自主呼吸试验成功后拔管失败和拔管失败相关结局的一致性。
关键词：Respiration, Artificial; *Airway Extubation; *Ventilator Weaning

--------
--------

## Seventeen Years Is Too Long to Move From the ICU to the Emergency Department., Danboise, Brook

6:1032-1034. DOI:10.1097/CCM.0000000000005472

## 从ICU转移到急诊科已是17年之久。
关键词：Retrospective Studies; *Intensive Care Units; *Emergency Service, Hospital

--------
--------

## After a Heart Attack, Who Should Care?

6:1030-1032. DOI:10.1097/CCM.0000000000005477

## 心脏病发作后，谁应该关心？
关键词：Humans; Health Knowledge, Attitudes, Practice; *Myocardial Infarction/therapy

--------
--------

## Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis.

6:1018-1020. DOI:10.1097/CCM.0000000000005480

## 二甲双胍：糖尿病脓毒症住院患者的无效保护剂。
关键词：Humans; *Diabetes Mellitus; *Metformin/therapeutic use; *Sepsis/drug therapy; Hypoglycemic Agents/therapeutic use; Protective Agents

--------
--------

## From Syphilis to Sepsis: Pilot Studies and the Importance of Staying Grounded.

6:1015-1018. DOI:10.1097/CCM.0000000000005539

## 从梅毒到败血症：初探性研究和保持接地的重要性。
关键词：Humans; Pilot Projects; *Sepsis; *Syphilis/drug therapy

--------
--------

## A Tale of Two ICUs: One for Women and One for Men?

6:1012-1015. DOI:10.1097/CCM.0000000000005538

## 两个ICU的故事：一个是女性，一个是男性？
关键词：Humans; Female; Male; *Intensive Care Units

--------
--------

## MEDucation: Healthcare Providers, Educators, and Families Partnering to Address the Educational Challenges of Children After Recovery From Critical Illness.

6:1010-1012. DOI:10.1097/CCM.0000000000005478

## 医疗服务：医疗保健提供者、教育者和家庭合作，解决儿童从危重病康复后面临的教育挑战。
关键词：Humans; Child; *Critical Illness/therapy; *Health Personnel; Educational Status; Parents

--------
--------

## The authors reply.

6:e592-e594. DOI:10.1097/CCM.0000000000005530

## 作者回复。

--------
--------

## Sleep and Circadian Health of Critical COVID-19 Survivors 3 Months After Hospital Discharge.

6:945-954. DOI:10.1097/CCM.0000000000005476

Abstract: 

OBJECTIVES: To evaluate the sleep and circadian rest-activity pattern of critical COVID-19 survivors 3 months after hospital discharge. 

DESIGN: Observational,  prospective study. 

SETTING: Single-center study. 

PATIENTS: One hundred  seventy-two consecutive COVID-19 survivors admitted to the ICU with acute  respiratory distress syndrome. 

INTERVENTIONS: Seven days of actigraphy for sleep  and circadian rest-activity pattern assessment; validated questionnaires;  respiratory tests at the 3-month follow-up. 

MEASUREMENTS AND MAIN RESULTS: The  cohort included 172 patients, mostly males (67.4%) with a median (25th-75th  percentile) age of 61.0 years (52.8-67.0 yr). The median number of days at the  ICU was 11.0 (6.00-24.0), and 51.7% of the patients received invasive mechanical  ventilation (IMV). According to the Pittsburgh Sleep Quality Index (PSQI), 60.5%  presented poor sleep quality 3 months after hospital discharge, which was further  confirmed by actigraphy. Female sex was associated with an increased score in the  PSQI (p < 0.05) and IMV during ICU stay was able to predict a higher  fragmentation of the rest-activity rhythm at the 3-month follow-up (p < 0.001).  Furthermore, compromised mental health measured by the Hospital Anxiety and  Depression Scale was associated with poor sleep quality (p < 0.001). 

CONCLUSIONS:  Our findings highlight the importance of considering sleep and circadian health  after hospital discharge. Within this context, IMV during the ICU stay could aid  in predicting an increased fragmentation of the rest-activity rhythm at the  3-month follow-up. Furthermore, compromised mental health could be a marker for  sleep disruption at the post-COVID period.

## COVID-19危重存活者出院后3个月的睡眠和昼夜节律健康。

目的：评价关键COVID-19存活者出院后3个月的睡眠和昼夜节律静息-活动模式。

设计：观察性，  前瞻性研究。

设置：单中心研究。

患者：100例  72例连续COVID-19存活者因急性  呼吸窘迫综合征。

干预：7天睡眠活动描记  和昼夜节律静息-活动模式评估；经验证的问卷；  3个月随访时的呼吸试验。

测量和主要结果：  队列包括172例患者，大部分是男性(67.4%)，中位数（第25-75百分位数）  百分位数）年龄为61.0岁（52.8-67.0岁）。以下时间点的中位天数  ICU为11.0(6.00-24.0)，51.7%的患者接受了侵入性机械治疗  通气(IMV)。根据匹兹堡睡眠质量指数(PSQI),60.5%  在出院后3个月表现睡眠质量差，进一步  通过活动描记术证实。

女性与以下方面的评分增加相关：  PSQI(p < 0.05)和ICU住院期间IMV能够预测更高的  3个月随访时的静息-活动节律破碎(p < 0.001)。此外，根据医院焦虑和  抑郁量表与睡眠质量差相关(p < 0.001)。

结论：  我们的发现强调了考虑睡眠和昼夜节律健康的重要性  出院后。在这种情况下，在ICU住院期间使用IMV可能有助于  预测静息-活动节律碎裂增加  3个月随访。此外，受损的心理健康可能是  COVID后期间睡眠中断。
关键词：Humans; Female; Male; Middle Aged; Prospective Studies; Intensive Care Units; *COVID-19; Survivors; Hospitals; *Patient Discharge; Sleep

--------
--------

## Systematic Review and Comparison of Publicly Available ICU Data Sets-A Decision Guide for Clinicians and Data Scientists., Sauer, Christopher M.

6:e581-e588. DOI:10.1097/CCM.0000000000005517

Abstract: 

OBJECTIVE: As data science and artificial intelligence continue to rapidly gain traction, the publication of freely available ICU datasets has become invaluable  to propel data-driven clinical research. In this guide for clinicians and  researchers, we aim to: 1) systematically search and identify all publicly  available adult clinical ICU datasets, 2) compare their characteristics, data  quality, and richness and critically appraise their strengths and weaknesses, and  3) provide researchers with suggestions, which datasets are appropriate for  answering their clinical question. 

DATA SOURCES: A systematic search was  performed in Pubmed, ArXiv, MedRxiv, and BioRxiv. 

STUDY SELECTION: We selected  all studies that reported on publicly available adult patient-level intensive  care datasets. 

DATA EXTRACTION: A total of four publicly available, adult,  critical care, patient-level databases were included (Amsterdam University  Medical Center data base [AmsterdamUMCdb], eICU Collaborative Research Database  eICU CRD], High time-resolution intensive care unit dataset [HiRID], and Medical  Information Mart for Intensive Care-IV). Databases were compared using a priori  defined categories, including demographics, patient characteristics, and data  richness. The study protocol and search strategy were prospectively registered.  

DATA SYNTHESIS: Four ICU databases fulfilled all criteria for inclusion and were  queried using SQL (PostgreSQL version 12; PostgreSQL Global Development Group)  and analyzed using R (R Foundation for Statistical Computing, Vienna, Austria).  The number of unique patient admissions varied between 23,106 (AmsterdamUMCdb)  and 200,859 (eICU-CRD). Frequency of laboratory values and vital signs was  highest in HiRID, for example, 5.2 (?±3.4) lactate values per day and 29.7 (?±10.2)  systolic blood pressure values per hour. Treatment intensity varied with  vasopressor and ventilatory support in 69.0% and 83.0% of patients in  AmsterdamUMCdb versus 12.0% and 21.0% in eICU-CRD, respectively. ICU mortality  ranged from 5.5% in eICU-CRD to 9.9% in AmsterdamUMCdb. 

CONCLUSIONS: We  identified four publicly available adult clinical ICU datasets. Sample size,  severity of illness, treatment intensity, and frequency of reported parameters  differ markedly between the databases. This should guide clinicians and  researchers which databases to best answer their clinical questions.

## 可公开发表的ICU数据集的系统回顾和比较-临床医生和数据科学家的决策指南。

目的：随着数据科学和人工智能持续快速获得吸引力，免费提供的ICU数据集的发表对于推动数据驱动的临床研究变得非常宝贵。在本临床医生和研究人员指南中，我们的目的是：1）系统检索和识别所有公开的成人临床ICU数据集，2）比较其特征、数据质量和丰富度，并严格评价其优势和劣势，3）向研究人员提供建议，哪些数据集适合回答其临床问题。

数据来源：在Pubmed、ArXiv、MedRxiv和BioRxiv中进行了系统的检索。

研究选择：我们选择了报告公开的成人患者级重症监护数据集的所有研究。

数据提取：共纳入4个公开的成人重症监护患者级别数据库（阿姆斯特丹大学医学中心数据库[AmsterdamUMCdb]、eICU合作研究数据库eICU CRD]、高时间分辨率重症监护室数据集[HiRID]和重症监护医学信息市场IV）。使用事先定义的类别比较数据库，包括人口统计学、患者特征和数据丰富度。前瞻性登记研究方案和检索策略。

数据综合：四个ICU数据库符合所有入选标准，使用SQL（PostgreSQL第12版；PostgreSQL全球开发组）进行查询，并使用R(R Foundation for Statistical Computing,Vienna,Austria)进行分析。独特患者入院的数量在23,106(AmsterdamUMCdb)和200,859(eICU-CRD)之间。HiRID中实验室值和生命体征的频率最高，例如，5.2(?±3.4)个乳酸盐值/天和29.7(?±10.2)个收缩压值/小时。AmsterdamUMCdb组69.0%和83.0%的患者治疗强度随血管加压药和通气支持的不同而不同vs 12.0%eICU-CRD中为21.0%。ICU死亡率范围从eICU-CRD的5.5%至AmsterdamUMCdb的9.9%。

结论：我们确定了4个可公开获取的成人临床ICU数据集。数据库之间的样本量、疾病严重程度、治疗强度和报告参数的频率存在显著差异。这将指导临床医生和研究人员使用哪些数据库来最佳地回答他们的临床问题。
关键词：Humans; Adult; Critical Care; *Intensive Care Units; Systematic Reviews as Topic; *Artificial Intelligence; Data Accuracy; Databases, Factual

--------
--------

## COVID-19, Critical Illness, and Sleep., Chatterjee, Arjun Bijoy

6:1021-1023. DOI:10.1097/CCM.0000000000005519

## COVID-19，危重病和睡眠。
关键词：Humans; Critical Illness; *COVID-19; SARS-CoV-2; Sleep

--------
--------

## Is This the Beginning of the End of Cytokine Adsorption?

6:1026-1029. DOI:10.1097/CCM.0000000000005509

## 这是否是细胞因子吸附结束的开始？
关键词：*Cytokines; *Extracorporeal Membrane Oxygenation; Adsorption

--------
--------

## Does Unprecedented ICU Capacity Strain, As Experienced During the COVID-19 Pandemic, Impact Patient Outcome?

6:e548-e556. DOI:10.1097/CCM.0000000000005464

Abstract: 

OBJECTIVES: To determine whether patients admitted to an ICU during times of unprecedented ICU capacity strain, during the COVID-19 pandemic in the United  Kingdom, experienced a higher risk of death. 

DESIGN: Multicenter, observational  cohort study using routine clinical audit data. 

SETTING: Adult general ICUs  participating the Intensive Care National Audit & Research Centre Case Mix  Programme in England, Wales, and Northern Ireland. 

PATIENTS: One-hundred  thirty-thousand six-hundred eighty-nine patients admitted to 210 adult general  ICUs in 207 hospitals. 

INTERVENTIONS: Multilevel, mixed effects, logistic  regression models were used to examine the relationship between levels of ICU  capacity strain on the day of admission (typical low, typical, typical high,  pandemic high, and pandemic extreme) and risk-adjusted hospital mortality.  

MEASUREMENTS AND MAIN RESULTS: In adjusted analyses, compared with patients  admitted during periods of typical ICU capacity strain, we found that COVID-19  patients admitted during periods of pandemic high or pandemic extreme ICU  capacity strain during the first wave had no difference in hospital mortality,  whereas those admitted during the pandemic high or pandemic extreme ICU capacity  strain in the second wave had a 17% (odds ratio [OR], 1.17; 95% CI, 1.05-1.30)  and 15% (OR, 1.15; 95% CI, 1.00-1.31) higher odds of hospital mortality,  respectively. For non-COVID-19 patients, there was little difference in trend  between waves, with those admitted during periods of pandemic high and pandemic  extreme ICU capacity strain having 16% (OR, 1.16; 95% CI, 1.08-1.25) and 30% (OR,  1.30; 95% CI, 1.14-1.48) higher overall odds of acute hospital mortality,  respectively. 

CONCLUSIONS: For patients admitted to ICU during the pandemic,  unprecedented levels of ICU capacity strain were significantly associated with  higher acute hospital mortality, after accounting for differences in baseline  characteristics. Further study into possible differences in the provision of care  and outcome for COVID-19 and non-COVID-19 patients is needed.

## 既往ICU容量负荷（如COVID-19期间发生的流行病）是否会影响患者结局？

目的：确定在英国COVID-19大流行期间，在ICU容量菌株前所未有的时期入住ICU的患者是否经历更高的死亡风险。

设计：采用常规临床稽查数据的多中心、观察性队列研究。

设置：在英格兰、威尔士和北爱尔兰参加重症监护国家稽查和研究中心病例混合项目的成人普通ICU。

患者：207家医院210间成人普通ICU的130689例患者。

干预：使用多水平、混合效应、logistic回归模型检查入院当天ICU能力菌株水平（典型低、典型、典型高、流行高和流行极端）与经风险调整的住院死亡率之间的关系。

测量和主要结果：在调整后的分析中，与典型ICU能力菌株期间入院的患者相比，我们发现COVID-19患者在第一波大流行期间高或大流行期间极端ICU能力菌株期间入院，住院死亡率无差异，而在第二波大流行期间高流行或大流行极端ICU能力菌株期间入院的患者住院死亡率的比值比分别高17%（比值比[or]，1.17；95%CI，1.05-1.30）和15%(or，1.15；95%CI，1.00-1.31)。对于非COVID-19患者，波之间的趋势几乎没有差异，在大流行期间高流行和大流行极端ICU能力菌株期间入院的患者急性住院死亡率的总体比值比分别高16%(OR，1.16；95%CI，1.08-1.25)和30%(OR，1.30；95%CI，1.14-1.48)。

结论：考虑基线特征的差异后，对于大流行期间入住ICU的患者，史无前例的ICU能力菌株水平与较高的急性医院死亡率显著相关。需要进一步研究COVID-19和非COVID-19患者在护理提供和结局方面的可能差异。
关键词：Humans; Intensive Care Units; Adult; Critical Care; Retrospective Studies; Pandemics; Hospital Mortality; *COVID-19/epidemiology

--------
--------

## Educational Outcomes of Childhood Survivors of Critical Illness-A Population-Based Linkage Study.

6:901-912. DOI:10.1097/CCM.0000000000005461

Abstract: 

OBJECTIVES: Major postintensive care sequelae affect up to one in three adult survivors of critical illness. Large cohorts on educational outcomes after  pediatric intensive care are lacking. We assessed primary school educational  outcomes in a statewide cohort of children who survived PICU during childhood.  

DESIGN: Multicenter population-based study on children less than 5 years admitted  to PICU. Using the National Assessment Program-Literacy and Numeracy database,  the primary outcome was educational achievement below the National Minimum  Standard (NMS) in year 3 of primary school. Cases were compared with controls  matched for calendar year, grade, birth cohort, sex, socioeconomic status,  Aboriginal and Torres Strait Islander status, and school. Multivariable logistic  regression models to predict educational outcomes were derived. 

SETTING: Tertiary  PICUs and mixed ICUs in Queensland, Australia. 

PATIENTS: Children less than 5  years admitted to PICU between 1998 and 2016. 

INTERVENTIONS: Not applicable.  

MEASUREMENTS AND MAIN RESULTS: Year 3 primary school data were available for  5,017 PICU survivors (median age, 8.0 mo at first PICU admission; interquartile  range, 1.9-25.2). PICU survivors scored significantly lower than controls across  each domain (p < 0.001); 14.03% of PICU survivors did not meet the NMS compared  with 8.96% of matched controls (p < 0.001). In multivariate analyses,  socioeconomic status (odds ratio, 2.14; 95% CI, 1.67-2.74), weight (0.94;  0.90-0.97), logit of Pediatric Index of Mortality-2 score (1.11; 1.03-1.19),  presence of a syndrome (11.58; 8.87-15.11), prematurity (1.54; 1.09-2.19),  chronic neurologic conditions (4.38; 3.27-5.87), chronic respiratory conditions  (1.65; 1.24-2.19), and continuous renal replacement therapy (4.20; 1.40-12.55)  were independently associated with a higher risk of not meeting the NMS.  

CONCLUSIONS: In this population-based study of childhood PICU survivors, 14.03%  did not meet NMSs in the standardized primary school assessment. Socioeconomic  status, underlying diseases, and severity on presentation allow  risk-stratification to identify children most likely to benefit from individual  follow-up and support.

## 危重病儿童期幸存者的教育结局-基于人群的连锁研究。

目的：重大重症监护后后遗症影响了多达三分之一危重疾病成人幸存者。缺乏儿科重症监护后教育结局的大型队列。我们在全州儿童队列中评估了儿童期PICU存活的儿童的小学教育结局。

设计：对5岁以下入住PICU的儿童进行多中心人群研究。使用国家评估项目-识字和数字数据库，主要结局是小学3年时的教育成就低于国家最低标准(NMS)。将病例与日历年、等级、出生队列、性别、社会经济地位、土著和托雷斯海峡岛民地位和学校匹配的对照进行比较。推导出了预测教育结局的多变量logistic回归模型。

设置：澳大利亚昆士兰第三PICU和混合ICU。

患者：1998年至2016年，小于5岁的儿童入住PICU。

干预：不适用。

测量和主要结果：5,017名PICU存活者的3年小学数据可用（中位年龄，首次入住PICU时8.0个月；四分位距，1.9-25.2）。在每个领域，PICU存活者的评分均显著低于对照组(p < 0.001)；14.03%的PICU存活者不符合NMS，而匹配对照组为8.96%(p < 0.001)。在多变量分析中，社会经济地位（比值比，2.14；95%CI，1.67-2.74）、体重(0.94；0.90-0.97)、儿科死亡率指数-2评分的logit(1.11；1.03-1.19)、存在综合征(11.58；8.87-15.11)、早产(1.54；1.09-2.19)、慢性神经系统疾病(4.38；3.27-5.87)、慢性呼吸系统疾病(1.65；1.24-2.19)，和连续肾脏替代治疗(4.20；1.40-12.55)与不满足NMS的风险升高独立相关。

结论：在这项儿童期PICU存活者人群研究中，14.03%在标准化小学评估中未达到NMS。社会经济状况、基础疾病和表现的严重程度允许进行风险分层，以确定最有可能从个体随访和支持中获益的儿童。
关键词：Humans; Length of Stay; Retrospective Studies; Child; Infant; Chronic Disease; Survivors; *Critical Illness; Educational Status; *Intensive Care Units, Pediatric

--------
--------

## Aberrant Fibrin Clot Structure Visualized Ex Vivo in Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

6:e557-e568. DOI:10.1097/CCM.0000000000005465

Abstract: 

OBJECTIVES: Disseminated fibrin-rich microthrombi have been reported in patients who died from COVID-19. Our objective is to determine whether the fibrin clot  structure and function differ between critically ill patients with or without  COVID-19 and to correlate the structure with clinical coagulation biomarkers.  

DESIGN: A cross-sectional observational study. Platelet poor plasma was used to  analyze fibrin clot structure; the functional implications were determined by  quantifying clot turbidity and porosity. 

SETTING: ICU at an academic medical  center and an academic laboratory. 

PATIENTS: Patients admitted from July 1 to  August 1, 2020, to the ICU with severe acute respiratory syndrome coronavirus 2  infection confirmed by reverse transcription-polymerase chain reaction or  patients admitted to the ICU with sepsis. 

INTERVENTIONS: None. 

MEASUREMENTS AND  MAIN RESULTS: Blood was collected from 36 patients including 26 ICU patients with  COVID-19 and 10 ICU patients with sepsis but without COVID-19 at a median of 11  days after ICU admission (interquartile range, 3-16). The cohorts were similar in  age, gender, body mass index, comorbidities, Sequential Organ Failure Assessment  (SOFA) score, and mortality. More patients with COVID-19 (100% vs 70%; p = 0.003)  required anticoagulation. Ex vivo fibrin clots formed from patients with COVID-19  appeared to be denser and to have smaller pores than those from patients with  sepsis but without COVID-19 (percent area of fluorescent fibrin 48.1% [SD, 16%]  vs 24.9% [SD, 18.8%]; p = 0.049). The turbidity and flow-through assays  corroborated these data; fibrin clots had a higher maximum turbidity in patients  with COVID-19 compared with patients without COVID-19 (0.168 vs 0.089 OD units; p  = 0.003), and it took longer for buffer to flow through these clots (216 vs  103 min; p = 0.003). In patients with COVID-19, d-dimer levels were positively  correlated with percent area of fluorescent fibrin (?? = 0.714, p = 0.047). Denser  clots (assessed by turbidity and thromboelastography) and higher SOFA scores were  independently associated with delayed clot lysis. 

CONCLUSIONS: We found aberrant  fibrin clot structure and function in critically ill patients with COVID-19.  These findings may contribute to the poor outcomes observed in COVID-19 patients  with widespread fibrin deposition.

## 严重急性呼吸综合征冠状病毒2感染的危重患者中离体可视化的异常纤维蛋白凝块结构。

目的：COVID-19死亡的患者报告了弥散性富含纤维蛋白的微血栓。我们的目的是确定有或无COVID-19的重症患者之间纤维蛋白凝块结构和功能是否存在差异，并将该结构与临床凝血生物标志物相关联。

设计：横断面观察性研究。使用弱血小板血浆分析纤维蛋白凝块结构；通过量化凝块浊度和孔隙度测定其功能意义。

地点：ICU，学术医学中心和学术实验室。

患者：2020年7月1日至8月1日入住ICU，经逆转录聚合酶链反应证实有严重急性呼吸综合征冠状病毒2型感染或伴有败血症的患者。

干预：无。

测量和主要结果：在入住ICU后平均11天（四分位距，3-16），从36名患者中采集血液，包括26名有COVID-19的ICU患者和10名有败血症但无COVID-19的ICU患者。队列在年龄、性别、体重指数、合并症、序贯器官衰竭评估(SOFA)评分和死亡率方面相似。更多的COVID-19患者（100%对比70%；p = 0.003）需要抗凝治疗。与没有COVID-19的脓毒症患者相比，COVID-19患者形成的离体纤维蛋白凝块更致密，孔更小（荧光纤维蛋白面积百分比48.1%[SD，16%]vs 24.9%[SD，18.8%]；p = 0.049）。浊度和流过试验证实了这些数据；与无COVID-19的患者相比，使用COVID-19的患者中纤维蛋白凝块的最大浊度更高（0.168 vs 0.089 OD单位；p = 0.003），缓冲液流过这些凝块的时间更长(216 vs 103 min；p = 0.003)。在COVID-19患者中，d-二聚体水平与荧光纤维蛋白面积百分比呈正相关(<unk><unk>=0.714，p=0.047)。更致密的凝块（通过浊度和血栓弹性成像评估）和更高的SOFA评分与延迟凝块溶解独立相关。

结论：我们在COVID-19重症患者中发现了异常的纤维蛋白凝块结构和功能。这些发现可能导致在广泛纤维蛋白沉积的COVID-19患者中观察到的不良结局。
关键词：Humans; Critical Illness; Cross-Sectional Studies; *COVID-19; Fibrinolysis; *Sepsis; *Thromboembolism; *Thrombosis; Fibrin

--------
--------

## Longitudinal Trends in Bleeding Complications on Extracorporeal Life Support Over the Past Two Decades-Extracorporeal Life Support Organization Registry Analysis., Willers, Anne

6:e569-e580. DOI:10.1097/CCM.0000000000005466

Abstract: 

OBJECTIVES: Data about inhospital outcomes in bleeding complications during extracorporeal life support (ECLS) have been poorly investigated. 

DESIGN:  Retrospective observational study. 

SETTING: Patients reported in Extracorporeal  Life Support Organization Registry. 

PATIENTS: Data of 53.644 adult patients  (greater than or equal to 18 yr old) mean age 51.4 ?± 15.9 years, 33.859 (64.5%)  male supported with single ECLS run between 01.01.2000 and 31.03.2020, and 19.748  cannulated for venovenous (V-V) ECLS and 30.696 for venoarterial (V-A) ECLS.  

INTERVENTIONS: Trends in bleeding complications, bleeding risk factors, and  mortality. 

MEASUREMENT AND MAIN RESULTS: Bleeding complications were reported in  14.786 patients (27.6%), more often in V-A ECLS compared with V-V (30.0% vs  21.9%; p < 0.001). Hospital survival in those who developed bleeding  complications was lower in both V-V ECLS (49.6% vs 66.6%; p < 0.001) and V-A ECLS  (33.9 vs 44.9%; p < 0.001). Steady decrease in bleeding complications in V-V and  V-A ECLS was observed over the past 20 years (coef., -1.124; p < 0.001 and  -1.661; p < 0.001). No change in mortality rates was reported over time in V-V or  V-A ECLS (coef., -0.147; p = 0.442 and coef., -0.195; p = 0.139).Multivariate  regression revealed advanced age, ecls duration, surgical cannulation, renal  replacement therapy, prone positioning as independent bleeding predictors in v-v  ecls and female gender, ecls duration, pre-ecls arrest or bridge to transplant,  therapeutic hypothermia, and surgical cannulation in v-a ecls. 

CONCLUSIONS: A  steady decrease in bleeding over the last 20 years, mostly attributable to  surgical and cannula-site-related bleeding has been found in this large cohort of  patients receiving ECLS support. However, there is not enough data to attribute  the decreasing trends in bleeding to technological refinements alone. Especially  reduction in cannulation site bleeding is also due to changes in timing, patient  selection, and ultrasound guided percutaneous cannulation. Other types of  bleeding, such as CNS, have remained stable, and overall bleeding remains  associated with a persistent increase in mortality.

## 过去二十年期间体外生活支持出血并发症的纵向趋势-体外生活支持组织注册分析。

目的：关于体外生命支持(ECLS)期间出血并发症的住院结局数据的研究很少。

设计：回顾性观察性研究。

设置：体外生命支持组织登记研究中报告的患者。

患者：53.644例成人患者（≥18岁）的数据平均年龄为51.4±15.9岁，33.859例(64.5%)男性支持在2000年1月1日至2020年3月31日期间进行单次ECLS，19.748例静脉-静脉(V-V)ECLS插管，30.696例静脉-动脉(V-A)ECLS插管。

干预：出血并发症、出血风险因素和死亡率的趋势。

测量和主要结果：14.786例患者(27.6%)报告了出血并发症，V-A ECLS比V-V更常见(30.0%vs 21.9%；p < 0.001)。V-V ECLS(49.6%vs 66.6%；p < 0.001)和V-A ECLS(33.9%vs 44.9%；p < 0.001)发生出血并发症的患者的住院生存率较低。在过去20年中，观察到V-V和V-A ECLS的出血并发症稳定减少（系数，-1.124；p < 0.001和-1.661；p < 0.001）。V-V或V-A ECLS中未报告死亡率随时间的变化（系数，-0.147；p = 0.442和系数，-0.195；p = 0.139）。多变量回归分析显示高龄、ecls持续时间、手术插管、肾脏替代治疗、俯卧位作为v-v ecls独立出血预测因素和女性性别、ecls持续时间、ecls前停搏或移植桥接、治疗性低温和v-a ecls手术插管。

结论：在接受ECLS支持的大型患者队列中发现，过去20年的出血稳步减少，主要归因于手术和插管部位相关出血。然而，没有足够的数据将出血减少的趋势仅归因于技术改进。尤其是减少插管部位出血也是由于时间、患者选择和超声引导下经皮插管的变化。其他类型的出血（例如CNS）保持稳定，总体出血与死亡率的持续增加相关。
关键词：Humans; Female; Male; Middle Aged; Aged; Adult; Cohort Studies; Retrospective Studies; Registries; *Extracorporeal Membrane Oxygenation/adverse effects; Catheterization/adverse effects

--------
--------

## Sex Differences in Treatment of Adult Intensive Care Patients: A Systematic Review and Meta-Analysis., Modra, Lucy J.

6:913-923. DOI:10.1097/CCM.0000000000005469

Abstract: 

OBJECTIVES: To evaluate and synthesize the available literature on sex differences in the treatment of adult ICU patients. 

DATA SOURCES: MEDLINE and  EMBASE. 

STUDY SELECTION: Two reviewers independently screened publications to  identify observational studies of adult ICU patients that explicitly examined the  association between sex and ICU treatment-specifically, mechanical ventilation,  renal replacement therapy, and length of stay. 

DATA EXTRACTION: We extracted data  independently and in duplicate: mean age, illness severity, use of mechanical  ventilation and renal replacement therapy, and length of stay in ICU and  hospital. We assessed risk of bias using the Newcastle-Ottawa Scale. We used a  DerSimonian-Laird random-effects model to calculate pooled odds ratios (ORs) and  mean differences between women and men. 

DATA SYNTHESIS: We screened 4,098  publications, identifying 21 eligible studies with 545,538 participants (42.7%  women). The study populations ranged from 246 to 261,255 participants (median  4,420). Most studies (76.2%) were at high risk of bias in at least one domain,  most commonly representativeness or comparability. Women were less likely than  men to receive invasive mechanical ventilation (OR, 0.83; 95% CI, 0.77-0.89; I2 =  90.4%) or renal replacement therapy (OR, 0.79; 95% CI, 0.70-0.90; I2 = 76.2%).  ICU length of stay was shorter in women than men (mean difference, -0.24 d; 95%  CI, -0.37 to -0.12; I2 = 89.9%). These findings persisted in meta-analysis of  data adjusted for illness severity and other confounders and also in sensitivity  analysis excluding studies at high risk of bias. There was no significant sex  difference in duration of mechanical ventilation or hospital length of stay.  

CONCLUSIONS: Women were less likely than men to receive mechanical ventilation or  renal replacement therapy and had shorter ICU length of stay than men. There is  substantial heterogeneity and risk of bias in the literature; however, these  findings persisted in sensitivity analyses.

## 成人重症监护患者治疗中的性别差异：一项系统回顾和荟萃分析。

目的：评价和整合关于成人ICU患者治疗中性别差异的现有文献。

数据来源：MEDLINE和EMBASE。

研究选择：两名评审员独立筛选了出版物，以识别ICU成人患者的观察性研究，该研究明确了性别与ICU治疗（尤其是机械通气、肾脏替代治疗）和住院时间之间的相关性。

数据提取：我们独立和重复提取数据：平均年龄、疾病严重程度、机械通气和肾脏替代治疗的使用以及ICU和医院住院时间。我们使用Newcastle-Ottawa量表评估了偏倚风险。我们使用DerSimonian-Laird随机效应模型计算合并比值比(OR)和女性与男性之间的平均差异。

数据综合：我们筛选了4098篇发表文献，确定了21项合格研究，545538例受试者（42.7%为女性）。研究人群范围为246 ~ 261,255例受试者（中位数4,420例）。大多数研究(76.2%)至少在一个领域存在较高的偏倚风险，最常见的是代表性或可比性。女性接受有创机械通气(OR，0.83；95%CI，0.77-0.89；I2 = 90.4%)或肾脏替代治疗(OR，0.79；95%CI，0.70-0.90；I2 = 76.2%)的可能性低于男性。女性ICU住院时间短于男性（平均差异，-0.24 d；95%CI，-0.37至-0.12；I2 = 89.9%）。这些结果在针对疾病严重程度和其他混杂因素调整的数据荟萃分析以及排除偏倚高风险研究的敏感性分析中持续存在。机械通气时间或住院时间无显著性别差异。

结论：女性接受机械通气或肾脏替代治疗的可能性低于男性，ICU住院时间短于男性。文献中存在显著的异质性和偏倚风险；但是，敏感性分析中仍存在这些结果。
关键词：Humans; Female; Male; Time Factors; Length of Stay; Adult; Critical Care; Respiration, Artificial; *Intensive Care Units; *Critical Illness/therapy; Sex Characteristics

--------
--------

## CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study., Stockmann, Helena

6:964-976. DOI:10.1097/CCM.0000000000005493

Abstract: 

OBJECTIVES: To investigate the effect of extracorporeal cytokine reduction by CytoSorb (CytoSorbents, Monmouth Junction, NJ) on COVID-19-associated vasoplegic  shock. 

DESIGN: Prospective, randomized controlled pilot study. 

SETTING: Eight  ICUs at three sites of the tertiary-care university hospital  Charit??-Universit?¤tsmedizin Berlin. 

PATIENTS: COVID-19 patients with vasoplegic  shock requiring norepinephrine greater than 0.2 ??g/kg/min, C-reactive protein  greater than 100 mg/L, and indication for hemodialysis. 

INTERVENTIONS:  Randomization of 1:1 to receive CytoSorb for 3-7 days or standard therapy. To  account for inadvertent removal of antibiotics, patients in the treatment group  received an additional dose at each adsorber change. 

MEASUREMENTS AND MAIN  RESULTS: The primary endpoint was time until resolution of vasoplegic shock,  estimated by Cox-regression. Secondary endpoints included mortality,  interleukin-6 concentrations, and catecholamine requirements. The study was  registered in the German Registry of Clinical Trials (DRKS00021447). From  November 2020 to March 2021, 50 patients were enrolled. Twenty-three patients  were randomized to receive CytoSorb and 26 patients to receive standard of care.  One patient randomized to cytokine adsorption was excluded due to withdrawal of  informed consent. Resolution of vasoplegic shock was observed in 13 of 23  patients (56.5%) in the CytoSorb and 12 of 26 patients (46.2%) in the control  group after a median of 5 days (interquartile range [IQR], 4-5 d) and 4 days  (IQR, 3-5 d). The hazard ratio (HR) for the primary endpoint, adjusted for the  predefined variables age, gender, extracorporeal membrane oxygenation-therapy, or  time from shock onset to study inclusion was HR, 1.23 (95% CI, 0.54-2.79); p =  0.63. The mortality rate was 78% in the CytoSorb and 73% in the control group  (unadjusted HR, 1.17 [95% CI, 0.61-2.23]; p = 0.64). The effects on inflammatory  markers, catecholamine requirements, and the type and rates of adverse events  were similar between the groups. 

CONCLUSIONS: In severely ill COVID-19 patients,  CytoSorb did not improve resolution of vasoplegic shock or predefined secondary  endpoints.

## COVID-19血管痉挛性休克和多器官功能衰竭患者的CytoSorb抢救：一项前瞻性、开放标签、随机对照初探性研究。

目的：研究CytoSorb(CytoSorbents,Monmouth Junction,NJ) 减少体外细胞因子对 COVID-19 血管麻痹性休克的影响。

设计：前瞻性、随机对照初探性研究。

设置：柏林夏里特医学院三级大学医院三个研究中心的8个ICU。

患者：需要去甲肾上腺素大于0.2 ?g/kg/min、C反应蛋白大于 100 mg/L 和血液透析指征的血管麻痹性休克 COVID-19 患者。

干预措施：以1:1的比例随机接受 CytoSorb 治疗3-7天或标准治疗。为了解释意外去除抗生素，治疗组患者在每次更换吸附器时接受了额外剂量。

测量和主要结果：主要终点是通过 Cox 回归估计的至血管麻痹性休克消退的时间。次要终点包括死亡率、白细胞介素-6浓度和儿茶酚胺需要量。本研究在德国临床试验注册中心注册 (DRKS00021447)。2020年11月至2021年3月，入组50例。23例患者随机接受 CytoSorb 治疗，26例患者接受标准治疗。1例随机接受细胞因子吸附的患者因撤回知情同意而被排除。在中位5天（四分位距 [IQR]，4-5天）和4天（IQR，3-5天）后，观察到 CytoSorb 组23例患者中的13例 (56.5%) 和对照组26例患者中的12例 (46.2%) 血管麻痹性休克消退。针对预先定义的变量年龄、性别、体外膜肺氧合治疗或从休克发作到研究入选的时间进行调整后，主要终点的风险比 (HR) 为HR，1.23(95%CI，0.54-2.79)；p = 0.63。CytoSorb 组的死亡率为78%，对照组为73%（未校正HR，1.17[95%CI，0.61-2.23]；p = 0.64）。两组之间对炎症标志物、儿茶酚胺需求以及不良事件类型和发生率的影响相似。

结论：在重症 COVID-19 患者中，CytoSorb不能改善血管麻痹性休克的缓解或预定的次要终点。
关键词：Humans; Treatment Outcome; Prospective Studies; Pilot Projects; Norepinephrine; Cytokines; Research Design; *COVID-19/therapy; *Shock; Multiple Organ Failure/therapy

--------
--------

## Frailty and Disability: Predictors or Outcomes or Both in Post COVID-19.

6:1023-1025. DOI:10.1097/CCM.0000000000005502

## 虚弱和残疾：COVID-19后的预测因素或结局或两者兼而有之。
关键词：Humans; Aged; *COVID-19; Frail Elderly; *Disabled Persons; *Frailty/epidemiology

--------
--------

## Factors Associated With Brain Tissue Oxygenation Changes After RBC Transfusion in Acute Brain Injury Patients., Gouv??a Bogossian, Elisa

6:e539-e547. DOI:10.1097/CCM.0000000000005460

Abstract: 

OBJECTIVES: Anemia is common after acute brain injury and can be associated with brain tissue hypoxia. RBC transfusion (RBCT) can improve brain oxygenation;  however, predictors of such improvement remain unknown. We aimed to identify the  factors associated with PbtO2 increase (greater than 20% from baseline value)  after RBCT, using a generalized mixed model. 

DESIGN: This is a multicentric  retrospective cohort study (2012-2020). 

SETTING: This study was conducted in  three European ICUs of University Hospitals located in Belgium, Switzerland, and  Austria. 

PATIENTS: All patients with acute brain injury who were monitored with  brain tissue oxygenation (PbtO2) catheters and received at least one RBCT.  

INTERVENTION: Patients received at least one RBCT. PbtO2 was recorded before, 1  hour, and 2 hours after RBCT. 

MEASUREMENTS AND MAIN RESULTS: We included 69  patients receiving a total of 109 RBCTs after a median of 9 days (5-13 d) after  injury. Baseline hemoglobin (Hb) and PbtO2 were 7.9 g/dL [7.3-8.7 g/dL] and 21 mm  Hg (16-26 mm Hg), respectively; 2 hours after RBCT, the median absolute Hb and  PbtO2 increases from baseline were 1.2 g/dL [0.8-1.8 g/dL] (p = 0.001) and 3 mm  Hg (0-6 mm Hg) (p = 0.001). A 20% increase in PbtO2 after RBCT was observed in 45  transfusions (41%). High heart rate (HR) and low PbtO2 at baseline were  independently associated with a 20% increase in PbtO2 after RBCT. Baseline PbtO2  had an area under receiver operator characteristic of 0.73 (95% CI, 0.64-0.83) to  predict PbtO2 increase; a PbtO2 of 20 mm Hg had a sensitivity of 58% and a  specificity of 73% to predict PbtO2 increase after RBCT. 

CONCLUSIONS: Lower PbtO2  values and high HR at baseline could predict a significant increase in brain  oxygenation after RBCT.

## 急性脑损伤患者输注 RBC 后脑组织氧合变化的相关因素。

目的：贫血在急性脑损伤后很常见，可能与脑组织缺氧有关。RBC 输注 (RBCT) 可改善脑氧合；然而，这种改善的预测因素仍不清楚。我们的目的是使用广义混合模型确定 RBCT 后 PbtO2 升高（较基线值大于20%）的相关因素。

设计：这是一项多中心回顾性队列研究 (2012-2020)。

单位：本研究在位于比利时、瑞士和奥地利的大学医院的三个欧洲 ICU 进行。

患者：所有使用脑组织氧合 (PbtO2) 导管监测并接受至少一次 RBCT 的急性脑损伤患者。

干预：患者接受至少一次RBCT。记录 RBCT 前、RBCT后1 h、2 h的PbtO2。

测量和主要结果：我们纳入了69例患者，在受伤后中位9天（5-13天）接受了总计109次RBCT。基线血红蛋白 (Hb) 和 PbtO2 分别为7.9 g/dL[7.3-8.7 g/dL] 和21 mmHg(16-26 mmHg)；RBCT后2小时，中位绝对 Hb 和 PbtO2 相对于基线的增加分别为1.2 g/dL[0.8-1.8 g/dL](p = 0.001) 和3 mmHg(0-6 mmHg)(p = 0.001)。在45例输血 (41%) 中观察到 RBCT 后 PbtO2 增加20%。基线时高心率 (HR) 和低 PbtO2 与 RBCT 后 PbtO2 增加20%独立相关。基线 PbtO2 预测 PbtO2 增加的受试者工作特征下面积为0.73(95%CI，0.64-0.83)；20 mmHg的 PbtO2 预测 RBCT 后 PbtO2 增加的敏感性为58%，特异性为73%。

结论：基线时较低的 PbtO2 值和较高的 HR 可以预测 RBCT 后脑氧合的显著增加。
关键词：Humans; Brain; Oxygen; Retrospective Studies; *Brain Injuries/complications/therapy; Erythrocyte Transfusion; Erythrocytes

--------
--------

## High-Flow Nasal Cannula in COVID-19 Pneumonia: Practical Issues.

6:e591-e592. DOI:10.1097/CCM.0000000000005483

## 高流量鼻导管在 COVID-19 肺炎中的应用：实际问题。
关键词：Humans; Oxygen Inhalation Therapy; *COVID-19; SARS-CoV-2; *Noninvasive Ventilation; *Respiratory Insufficiency/therapy; Cannula

--------
--------

## Low Tidal Volume Ventilation for Emergency Department Patients: A Systematic Review and Meta-Analysis on Practice Patterns and Clinical Impact.

6:986-998. DOI:10.1097/CCM.0000000000005459

Abstract: 

OBJECTIVES: Data suggest that low tidal volume ventilation (LTVV) initiated in the emergency department (ED) has a positive impact on outcome. This systematic  review and meta-analysis quantify the impact of ED-based LTVV on outcomes and  ventilator settings in the ED and ICU. 

DATA SOURCES: We systematically reviewed  MEDLINE, EMBASE, Scopus, Cochrane Central Register of Controlled Trials, Cochrane  Database of Systematic Reviews, references, conferences, and ClinicalTrials.gov.  

STUDY SELECTION: Randomized and nonrandomized studies of mechanically ventilated  ED adults were eligible. 

DATA EXTRACTION: Two reviewers independently screened  abstracts. The primary outcome was mortality. Secondary outcomes included  ventilation duration, lengths of stay, and occurrence rate of acute respiratory  distress syndrome (ARDS). We assessed impact of ED LTVV interventions on ED and  ICU tidal volumes. 

DATA SYNTHESIS: The search identified 1,023 studies. Eleven  studies (n = 12,912) provided outcome data and were meta-analyzed; 10 additional  studies (n = 1,863) provided descriptive ED tidal volume data. Overall quality of  evidence was low. Random effect meta-analytic models revealed that ED LTVV was  associated with lower mortality (26.5%) versus non-LTVV (31.1%) (odds ratio, 0.80  [0.72-0.88]). ED LTVV was associated with shorter ICU (mean difference, -1.0; 95%  CI, -1.7 to -0.3) and hospital (mean difference, -1.2; 95% CI, -2.3 to -0.1)  lengths of stay, more ventilator-free days (mean difference, 1.4; 95% CI,  0.4-2.4), and lower occurrence rate (4.5% vs 8.3%) of ARDS (odds ratio, 0.57  [0.44-0.75]). ED LTVV interventions were associated with reductions in ED  (-1.5-mL/kg predicted body weight [PBW] [-1.9 to -1.0]; p < 0.001) and ICU  (-1.0-mL/kg PBW [-1.8 to -0.2]; p = 0.01) tidal volume. 

CONCLUSIONS: The use of  LTVV in the ED is associated with improved clinical outcomes and increased use of  lung protection, recognizing low quality of evidence in this domain.  Interventions aimed at implementing and sustaining LTVV in the ED should be  explored.

## 急诊科患者的低潮气量通气：实践模式和临床影响的系统综述和荟萃分析。

目的：数据表明，在急诊科 (ED) 开始的低潮气量通气 (LTVV) 对结局有积极影响。该系统综述和荟萃分析量化了基于 ED 的 LTVV 对 ED 和 ICU 结局和呼吸机设置的影响。

数据来源：我们系统回顾了MEDLINE,EMBASE,Scopus,Cochrane Central Register of Controlled Trials,Cochrane Database of Systematic Reviews,references,conferences,andClinicalTrials.gov.研究选择：机械通气 ED 成人的随机和非随机研究均合格。

数据提取：两名评审员独立筛选摘要。主要结局是死亡率。次要结局包括通气持续时间、住院时间和急性呼吸窘迫综合征 (ARDS) 的发生率。我们评估了 ED LTVV 干预对 ED 和 ICU 潮气量的影响。

数据综合：检索识别出1,023项研究。11项研究 (n = 12,912) 提供了结局数据并进行了荟萃分析；另外10项研究 (n = 1,863) 提供了描述性 ED 潮气量数据。证据的总体质量较低。随机效应荟萃分析模型显示，与非LTVV(31.1%) 相比，ED LTVV与较低的死亡率 (26.5%) 相关（比值比，0.80[0.72-0.88]）。ED LTVV 与ICU（平均差异，-1.0；95%CI，-1.7至-0.3）和住院（平均差异，-1.2；95%CI，-2.3至-0.1）时间更短、无呼吸机天数更多（平均差异，1.4；95%CI，0.4-2.4）和 ARDS 发生率更低 (4.5%vs 8.3%) 相关（比值比，0.57[0.44-0.75]）。ED LTVV 干预与ED（-1.5 mL/kg预测体重 [PBW][-1.9至-1.0]；p < 0.001）和ICU（-1.0 mL/kg PBW[-1.8至-0.2]；p = 0.01）潮气量减少相关。

结论：在 ED 中使用 LTVV 与临床结局改善和肺保护的使用增加相关，认识到该领域的证据质量较低。应探讨旨在在 ED 实施和维持 LTVV 的干预措施。
关键词：Humans; Intensive Care Units; Adult; Emergency Service, Hospital; Randomized Controlled Trials as Topic; Lung; Tidal Volume; *Respiratory Distress Syndrome/therapy; *Respiration, Artificial

--------
--------

## Association of Metformin Use During Hospitalization and Mortality in Critically Ill Adults With Type 2 Diabetes Mellitus and Sepsis.

6:935-944. DOI:10.1097/CCM.0000000000005468

Abstract: 

OBJECTIVES: Whether metformin exposure is associated with improved outcomes in patients with type 2 diabetes mellitus and sepsis. 

DESIGN: Retrospective cohort  study. 

SETTING: Patients admitted to ICUs in 16 hospitals in Pennsylvania from  October 2008 to December 2014. 

PATIENTS: Adult critical ill patients with type 2  diabetes mellitus and sepsis. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS:  We conducted a retrospective cohort study to compare 90-day mortality in diabetic  patients with sepsis with and without exposure to metformin during  hospitalization. Data were obtained from the electronic health record of a large  healthcare system in Pennsylvania from October 2008 to December 2014, on patients  admitted to the ICU at any of the 16 hospitals within the system. The primary  outcome was mortality at 90 days. The absolute and adjusted odds ratio (OR) with  95% CI were calculated in a propensity score-matched cohort. Among 14,847  patients with type 2 diabetes mellitus and sepsis, 682 patients (4.6%) were  exposed to metformin during hospitalization and 14,165 (95.4%) were not. Within a  total of 2,691 patients subjected to propensity score-matching at a 1:4 ratio,  exposure to metformin (n = 599) was associated with decreased 90-day mortality  (71/599, 11.9% vs 475/2,092, 22.7%; OR, 0.46; 95% CI, 0.35-0.60), reduced severe  acute kidney injury (50% vs 57%; OR, 0.75; 95% CI, 0.62-0.90), less Major Adverse  Kidney Events at 1 year (OR, 0.27; 95% CI, 0.22-0.68), and increased renal  recovery (95% vs 86%; OR, 6.43; 95% CI, 3.42-12.1). 

CONCLUSIONS: Metformin  exposure during hospitalization is associated with a decrease in 90-day mortality  in patients with type 2 diabetes mellitus and sepsis.

## 住院期间使用二甲双胍与2型糖尿病和败血症危重成人患者死亡率的相关性。

目的：二甲双胍暴露是否与2型糖尿病和败血症患者结局改善相关。

设计：回顾性队列研究。

地点：2008年10月至2014年12月宾夕法尼亚州16家医院ICU收治的患者。

患者：2型糖尿病和败血症成人重症患者。

干预：无。

测量和主要结果：我们进行了一项回顾性队列研究，以比较住院期间暴露于和未暴露于二甲双胍的伴有败血症的糖尿病患者的90天死亡率。数据来自2008年10月至2014年12月宾夕法尼亚州一家大型医疗系统的电子健康记录，关于系统内16家医院中任何一家入住ICU的患者。主要结局为90天时的死亡率。在倾向评分匹配队列中计算绝对和校正比值比 (OR) 及95%CI。在14,847例2型糖尿病和败血症患者中，682例患者 (4.6%) 在住院期间暴露于二甲双胍，14,165例患者 (95.4%) 未暴露于二甲双胍。在总计2,691例以1:4比例进行倾向评分匹配的患者中，暴露于二甲双胍 (n = 599) 与90天死亡率降低 (71/599，11.9%vs 475/2,092，22.7%；OR，0.46；95%CI，0.35-0.60)、重度急性肾损伤降低 (50%vs 57%；OR，0.75；95%CI，0.62-0.90) 相关，1年时主要肾脏不良事件减少 (OR，0.27；95%CI，0.22-0.68)，肾脏恢复增加 (95%vs 86%；OR，6.43；95%CI，3.42-12.1)。

结论：住院期间二甲双胍暴露与2型糖尿病和败血症患者90天死亡率降低相关。
关键词：Humans; Critical Illness; Adult; Retrospective Studies; Hospitalization; *Metformin/therapeutic use; *Diabetes Mellitus, Type 2/complications/drug therapy; *Sepsis/complications/drug therapy

--------
--------

## Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial., Drewry, Anne M.

6:924-934. DOI:10.1097/CCM.0000000000005470

Abstract: 

OBJECTIVES: To test the hypothesis that forced-air warming of critically ill afebrile sepsis patients improves immune function compared to standard  temperature management. 

DESIGN: Single-center, prospective, open-label,  randomized controlled trial. 

SETTING: One thousand two hundred-bed academic  medical center. 

PATIENTS: Eligible patients were mechanically ventilated septic  adults with: 1) a diagnosis of sepsis within 48 hours of enrollment; 2)  anticipated need for mechanical ventilation of greater than 48 hours; and 3) a  maximum temperature less than 38.3?°C within the 24 hours prior to enrollment.  

Primary exclusion criteria included: immunologic diseases, immune-suppressing  medications, and any existing condition sensitive to therapeutic hyperthermia  (e.g., brain injury). The primary outcome was monocyte human leukocyte antigen  (HLA)-DR expression, with secondary outcomes of CD3/CD28-induced interferon gamma  (IFN-??) production, mortality, and 28-day hospital-free days. 

INTERVENTIONS:  External warming using a forced-air warming blanket for 48 hours, with a goal  temperature 1.5?°C above the lowest temperature documented in the previous 24  hours. 

MEASUREMENTS AND MAIN RESULTS: We enrolled 56 participants in the study.  No differences were observed between the groups in HLA-DR expression (692 vs  2,002; p = 0.396) or IFN-?? production (31 vs 69; p = 0.678). Participants  allocated to external warming had lower 28-day mortality (18% vs 43%; absolute  risk reduction, 25%; 95% CI, 2-48%) and more 28-day hospital-free days  (difference, 2.6 d; 95% CI, 0-11.6). 

CONCLUSIONS: Participants randomized to  external forced-air warming did not have a difference in HLA-DR expression or  IFN-?? production. In this pilot study, however, 28-day mortality was lower in the  intervention group. Future research should seek to better elucidate the impact of  temperature modulation on immune and nonimmune organ failure pathways in sepsis.

## 治疗性高热与发热危重症脓毒症患者的生存率改善相关：一项初探性随机化试验。

目的：检验与标准温度管理相比，强制空气加温重症无热败血症患者改善免疫功能的假设。

设计：单中心、前瞻性、开放标签、随机对照试验。

单位：一千二百张床位的学术医学中心。

患者：合格患者为机械通气的脓毒症成人患者：1）入组前48小时内诊断为脓毒症；2）预期需要机械通气超过48小时；和3）入组前24小时内最高体温低于38.3℃。

主要排除标准包括：免疫性疾病、免疫抑制药物和对治疗性体温过高敏感的任何现有疾病（例如，脑损伤）。主要结局是单核细胞人类白细胞抗原 (HLA)-DR 表达，次要结局是 CD3/CD28 诱导的干扰素γ (IFN-ō?) 产生、死亡率和28天无住院天数。

干预：使用强制空气加温毯进行外部加温48小时，目标温度比之前24小时内记录的最低温度高1.5℃。

测量和主要结果：我们入组了56例受试者。两组之间的 HLA-DR 表达 (692 vs 2,002;p = 0.396) 或IFN-ō?产生 (31 vs 69;p = 0.678) 没有差异。分配到外部加温组的受试者28天死亡率较低（18%vs 43%；绝对风险降低，25%；95%CI，2-48%），28天无住院天数较多（差异，2.6天；95%CI，0-11.6）。

结论：随机接受外部强制空气加温的参与者在 HLA-DR 表达或IFN-ō?产生方面没有差异。然而，在这项初探性研究中，干预组的28天死亡率较低。未来的研究应该寻求更好地阐明温度调节对脓毒症免疫和非免疫器官衰竭途径的影响。
关键词：Humans; Prospective Studies; Adult; Pilot Projects; *COVID-19; SARS-CoV-2; Critical Illness/therapy; *Sepsis/therapy; *Hyperthermia, Induced; HLA-DR Antigens

--------
--------

## Intravascular Versus Surface Cooling in Patients Resuscitated From Cardiac Arrest: A Systematic Review and Network Meta-Analysis With Focus on Temperature  Feedback., Ramadanov, Nikolai

6:999-1009. DOI:10.1097/CCM.0000000000005463

Abstract: 

OBJECTIVE: The aim of the study was to compare the effect of intravascular cooling (IC), surface cooling with temperature feedback (SCF), and surface  cooling without temperature feedback (SCnoF) on neurologic outcome and survival  in patients successfully resuscitated from cardiac arrest (CA) and treated with  targeted temperature management (TTM) at 32-34?°C. 

DATA SOURCES: We performed a  systematic review on Cochrane Central Register of Controlled Trials, Cochrane  Database of Systematic Reviews, MEDLINE, SCOPUS, CINAHL, Web of Science, and  Clinical Trials up to June 30, 2021. 

STUDY SELECTION: We included randomized and  nonrandomized studies on IC, SCF, and SCnoF in adult humans resuscitated from CA  undergoing TTM, reporting neurologic outcome or survival. 

DATA EXTRACTION: We  performed a network meta-analysis to assess the comparative effects of IC, SCF,  and SCnoF. The overall effect between two cooling methods included the effect of  direct and indirect comparisons. Results are given as odds ratios (OR) and 95%  CIs. Rankograms estimated the probability of TTM methods being ranked first,  second, and third best interventions. 

DATA SYNTHESIS: A total of 14 studies  involving 4,062 patients met the inclusion criteria. Four studies were randomized  controlled studies, and 10 studies were nonrandomized observational studies. IC  compared with SCnoF was significantly associated with better neurologic outcome  (OR, 0.6; 95% CI, 0.49-0.74) and survival (OR, 0.8; 95% CI, 0.66-0.96). IC  compared with SCF, and SCF compared with SCnoF did not show significant  differences in neurologic outcome and survival. The rankogram showed that IC had  the highest probability to be the most beneficial cooling method, followed by SCF  and SCnoF. 

CONCLUSIONS: Our results suggest that in patients resuscitated from CA  and treated with TTM at 32-34?°C, IC has the highest probability of being the most  beneficial cooling method for survival and neurologic outcome.

## 心脏骤停复苏患者的血管内与表面冷却比较：一项关注温度反馈的系统综述和网络荟萃分析。

目的：本研究的目的是比较血管内冷却 (IC)、表面冷却与温度反馈 (SCF)、以及无温度反馈的表面冷却 (SCnoF) 对心脏骤停 (CA) 成功复苏并在32-34℃下接受靶向温度管理 (TTM) 治疗的患者的神经系统结局和存活率的影响。

数据来源：我们对 Cochrane 临床对照试验中心注册数据库进行了系统综述，Cochrane 系统综述数据库、MEDLINE、SCOPUS、CINAHL、Web of Science和截至2021年06月30日的临床试验。

研究选择：我们纳入了在接受 TTM 的 CA 复苏的成人中进行IC、SCF和 SCnoF 的随机和非随机研究，报告了神经系统结局或生存期。

数据提取：我们进行了一项网络荟萃分析，以评估IC、SCF和 SCnoF 的比较效应。两种冷却方法之间的总体效果包括直接和间接比较的效果。结果表示为比值比 (OR) 和95%CI。等级图估计了 TTM 方法排在第一、第二和第三最佳干预措施的概率。

数据综合：共有14项研究（涉及4062例患者）符合入选标准。4项研究为随机对照研究，10项研究为非随机观察性研究。与 SCnoF 相比，IC与更好的神经系统结局 (OR，0.6；95%CI，0.49-0.74) 和生存率 (OR，0.8；95%CI，0.66-0.96) 显著相关。IC 与 SCF 相比，SCF与 SCnoF 相比，在神经系统结局和生存率方面未显示出显著差异。等级图显示，IC是最有益的冷却方法的概率最高，其次是 SCF 和SCnoF。

结论：我们的结果表明，在从 CA 复苏并用 TTM 在32-34℃治疗的患者中，IC是对生存和神经系统结局最有益的冷却方法的概率最高。
关键词：Humans; Adult; Feedback; *Cardiopulmonary Resuscitation/methods; *Heart Arrest/complications; *Hypothermia, Induced/methods; Network Meta-Analysis; Temperature

--------
--------

## Patient-Centered Outcomes Following COVID-19: Frailty and Disability Transitions in Critical Care Survivors.

6:955-963. DOI:10.1097/CCM.0000000000005488

Abstract: 

OBJECTIVES: As the pandemic advances, the interest in the long-lasting consequences of COVID-19 increases. However, a few studies have explored  patient-centered outcomes in critical care survivors. We aimed to investigate  frailty and disability transitions in COVID-19 patients admitted to ICUs. 

DESIGN:  Prospective cohort study. 

SETTING: University hospital in Sao Paulo. 

PATIENTS:  Survivors of COVID-19 ICU admissions. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN  RESULTS: We assessed frailty using the Clinical Frailty Scale (CFS). We also  evaluated 15 basic, instrumental, and mobility activities. Baseline frailty and  disability were defined by clinical conditions 2-4 weeks before COVID-19, and  post-COVID-19 was characterized 90 days (day 90) after hospital discharge. We  used alluvial flow diagrams to visualize transitions in frailty status, Venn  diagrams to describe the overlap between frailty and disabilities in activities  of daily living, and linear mixed models to explore the occurrence of new  disabilities following critical care in COVID-19. We included 428 participants  with a mean age of 64 years, 57% males, and a median Simplified Acute Physiology  Score-3 score of 59. Overall, 14% were frail at baseline. We found that 124/394  participants (31%) were frail at day 90, 70% of whom were previously non-frail.  The number of disabilities also increased (mean difference, 2.46; 95% CI,  2.06-2.86), mainly in participants who were non-frail before COVID-19. Higher  pre-COVID-19 CFS scores were independently associated with new-onset  disabilities. At day 90, 135 patients (34%) were either frail or disabled.  

CONCLUSIONS: Frailty and disability were more frequent 90 days after hospital  discharge compared with baseline in COVID-19 patients admitted to the ICU. Our  results show that most COVID-19 critical care survivors transition to poorer  health status, highlighting the importance of long-term medical follow-up for  this population.

## COVID-19 后以患者为中心的结局：重症监护幸存者的虚弱和残疾转变。

目的：随着大流行的进展，人们对 COVID-19 长期后果的兴趣增加。然而，一些研究探索了重症监护幸存者以患者为中心的结局。我们的目的是调查入住 ICU 的 COVID-19 患者的虚弱和残疾转变。

设计：前瞻性队列研究。

单位：圣保罗大学医院。

患者：入住 COVID-19 ICU 的幸存者。

干预：无。

测量和主要结果：我们使用临床虚弱量表 (CFS) 评估虚弱。我们还评估了15项基本、工具和活动。基线虚弱和残疾定义为 COVID-19 前2-4周的临床状况，COVID-19后在出院后90天（第90天）进行表征。我们使用冲积流图来可视化虚弱状态的转变，使用维恩图来描述日常生活活动中虚弱和残疾之间的重叠，使用线性混合模型来探索 COVID-19 重症监护后新发残疾的发生。我们纳入了428例受试者，平均年龄为64岁，57%为男性，简化急性生理学评分-3分的中位数为59分。总体而言，14%的患者在基线时虚弱。我们发现124/394的参与者 (31%) 在第90天虚弱，其中70%以前不虚弱。致残人数也增加（平均差异，2.46；95%CI，2.06-2.86），主要发生在 COVID-19 前非虚弱的参与者中。较高的 COVID-19 前 CFS 评分与新发残疾独立相关。在第90天，135例患者 (34%) 虚弱或残疾。

结论：在入住 ICU 的 COVID-19 患者中，与基线相比，出院后90天虚弱和残疾更常见。我们的结果显示，大多数 COVID-19 重症监护幸存者向较差的健康状况过渡，突出了对该人群进行长期医学随访的重要性。
关键词：Humans; Female; Male; Middle Aged; Prospective Studies; Critical Care; Activities of Daily Living; *COVID-19; Survivors; *Frailty/epidemiology; *Fatigue Syndrome, Chronic; Brazil; Critical Illness/epidemiology; Patient-Centered Care

--------
--------

## Drp1/Fis1-Dependent Pathologic Fission and Associated Damaged Extracellular Mitochondria Contribute to Macrophage Dysfunction in Endotoxin Tolerance., Mukherjee, Riddhita

6:e504-e515. DOI:10.1097/CCM.0000000000005437

Abstract: 

OBJECTIVES: Recent publications have shown that mitochondrial dynamics can govern the quality and quantity of extracellular mitochondria subsequently impacting  immune phenotypes. This study aims to determine if pathologic mitochondrial  fission mediated by Drp1/Fis1 interaction impacts extracellular mitochondrial  content and macrophage function in sepsis-induced immunoparalysis. 

DESIGN:  Laboratory investigation. 

SETTING: University laboratory. 

SUBJECTS: C57BL/6 and  BALB/C mice. 

INTERVENTIONS: Using in vitro and murine models of endotoxin  tolerance (ET), we evaluated changes in Drp1/Fis1-dependent pathologic fission  and simultaneously measured the quantity and quality of extracellular  mitochondria. Next, by priming mouse macrophages with isolated healthy  mitochondria (MC) and damaged mitochondria, we determined if damaged  extracellular mitochondria are capable of inducing tolerance to subsequent  endotoxin challenge. Finally, we determined if inhibition of Drp1/Fis1-mediated  pathologic fission abrogates release of damaged extracellular mitochondria and  improves macrophage response to subsequent endotoxin challenge. 

MEASUREMENTS AND  MAIN RESULTS: When compared with na??ve macrophages (NMs), endotoxin-tolerant  macrophages (ETM) demonstrated Drp1/Fis1-dependent mitochondrial dysfunction and  higher levels of damaged extracellular mitochondria (Mitotracker-Green +  events/50 ??L: ETM = 2.42 ?? 106 ?± 4,391 vs NM = 5.69 ?? 105 ?± 2,478; p < 0.001).  Exposure of NMs to damaged extracellular mitochondria (MH) induced  cross-tolerance to subsequent endotoxin challenge, whereas MC had minimal effect  (tumor necrosis factor [TNF]-?± [pg/mL]: NM = 668 ?± 3, NM + MH = 221 ?± 15, and NM  + Mc = 881 ?± 15; p < 0.0001). Inhibiting Drp1/Fis1-dependent mitochondrial  fission using heptapeptide (P110), a selective inhibitor of Drp1/Fis1  interaction, improved extracellular mitochondrial function (extracellular  mitochondrial membrane potential, JC-1 [R/G] ETM = 7 ?± 0.5 vs ETM + P110 =  19 ?± 2.0; p < 0.001) and subsequently improved immune response in ETMs (TNF-?±  [pg/mL]; ETM = 149 ?± 1 vs ETM + P110 = 1,150 ?± 4; p < 0.0001). Similarly,  P110-treated endotoxin tolerant mice had lower amounts of damaged extracellular  mitochondria in plasma (represented by higher extracellular mitochondrial  membrane potential, TMRM/MT-G: endotoxin tolerant [ET] = 0.04 ?± 0.02 vs ET + P110  = 0.21 ?± 0.02; p = 0.03) and improved immune response to subsequent endotoxin  treatment as well as cecal ligation and puncture. 

CONCLUSIONS: Inhibition of  Drp1/Fis1-dependent mitochondrial fragmentation improved macrophage function and  immune response in both in vitro and in vivo models of ET. This benefit is  mediated, at least in part, by decreasing the release of damaged extracellular  mitochondria, which contributes to endotoxin cross-tolerance. Altogether, these  data suggest that alterations in mitochondrial dynamics may play an important  role in sepsis-induced immunoparalysis.

## Drp1/Fis1-依赖性病理性裂变和相关的细胞外线粒体损伤促进内毒素耐受中的巨噬细胞功能障碍。

目的：近期发表的文献表明，线粒体动力学可控制随后影响细胞外线粒体质量和数量  免疫表型。本研究旨在确定病理性线粒体  Drp1/Fis1相互作用介导的裂变对胞外线粒体的影响  败血症诱导的免疫麻痹中的含量和巨噬细胞功能。

设计：  实验室检查。

单位：大学实验室。

受试者：C57BL/6和  BALB/C小鼠。

干预：使用内毒素的体外和小鼠模型  耐受(ET)，我们评估了Drp1/Fis1依赖性病理性裂变的变化  同时测定细胞外  线粒体。接下来，用分离的健康小鼠巨噬细胞启动小鼠巨噬细胞  线粒体(MC)和受损线粒体，我们确定是否受损  胞外线粒体能够诱导对后续  内毒素挑战。最后，我们确定是否抑制Drp1/Fis1-介导的  病理性裂变消除了受损细胞外线粒体的释放，以及  改善巨噬细胞对后续内毒素激发的反应。测量值和  主要结果：与天然巨噬细胞(NM)相比，内毒素耐受  巨噬细胞(ETM)表现出Drp1/Fis1-依赖性线粒体功能障碍和  受损的胞外线粒体水平较高（Mitotracker-Green +  事件/50μ?L：ETM = 2.42μ-106 μm±4,391对比NM = 5.69 μm-105 μm±2,478；p < 0.001）。NM暴露于损伤的细胞外线粒体(MH)诱导  对后续内毒素激发的交叉耐受，而MC的影响极小  （肿瘤坏死因子[TNF]-β±[pg/mL]：NM = 668 μm±3，NM + MH = 221 μm±15，和NM  + Mc = 881?±15；p < 0.0001）。抑制Drp1/Fis1依赖性线粒体  使用七肽(P110)裂解，Drp1/Fis1的选择性抑制剂  相互作用，改善细胞外线粒体功能（细胞外  线粒体膜电位，JC-1[R/G]ETM = 7 μm±0.5对比ETM + P110 =  19Μ±2.0；p < 0.001），随后改善了ETM中的免疫应答(TNF-Μ±2.0)。  [pg/mL]；ETM = 149?±1 vs ETM + P110 = 1,150?4；P < 0.0001）。同样，  P110处理的内毒素耐受小鼠细胞外的损伤量较低  血浆中的线粒体（由较高的胞外线粒体代表）  膜电位，TMRM/MT-G：内毒素耐受性[ET]= 0.04 μm±0.02 vs ET + P110  = 0.21 ?± 0.02;p = 0.03），并改善了对随后内毒素的免疫应答  治疗以及盲肠结扎和穿刺。

结论：抑制  Drp1/Fis1-依赖性线粒体碎片化改善巨噬细胞功能和  ET体外和体内模型中的免疫应答。该获益为  至少部分通过减少受损细胞外信号的释放介导  线粒体，有助于内毒素交叉耐受。总之，这些  数据表明，线粒体动力学的改变可能起着重要作用  在败血症诱导的免疫麻痹中的作用。
关键词：Humans; Animals; Mice, Inbred C57BL; Mice; Mice, Inbred BALB C; *Sepsis/pathology; Dynamins/genetics/*metabolism/pharmacology; Endotoxin Tolerance; Endotoxins; Macrophages; Membrane Proteins/genetics; Mitochondria; Mitochondrial Dynamics/physiology; Mitochondrial Proteins

--------
--------

## Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome., Seeliger, Benjamin

6:e526-e538. DOI:10.1097/CCM.0000000000005441

Abstract: 

OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) is a potentially lifesaving procedure in acute respiratory distress syndrome (ARDS) due to  COVID-19. Previous studies have shown a high prevalence of clinically silent  cerebral microbleeds in patients with COVID-19. Based on this fact, together with  the hemotrauma and the requirement of therapeutic anticoagulation on ECMO  support, we hypothesized an increased risk of intracranial hemorrhages (ICHs). We  analyzed ICH occurrence rate, circumstances and clinical outcome in patients that  received ECMO support due to COVID-19-induced ARDS in comparison to viral  non-COVID-19-induced ARDS intracerebral hemorrhage. 

DESIGN: Multicenter,  retrospective analysis between January 2010 and May 2021. 

SETTING: Three tertiary  care ECMO centers in Germany and Switzerland. 

PATIENTS: Two-hundred ten ARDS  patients on ECMO support (COVID-19, n = 142 vs viral non-COVID, n = 68).  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Evaluation of ICH occurrence  rate, parameters of coagulation and anticoagulation strategies, inflammation, and  ICU survival. COVID-19 and non-COVID-19 ARDS patients showed comparable disease  severity regarding Sequential Organ Failure Assessment score, while the  oxygenation index before ECMO cannulation was higher in the COVID group (82 vs  65 mm Hg). Overall, ICH of any severity occurred in 29 of 142 COVID-19 patients  (20%) versus four of 68 patients in the control ECMO group (6%). Fifteen of those  29 ICH events in the COVID-19 group were classified as major (52%) including nine  fatal cases (9/29, 31%). In the control group, there was only one major ICH event  (1/4, 25%). The adjusted subhazard ratio for the occurrence of an ICH in the  COVID-19 group was 5.82 (97.5% CI, 1.9-17.8; p = 0.002). The overall ICU  mortality in the presence of ICH of any severity was 88%. 

CONCLUSIONS: This  retrospective multicenter analysis showed a six-fold increased adjusted risk for  ICH and a 3.5-fold increased incidence of ICH in COVID-19 patients on ECMO.  Prospective studies are needed to confirm this observation and to determine  whether the bleeding risk can be reduced by adjusting anticoagulation strategies.

## 体外膜式氧合的颅内出血：COVID-19与其他病毒性急性呼吸窘迫综合征的差异。

目的：体外膜肺氧合(ECMO)是急性呼吸窘迫综合征(ARDS)患者的潜在救命手术，原因如下  副本-19。既往研究表明，临床无症状的患病率较高  COVID-19患者的脑微出血。基于这一事实，与  ECMO时的血伤和抗凝治疗的需求  因此，我们假设颅内出血(ICH)的风险增加。We  分析了患者的ICH发生率、情况和临床结局  由于与病毒相比，COVID-19诱导的ARDS，接受ECMO支持  非-COVID-19诱导的ARDS脑出血。

设计：多中心，  2010年1月至2021年5月的回顾性分析。

设置：三级  德国和瑞士的ECMO治疗中心。

患者：210例ARDS  ECMO支持的患者（COVID-19，n = 142 vs病毒性非COVID，n = 68）。

干预：无。

测量和主要结果：ICH发生率评价  速率、凝血参数和抗凝策略、炎症，以及  ICU存活率。COVID-19和非COVID-19 ARDS患者显示了相当的疾病  严重程度关于序贯器官衰竭评估评分，而  COVID组ECMO插管前的氧合指数更高（82 vs  65 mmHg）。总体而言，142例COVID-19患者中的29例发生任何严重程度的ICH  (20%)对比对照ECMO组68例患者中的4例(6%)。其中15例  COVID-19组的29起ICH事件归类为重大(52%)，包括9起  致死性病例(9/29，31%)。在对照组中，仅有一起重大ICH事件  (1/4, 25%).以下患者中ICH发生率的校正亚风险比  COVID-19组为5.82(97.5%CI，1.9-17.8；p = 0.002)。整个ICU  存在任何严重程度的ICH时，死亡率为88%。

结论：这  回顾性多中心分析显示校正后风险增加6倍  ICH和3.5倍在接受ECMO的COVID-19患者中ICH发生率增加。  需要前瞻性研究来证实该观察结果并确定  是否可以通过调整抗凝策略来降低出血风险。
关键词：Humans; Retrospective Studies; *Respiratory Distress Syndrome/epidemiology/therapy; *COVID-19/complications/therapy; *Extracorporeal Membrane Oxygenation/adverse effects/methods; Anticoagulants/therapeutic use; Intracranial Hemorrhages/drug therapy/epidemiology/etiology

--------
--------

## ICU Versus High-Dependency Care Unit for Patients With Acute Myocardial Infarction: A Nationwide Propensity Score-Matched Cohort Study., Ohbe, Hiroyuki

6:977-985. DOI:10.1097/CCM.0000000000005440

Abstract: 

OBJECTIVES: To compare the outcomes of patients with acute myocardial infarction who were treated in ICUs versus high-dependency care units (HDUs). 

DESIGN: A  nationwide, propensity score-matched, retrospective cohort study of a national  administrative inpatient database in Japan from July 2010 to March 2018. 

SETTING:  Six hundred sixty-six acute-care hospitals with ICU and/or HDU beds covering  about 75% of all ICU beds and 70% of all HDU beds in Japan. 

PATIENTS: Adult  patients who were hospitalized for acute myocardial infarction and admitted to  the ICU or HDU on the day of hospital admission. Propensity score-matching  analysis was performed to compare the inhospital mortality between patients  treated in the ICU and HDU on the day of hospital admission. 

INTERVENTIONS: ICU  or HDU admission on the day of hospital admission. 

MEASUREMENTS AND MAIN RESULTS:  Of 135,142 eligible patients, 89,382 (66%) were admitted to the ICU and 45,760  (34%) were admitted to the HDU on the day of admission. After propensity score  matching, there was no statistically significant difference in inhospital  mortality between the ICU and HDU groups (5.0% vs 5.5%; difference, -0.5%; 95%  CI, -1.0% to 0.1%). In the subgroup analyses, inhospital mortality was  significantly lower in the ICU group than that in the HDU group among patients  with Killip class IV (25.6% vs 28.4%; difference, -2.9%; 95% CI, -5.4% to -0.3%),  patients who underwent intubation (40.0% vs 46.6%; difference, -6.6%; 95% CI,  -10.6% to -2.7%), and patients who received mechanical circulatory support (21.8%  vs 24.7%; difference, -2.8%; 95% CI, -5.5% to -0.2%). 

CONCLUSIONS: Critical care  in the ICU compared with that in the HDU was not associated with reduced  inhospital mortality among the entire cohort of patients with acute myocardial  infarction but was associated with reduced inhospital mortality among the subsets  of patients with Killip class IV, intubation, or mechanical circulatory support.

## 急性心肌梗死患者ICU与高依赖性监护病房的比较：全国倾向评分匹配队列研究。

目的：比较在ICU与高依赖性监护病房(HDU)接受治疗的急性心肌梗死患者的结局。

设计：A  国家、倾向评分匹配的回顾性队列研究  2010年7月至2018年3月日本住院患者管理数据库。

设置：  666家急症医院，ICU和/或HDU床位覆盖  日本约75%的ICU床位和70%的HDU床位。

患者：成人  因急性心肌梗死而住院的患者  入院当天的ICU或HDU。倾向评分匹配  分析比较患者之间的住院死亡率  入院当天在ICU和HDU接受治疗。

干预措施：ICU  或在入院当天入住HDU。

测量和主要结果：  在135,142例合格患者中，89,382例(66%)进入ICU，45,760例  (34%)在入院当天进入HDU。倾向评分后  匹配，住院时间无统计学显著差异  ICU和HDU组之间的死亡率（5.0%vs 5.5%；差异，-0.5%；95%）  CI，-1.0%至0.1%）。在亚组分析中，住院死亡率为  ICU组患者显著低于HDU组  Killip IV级（25.6%vs 28.4%；差异，-2.9%；95%CI，-5.4%至-0.3%），  接受插管的患者（40.0%vs 46.6%；差异，-6.6%；95%CI，  -10.6% to -2.7%),和接受机械循环支持的患者（21.8%  vs 24.7%；差异，-2.8%；95%CI，-5.5%至-0.2%）。

结论：重症监护  ICU与HDU相比，与减少  急性心肌梗死患者整个队列的住院死亡率  梗死，但与亚组中住院死亡率降低相关  Killip IV级插管患者，或机械循环支持。
关键词：Humans; Adult; Cohort Studies; Propensity Score; Retrospective Studies; Hospital Mortality; *Intensive Care Units; *Myocardial Infarction/therapy

--------
--------

## Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield.

6:e516-e525. DOI:10.1097/CCM.0000000000005439

Abstract: 

OBJECTIVES: Brain biopsy is a useful surgical procedure in the management of patients with suspected neoplastic lesions. Its role in neurologic diseases of  unknown etiology remains controversial, especially in ICU patients. This study  was undertaken to determine the feasibility, safety, and the diagnostic yield of  brain biopsy in critically ill patients with neurologic diseases of unknown  etiology. We also aimed to compare these endpoints to those of non-ICU patients  who underwent a brain biopsy in the same clinical context. 

DESIGN: Monocenter,  retrospective, observational cohort study. 

SETTING: A French tertiary center.  

PATIENTS: All adult patients with neurologic diseases of unknown etiology under  mechanical ventilation undergoing in-ICU brain biopsy between January 2008 and  October 2020 were compared with a cohort of non-ICU patients. 

INTERVENTIONS:  None. 

MEASUREMENTS AND MAIN RESULTS: Among the 2,207 brain-biopsied patients  during the study period, 234 biopsies were performed for neurologic diseases of  unknown etiology, including 29 who were mechanically ventilated and 205 who were  not ICU patients. Specific histological diagnosis and final diagnosis rates were  62.1% and 75.9%, respectively, leading to therapeutic management modification in  62.1% of cases. Meningitis on prebiopsy cerebrospinal fluid analysis was the sole  predictor of obtaining a final diagnosis (2.3 [1.4-3.8]; p = 0.02). ICU patients  who experienced therapeutic management modification after the biopsy had longer  survival (p = 0.03). The grade 1 to 4 (mild to severe) complication rates were:  24.1%, 3.5%, 0%, and 6.9%, respectively. Biopsy-related mortality was  significantly higher in ICU patients compared with non-ICU patients (6.9% vs 0%;  p = 0.02). Hematological malignancy was associated with biopsy-related mortality  (1.5 [1.01-2.6]; p = 0.04). 

CONCLUSIONS: Brain biopsy in critically ill patients  with neurologic disease of unknown etiology is associated with high diagnostic  yield, therapeutic modifications and postbiopsy survival advantage. Safety  profile seems acceptable in most patients. The benefit/risk ratio of brain biopsy  in this population should be carefully weighted.

## 危重患者病因不明的神经系统疾病的脑活检：可行性、安全性和诊断率。

目的：脑活检是管理疑似肿瘤病变患者的有用外科手术。它在下列神经系统疾病中的作用  病因不明仍有争议，尤其在ICU患者中。本研究  旨在确定以下研究的可行性、安全性和诊断率  伴有未知神经系统疾病的重症患者的脑活检  病因。我们还旨在将这些终点与非ICU患者的终点进行比较  在相同临床背景下接受脑活检。

设计：单中心，  回顾性、观察性队列研究。

地点：法国第三中心。

患者：所有病因不明的神经系统疾病成年患者  2008年1月至2008年1月接受机械通气的ICU脑活组织检查  2020年10月与一个非ICU患者队列进行比较。

干预：  无。

测量和主要结果：在2207例脑活检患者中  在研究期间，在以下患者中进行了234次活检，以诊断神经系统疾病  病因不明，包括29例机械通气患者和205例  不是ICU患者。特异性组织学诊断和最终确诊率为  分别为62.1%和75.9%，导致  62.1%的病例。活检前脑脊液分析脑膜炎是唯一  获得最终诊断的预测因子(2.3[1.4-3.8]；p = 0.02)。ICU患者  在活检更长时间后经历治疗管理改变的患者  生存期(p = 0.03)。1-4级（轻度至重度）并发症发生率为：  分别为24.1%、3.5%、0%和6.9%。活检相关死亡率为  与非ICU患者相比，ICU患者显著更高（6.9%vs 0%；  p = 0.02).血液恶性肿瘤与活检相关死亡率相关  (1.5 [1.01-2.6]; p = 0.04).结论：重症患者的脑活检  病因不明的神经系统疾病与高诊断性相关  缓解率、治疗调整和活检后生存优势。安全性  在大多数患者中似乎可接受。脑活检获益/风险比  应仔细权衡该人群。
关键词：Humans; Adult; Brain; Respiration, Artificial; Retrospective Studies; Feasibility Studies; *Critical Illness/therapy; *Nervous System Diseases/diagnosis/etiology; Biopsy/adverse effects/methods

--------
--------

## Daily Written Care Summaries for Families of Critically Ill Patients: A Randomized Controlled Trial., Greenberg, Jared A.

5:e502-e503. DOI:10.1097/CCM.0000000000005583

Abstract: 

OBJECTIVES: To determine the effect of daily written updates on the satisfaction and psychologic symptoms of families of ICU patients. 

DESIGN: Randomized  controlled trial. 

SETTING: Single, urban academic medical center. 

SUBJECTS:  Surrogates of nondecisional, critically ill adults with high risk of mortality (n  = 252) enrolled from June 2019 to January 2021. 

INTERVENTIONS: Usual  communication with the medical team with or without written communication  detailing the suspected cause and management approach of each ICU problem,  updated each day. 

MEASUREMENTS AND MAIN RESULTS: Participants completed surveys  at three time points during the ICU stay: enrollment (n = 252), 1 week (n = 229),  and 2 weeks (n = 109) after enrollment. Satisfaction with care was measured using  the Critical Care Family Needs Inventory (CCFNI). The presence of anxiety,  depression, and acute stress were assessed using the Hospital Anxiety and  Depression Scale (HADS) and Impact of Events Scale Revised (IES-R). CCFNI, HADS,  and IES-R scores were similar among participants assigned to the intervention  group and control group upon enrollment and during the first week after  enrollment (p > 0.05). From enrollment to the second week after enrollment, there  was an improvement in CCFNI and HADS scores among participants assigned to the  intervention group versus the control group. At week 2, CCFNI scores were  significantly lower among participants in the intervention group versus the  control group, indicating greater satisfaction with care: 15.1 (95% CI,  14.2-16.0) versus 16.4, (95% CI, 15.5-17.3); p = 0.04. In addition, 2 weeks after  enrollment, the odds of symptoms of anxiety, depression, and acute stress among  participants assigned to the intervention versus control group were 0.16 (95% CI,  0.03-0.82; p = 0.03); 0.15 (95% CI, 0.01-1.87; p = 0.14); and 0.27 (95% CI,  0.06-1.27; p = 0.10), respectively. 

CONCLUSIONS: Written communication improved  satisfaction and the emotional well-being of families of critically ill patients,  supporting its use as a supplement to traditional communication approaches.

## 危重患者家庭的每日书面护理总结：一项随机化对照试验。

目的：确定每日书面更新对ICU患者家庭满意度和心理症状的影响。

设计：随机  对照试验。

单位：单所、城市学术医学中心。

受试者：  具有高死亡风险的非决定性重症成人的替代物（n  = 252）。

干预措施：通常  与医疗团队进行沟通（有或无书面沟通）  详细说明了每个ICU问题的可疑原因和处理方法，  每天更新。

测量和主要结果：受试者完成调查  在ICU住院期间的3个时间点：入组(n = 252)，1周(n = 229)，  入组后2周(n = 109)。使用以下量表测量护理满意度  重症监护家庭需求量表(CCFNI)。存在焦虑，  使用医院焦虑和  抑郁量表(HADS)和事件影响量表修订版(IES-R)。CCFNI、HADS、  且分配到干预组的受试者IES-R评分相似  入组时和入组后第1周的对照组  入组(p > 0.05)。从入组至入组后第2周，有  CCFNI和HADS评分在分配至  干预组与对照组。第2周时，CCFNI评分为  与对照组相比，干预组受试者的  对照组，表示护理满意度更高：15.1（95%CI，  14.2-16.0）；16.4(95%CI，15.5-17.3)；p = 0.04。此外，2周后  入组，受试者出现焦虑、抑郁和急性应激症状的几率  与对照组相比，分配至干预组的受试者为0.16（95%CI，  0.03-0.82；p = 0.03）；0.15(95%CI，0.01-1.87；p = 0.14)；0.27（95%CI，  0.06-1.27；p = 0.10）。

结论：书面沟通改善  重症患者家属的满意度和情感幸福感，  支持将其用作传统沟通方法的补充。

--------
--------

## Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.

5:e500-e502. DOI:10.1097/CCM.0000000000005404

Abstract: 

OBJECTIVES: To determine whether angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme (ACE) inhibitors are associated with improved  outcomes in hospitalized patients with COVID-19 according to sex and to report  sex-related differences in renin-angiotensin system (RAS) components. 

DESIGN:  Prospective observational cohort study comparing the effects of ARB or ACE  inhibitors versus no ARBs or ACE inhibitors in males versus females. Severe acute  respiratory syndrome coronavirus 2 downregulates ACE-2, potentially increasing  angiotensin II (a pro-inflammatory vasoconstrictor). Sex-based differences in RAS  dysregulation may explain sex-based differences in responses to ARBs because the  ACE2 gene is on the X chromosome. We recorded baseline characteristics,  comorbidities, prehospital ARBs or ACE inhibitor treatment, use of organ support  and mortality, and measured RAS components at admission and days 2, 4, 7, and 14  in a subgroup (n = 46), recorded d-dimer (n = 967), comparing males with females.  

SETTING: ARBs CORONA I is a multicenter Canadian observational cohort of patients  hospitalized with acute COVID-19. This analysis includes patients admitted to 10  large urban hospitals across the four most populated provinces. 

PATIENTS:  One-thousand six-hundred eighty-six patients with polymerase chain  reaction-confirmed COVID-19 (February 2020 to March 2021) for acute COVID-19  illness were included. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Males  on ARBs before admission had decreased use of ventilation (adjusted odds ratio  [aOR] = 0.52; p = 0.007) and vasopressors (aOR = 0.55; p = 0.011) compared with  males not on ARBs or ACE inhibitors. No significant effects were observed in  females for these outcomes. The test for interaction was significant for use of  ventilation (p = 0.006) and vasopressors (p = 0.044) indicating significantly  different responses to ARBs according to sex. Males had significantly higher  plasma ACE-1 at baseline and angiotensin II at day 7 and 14 than females.  

CONCLUSIONS: ARBs use was associated with less ventilation and vasopressors in  males but not females. Sex-based differences in RAS dysregulation may contribute  to sex-based differences in outcomes and responses to ARBs in COVID-19.

DOI: 10.1097/CCM.0000000000005589

## 与COVID-19住院男性患者预后改善相关的肾素-血管紧张素系统通路治疗。

目的：确定血管紧张素受体阻滞剂(ARB)或血管紧张素转换酶(ACE)抑制剂是否与改善  根据性别和报告的COVID-19住院患者的结局  肾素-血管紧张素系统(RAS)组分的性别相关差异。

设计：  比较ARB或ACE效应的前瞻性观察性队列研究  男性vs女性中的抑制剂vs无ARB或ACE抑制剂。重度急性  呼吸综合征冠状病毒2下调ACE-2，可能增加  血管紧张素II（一种促炎性血管收缩剂）。RAS中基于性别的差异  调节异常可能解释ARB应答的性别差异，因为  ACE2基因位于X染色体上。我们记录了基线特征，  合并症，院前ARB或ACE抑制剂治疗，使用器官支持  和死亡率，并在入院时和第2、4、7、14天测量RAS组分  亚组中(n = 46)，记录d-二聚体(n = 967)，比较男性和女性。

背景：ARB CORONA I是加拿大患者的多中心观察性队列  因急性COVID-19住院。该分析包括10位住院患者  四个人口最多的省份的大城市医院。

患者：  1686例聚合酶链患者  反应确认的急性COVID-19（2020年2月至2021年3月）  疾病包括在内。

干预：无。

测量和主要结果：雄性  入院前使用ARB的患者通气减少（调整后比值比  [aOR]= 0.52；p = 0.007）和血管加压药(aOR = 0.55；p = 0.011)与  未接受ARB或ACE抑制剂的男性。在  这些结局的女性。相互作用检验对于  通气量(p = 0.006)和血管加压素(p = 0.044)显著  不同性别对ARB的不同反应。男性显著更高  基线时血浆ACE-1和第7天和第14天血管紧张素II高于雌性。

结论：ARB使用与通气和血管加压素减少相关  男性而非女性。RAS失调中基于性别的差异可能导致  COVID-19中ARB结局和反应的性别差异。

--------
--------

## A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation.

Abstract: 

OBJECTIVES: We designed this study to test whether clazakizumab, a direct interleukin-6 inhibitor, benefits patients hospitalized with severe or critical  COVID-19 disease accompanied by hyperinflammation. 

DESIGN: Multicenter,  randomized, double-blinded, placebo-controlled, seamless phase II/III trial.  

SETTING: Five U.S. medical centers. 

PATIENTS: Adults inpatients with severe  COVID-19 disease and hyperinflammation. 

INTERVENTIONS: Eighty-one patients  enrolled in phase II, randomized 1:1:1 to low-dose (12.5 mg) or high-dose (25 mg)  clazakizumab or placebo. Ninety-seven patients enrolled in phase III, randomized  1:1 to high-dose clazakizumab or placebo. 

MEASUREMENTS AND MAIN RESULTS: The  primary outcome was 28-day ventilator-free survival. Secondary outcomes included  overall survival ,frequency and duration of intubation, and frequency and  duration of ICU admission. Per Data Safety and Monitoring Board recommendations,  additional secondary outcomes describing clinical status and status changes, as  measured by an ordinal scale, were added. Bayesian cumulative proportional odds,  logistic, and Poisson regression models were used. The low-dose arm was dropped  when the phase II study suggested superiority of the high-dose arm. We report on  152 patients, 74 randomized to placebo and 78 to high-dose clazakizumab. Patients  receiving clazakizumab had greater odds of 28-day ventilator-free survival (odds  ratio [OR] = 3.84; p [OR > 1] 99.9%), as well as overall survival at 28 and 60  days (OR = 1.75; p [OR > 1] 86.5% and OR = 2.53; p [OR > 1] 97.7%). Clazakizumab  was associated with lower odds of intubation (OR = 0.2; p [OR] < 1; 99.9%) and  ICU admission (OR = 0.26; p [OR < 1] 99.6%); shorter durations of ventilation and  ICU stay (risk ratio [RR] < 0.75; p [RR < 1] > 99% for both); and greater odds of  improved clinical status at 14, 28, and 60 days (OR = 2.32, p [OR > 1] 98.1%; OR  = 3.36, p [OR > 1] 99.6%; and OR = 3.52, p [OR > 1] 99.8%, respectively).  

CONCLUSIONS: Clazakizumab significantly improved 28-day ventilator-free survival,  28- and 60-day overall survival, as well as clinical outcomes in hospitalized  patients with COVID-19 and hyperinflammation.

DOI: 10.1097/CCM.0000000000005591

## Clazakizumab治疗COVID-19肺炎伴高炎症状态的随机、双盲、安慰剂对照试验。

目的：我们设计本研究旨在检测克拉珠单抗（一种直接白细胞介素-6抑制剂）是否对重度或危重住院患者有益  COVID-19疾病伴炎症反应。

设计：多中心，  随机、双盲、安慰剂对照、无缝II/III期试验。

单位：美国5家医学中心。

患者：重度住院患者  COVID-19疾病和炎症。

干预：81例患者  入组II期研究，以1:1:1的比例随机分配至低剂量组(12.5 mg)或高剂量组(25 mg)  clazakizumab或安慰剂。97例患者入组III期研究，随机化  1:1至高剂量clazakizumab或安慰剂。

测量和主要结果：  主要结局为28天无呼吸机生存。次要结局包括  总生存期，插管频率和持续时间，以及频率和  ICU住院时间。根据数据安全性监查委员会的建议，  描述临床状态和状态变化的其他次要结局，如  增加了序数标尺测量结果。Bayesian累积比例优势比，  使用logistic和泊松回归模型。去掉低剂量组  II期研究表明高剂量组具有优效性。我们报告  152例患者，74例随机接受安慰剂，78例接受高剂量clazakizumab。患者  接受clazakizumab的患者28天无呼吸机生存的几率更大（  比值[OR]= 3.84；p[OR > 1]99.9%），以及28和60时的总生存期  天（OR = 1.75；p[OR > 1]86.5%和OR = 2.53；p[OR > 1]97.7%）。克拉珠单抗  插管率较低(OR = 0.2；p[OR]< 1；99.9%)且  入住ICU(OR = 0.26；p[OR < 1]99.6%)；通气时间更短，  留住ICU（两者的风险比[RR]<0.75；p[RR<1]>99%）；  第14、28天临床状态改善，和60天（OR = 2.32，p[OR > 1]98.1%；OR  = 3.36，p[OR > 1]99.6%；OR = 3.52，p[OR > 1]99.8%）。

结论：Clazakizumab显著改善了28天无呼吸机生存，  住院患者的28天和60天总生存期以及临床结局  伴有COVID-19和过度炎症的患者。

--------
--------

## Tracheostomy Practices and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation: An Analysis of the Extracorporeal Life  Support Organization Registry., Kohne, Joseph G.

Abstract: 

OBJECTIVES: The use of extracorporeal membrane oxygenation (ECMO) in patients with COVID-19 has been supported by major healthcare organizations, yet the role  of specific management strategies during ECMO requires further study. We sought  to characterize tracheostomy practices, complications, and outcomes in  ECMO-supported patients with acute respiratory failure related to COVID-19.  

DESIGN: Retrospective cohort study. 

SETTING: ECMO centers contributing to the  Extracorporeal Life Support Organization Registry. 

PATIENTS: Patients 16 years or  older receiving venovenous ECMO for respiratory support for: 1) COVID-19 in 2020  and 2021 (through October 2021) and 2) pre-COVID-19 viral pneumonia in 2019.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: We identified 7,047 patients  who received ECMO support for acute respiratory failure related to COVID-19. A  total of 32% of patients were recorded as having a tracheostomy procedure during  ECMO, and 51% had a tracheostomy at some point during hospitalization. The  frequency of tracheostomy was similar in pre-COVID-19 viral pneumonia, but  tracheostomies were performed 3 days earlier compared with patients with COVID-19  (median 6.7 d [interquartile range [IQR], 3.0-12.0 d] vs 10.0 d [IQR, 5.0-16.5  d]; p < 0.001). More patients were mobilized with pre-COVID-19 viral pneumonia,  but receipt of a tracheostomy during ECMO was associated with increased  mobilization in both cohorts. More bleeding complications occurred in patients  who received a tracheostomy, with 9% of patients with COVID-19 who received a  tracheostomy reported as having surgical site bleeding. 

CONCLUSIONS:  Tracheostomies are performed in COVID-19 patients receiving ECMO at rates similar  to practices in pre-COVID-19 viral pneumonia, although later during the course of  ECMO. Receipt of a tracheostomy was associated with increased patient  mobilization. Overall mortality was similar between those who did and did not  receive a tracheostomy.

DOI: 10.1097/CCM.0000000000005579

## 体外膜肺氧合支持下COVID-19患者的气管造口术实践和结局：体外生活分析  支持组织注册。

目的：主要医疗保健组织支持在COVID-19患者中使用体外膜肺氧合(ECMO)，但其作用  ECMO期间的具体管理策略还需要进一步研究。我们寻求  表征气管造口术操作、并发症和结局  ECMO支持的与COVID-19相关的急性呼吸衰竭患者。

设计：回顾性队列研究。

设置：ECMO中心参与  体外生命支持组织注册。

患者：患者16岁或  接受静脉-静脉ECMO支持呼吸的老年患者：1）2020年COVID-19  和2021（至2021年10月）和2）2019年COVID-19前病毒性肺炎。

干预：无。

测量和主要结果：我们确定了7,047例患者  接受ECMO支持治疗与COVID-19相关的急性呼吸衰竭。A  总计32%的患者记录为在  ECMO，51%在住院期间的某个时间点进行了气管造口术。事件  COVID-19前病毒性肺炎的气管造口术频率相似，但  与COVID-19患者相比，气管造口术提前3天进行  （中位数6.7天[四分位距[IQR]，3.0-12.0天]vs 10.0天[IQR，5.0-16.5天]）  d]; p < 0.001).动员更多的pre-COVID-19病毒性肺炎患者，  但在ECMO期间接受气管造口术与增加  两个队列中的活动。患者发生的出血并发症更多  接受气管造口术的患者，9%的COVID-19患者接受  气管造口术报告手术部位出血。

结论：  在接受ECMO的COVID-19患者中以相似的速率进行了气管造口术  在前COVID-19病毒性肺炎实践中，尽管在病程的后期  ECMO.接受气管造口术与患者增加相关  活动。有和无死亡率的患者总体死亡率相似  接受气管造口术。

--------
--------

## The authors reply., Barichello, Tatiana
DOI: 10.1097/CCM.0000000000005484

## 作者回复。

--------
--------

## Key Role of Gut Microbiota in Neuroinflammation of Septic Patients.

## 肠道菌群在脓毒症患者神经炎症中的关键作用。
关键词：Humans; *Gastrointestinal Microbiome; *Sepsis; Neuroinflammatory Diseases

--------
--------

## The author replies.

5:e499-e500. DOI:10.1097/CCM.0000000000005482

## 作者回复。

--------
--------

## Refractory Anaphylaxis Needing Emergency Intubation Supported by Expert Opinion and Published Guidelines: Could We Use Off-Label Drugs to Avoid It?, Honore, Patrick M.

5:e498-e499. DOI:10.1097/CCM.0000000000005399

## 专家意见和已发表指南支持难治性过敏性反应需要紧急插管：我们可以使用标签外药物来避免吗？
关键词：Humans; Off-Label Use; Expert Testimony; *Anaphylaxis/drug therapy/prevention & control; Drug Labeling; Intubation, Intratracheal

--------
--------

## Phase 2 Vitamin C Sepsis Trials: Another Brick in the (Evidence) Wall?, Agarwal, Ankita

5:897-899. DOI:10.1097/CCM.0000000000005432

## 2期维生素C败血症试验：（证据）墙中的另一块砖？
关键词：Humans; Vitamins; *Sepsis/drug therapy; *Ascorbic Acid/therapeutic use

--------
--------

## Falling for It: Of Falls, Families, and Delirium.

5:889-891. DOI:10.1097/CCM.0000000000005431

## 跌倒：跌倒、家庭和谵妄。
关键词：Humans; *Accidental Falls; *Delirium/epidemiology/etiology; Fear

--------
--------

## Heterogeneity in Clinical Presentations of Sepsis: Challenges and Implications for "One-Size-Fits-All" Time-to-Antibiotic Measures.

5:886-889. DOI:10.1097/CCM.0000000000005430

## 败血症临床表现的异质性：“一刀切”的抗生素测量时间的挑战和影响。
关键词：Humans; Emergency Service, Hospital; *Sepsis/drug therapy; *Anti-Bacterial Agents/therapeutic use

--------
--------

## Moving Forward: Frailty and Adverse Sepsis Outcomes.

5:880-882. DOI:10.1097/CCM.0000000000005377

## 下一步：虚弱和不良败血症结局。
关键词：Humans; Aged; Geriatric Assessment; *Sepsis; Frail Elderly; *Frailty

--------
--------

## Death and Dying in the ICU., Mols, Georg

5:878-880. DOI:10.1097/CCM.0000000000005380

## ICU中死亡和濒死。
关键词：Humans; Intensive Care Units; *Attitude to Death; *Terminal Care

--------
--------

## What Socioeconomic Disadvantage Means for Critical Illness Recovery, Clinical Care, and Research.

5:876-878. DOI:10.1097/CCM.0000000000005414

## 危重疾病康复、临床护理和研究的社会经济劣势意味着什么。
关键词：Humans; Risk Factors; Socioeconomic Factors; *Critical Illness/therapy

--------
--------

## The Child With Severe Chronic Illness in the ICU: A Concise Review.

5:848-859. DOI:10.1097/CCM.0000000000005512

Abstract: 

OBJECTIVES: Children with severe chronic illness are a prevalent, impactful, vulnerable group in PICUs, whose needs are insufficiently met by transitory care  models and a narrow focus on acute care needs. Thus, we sought to provide a  concise synthetic review of published literature relevant to them and a  compilation of strategies to address their distinctive needs. 

DATA SOURCES:  English language articles were identified in MEDLINE using a variety of phrases  related to children with chronic conditions, prolonged admissions, resource  utilization, mortality, morbidity, continuity of care, palliative care, and other  critical care topics. Bibliographies were also reviewed. 

STUDY SELECTION:  Original articles, review articles, and commentaries were considered. 

DATA  EXTRACTION: Data from relevant articles were reviewed, summarized, and integrated  into a narrative synthetic review. 

DATA SYNTHESIS: Children with serious chronic  conditions are a heterogeneous group who are growing in numbers and complexity,  partly due to successes of critical care. Because of their prevalence, prolonged  stays, readmissions, and other resource use, they disproportionately impact  PICUs. Often more than other patients, critical illness can substantially  negatively affect these children and their families, physically and  psychosocially. Critical care approaches narrowly focused on acute care and  transitory/rotating care models exacerbate these problems and contribute to  ineffective communication and information sharing, impaired relationships, subpar  and untimely decision-making, patient/family dissatisfaction, and moral distress  in providers. Strategies to mitigate these effects and address these patients'  distinctive needs include improving continuity and communication, primary and  secondary palliative care, and involvement of families. However, there are  limited outcome data for most of these strategies and little consensus on which  outcomes should be measured. 

CONCLUSIONS: The future of pediatric critical care  medicine is intertwined with that of children with serious chronic illness. More  concerted efforts are needed to address their distinctive needs and study the  effectiveness of strategies to do so.

## ICU中的重度慢性疾病儿童：一项简要审查。

目的：在PICU中，重度慢性疾病儿童是一个普遍、有影响力的弱势群体，其需求无法通过过渡性护理充分满足  模型和狭义的急性护理需求重点。因此，我们试图提供  对与其相关的已发表文献进行的简要综合审查，以及  编写策略以满足其独特需求。

数据来源：  在MEDLINE中使用各种短语识别英语文章  与慢性疾病儿童、长期住院、资源  治疗的利用、死亡率、发病率、治疗的连续性、姑息治疗和其他  重症监护主题。还对参考书目进行了审查。

研究选择：  考虑了原始文章、综述文章和评论。数据  摘录：对相关文章中的数据进行审核、总结和整合  纳入叙述性合成综述。

资料综合：严重慢性  疾病是一个在数量和复杂性上不断增长的异质性群体，  部分原因是重症监护成功。由于其患病率，延长  住院、再次入院和其他资源使用，它们的影响不成比例  PICU。危重病患者通常多于其他患者  对这些儿童及其家庭、身体和  精神心理性。重症监护方法狭义地侧重于急性护理和  一过性/轮换护理模型加剧了这些问题，并导致  沟通和信息共享无效、人际关系受损、低于标准  决策不及时、患者/家庭不满和道德困扰  在提供者中。减轻这些影响并解决这些患者的策略  独特的需求包括改善连续性和沟通，主要和  次要姑息治疗和家庭参与。然而，有  大多数这些策略的结局数据有限，几乎没有达成共识  应测量结局。

结论：儿科重症监护的未来  药物与严重慢性疾病儿童的药物交织在一起。更多  需要协调一致的努力来解决其独特的需求，并研究  策略的有效性。
关键词：Humans; Intensive Care Units; Child; Palliative Care; Chronic Disease; *Critical Illness/therapy; *Family

--------
--------

## Do Tracheostomy and Gastrostomy Confer Immortality in COVID-19?

5:891-893. DOI:10.1097/CCM.0000000000005504

## COVID-19中气管造口术和胃造口术是否能带来永生？
关键词：Humans; Respiration, Artificial; Retrospective Studies; *COVID-19; *Tracheostomy; Gastrostomy

--------
--------

## Effects of Prone Position on Lung Recruitment and Ventilation-Perfusion Matching in Patients With COVID-19 Acute Respiratory Distress Syndrome: A Combined CT  Scan/Electrical Impedance Tomography Study.

5:723-732. DOI:10.1097/CCM.0000000000005450

Abstract: 

OBJECTIVES: Prone positioning allows to improve oxygenation and decrease mortality rate in COVID-19-associated acute respiratory distress syndrome  (C-ARDS). However, the mechanisms leading to these effects are not fully  understood. The aim of this study is to assess the physiologic effects of  pronation by the means of CT scan and electrical impedance tomography (EIT).  

DESIGN: Experimental, physiologic study. 

SETTING: Patients were enrolled from  October 2020 to March 2021 in an Italian dedicated COVID-19 ICU. 

PATIENTS:  Twenty-one intubated patients with moderate or severe C-ARDS. 

INTERVENTIONS:  First, patients were transported to the CT scan facility, and image acquisition  was performed in prone, then supine position. Back to the ICU, gas exchange,  respiratory mechanics, and ventilation and perfusion EIT-based analysis were  provided toward the end of two 30 minutes steps (e.g., in supine, then prone  position). 

MEASUREMENTS AND MAIN RESULTS: Prone position induced recruitment in  the dorsal part of the lungs (12.5% ?± 8.0%; p < 0.001 from baseline) and  derecruitment in the ventral regions (-6.9% ?± 5.2%; p < 0.001). These changes led  to a global increase in recruitment (6.0% ?± 6.7%; p < 0.001). Respiratory system  compliance did not change with prone position (45 ?± 15 vs 45 ?± 18 mL/cm H2O in  supine and prone position, respectively; p = 0.957) suggesting a decrease in  atelectrauma. This hypothesis was supported by the decrease of a time-impedance  curve concavity index designed as a surrogate for atelectrauma (1.41 ?± 0.16 vs  1.30 ?± 0.16; p = 0.001). Dead space measured by EIT was reduced in the ventral  regions of the lungs, and the dead-space/shunt ratio decreased significantly (5.1  [2.3-23.4] vs 4.3 [0.7-6.8]; p = 0.035), showing an improvement in  ventilation-perfusion matching. 

CONCLUSIONS: Several changes are associated with  prone position in C-ARDS: increased lung recruitment, decreased atelectrauma, and  improved ventilation-perfusion matching. These physiologic effects may be  associated with more protective ventilation.

## 仰卧位对COVID-19急性呼吸窘迫综合征患者肺复张和通气灌注匹配的影响：联合CT  扫描/电阻抗断层成像研究。

目的：俯卧位可改善COVID-19相关急性呼吸窘迫综合征的氧合，降低死亡率  (C-ARDS)。然而，导致这些效应的机制并不完全  理解。本研究的目的是评估  通过CT扫描和电阻抗断层成像(EIT)旋前。

设计：实验性、生理学研究。

设置：患者从  2020年10月至2021年3月，在意大利专用COVID-19 ICU。

患者：  21例中度或重度C-ARDS插管患者。

干预：  首先，将患者运送至CT扫描机构，并进行图像采集  患者取俯卧位，然后仰卧位。回到ICU，进行气体交换，  呼吸力学、基于EIT的通气和灌注分析  准备两个30 min的步骤结束（例如，仰卧位，然后俯卧）  位置）。

测量和主要结果：俯卧位诱导的肺复张  肺背侧部分（12.5%?±8.0%；p < 0.001，较基线）和  腹侧区皮肤脱落（分别为-6.9%和±5.2%；p < 0.001）。这些变更导致  全球招募数量增加(6.0%τ±6.7%；p < 0.001)。呼吸系统  俯卧位时依从性没有变化（45?±15 vs 45?±18 mL/cm H2O，  仰卧位和俯卧位；p = 0.957），提示  创伤性休克。时间-阻抗降低支持该假设  作为非创伤性替代指标的曲线凹度指数（分别为1.41±0.16vs  1.30 ?± 0.16; p = 0.001).腹侧通过EIT测量的死腔减少  肺脏区域，以及死腔/分流比显著下降（5.1  [2.3-23.4]vs 4.3[0.7-6.8]；p = 0.035），显示了  通气-灌注匹配。

结论：一些变化与  C-ARDS俯卧位：增加肺复张，减少肺不张创伤，和  改善通气-灌注匹配。这些生理效应可能是  与更多的保护性通气相关。
关键词：Humans; Perfusion; Tomography, X-Ray Computed; *COVID-19; Prone Position; *Respiratory Distress Syndrome/diagnostic imaging/therapy; Electric Impedance; Lung/diagnostic imaging; Positive-Pressure Respiration/methods

--------
--------

## A Retrospective Observational Study Exploring 30- and 90-Day Outcomes for Patients With COVID-19 After Percutaneous Tracheostomy and Gastrostomy Placement., Kiser, Stephanie B.

5:819-824. DOI:10.1097/CCM.0000000000005451

Abstract: 

OBJECTIVES: To determine the 30- and 90-day outcomes of COVID-19 patients receiving tracheostomy and percutaneous endoscopic gastrostomy (PEG). 

DESIGN:  Retrospective observational study. 

SETTING: Multisite, inpatient. 

PATIENTS:  Hospitalized COVID-19 patients who received tracheostomy and PEG at four Boston  hospitals. 

INTERVENTIONS: Tracheostomy and PEG placement. 

MEASUREMENTS AND MAIN  RESULTS: The primary outcome was mortality at 30 and 90 days post-procedure.  Secondary outcomes included continued device presence, place of residence,  complications, and rehospitalizations. Eighty-one COVID-19 patients with  tracheostomy and PEG placement were included. At 90 days post-device placement,  the mortality rate was 9.9%, 2.7% still had the tracheostomy, 32.9% still had the  PEG, and 58.9% were at home. 

CONCLUSIONS: More than nine-in-10 patients in our  population of COVID-19 patients who underwent tracheostomy and PEG were alive 90  days later and most were living at home. This study provides new information  regarding the outcomes of this patient population that may serve as a step in  guiding clinicians, patients, and families when making decisions regarding these  devices.

## 一项探讨COVID-19患者接受经皮气管造口术和胃造口术后30天和90天结局的回顾性观察性研究。

目的：确定接受气管造口术和经皮内镜下胃造瘘术(PEG)的COVID-19患者的30天和90天结局。

设计：  回顾性观察性研究。

设置：多家研究中心，住院患者。

患者：  住院COVID-19在4个波士顿接受气管造口术和PEG的患者  医院。

干预：气管造口术和PEG置入。测量和主要  结果：主要结局是术后30天和90天的死亡率。次要结局包括继续使用器械、居住地、  并发症和再次住院。81例COVID-19患者发生  包括气管造口术和PEG置入。器械置入后90天，  死亡率9.9%，2.7%仍行气管造口术，32.9%仍行气管切开术。  PEG，58.9%在家。

结论：我们的研究中有超过9/10的患者  接受气管造口术和PEG的COVID-19患者人群存活90  几天后，大多数患者仍在家中。本研究提供了新信息  关于该患者人群的结局，可能作为  指导临床医生、患者和家属做出这些决定  器械。
关键词：Humans; Retrospective Studies; *COVID-19; *Gastrostomy; Boston; Tracheostomy

--------
--------

## Ventilator-Associated Lower Respiratory Tract Bacterial Infections in COVID-19 Compared With Non-COVID-19 Patients.

5:825-836. DOI:10.1097/CCM.0000000000005462

Abstract: 

OBJECTIVES: Ventilator-associated lower respiratory tract infections (VA-LRTIs) are associated with prolonged length of stay and increased mortality. We aimed to  investigate the occurrence of bacterial VA-LRTI among mechanically ventilated  COVID-19 patients and compare these findings to non-COVID-19 cohorts throughout  the first and second wave of the pandemic. 

DESIGN: Retrospective cohort study.  

SETTING: Karolinska University Hospital, Stockholm, Sweden. 

PATIENTS: All  patients greater than or equal to 18 years treated with mechanical ventilation  between January 1, 2011, and December 31, 2020. 

INTERVENTIONS: None. 

MEASUREMENTS  AND MAIN RESULTS: The cohort consisted of 20,223 ICU episodes (479 COVID-19),  with a VA-LRTI incidence proportion of 30% (129/426) in COVID-19 and 18%  (1,081/5,907) in non-COVID-19 among patients ventilated greater than or equal to  48 hours. The median length of ventilator treatment for COVID-19 patients was 10  days (interquartile range, 5-18 d), which was significantly longer than for all  other investigated specific diagnoses. The VA-LRTI incidence rate per 1,000  ventilator days at risk was 31 (95% CI, 26-37) for COVID-19 and 34 (95% CI,  32-36) for non-COVID-19. With COVID-19 as reference, adjusted subdistribution  hazard ratios for VA-LRTI was 0.29-0.50 (95% CI, < 1) for influenza, bacterial  pneumonia, acute respiratory distress syndrome, and severe sepsis, but 1.38 (95%  CI, 1.15-1.65) for specific noninfectious diagnoses. Compared with COVID-19 in  the first wave of the pandemic, COVID-19 in the second wave had adjusted  subdistribution hazard ratio of 1.85 (95% CI, 1.14-2.99). In early VA-LRTI  Staphylococcus aureus was more common and Streptococcus pneumoniae, Haemophilus  influenzae, and Escherichia coli less common in COVID-19 patients, while Serratia  species was more often identified in late VA-LRTI. 

CONCLUSIONS: COVID-19 is  associated with exceptionally long durations of mechanical ventilation treatment  and high VA-LRTI occurrence proportions. The incidence rate of VA-LRTI was  compared with the pooled non-COVID-19 cohort, however, not increased in COVID-19.  Significant differences in the incidence of VA-LRTI occurred between the first  and second wave of the COVID-19 pandemic.

## COVID-19与非COVID-19患者的呼吸机相关下呼吸道细菌感染的比较。

目的：呼吸机相关下呼吸道感染(VA-LRTI)与住院时间延长和死亡率增加相关。我们的目标是  调查机械通气患者中细菌性VA-LRTI的发生情况  整个研究期间，COVID-19患者将这些结果与非COVID-19队列进行比较  第一波和第二波大流行。

设计：回顾性队列研究。

单位：Karolinska University Hospital,Stockholm,Sweden。

患者：全部  接受机械通气治疗的≥18岁患者  2011年1月1日至2020年12月31日。

干预：无。测量  主要结果：队列包括20223例ICU发作（479例COVID-19），  COVID-19中VA-LRTI发生率比例为30%(129/426)，18%  (1,081/5,907)，非-COVID-19中，通气≥  48小时。COVID-19患者呼吸机治疗的中位时长为10  天（四分位距，5-18天），显著长于所有  其他研究的特定诊断。每1,000人中VA-LRTI的发生率  COVID-19的通气风险天数为31(95%CI，26-37)，COVID-19为34（95%CI，  32-36）。以COVID-19为参照，调整亚分布  细菌性流感的VA-LRTI风险比为0.29-0.50(95%CI，< 1)  肺炎、急性呼吸窘迫综合征和重度败血症，但1.38(95%)  CI，1.15-1.65）。与COVID-19相比在  第一波大流行，第二波的COVID-19已经调整  亚分布风险比为1.85(95%CI，1.14-2.99)。早期VA-LRTI  金黄色葡萄球菌多见，肺炎链球菌、嗜血杆菌  流感和大肠杆菌在COVID-19患者中不常见，而沙雷菌属  在晚期VA-LRTI中更常识别种属。

结论：COVID-19是  与长期机械通气治疗相关  和高VA-LRTI发生率比例。VA-LRTI的发生率为  但是，与非COVID-19队列相比，COVID-19队列没有增加。VA-LRTI发生率的显著差异发生在  第二波COVID-19大流行。
关键词：Humans; Retrospective Studies; Pandemics; Respiratory System; Ventilators, Mechanical; *COVID-19/epidemiology/therapy; *Pneumonia, Ventilator-Associated/epidemiology; *Respiratory Tract Infections/epidemiology; *Staphylococcal Infections/epidemiology

--------
--------

## The Puzzles of Ventilator-Associated Pneumonia and COVID-19: Absolute Knowns and Relative Unknowns.

5:894-896. DOI:10.1097/CCM.0000000000005475

## 呼吸机相关性肺炎和COVID-19的困惑：绝对未知和相对未知。
关键词：Humans; *COVID-19; SARS-CoV-2; *Pneumonia, Ventilator-Associated/epidemiology

--------
--------

## Prone Position and COVID-19: Mechanisms and Effects.

5:873-875. DOI:10.1097/CCM.0000000000005486

## 俯卧位和COVID-19：机制和效应。
关键词：Humans; *COVID-19; SARS-CoV-2; Prone Position; Patient Positioning

--------
--------

## A Minimally Invasive and Highly Effective Extracorporeal CO2 Removal Device Combined With a Continuous Renal Replacement Therapy., Zanella, Alberto

5:e468-e476. DOI:10.1097/CCM.0000000000005428

Abstract: 

OBJECTIVES: Extracorporeal carbon dioxide removal is used to treat patients suffering from acute respiratory failure. However, the procedure is hampered by  the high blood flow required to achieve a significant CO2 clearance. We aimed to  develop an ultralow blood flow device to effectively remove CO2 combined with  continuous renal replacement therapy (CRRT). 

DESIGN: Preclinical,  proof-of-concept study. 

SETTING: An extracorporeal circuit where 200 mL/min of  blood flowed through a hemofilter connected to a closed-loop dialysate circuit.  An ion-exchange resin acidified the dialysate upstream, a membrane lung to  increase Pco2 and promote CO2 removal. 

PATIENTS: Six, 38.7 ?± 2.0-kg female pigs.  

INTERVENTIONS: Different levels of acidification were tested (from 0 to 5  mEq/min). Two l/hr of postdilution CRRT were performed continuously. The  respiratory rate was modified at each step to maintain arterial Pco2 at 50 mm Hg.  

MEASUREMENTS AND MAIN RESULTS: Increasing acidification enhanced CO2 removal  efficiency of the membrane lung from 30 ?± 5 (0 mEq/min) up to 145 ?± 8 mL/min (5  mEq/min), with a 483% increase, representing the 73% ?± 7% of the total body CO2  production. Minute ventilation decreased accordingly from 6.5 ?± 0.7 to 1.7 ?±  0.5 L/min. No major side effects occurred, except for transient tachycardia  episodes. As expected from the alveolar gas equation, the natural lung Pao2  dropped at increasing acidification steps, given the high dissociation between  the oxygenation and CO2 removal capability of the device, thus Pao2 decreased.  

CONCLUSIONS: This new extracorporeal ion-exchange resin-based multiple-organ  support device proved extremely high efficiency in CO2 removal and continuous  renal support in a preclinical setting. Further studies are required before  clinical implementation.

## 微创和高效体外CO2清除装置联合连续肾脏替代治疗。

目的：体外二氧化碳清除用于治疗急性呼吸衰竭患者。但是，该程序受到以下因素的限制  实现显著CO2清除所需的高血流量。我们的目标是  开发超低血流量装置，有效去除CO2结合  连续性肾脏替代治疗(CRRT)。

设计：临床前，  概念验证研究。

设置：体外循环回路，200 mL/min  血液流经连接闭环透析液回路的血液滤器。将上游透析液酸化的离子交换树脂，膜肺  增加Pco2，促进CO2清除。

患者：6头38.7 μm±2.0 kg的雌性猪。

干预：检测不同酸化水平(0-5)  mEq/min）。连续进行2 l/hr后稀释CRRT。事件  在每个步骤调整呼吸速率，将动脉Pco2维持在50 mmHg。

测量和主要结果：增加酸化增强了CO2去除  膜肺的效率从30 μm±5(0 mEq/min)至145 μm±8 mL/min(5 μm)  mEq/min），增加483%，表示体内CO2总量的73%±7%  生产。分钟通气量相应地从6.5?±0.7下降至1.7?±  0.5 L/分钟。除一过性心动过速外，未发生重大副作用  发作。正如根据肺泡气体方程所预期的，自然肺Pao2  在增加酸化步骤时下降，因为  该装置的氧合和CO2清除能力，Pao2降低。

结论：这种新型体外离子交换树脂基多器官  证明支撑装置具有非常高的CO2去除效率和持续性  临床前背景中的肾脏支持。之前还需要进一步的研究  临床实施。
关键词：Humans; Female; Oxygen; Animals; Swine; *Continuous Renal Replacement Therapy; Carbon Dioxide; Dialysis Solutions; Respiration, Artificial/methods

--------
--------

## Early Neuromuscular Blockade in Moderate-to-Severe Pediatric Acute Respiratory Distress Syndrome., Rudolph, Michelle W.

5:e445-e457. DOI:10.1097/CCM.0000000000005426

Abstract: 

OBJECTIVES: The use of neuromuscular blocking agents (NMBAs) in pediatric acute respiratory distress syndrome (PARDS) is common but unsupported by efficacy data.  We sought to compare the outcomes between patients with moderate-to-severe PARDS  receiving continuous NMBA during the first 48 hours of endotracheal intubation  (early NMBA) and those without. 

DESIGN: Secondary analysis of data from the  Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE)  clinical trial, a pediatric multicenter cluster randomized trial of sedation.  

SETTING: Thirty-one PICUs in the United States. 

PATIENTS: Children 2 weeks to 17  years receiving invasive mechanical ventilation (MV) for moderate-to-severe PARDS  (i.e., oxygenation index ?‰? 8 and bilateral infiltrates on chest radiograph on  days 0-1 of endotracheal intubation). 

INTERVENTIONS: NMBA for the entire duration  of days 1 and 2 after intubation. 

MEASUREMENTS AND MAIN RESULTS: Among 1,182  RESTORE patients with moderate-to-severe PARDS, 196 (17%) received early NMBA for  a median of 50.0% ventilator days (interquartile range, 33.3-60.7%). The  propensity score model predicting the probability of receiving early NMBA  included high-frequency oscillatory ventilation on days 0-2 (odds ratio [OR],  7.61; 95% CI, 4.75-12.21) and severe PARDS on days 0-1 (OR, 2.16; 95% CI,  1.50-3.12). After adjusting for risk category, early use of NMBA was associated  with a longer duration of MV (hazard ratio, 0.57; 95% CI, 0.48-0.68; p < 0.0001),  but not with mortality (OR, 1.62; 95% CI, 0.92-2.85; p = 0.096) compared with no  early use of NMBA. Other outcomes including cognitive, functional, and physical  impairment at 6 months post-PICU discharge were similar. Outcomes did not differ  when comparing high versus low NMBA usage sites or when patients were stratified  by baseline Pao2/Fio2 less than 150. 

CONCLUSIONS: Early NMBA use was associated  with a longer duration of MV. This propensity score analysis underscores the need  for a randomized controlled trial in pediatrics.

## 中重度儿科急性呼吸窘迫综合征的早期神经肌肉阻滞。

目的：神经肌肉阻滞剂(NMBA)在儿科急性呼吸窘迫综合征(PARDS)中的使用很常见，但未得到疗效数据的支持。我们试图比较中度至重度PARDS患者之间的结局  在气管插管的前48小时内持续接受NMBA  （早期NMBA）和无。

设计：对  呼吸衰竭镇静滴定的随机评估(RESTORE)  镇静的儿科多中心集群随机临床试验。

环境：美国31家PICU。

患者：2周至17岁的儿童  接受有创机械通气(MV)治疗中重度PARDS的年数  （即氧合指数 ≥ 8和胸部x光片双侧浸润  气管插管的第0-1天）。

干预：在整个研究期间给予NMBA  插管后第1天和第2天。

测量和主要结果：1,182名受试者中  RESTORE中-重度PARDS患者，196例(17%)接受早期NMBA治疗  呼吸机使用天数中位数为50.0%（四分位距，33.3-60.7%）。事件  倾向评分模型预测接受早期NMBA的概率  包括第0-2天的高频振荡通气（比值比[OR]，  7.61；95%CI，4.75-12.21）和第0-1天重度PARDS（OR，2.16；95%CI，  1.50-3.12).校正风险类别后，早期使用NMBA与  MV持续时间更长（风险比，0.57；95%CI，0.48-0.68；p < 0.0001），  但与无死亡相比，无死亡(OR，1.62；95%CI，0.92-2.85；p = 0.096)  早期使用NMBA。其他结局，包括认知、功能和身体  PICU出院后6个月的损害相似。结局无差异  比较高、低NMBA使用率的研究中心或对患者进行分层时  按基线Pao2/Fio2 < 150。

结论：早期使用NMBA与  MV持续时间更长。该倾向评分分析强调了需求  儿科随机对照试验。
关键词：Humans; Propensity Score; Respiration, Artificial; Child; *Respiratory Distress Syndrome/therapy; *Anesthetics; *High-Frequency Ventilation; *Neuromuscular Blockade; *Neuromuscular Diseases; *Pediatrics

--------
--------

## Monitoring Spinal Cord Tissue Oxygen in Patients With Acute, Severe Traumatic Spinal Cord Injuries., Visagan, Ravindran

5:e477-e486. DOI:10.1097/CCM.0000000000005433

Abstract: 

OBJECTIVES: To determine the feasibility of monitoring tissue oxygen tension from the injury site (pscto2) in patients with acute, severe traumatic spinal cord  injuries. 

DESIGN: We inserted at the injury site a pressure probe, a  microdialysis catheter, and an oxygen electrode to monitor for up to a week  intraspinal pressure (ISP), spinal cord perfusion pressure (SCPP), tissue  glucose, lactate/pyruvate ratio (LPR), and pscto2. We analyzed 2,213 hours of  such data. Follow-up was 6-28 months postinjury. 

SETTING: Single-center  neurosurgical and neurocritical care units. 

SUBJECTS: Twenty-six patients with  traumatic spinal cord injuries, American spinal injury association Impairment  Scale A-C. Probes were inserted within 72 hours of injury. 

INTERVENTIONS:  Insertion of subarachnoid oxygen electrode (Licox; Integra LifeSciences,  Sophia-Antipolis, France), pressure probe, and microdialysis catheter.  

MEASUREMENTS AND MAIN RESULTS: pscto2 was significantly influenced by ISP (pscto2  26.7 ?± 0.3 mm Hg at ISP > 10 mmHg vs pscto2 22.7 ?± 0.8 mm Hg at ISP ?‰¤ 10 mm Hg),  SCPP (pscto2 26.8 ?± 0.3 mm Hg at SCPP < 90 mm Hg vs pscto2 32.1 ?± 0.7 mm Hg at  SCPP ?‰? 90 mm Hg), tissue glucose (pscto2 26.8 ?± 0.4 mm Hg at glucose < 6 mM vs  32.9 ?± 0.5 mm Hg at glucose ?‰? 6 mM), tissue LPR (pscto2 25.3 ?± 0.4 mm Hg at LPR >  30 vs pscto2 31.3 ?± 0.3 mm Hg at LPR ?‰¤ 30), and fever (pscto2 28.8 ?± 0.5 mm Hg at  cord temperature 37-38?°C vs pscto2 28.7 ?± 0.8 mm Hg at cord temperature ?‰? 39?°C).  Tissue hypoxia also occurred independent of these factors. Increasing the Fio2 by  0.48 increases pscto2 by 71.8% above baseline within 8.4 minutes. In patients  with motor-incomplete injuries, fluctuations in pscto2 correlated with  fluctuations in limb motor score. The injured cord spent 11% (39%) hours at  pscto2 less than 5 mm Hg (< 20 mm Hg) in patients with motor-complete outcomes,  compared with 1% (30%) hours at pscto2 less than 5 mm Hg (< 20 mm Hg) in patients  with motor-incomplete outcomes. Complications were cerebrospinal fluid leak  (5/26) and wound infection (1/26). 

CONCLUSIONS: This study lays the foundation  for measuring and altering spinal cord oxygen at the injury site. Future studies  are required to investigate whether this is an effective new therapy.

## 急性、重度创伤性脊髓损伤患者的脊髓组织氧监测。

目的：确定在急性重度创伤性脊髓患者中监测损伤部位(pscto2)组织氧张力的可行性  损伤。

设计：我们在损伤部位插入一个压力探头，一个  微透析导管和氧气电极，用于长达一周的监测  椎管内压(ISP)、脊髓灌注压(SCPP)、组织  葡萄糖、乳酸/丙酮酸比值(LPR)和pscto2。我们分析了2,213小时的  此类数据。伤后随访6-28个月。

设置：单中心  神经外科和神经重症监护室。

受试者：26例患者  创伤性脊髓损伤，美国脊髓损伤协会损伤  损伤72小时内插入探针。

干预：  插入蛛网膜下氧电极（Licox;Integra LifeSciences,  Sophia-Antipolis，法国），压力探头和微透析导管。

测量值和主要结果：ISP对pscto2有显著影响（pscto2  inr 26.7±0.3 mmHg，ISP > 10 mmHg；inr 22.7±0.8 mmHg，ISP?‰?10 mmHg），  SCPP（在SCPP < 90 mmHg时pscto2 26.8 μm Hg vs在SCPP < 90 mmHg时pscto2 32.1 μm Hg vs在SCPP < 90 mmHg时pscto2 32.1 μm Hg vs 0.7 mmHg）  SCPP ≥ 90 mmHg），组织葡萄糖（pscto2 26.8?±0.4 mmHg，葡萄糖 < 6 mm vs  血糖 ≥ 6 mm时为32.9±0.5 mmHg，组织LPR（LPR > 时为pscto2 25.3?±0.4 mmHg）  30 vs. pscto2（在LPR??‰30时为31.3±0.3 mmHg），发热(pscto2 28.8 μm Hg±0.5 mmHg)  脐带温度37-38?°C对比pscto2 28.7±0.8 mmHg，脐带温度 ≥ 39?°C）。组织缺氧的发生也与这些因素无关。Fio2增加幅度  8.4 min内pscto2升高0.48%，高于基线值71.8%。患者  伴有运动不全损伤，pscto2波动与  肢体运动评分波动。受损的脐带在以下时间花费11%(39%)小时  具有运动完全结局的患者的pscto2小于5 mmHg(< 20 mmHg)，  相比1%(30%)小时，pscto2 < 5 mmHg(< 20 mmHg)的患者  伴电机不完整结局。并发症为脑脊液漏  (5/26)和伤口感染(1/26)。

结论：本研究为  用于测量和改变损伤部位的脊髓氧含量。未来研究  需要研究这是否是一种有效的新疗法。
关键词：Humans; Oxygen; *Spinal Cord Injuries; *Cerebrospinal Fluid Pressure; Glucose; Spinal Cord

--------
--------

## A Multicenter Cohort Study of Falls Among Patients Admitted to the ICU.

5:810-818. DOI:10.1097/CCM.0000000000005423

Abstract: 

OBJECTIVES: To determine the incidence of falls, risk factors, and adverse outcomes, among patients admitted to the ICU. 

DESIGN: Retrospective cohort study.  

SETTING: Seventeen ICUs in Alberta, Canada. 

PATIENTS: Seventy-three thousand four  hundred ninety-five consecutive adult patient admissions between January 1, 2014,  and December 31, 2019. 

MEASUREMENTS AND MAIN RESULTS: A mixed-effects negative  binomial regression model was used to examine risk factors associated with falls.  Linear and logistic regression models were used to evaluate adverse outcomes. Six  hundred forty patients experienced 710 falls over 398,223 patient days (incidence  rate of 1.78 falls per 1,000 patient days [95% CI, 1.65-1.91]). The daily  incidence of falls increased during the ICU stay (e.g., day 1 vs day 7; 0.51 vs  2.43 falls per 1,000 patient days) and varied significantly between ICUs (range,  0.37-4.64 falls per 1,000 patient days). Male sex (incidence rate ratio [IRR],  1.37; 95% CI, 1.15-1.63), previous invasive mechanical ventilation (IRR, 1.82;  95% CI, 1.40-2.38), previous sedative and analgesic medication infusions (IRR,  1.60; 95% CI, 1.15-2.24), delirium (IRR, 3.85; 95% CI, 3.23-4.58), and patient  mobilization (IRR, 1.26; 95% CI, 1.21-1.30) were risk factors for falling. Falls  were associated with longer ICU (ratio of means [RM], 3.10; 95% CI, 2.86-3.36)  and hospital (RM, 2.21; 95% CI, 2.01-2.42) stays, but lower odds of death in the  ICU (odds ratio [OR], 0.09; 95% CI, 0.05-0.17) and hospital (OR, 0.21; 95% CI,  0.14-0.30). 

CONCLUSIONS: We observed that among ICU patients, falls occur  frequently, vary substantially between ICUs, and are associated with modifiable  risk factors, longer ICU and hospital stays, and lower risk of death. Our study  suggests that fall prevention strategies should be considered for critically ill  patients admitted to ICU.

## 一项入ICU患者跌倒的多中心队列研究。

目的：确定入住ICU的患者中跌倒的发生率、风险因素和不良结局。

设计：回顾性队列研究。

设置：加拿大艾伯塔省17间ICU。

患者：73004  195名连续成年患者于2014年1月1日住院，  2019年12月31日。

测量和主要结果：混合效应的负面影响  使用二项式回归模型检查与跌倒相关的风险因素。线性和logistic回归模型用于评价不良结局。6名  398，223患者日内，140例患者发生了710次跌倒（发生率  发生率为1.78次跌倒/1,000患者日[95%CI，1.65-1.91]）。每日  在ICU住院期间跌倒的发生率增加（例如，第1天与第7天；0.51vs  2.43次跌倒/1000患者天），在ICU之间差异显著（范围，  0.37-4.64次跌倒/1000患者天）。男性（发生率比[IRR]，  1.37；95%CI，1.15-1.63），既往有创机械通气（IRR，1.82；  95%CI，1.40-2.38），既往镇静和镇痛药物输注（IRR，  1.60；95%CI，1.15-2.24），谵妄(IRR，3.85；95%CI，3.23-4.58)和患者  动员（IRR，1.26；95%CI，1.21-1.30）是跌倒的风险因素。跌倒  与ICU时间较长相关（均值比[RM]，3.10；95%CI，2.86-3.36）  和住院(RM，2.21；95%CI，2.01-2.42)，但在  ICU（比值比[OR]，0.09；95%CI，0.05-0.17）和医院（OR，0.21；95%CI，  0.14-0.30).结论：我们观察到在ICU患者中，跌倒发生  通常情况下，ICU之间存在显著差异，并与可修改的  危险因素，ICU和住院时间较长，死亡风险较低。我们的研究  提示危重患者应考虑预防跌倒策略  ICU患者。
关键词：Humans; Male; Adult; Cohort Studies; Retrospective Studies; *Intensive Care Units; *Accidental Falls; Alberta/epidemiology

--------
--------

## Differential Effects of Gamma-Aminobutyric Acidergic Sedatives on Risk of Post-Extubation Delirium in the ICU: A Retrospective Cohort Study From a New  England Health Care Network.

5:e434-e444. DOI:10.1097/CCM.0000000000005425

Abstract: 

OBJECTIVES: To evaluate whether different gamma-aminobutyric acidergic (GABAergic) sedatives such as propofol and benzodiazepines carry differential  risks of post-extubation delirium in the ICU. 

DESIGN: Retrospective cohort study.  

SETTING: Seven ICUs in an academic hospital network, Beth Israel Deaconess  Medical Center (Boston, MA). 

PATIENTS: Ten thousand five hundred and one adult  patients mechanically ventilated for over 24 hours. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: We tested the hypothesis that benzodiazepine  versus propofol-based sedation is associated with fewer delirium-free days within  14 days after extubation. Further, we hypothesized that the measured sedation  level evoked by GABAergic drugs is a better predictor of delirium than the drug  dose administered. The proportion of GABAergic drug-induced deep sedation was  defined as the ratio of days with a mean Richmond Agitation-Sedation Scale of  less than or equal to -3 during mechanical ventilation. Multivariable regression  and effect modification analyses were used. Delirium-free days were lower in  patients who received a high proportion of deep sedation using benzodiazepine  compared with propofol-based sedation (adjusted absolute difference, -1.17 d; 95%  CI, -0.64 to -1.69; p < 0.001). This differential effect was magnified in elderly  patients (age > 65) and in patients with liver or kidney failure  (p-for-interaction < 0.001) but not observed in patients who received a low  proportion of deep sedation (p = 0.95). GABAergic-induced deep sedation days  during mechanical ventilation was a better predictor of post-extubation delirium  than the GABAergic daily average effective dose (area under the curve 0.76 vs  0.69; p < 0.001). 

CONCLUSIONS: Deep sedation during mechanical ventilation with  benzodiazepines compared with propofol is associated with increased risk of  post-extubation delirium. Our data do not support the view that  benzodiazepine-based compared with propofol-based sedation in the ICU is an  independent risk factor of delirium, as long as deep sedation can be avoided in  these patients.

## ICU中γ-氨基丁酸能镇静剂对拔管后谵妄风险的不同影响：一项新的回顾性队列研究  英国医疗保健网络。

目的：评价不同γ-氨基丁酸(GABAergic)镇静剂（如丙泊酚和苯二氮卓类）是否存在差异  ICU中拔管后谵妄的风险。

设计：回顾性队列研究。

设置：学术医院网络中的7间ICU，Beth Israel Deaconess  医学中心（马萨诸塞州波士顿）。

患者：一万五百一成人  机械通气超过24小时的患者。

干预：无。

测量值和主要结果：我们检验了苯二氮卓类  与基于丙泊酚的镇静相比，丙泊酚可以缩短术后无谵妄的天数  拔管后14天。此外，我们假设测得的镇静  gaba能药物诱发的水平是比药物更好的谵妄预测因子  给药剂量。gaba能药物诱导的深度镇静的比例为  定义为平均Richmond躁动-镇静量表评分为  机械通气期间低于或等于-3。多变量回归  使用了效应调整分析。无谵妄天数较短  使用苯二氮卓类药物接受较高比例深度镇静的患者  与丙泊酚镇静相比（校正的绝对差异，-1.17 d；95%）  CI，-0.64至-1.69；p < 0.001）。这种差异效应在老年人中被放大  患者（年龄 > 65岁）和肝衰竭或肾衰竭患者  （相互作用p值 < 0.001），但在接受低剂量  深度镇静的比例(p = 0.95)。GABAergic-诱导的深度镇静天数  机械通气期间是拔管后谵妄的更好预测因素  高于gaba能每日平均有效剂量（曲线下面积0.76 vs  0.69; p < 0.001).结论：机械通气期间深度镇静  与丙泊酚相比，苯二氮卓类药物与下列风险增加相关  拔管后谵妄。我们的数据不支持以下观点  在ICU中，以苯二氮卓类为基础的镇静与以丙泊酚为基础的镇静相比是一种  谵妄的独立风险因素，只要可以避免深度镇静  这些患者。
关键词：Humans; Aged; Intensive Care Units; Adult; Retrospective Studies; Delivery of Health Care; Respiration, Artificial/adverse effects; Hypnotics and Sedatives/adverse effects; *Delirium/chemically induced/etiology; *Propofol/adverse effects; Airway Extubation; Benzodiazepines/adverse effects

--------
--------

## Evaluating Vitamin C in Septic Shock: A Randomized Controlled Trial of Vitamin C Monotherapy., Wacker, David A.

5:e458-e467. DOI:10.1097/CCM.0000000000005427

Abstract: 

OBJECTIVES: To determine whether IV vitamin C therapy reduces 28-day mortality in patients with septic shock. 

DESIGN: Multicenter, double-blinded, randomized  controlled trial. 

SETTING: One academic medical ICU and four community ICUs.  

PATIENTS: Of 167 adult patients within 24 hours of vasopressor initiation for  septic shock, 126 consented to participation, and 124 received study drug and  were included in analysis. 

INTERVENTIONS: IV vitamin C (10 mg/mL in normal  saline) administered as a 1,000-mg bolus over 30 minutes followed by continuous  infusion of 250 mg/hr for 96 hours or placebo of equal volumes of normal saline.  

MEASUREMENTS AND MAIN RESULTS: Of 124 subjects receiving study drug and included  in analysis, 60 received vitamin C and 64 placebo. The primary outcome of  all-cause 28-day mortality (vitamin C, 26.7%; placebo, 40.6%; p = 0.10) was lower  in the vitamin C arm but did not reach statistical significance. Initiation of  renal replacement therapy was higher in the vitamin C arm (vitamin C, 16.7%;  placebo, 3.3%; p = 0.015), as was volume of fluid administration within 6 hours  of study drug initiation (vitamin C, 1.07 L; placebo, 0.76 L; p = 0.03). There  were no statistically significant differences in other secondary outcomes. In  post hoc subgroup analysis, there was a decrease in 28-day mortality in the  vitamin C arm among patients requiring positive-pressure ventilation at the time  of enrollment (vitamin C, 36.3%; placebo, 60.0%; p = 0.05). This trial is  registered at clinicaltrials.gov under identifier NCT03338569. 

CONCLUSIONS:  Vitamin C monotherapy failed to significantly reduce mortality in septic shock  patients as hypothesized. Our findings do not support its routine clinical use  for this purpose.

## 评价维生素C在感染性休克中的作用：一项维生素C单药治疗的随机对照试验。

目的：确定IV维生素C治疗是否可降低感染性休克患者的28天死亡率。

设计：多中心、双盲、随机  对照试验。

单位：1个学术型内科ICU和4个社区ICU。

患者：在167例血管加压素开始治疗24小时内的成人患者中  脓毒性休克，126例同意参加研究，124例接受研究药物和  纳入分析。

干预：静脉注射维生素C（正常情况下为10 mg/mL）  生理盐水），以1000 mg推注30 min，然后连续给药  以250 mg/h的速率输注96小时或等体积生理盐水安慰剂。

测量和主要结果：在124名接受研究药物的受试者中，包括  分析中，60名患者接受维生素C治疗，64名患者接受安慰剂治疗。主要结局  全因28天死亡率（维生素C，26.7%；安慰剂，40.6%；p = 0.10）较低  维生素C组未达到统计学显著性。开始  维生素C组的肾脏替代疗法较高（维生素C，16.7%；  安慰剂，3.3%；p = 0.015），6小时内的输液量也是如此  的治疗开始（维生素C，1.07 L；安慰剂，0.76 L；p = 0.03）。有  其他次要结局无统计学显著差异。In  事后亚组分析显示，治疗组28天死亡率降低  在当时需要正压通气的患者中的维生素C组  的受试者数量（维生素C，36.3%；安慰剂，60.0%；p = 0.05）。本试验为  在临床试验中注册。标识NCT03338569下的gov。

结论：  维生素C单药治疗未能显著降低感染性休克的死亡率  假设患者。我们的结果不支持其常规临床应用  出于此目的。
关键词：Humans; Double-Blind Method; Adult; *Shock, Septic; Ascorbic Acid/therapeutic use; Saline Solution/therapeutic use; Vasoconstrictor Agents/therapeutic use; Vitamins/therapeutic use

--------
--------

## Resuscitation in Out-of-Hospital Cardiac Arrest Patients With COVID? Never Tell Me the Odds!, Barnicle, Ryan N.

5:883-885. DOI:10.1097/CCM.0000000000005411

## 院外心脏骤停COVID患者的复苏？从不告诉我几率！
关键词：Humans; *COVID-19; *Cardiopulmonary Resuscitation; *Emergency Medical Services; *Out-of-Hospital Cardiac Arrest/therapy

--------
--------

## Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients., Bidaut, Auriane

5:e426-e433. DOI:10.1097/CCM.0000000000005424

Abstract: 

OBJECTIVES: Temporary circulatory support (TCS) as a bridge-to-left ventricular assist device (BTL) in cardiogenic shock patients has been increasing, but  limited data exists on this BTL strategy. We aimed at analyzing the outcome of  BTL patients in a population of cardiogenic shock patients compared with those  without TCS at the time of the left ventricular assist device (LVAD) surgery and  identify predictors of postoperative mortality in this specific population.  

DESIGN: A multicenter retrospective observational study conducted in 19 centers  from 2006 to 2016. 

SETTING: Nineteen French centers. 

PATIENTS: A total of 329  cardiogenic shock patients at the time of LVAD implantation were analyzed.  

Patients were divided in three groups: those under TCS at the time of LVAD  implantation (n = 173), those with TCS removal before LVAD surgery (n = 24), and  those who did not undergo a bridging strategy (n = 152). Primary endpoint was  30-day mortality. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Among the  BTL group, 68 (39.3%), 18 (10.4%), and 15 (8.7%) patients were under venoarterial  extracorporeal membrane oxygenation, Impella, and IABP support alone, and 72  patients (20.6%) were under multiple TCS support. BTL patients presented similar  30 days survival compared with the TCS removal and non-BTL groups. However, BTL  group had a significantly longer ICU duration stay, with two-fold duration of  mechanical ventilation time, but the three groups experienced similar  postoperative complications. 

Multivariate analysis identified three independent  predictors of mortality in the BTL group: combined surgery with LVAD, body mass  index (BMI), and heart failure (HF) duration. BTL strategy was not an independent  predictor of mortality in cardiogenic shock patients who underwent LVAD.  

CONCLUSIONS: BTL strategy is not associated with a lower survival among  cardiogenic shock patients with LVAD implantation. Predictors of mortality are  combined surgery with LVAD, higher BMI, and HF duration.

## 临时循环支持作为心源性休克患者桥接至左心室辅助装置策略的结局。

OBJECTIVES: Temporary circulatory support (TCS) as a bridge-to-left ventricular assist device (BTL) in cardiogenic shock patients has been increasing, but  limited data exists on this BTL strategy. We aimed at analyzing the outcome of  BTL patients in a population of cardiogenic shock patients compared with those  without TCS at the time of the left ventricular assist device (LVAD) surgery and  identify predictors of postoperative mortality in this specific population.  

DESIGN: A multicenter retrospective observational study conducted in 19 centers  from 2006 to 2016. 

SETTING: Nineteen French centers. 

PATIENTS: A total of 329  cardiogenic shock patients at the time of LVAD implantation were analyzed.  

Patients were divided in three groups: those under TCS at the time of LVAD  implantation (n = 173), those with TCS removal before LVAD surgery (n = 24), and  those who did not undergo a bridging strategy (n = 152). Primary endpoint was  30-day mortality. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Among the  BTL group, 68 (39.3%), 18 (10.4%), and 15 (8.7%) patients were under venoarterial  extracorporeal membrane oxygenation, Impella, and IABP support alone, and 72  patients (20.6%) were under multiple TCS support. BTL patients presented similar  30 days survival compared with the TCS removal and non-BTL groups. However, BTL  group had a significantly longer ICU duration stay, with two-fold duration of  mechanical ventilation time, but the three groups experienced similar  postoperative complications. 

Multivariate analysis identified three independent  predictors of mortality in the BTL group: combined surgery with LVAD, body mass  index (BMI), and heart failure (HF) duration. BTL strategy was not an independent  predictor of mortality in cardiogenic shock patients who underwent LVAD.  

CONCLUSIONS: BTL strategy is not associated with a lower survival among  cardiogenic shock patients with LVAD implantation. Predictors of mortality are  combined surgery with LVAD, higher BMI, and HF duration.
关键词：Humans; Treatment Outcome; Retrospective Studies; *Extracorporeal Membrane Oxygenation/adverse effects; *Heart Failure/complications/surgery; *Heart-Assist Devices/adverse effects; Shock, Cardiogenic/etiology/surgery

--------
--------

## Patient Heterogeneity and the J-Curve Relationship Between Time-to-Antibiotics and the Outcomes of Patients Admitted With Bacterial Infection.

5:799-809. DOI:10.1097/CCM.0000000000005429

Abstract: 

OBJECTIVES: Sepsis remains a leading and preventable cause of hospital utilization and mortality in the United States. Despite updated guidelines, the  optimal definition of sepsis as well as optimal timing of bundled treatment  remain uncertain. Identifying patients with infection who benefit from early  treatment is a necessary step for tailored interventions. In this study, we aimed  to illustrate clinical predictors of time-to-antibiotics among patients with  severe bacterial infection and model the effect of delay on risk-adjusted  outcomes across different sepsis definitions. 

DESIGN: A multicenter retrospective  observational study. 

SETTING: A seven-hospital network including academic  tertiary care center. 

PATIENTS: Eighteen thousand three hundred fifteen patients  admitted with severe bacterial illness with or without sepsis by either acute  organ dysfunction (AOD) or systemic inflammatory response syndrome positivity.  

MEASUREMENTS AND MAIN RESULTS: The primary exposure was time to antibiotics. We  identified patient predictors of time-to-antibiotics including demographics,  chronic diagnoses, vitals, and laboratory results and determined the impact of  delay on a composite of inhospital death or length of stay over 10 days.  Distribution of time-to-antibiotics was similar across patients with and without  sepsis. For all patients, a J-curve relationship between time-to-antibiotics and  outcomes was observed, primarily driven by length of stay among patients without  AOD. Patient characteristics provided good to excellent prediction of  time-to-antibiotics irrespective of the presence of sepsis. Reduced  time-to-antibiotics was associated with improved outcomes for all time points  beyond 2.5 hours from presentation across sepsis definitions. 

CONCLUSIONS:  Antibiotic timing is a function of patient factors regardless of sepsis criteria.  Similarly, we show that early administration of antibiotics is associated with  improved outcomes in all patients with severe bacterial illness. Our findings  suggest identifying infection is a rate-limiting and actionable step that can  improve outcomes in septic and nonseptic patients.

## 抗生素使用时间与因细菌感染入院患者结局之间的患者异质性和J曲线关系。

目的：在美国，败血症仍是医院使用和死亡的主要和可预防原因。尽管更新了指南，但是败血症的最佳定义以及最佳的捆绑式治疗时机仍不确定。识别从早期治疗中获益的感染患者是定制干预措施的必要步骤。在本研究中，我们的目的是阐明严重细菌感染患者中至抗生素治疗时间的临床预测因素，并在不同的败血症定义中建模延迟对风险调整结局的影响。

设计：多中心回顾性观察性研究。

单位：包括学术性三级医疗中心在内的七医院网络。

患者：183015例急性器官功能障碍(AOD)或全身炎症反应综合征阳性的严重细菌性疾病伴或不伴败血症的患者。

测量和主要结果：主要暴露时间是抗生素。我们确定了抗生素使用时间的患者预测因素，包括人口统计学、慢性诊断、生命体征和实验室结果，并确定了延迟对住院死亡或住院时间超过10天的复合终点的影响。有和无败血症患者的至抗生素时间分布相似。对于所有患者，观察到抗生素使用时间与结局之间的J曲线关系，主要由无AOD患者的住院时间驱动。无论是否存在败血症，患者特征均提供了良好至极佳的抗生素使用时间预测。在不同的败血症定义中，抗生素使用时间缩短与超过2.5小时的所有时间点的结局改善相关。

结论：不考虑败血症标准，抗生素治疗时机是患者因素的函数。同样，我们的研究显示，在所有严重细菌性疾病患者中，早期给予抗生素与改善结局相关。我们的研究结果表明，识别感染是一个限速且可采取行动的步骤，可以改善败血症和非败血症患者的结局。
关键词：Humans; Retrospective Studies; Hospital Mortality; United States; Anti-Bacterial Agents/therapeutic use; Hospitalization; *Sepsis; *Shock, Septic; *Bacterial Infections/drug therapy

--------
--------

## Impact of the Coronavirus Disease 2019 Pandemic on Moral Distress Among Nurses and Physicians in Spanish ICUs., Rodriguez-Ruiz, Emilio

5:e487-e497. DOI:10.1097/CCM.0000000000005434

Abstract: 

OBJECTIVES: To assess the impact of COVID-19 pandemic on moral distress (MD) among healthcare professionals (HCPs) (physicians and nurses) in Spanish ICUs.  

DESIGN: Cross-sectional, prospective study. 

SETTING: ICUs in Spain. 

PARTICIPANTS:  HCPs currently working in Spanish ICUs. 

INTERVENTIONS: Data were collected via  electronic survey with the use of a 50-item questionnaire in two different  periods: prepandemic (October-December 2019) and during the second wave of  COVID-19 (September-November 2020). 

MEASUREMENTS AND MAIN RESULTS: During the  prepandemic and pandemic periods, 1,065 (57.1% nurses) and 1,115 (58.5% nurses)  HCPs completed the questionnaire, respectively. Higher MD levels were reported  during COVID-19 pandemic, particularly among ICU nurses, when compared with the  prepandemic period. Before COVID-19, physicians reported significantly higher  levels of MD than ICU nurses (80.0 [interquartile range {IQR}, 40.0-135.0] vs  61.0 [IQR, 35.0-133.0]; p = 0.026). These differences disappeared during the  pandemic period (81.0 [IQR, 39.0-138.5] vs 74.0 [IQR, 41.0-143.0]; p = 0.837).  During the pandemic, younger and less experienced HCPs working in hospital areas  that were converted in ICU or in ICUs with multiple occupancy rooms reported  higher MD levels. In addition, HCPs who were off work for psychologic burden  reported higher MD levels (108.0 [IQR, 66.0-139.0] vs 76.0 [IQR, 40.0-141.0]; p <  0.05). In the prepandemic period, patient-level root causes were the most morally  distressing for nurses, whereas physicians reported higher MD on system-level  root causes. During the pandemic, both groups reported higher MD on system-level  root causes. During COVID-19, significantly more HCPs considered leaving their  job due to MD. 

CONCLUSIONS: MD has increased among ICU HCPs in Spain during  COVID-19 pandemic. Physicians reported higher MD levels than nurses in the  prepandemic period, whereas both HCPs groups reported similar MD levels in the  pandemic period. Strategies are needed and should be implemented to mitigate MD  among HCPs.

## 2019年冠状病毒病流行对西班牙ICU护士和医生的精神压力的影响。

目的：评估COVID-19大流行对西班牙ICU中医疗保健专业人员(HCP)（医生和护士）的道德困扰(MD)的影响。

设计：横断面、前瞻性研究。

设置：西班牙的ICU。

参与者：目前在西班牙ICU工作的HCP。

干预：在流行前（2019年10月-12月）和COVID-19第二波期间（2020年9月-11月），使用50项问卷通过电子调查收集数据。

测量和主要结果：在大流行前和大流行期间，分别有1,065名（57.1%护士）和1,115名（58.5%护士）HCP完成了问卷。与大流行前期相比，COVID-19大流行期间报告了更高的MD水平，尤其是ICU护士。在COVID-19之前，医生报告MD水平显著高于ICU护士（80.0[四分位距{IQR}，40.0-135.0]vs 61.0[IQR，35.0-133.0]；p = 0.026）。这些差异在流行期消失(81.0[IQR，39.0-138.5]vs 74.0[IQR，41.0-143.0]；p = 0.837)。在大流行期间，在医院区域工作的较年轻和经验较少的HCP（在ICU或多占用室的ICU中转换）报告MD水平较高。此外，由于心理负担而停止工作的HCP报告MD水平较高(108.0[IQR，66.0-139.0]vs 76.0[IQR，40.0-141.0]；p < 0.05)。在大流行前期，患者级别的根本原因是护士最令人痛苦的道德原因，而医生报告的系统级别根本原因MD更高。在大流行期间，两组均报告了较高的系统级根本原因MD。在COVID-19期间，显著更多的HCP考虑因MD而离开工作。

结论：在西班牙COVID-19大流行期间，ICU HCP中MD增加。在大流行前期，医生报告的MD水平高于护士，而两个HCP组在大流行期报告的MD水平相似。需要并应实施策略以减轻HCP之间的MD。
关键词：Humans; Prospective Studies; Intensive Care Units; Pandemics; Cross-Sectional Studies; *COVID-19; *Physicians/psychology; Morals

--------
--------

## Simulation Versus Interactive Mobile Learning for Teaching Extracorporeal Membrane Oxygenation to Clinicians: A Randomized Trial., Gannon, Whitney D.

5:e415-e425. DOI:10.1097/CCM.0000000000005376

Abstract: 

OBJECTIVES: Extracorporeal membrane oxygenation has become integral to critical care. Data informing optimal extracorporeal membrane oxygenation education  modalities are lacking. We aimed to compare the effect of high-fidelity  simulation versus interactive mobile learning on extracorporeal membrane  oxygenation knowledge acquisition and retention among clinicians. 

DESIGN:  Observer-blinded, randomized controlled trial. 

SETTING: A single academic medical  center. 

SUBJECTS: Forty-four critical care clinicians with limited extracorporeal  membrane oxygenation experience. 

INTERVENTIONS: Participants were randomized to  receive: 1) simulation: three high-fidelity training scenarios, 2) QuizTime: 15  total multiple-choice questions delivered over 3 weeks via mobile device, or 3)  experiential: no formal training. Participants completed a survey, written  knowledge examination, and simulation assessment prior to randomization,  immediately following the intervention, and 4 month postintervention.  

MEASUREMENTS AND MAIN RESULTS: The primary outcome was knowledge about  extracorporeal membrane oxygenation assessed by score on the immediate  postintervention written examination. Secondary outcomes included performance in  extracorporeal membrane oxygenation simulation postintervention and 4 months  later assessed by a rater blinded to group assignment. Clinicians randomized to  simulation (n = 15), QuizTime (n = 14), and experiential (n = 15) had similar  baseline characteristics. Adjusting for baseline knowledge, postintervention  examination scores were higher in the simulation group (90.0%; interquartile  range, 85.0-90.0%) than the QuizTime group (70.0%; interquartile range,  65.0-80.0%; p = 0.0003) and the experiential group (75.0%; interquartile range,  65.0-80.0%; p = 0.001). Scores did not differ between the groups at 4 months (p >  0.05 in all analyses). In postintervention extracorporeal membrane oxygenation  simulations, the simulation group demonstrated shorter time to critical action  compared with QuizTime (80.0 s [interquartile range, 54.0-111.0 s] vs 300.0 s  [interquartile range 85.0-300.0 s]; p = 0.02) and compared with both QuizTime  (45.0 s [interquartile range, 34.0-92.5 s] vs 255.5 s [interquartile range,  102.0-300.0 s]; p = 0.008) and experiential (300.0 s [interquartile range,  58.0-300.0 s]; p = 0.009) at 4 months. 

CONCLUSIONS: Simulation was superior to  QuizTime and experiential learning with regard to extracorporeal membrane  oxygenation knowledge acquisition. Further studies are needed to ascertain the  effect of these interventions on knowledge retention, clinical performance, and  patient outcomes.

## 对临床医生进行体外膜肺氧合教学的模拟与交互式移动学习：一项随机试验。

目的：体外膜肺氧合已成为重症监护的重要组成部分。缺乏告知最佳体外膜肺氧合教育方式的数据。我们旨在比较高保真模拟与交互式移动学习对临床医生体外膜肺氧合知识获取和保留的影响。

设计：观察者盲法随机对照试验。

单位：单一的学术医学中心。

受试者：44名体外膜肺氧合经验有限的重症临床医生。

干预：参与者随机接受：1）模拟：三种高保真培训场景，2）QuizTime：3周内通过移动设备总共提供15个多选问题，或3）经验性：未进行正式培训。受试者在随机分组前、干预后即刻和干预后4个月完成调查、书面知识检查和模拟评估。

测量和主要结果：主要结局是对体外膜肺氧合的了解，通过干预后即刻书面检查评分进行评估。次要结局包括介入术后和4个月后由对分组设盲的评定者进行体外膜氧合模拟的性能评估。随机分配到模拟组(n = 15)、QuizTime(n = 14)和经验性组(n = 15)的临床医生具有相似的基线特征。调整基线知识后，模拟组（90.0%；四分位距，85.0-90.0%）的干预后检查评分高于QuizTime组（70.0%；四分位距，65.0-80.0%；p = 0.0003）和经验组（75.0%；四分位距，65.0-80.0%；p = 0.001）。第4个月时两组间的评分无差异（所有分析中p > 0.05）。在干预后体外膜氧合模拟中，模拟组显示出比QuizTime（80.0 s[四分位距，54.0-111.0 s]vs 300.0 s[四分位距85.0-300.0 s]；p = 0.02）和两种QuizTime（45.0 s[四分位距，34.0-92.5 s]vs 255.5 s[四分位距，102.0-300.0 s]；p = 0.008）和4个月时的体验（300.0 s[四分位距，58.0-300.0 s]；p = 0.009）。

结论：在体外膜肺氧合知识获取方面，模拟优于QuizTime和体验式学习。还需要进一步的研究来确定这些干预措施对知识保留、临床表现和患者结局的影响。
关键词：Humans; Critical Care; Retrospective Studies; Academic Medical Centers; Computer Simulation; *Extracorporeal Membrane Oxygenation/education; *Simulation Training

--------
--------

## Beyond the Alveolar Epithelium: Plasma Soluble Receptor for Advanced Glycation End Products Is Associated With Oxygenation Impairment, Mortality, and  Extrapulmonary Organ Failure in Children With Acute Respiratory Distress  Syndrome.

5:837-847. DOI:10.1097/CCM.0000000000005373

Abstract: 

OBJECTIVES: Soluble receptor for advanced glycation end products is a known plasma marker of alveolar epithelial injury. However, RAGE is also expressed on  cell types beyond the lung, and its activation leads to up-regulation of  pro-inflammatory mediators. We sought to examine the relationship between plasma  soluble receptor for advanced glycation end products and primary pulmonary  dysfunction, extrapulmonary organ dysfunction, and mortality in pediatric acute  respiratory distress syndrome patients at two early time points following acute  respiratory distress syndrome diagnosis and compare these results to plasma  surfactant protein-D, a marker of pure alveolar epithelial injury. 

DESIGN:  Prospective observational study. 

SETTING: Five academic PICUs. 

PATIENTS: Two  hundred fifty-eight pediatric patients 30 days to 18 years old meeting Berlin  Criteria for acute respiratory distress syndrome. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: Plasma was collected for soluble receptor for  advanced glycation end products and surfactant protein-D measurements within 24  hours (day 1) and 48 to 72 hours (day 3) after acute respiratory distress  syndrome diagnosis. Similar to surfactant protein-D, plasma soluble receptor for  advanced glycation end products was associated with a higher oxygenation index (p  < 0.01) and worse lung injury score (p < 0.001) at the time of acute respiratory  distress syndrome diagnosis. However, unlike surfactant protein-D, plasma soluble  receptor for advanced glycation end products was associated with worse  extrapulmonary Pediatric Logistic Organ Dysfunction score during ICU stay (day 3;  p < 0.01) and positively correlated with plasma levels of interleukin-6 (p <  0.01), tumor necrosis factor-?± (p < 0.01), and angiopoietin-2 (p < 0.01). Among  children with indirect lung injury, plasma soluble receptor for advanced  glycation end products was associated with mortality independent of age, sex,  race, cancer/bone marrow transplant, and Pediatric Risk of Mortality score (day  3; odds ratio, 3.14; 95% CI, 1.46-6.75; p < 0.01). 

CONCLUSIONS: Unlike surfactant  protein-D, which is primarily localized to the alveolar epithelium plasma soluble  receptor for advanced glycation end products is systemically expressed and  correlates with markers of inflammation, extrapulmonary multiple organ  dysfunction, and death in pediatric acute respiratory distress syndrome with  indirect lung injury. This suggests that unlike surfactant protein-D, soluble  receptor for advanced glycation end products is a multifaceted marker of alveolar  injury and increased inflammation and that receptor for advanced glycation end  products activation may contribute to the pathogenesis of multiple organ failure  among children with indirect acute respiratory distress syndrome.

## 除了肺泡上皮：晚期糖基化终末产物的血浆可溶性受体与急性呼吸窘迫综合征儿童中的氧合损害、死亡和肺外器官衰竭相关。

目的：晚期糖基化终末产物的可溶性受体是肺泡上皮损伤的已知血浆标志物。然而，RAGE也在肺以外的细胞类型上表达，其激活导致促炎介质上调。我们试图检测晚期糖基化终末产物的血浆可溶性受体与原发性肺功能障碍、肺外器官功能障碍、急性呼吸窘迫综合征患儿在急性呼吸窘迫综合征诊断后两个早期时间点的死亡率，并将这些结果与血浆表面活性蛋白-D（纯肺泡上皮损伤的标志物）进行比较。

设计：前瞻性观察性研究。

单位：5家学术型PICU。

患者：258例符合急性呼吸窘迫综合征柏林标准的30天至18岁的儿科患者。

干预：无。

测定和主要结果：在急性呼吸窘迫综合征确诊后24小时（第1天）和48-72小时（第3天）内采集血浆，用于可溶性晚期糖基化终末产物受体和表面活性蛋白-D测量。与表面活性蛋白D相似，晚期糖基化终末产物的血浆可溶性受体与急性呼吸窘迫综合征诊断时较高的氧合指数(p < 0.01)和较差的肺损伤评分(p < 0.001)相关。然而，与表面活性蛋白-D不同，晚期糖基化终末产物的血浆可溶性受体与较差的肺外儿科在ICU住院期间（第3天；p < 0.01）的逻辑器官功能障碍评分相关，并与白介素-6(p < 0.01)、肿瘤坏死因子-gi±(p < 0.01)的血浆水平呈正相关。和血管生成素-2(p < 0.01)。在间接肺损伤的儿童中，晚期糖基化终末产物的血浆可溶性受体与死亡率相关，与年龄、性别、人种、癌症/骨髓移植和儿童死亡风险评分无关（第3天；比值比，3.14；95%CI，1.46-6.75；p < 0.01）。

结论：与主要定位于肺泡上皮的表面活性蛋白-D不同，晚期糖基化终末产物的血浆可溶性受体全身表达，并与炎症、肺外多器官功能障碍和间接肺损伤的小儿急性呼吸窘迫综合征死亡标志物相关。这表明，与表面活性蛋白-D不同，晚期糖基化终末产物的可溶性受体是肺泡损伤和炎症增加的多方面标志物，晚期糖基化终末产物受体活化可能导致间接急性呼吸窘迫综合征患儿发生多器官衰竭。
关键词：Humans; Adolescent; Child; Infant; Infant, Newborn; Child, Preschool; Biomarkers; Lung; Inflammation; *Respiratory Distress Syndrome; *Lung Injury; Epithelium; Glycation End Products, Advanced; Pulmonary Surfactant-Associated Protein D; Receptor for Advanced Glycation End Products; Surface-Active Agents

--------
--------

## Neighborhood Socioeconomic Disadvantage and Disability After Critical Illness.

5:733-741. DOI:10.1097/CCM.0000000000005364

Abstract: 

OBJECTIVES: Factors common to socioeconomically disadvantaged neighborhoods, such as low availability of transportation, may limit access to restorative care  services for critical illness survivors. Our primary objective was to evaluate  whether neighborhood socioeconomic disadvantage was associated with an increased  disability burden after critical illness. Our secondary objective was to  determine if the effect differed for those discharged to the community compared  with those discharged to a facility. 

DESIGN: Longitudinal cohort study with  linked Medicare claims data. 

SETTING: United States. 

PATIENTS: One hundred  ninety-nine older adults, contributing to 239 ICU admissions, who underwent  monthly assessments of disability for 12 months following hospital discharge in  13 different functional tasks from 1998 to 2017. 

MEASUREMENTS AND MAIN RESULTS:  Neighborhood disadvantage was assessed using the area deprivation index, a 1-100  ranking evaluating poverty, housing, and employment metrics. Those living in  disadvantaged neighborhoods (top quartile of scores) were less likely to  self-identify as non-Hispanic White compared with those in more advantaged  neighborhoods. In adjusted models, older adults living in disadvantaged  neighborhoods had a 9% higher disability burden over the 12 months following ICU  discharge compared with those in more advantaged areas (rate ratio, 1.09; 95%  Bayesian credible interval, 1.02-1.16). In the secondary analysis adjusting for  discharge destination, neighborhood disadvantage was associated with a 14%  increase in disability burden over 12 months of follow-up (rate ratio, 1.14; 95%  credible interval, 1.07-1.21). Disability burden was 10% higher for those living  in disadvantaged neighborhoods and discharged home as compared with those  discharged to a facility, but this difference was not statistically significant  (interaction rate ratio, 1.10; 95% credible interval, 0.98-1.25). 

CONCLUSIONS:  Neighborhood socioeconomic disadvantage is associated with a higher disability  burden in the 12 months after a critical illness. Future studies should evaluate  barriers to functional recovery for ICU survivors living in disadvantaged  neighborhoods.

## 危重病后的社区社会经济不利因素和残疾。

目的：社会经济地位不利的社区的常见因素，如交通状况较差，可能限制危重疾病幸存者获得恢复性护理服务。我们的主要目的是评估邻里社会经济劣势是否与危重疾病后残疾负担增加相关。我们的次要目的是确定出院进入社区的患者与出院进入机构的患者的影响是否不同。

设计：含医疗保险索赔数据的纵向队列研究。

设置：美国。

患者：1998-2017年，在出院后12个月内，在13项不同的功能任务中，对239例ICU入院的199例老年人进行了每月一次的残疾评估。

测量和主要结果：使用面积剥夺指数评估了社区劣势，该指数为1-100，用于评估贫困、住房和就业指标。与处于更有利环境的人相比，生活在不利环境中的人（得分最高四分位数）不太可能自我认定为非西班牙裔白人。在调整后的模型中，生活在贫困社区的老年人在离开ICU后12个月内的残疾负担比生活在较贫困地区的老年人高9%（率比，1.09；95%贝叶斯置信区间，1.02-1.16）。在校正了出院目的地的次要分析中，邻居劣势与12个月随访期间残疾负担增加14%相关（率比，1.14；95%置信区间，1.07-1.21）。居住在贫困社区和出院回家的人与出院回家的人相比，残疾负担高10%，但这种差异没有统计学意义（相互作用率比，1.10；95%置信区间，0.98-1.25）。

结论：在危重病后的12个月内，周围社会经济劣势与较高的残疾负担相关。未来的研究应评估生活在贫困环境中的ICU幸存者的功能恢复障碍。
关键词：Humans; Aged; Longitudinal Studies; Socioeconomic Factors; United States/epidemiology; *Critical Illness; Bayes Theorem; *Medicare; Residence Characteristics

--------
--------

## Preexisting Clinical Frailty Is Associated With Worse Clinical Outcomes in Patients With Sepsis., Lee, Hong Yeul

5:780-790. DOI:10.1097/CCM.0000000000005360

Abstract: 

OBJECTIVES: Frailty is a multidimensional syndrome or state of increased vulnerability to poor resolution of homoeostasis following a stressor event.  Frailty is common in patients with sepsis. Sepsis and frailty are both associated  with older age and chronic medical conditions. However, there is limited evidence  about the direct association between frailty and sepsis. The aim of this study is  to determine the association between preexisting clinical frailty and clinical  outcomes in patients with sepsis. 

DESIGN: A nationwide propensity score-matched  cohort study analyzing data prospectively collected between September 2019 and  February 2020. 

SETTING: Nineteen tertiary or university-affiliated hospitals in  South Korea. 

PATIENTS: Adult patients who were diagnosed with sepsis.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Frailty status was assessed  using the Clinical Frailty Scale. All patients were classified as "frail"  (Clinical Frailty Scale score, 5-9) or "nonfrail" (Clinical Frailty Scale score,  1-4). Propensity score matching identified comparable nonfrail patients. The  primary outcome was inhospital mortality. Multivariable logistic regression  analysis was used to evaluate the association between frailty and inhospital  mortality. The propensity score-matched cohort comprised 468 nonfrail patients  and 468 frail patients; all covariate imbalances were alleviated. In the matched  cohort (mean age, 69 ?± 14 yr), 27.2% had septic shock at presentation. Inhospital  mortality was 34.2% in the frail group and 26.9% in the nonfrail group (p =  0.019). The adjusted odds ratio for inhospital mortality in the frail group  compared with the nonfrail group was 2.00 (95% CI, 1.39-2.89; p < 0.001). Among  the patients who survived to discharge, the frail group was less likely to be  discharged home compared with the nonfrail group, 64.0% versus 81.3%,  respectively (p < 0.001). 

CONCLUSIONS: In patients with sepsis, preexisting  clinical frailty is associated with worse clinical outcomes than that in nonfrail  patients, including inhospital mortality and discharge to home.

## 既存临床虚弱与败血症患者临床结局较差相关。

目的：虚弱是一种多维度综合征或应激源事件后对内环境稳态不良缓解的易感性增加的状态。虚弱在败血症患者中常见。败血症和虚弱均与高龄和慢性疾病相关。但是，关于虚弱和败血症之间直接相关性的证据有限。本研究的目的是确定败血症患者中既存的临床虚弱与临床结局之间的相关性。

设计：一项全国倾向评分匹配队列研究，分析2019年9月至2020年2月期间前瞻性收集的数据。

单位：韩国19家三级或大学附属医院。

患者：确诊为败血症的成人患者。

干预：无。

测量和主要结果：使用临床虚弱量表评估虚弱状态。所有患者均被分类为“虚弱”（临床虚弱量表评分，5-9）或“非虚弱”（临床虚弱量表评分，1-4）。倾向评分匹配确定了相当的非虚弱患者。主要结局为住院死亡率。使用多变量logistic回归分析评价虚弱与住院死亡率之间的相关性。倾向评分匹配队列包括468例非虚弱患者和468例虚弱患者；所有协变量不平衡均得到缓解。在匹配的队列中（平均年龄，69±14岁），27.2%的患者在就诊时存在脓毒性休克。虚弱组住院死亡率为34.2%，非虚弱组为26.9%(p = 0.019)。与非虚弱组相比，虚弱组住院死亡率的调整比值比为2.00(95%CI，1.39-2.89；p < 0.001)。在存活出院的患者中，与非虚弱组相比，虚弱组不太可能出院回家，分别为64.0%与81.3%(p < 0.001)。

结论：在败血症患者中，与非虚弱患者相比，预先存在的临床虚弱患者的临床结局更差，包括住院死亡率和出院回家。
关键词：Humans; Middle Aged; Aged; Cohort Studies; Aged, 80 and over; Risk Factors; Frail Elderly; *Frailty/complications/epidemiology; *Sepsis/complications/epidemiology

--------
--------

## Hastening Death in Canadian ICUs: End-of-Life Care in the Era of Medical Assistance in Dying., Andersen, Sarah K.

5:742-749. DOI:10.1097/CCM.0000000000005359

Abstract: 

OBJECTIVES: Since 2016, Canada has allowed for euthanasia based on strict criteria under federal medical assistance in dying legislation. The purpose of  this study was to determine how Canadian intensivists perceive medical assistance  in dying and whether they believe their approach to withdrawal of life-sustaining  therapies has changed following introduction of medical assistance in dying.  

DESIGN: Electronic survey. 

SETTING: Participants were recruited from 11 PICU  programs and 14 adult ICU programs across Canada. All program leaders for whom  contact information was available were approached for participation.  

PARTICIPANTS: We invited intensivists and critical care trainees employed between  December 2019 and May 2020 to participate using a snowball sampling technique in  which department leaders distributed study information. All responses were  anonymous. Quantitative data were analyzed using descriptive statistics.  Categorical variables were analyzed using Pearson chi-square test. 

INTERVENTIONS:  Not applicable. 

MEASUREMENTS AND MAIN RESULTS: We obtained 150 complete  questionnaires (33% response rate), of which 50% were adult practitioners and 50%  pediatric. Most were from academic centers (81%, n = 121). Of respondents, 86% (n  = 130) were familiar with medical assistance in dying legislation, 71% in favor,  14% conflicted, and 11% opposed. Only 5% (n = 8) thought it had influenced their  approach to withdrawal of life-sustaining therapies. Half of participants had no  standardized protocol for withdrawal of life-sustaining therapies in their unit,  and 41% (n = 62) had observed medications given in disproportionately high doses  during withdrawal of life-sustaining therapies, with 13% having personally  administered such doses. Most (80%, n = 120) had experienced explicit requests  from families to hasten death, and almost half (47%, n = 70) believed it was  ethically permissible to intentionally hasten death following withdrawal of  life-sustaining therapies. 

CONCLUSIONS: Most Canadian intensivists surveyed do  not think that medical assistance in dying has changed their approach to end of  life in the ICU. A significant minority are ethically conflicted about the  current approach to assisted dying/euthanasia in Canada. Almost half believe it  is ethical to intentionally hasten death during withdrawal of life-sustaining  therapies if death is expected.

## 加拿大ICU中的加速死亡：濒死医疗救助时代的临终关怀。

目的：自2016年以来，加拿大根据联邦死亡医疗救助法规中的严格标准允许实施安乐死。本研究的目的是确定加拿大重症监护医生如何看待死亡时的医疗援助，以及他们是否认为在引入死亡时的医疗援助后，他们撤除维持生命治疗的方法发生了变化。

设计：电子调查。

设置：参与者从加拿大的11个PICU项目和14个成人ICU项目中招募。联系联系所有项目负责人并提供其联系信息。

参加者：我们邀请2019年12月至2020年5月期间雇佣的重症监护医生和重症监护学员使用雪球采样技术参加研究，部门负责人在该技术中分发研究信息。所有回复均为匿名。使用描述性统计分析定量数据。分类变量采用Pearson卡方检验。

干预：不适用。

测量和主要结果：我们获得了150份完整的问卷（33%应答率），其中50%为成人从业者，50%为儿童。大多数来自学术中心(81%，n = 121)。在答复者中，86%(n = 130)熟悉濒死立法方面的医疗援助，71%赞成，14%冲突，11%反对。仅5%(n = 8)认为这影响了他们停止维持生命治疗的方法。一半的受试者在其单位中没有停止维持生命治疗的标准化方案，41%(n = 62)的受试者在停止维持生命治疗期间观察到不成比例的高剂量给药，13%的受试者亲自给予了此类剂量。大多数(80%，n = 120)经历了家庭加速死亡的明确要求，几乎一半(47%，n = 70)认为，在停止维持生命的治疗后，在伦理上允许故意加速死亡。

结论：大多数接受调查的加拿大重症监护医生认为，对死亡患者的医疗救助改变了他们在ICU中的临终方法。对于加拿大目前的辅助死亡/安乐死方法，相当多的少数人在伦理上产生矛盾。几乎一半的人认为，在预期死亡的情况下，在停止维持生命的治疗时故意加速死亡是合乎伦理的。
关键词：Humans; Intensive Care Units; Adult; Child; Canada; *Terminal Care; *Euthanasia; Medical Assistance

--------
--------

## Hyperdynamic Left Ventricular Ejection Fraction in ICU Patients With Sepsis., Chotalia, Minesh

5:770-779. DOI:10.1097/CCM.0000000000005315

Abstract: 

OBJECTIVES: To evaluate the cause and prognosis of hyperdynamic left ventricular ejection fraction in critically ill patients with sepsis. 

DESIGN: Retrospective,  single-center cohort study. 

SETTING: University Hospital ICU, Birmingham, United  Kingdom. 

PATIENTS: ICU patients who received a transthoracic echocardiogram  within 7 days of sepsis between April 2016 and December 2019. 

INTERVENTION: None.  

MEASUREMENTS AND MAIN RESULTS: The 90-day mortality rates of normal (55-70%),  depressed (< 55%), and hyperdynamic left ventricular ejection fraction (> 70%)  were compared. Multivariate logistic regression analysis was performed to  determine the association of left ventricular ejection fraction phenotypes with  mortality and the association of clinical variables with left ventricular  ejection fraction phenotypes. One thousand fourteen patients met inclusion  criteria and were 62 years old (interquartile range, 47-72), with mostly  respiratory infections (n = 557; 54.9%). Ninety-day mortality was 32.1% (n =  325). Patients with hyperdynamic left ventricular ejection fraction had a higher  mortality than depressed and normal left ventricular ejection fraction cohorts  (58.9% [n = 103] vs 34.0% [n = 55] vs 24.7% [n = 167]; p < 0.0001, respectively).  After multivariate logistic regression, hyperdynamic left ventricular ejection  fraction was independently associated with mortality (odds ratio, 3.90  [2.09-7.40]), whereas depressed left ventricular ejection fraction did not (odds  ratio, 0.62 [0.28-1.37]). Systemic vascular resistance was inversely associated  with hyperdynamic left ventricular ejection fraction (odds ratio, 0.79  [0.58-0.95]), and age, frailty, and ischemic heart disease were associated with  depressed left ventricular ejection fraction. 

CONCLUSIONS: Hyperdynamic left  ventricular ejection fraction was associated with mortality in septic ICU  patients and may reflect unmitigated vasoplegia from sepsis. Depressed left  ventricular ejection fraction was not associated with mortality but was  associated with cardiovascular disease.

## ICU脓毒症患者的高动力性左心室射血分数。

目的：评估脓毒症重症患者的高动力性左心室射血分数的原因和预后。

设计：回顾性、单中心队列研究。

单位：University Hospital ICU,Birmingham,United Kingdom。

患者：2016年4月至2019年12月脓毒症7天内接受经胸超声心动图检查的ICU患者。

干预：无。

测量和主要结果：比较了正常(55-70%)、抑制(<55%)和高动力左心室射血分数(>70%)的90天死亡率。进行了多变量logistic回归分析，以确定左心室射血分数表型与死亡率的相关性以及临床变量与左心室射血分数表型的相关性。1414名患者符合入选标准，年龄为62岁（四分位距：47-72），主要为呼吸道感染(n = 557；54.9%)。90天死亡率为32.1%(n = 325)。左心室射血分数高动力患者的死亡率高于左心室射血分数降低和正常队列（分别为58.9%[n = 103]vs 34.0%[n = 55]vs 24.7%[n = 167]；p < 0.0001）。多变量logistic回归后，高动力性左心室射血分数与死亡率独立相关（比值比，3.90[2.09-7.40]），而左心室射血分数降低不相关（比值比，0.62[0.28-1.37]）。全身血管阻力与高动力性左心室射血分数呈负相关（比值比，0.79[0.58-0.95]），年龄、虚弱和缺血性心脏病与左心室射血分数降低相关。

结论：高动力性左心室射血分数与败血症ICU患者的死亡率相关，可能反映了未减轻的败血症所致的血管麻痹。左心室射血分数降低与死亡率无关，但与心血管疾病相关。
关键词：Humans; Intensive Care Units; Cohort Studies; Retrospective Studies; Stroke Volume; *Sepsis; *Ventricular Dysfunction, Left/etiology; Ventricular Function, Left

--------
--------

## Coronavirus Disease 2019 and Out-of-Hospital Cardiac Arrest: No Survivors.

5:791-798. DOI:10.1097/CCM.0000000000005374

Abstract: 

OBJECTIVES: To describe and compare survival among patients with out-of-hospital cardiac arrest as a function of their status for coronavirus disease 2019.  

DESIGN: We performed an observational study of out-of-hospital cardiac arrest  patients between March 2020 and December 2020. Coronavirus disease 2019 status  (confirmed, suspected, or negative) was defined according to the World Health  Organization's criteria. 

SETTING: Information on the patients and their care was  extracted from the French national out-of-hospital cardiac arrest registry. 

The  French prehospital emergency medical system has two tiers: the fire department  intervenes rapidly to provide basic life support, and mobile ICUs provide  advanced life support. The study data (including each patient's coronavirus  disease 2019 status) were collected by 95 mobile ICUs throughout France.  

PATIENTS: We included 6,624 out-of-hospital cardiac arrest patients: 127 cases  with confirmed coronavirus disease 2019, 473 with suspected coronavirus disease  2019, and 6,024 negative for coronavirus disease 2019. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: The "confirmed" and "suspected" groups of  coronavirus disease 2019 patients had similar characteristics and were more  likely to have suffered an out-of-hospital cardiac arrest with a respiratory  cause (confirmed: 53.7%, suspected coronavirus disease 2019: 56.5%; p = 0.472)  than noncoronavirus disease 2019 patients (14.0%; p < 0.001 vs confirmed  coronavirus disease 2019 patients). Advanced life support was initiated for 57.5%  of the confirmed coronavirus disease 2019 patients, compared with 64.5% of the  suspected coronavirus disease 2019 patients (p = 0.149) and 70.6% of the  noncoronavirus disease 2019 ones (p = 0.002). The survival rate at 30-day  postout-of-hospital cardiac arrest was 0% in the confirmed coronavirus disease  2019 group, 0.9% in the suspected coronavirus disease 2019 group (p = 0.583 vs  confirmed), and 3.5% (p = 0.023) in the noncoronavirus disease 2019 group.  

CONCLUSIONS: Our results highlighted a zero survival rate in out-of-hospital  cardiac arrest patients with confirmed coronavirus disease 2019. This finding  raises important questions with regard to the futility of resuscitation for  coronavirus disease 2019 patients and the management of the associated risks.

## 2019年冠状病毒病和院外心脏骤停：无存活者。

目的：描述和比较2019年医院外心脏骤停患者的生存率，作为其冠状病毒疾病状态的函数。

设计：我们对2020年3月至2020年12月期间的院外心脏骤停患者进行了观察性研究。根据世界卫生组织的标准定义了2019年冠状病毒病状态（确认、疑似或阴性）。

背景：从法国国家院外心脏骤停登记研究中提取患者及其护理的信息。

法国院前急救医疗系统分两层：消防部门快速介入，提供基础生命支持；移动ICU提供高级生命支持。研究数据（包括每例患者的冠状病毒病2019状态）通过法国95个移动ICU收集。

患者：我们纳入了6624例院外心脏骤停患者：127例确诊冠状病毒病2019例，473例疑似冠状病毒病2019例，6024例冠状病毒病阴性2019例。

干预：无。

测量和主要结果：2019例“确诊”和“疑似”冠状病毒病组患者具有相似的特征，与2019例非冠状病毒病组患者（14.0%；p < 0.001 vs证实的冠状病毒病2019例患者）。2019例确诊的冠状病毒疾病患者中57.5%启动了高级生命支持，2019例疑似冠状病毒疾病患者中64.5%启动了高级生命支持(p = 0.149)，2019例非冠状病毒疾病患者中70.6%启动了高级生命支持(p = 0.002)。确诊的2019年冠状病毒病组的30天院外心脏骤停生存率为0%，2019年疑似冠状病毒病组的30天院外心脏骤停生存率为0.9%（p = 0.583 vs确诊），2019年疑似冠状病毒病组的30天院外心脏骤停生存率为3.5%(p = 0.023)。非冠状病毒病2019组。

结论：我们的结果强调，确诊为冠状病毒病的院外心脏骤停患者的生存率为零2019。这一发现引发了关于2019例冠状病毒疾病患者复苏无效以及相关风险管理的重要问题。
关键词：Humans; Registries; *COVID-19; *Cardiopulmonary Resuscitation/methods; *Emergency Medical Services/methods; *Out-of-Hospital Cardiac Arrest/epidemiology/therapy

--------
--------

## Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults., Hines, Melissa R.

5:860-872. DOI:10.1097/CCM.0000000000005361

Abstract: 

OBJECTIVE: Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome that often requires critical care support and remains difficult to diagnose.  These guidelines are meant to aid in the early recognition, diagnosis, supportive  care, and treatment of patients with hemophagocytic lymphohistiocytosis in ICUs.  

DATA SOURCES: The literature searches were performed with PubMed (MEDLINE). 

STUDY  SELECTION: Keywords and medical subject headings terms for literature search  included "macrophage activation syndrome," hemophagocytic lymphohistiocytosis,"  and "hemophagocytic syndrome." DATA EXTRACTION: The Histiocyte Society developed  these consensus recommendations on the basis of published reports and expert  opinions with level of evidence provided for each recommendation. They were  endorsed by the Society of Critical Care Medicine. 

DATA SYNTHESIS: Testing for  hemophagocytic lymphohistiocytosis should be initiated promptly in all patients  admitted to ICUs with an unexplained or disproportionate inflammatory response,  especially those with rapid clinical deterioration. Meeting five or more of eight  hemophagocytic lymphohistiocytosis 2004 diagnostic criteria serves as a valuable  diagnostic tool for hemophagocytic lymphohistiocytosis. Early aggressive critical  care interventions are often required to manage the multisystem organ failure  associated with hemophagocytic lymphohistiocytosis. Thorough investigation of the  underlying triggers of hemophagocytic lymphohistiocytosis, including infections,  malignancies, and autoimmune/autoinflammatory diseases, is essential. Early  steroid treatment is indicated for patients with familial hemophagocytic  lymphohistiocytosis and is often valuable in patients with acquired  hemophagocytic lymphohistiocytosis (i.e., secondary hemophagocytic  lymphohistiocytosis) without previous therapy, including macrophage activation  syndrome (hemophagocytic lymphohistiocytosis secondary to  autoimmune/autoinflammatory disease) without persistent or relapsing disease.  Steroid treatment should not be delayed, particularly if organ dysfunction is  present. In patients with macrophage activation syndrome, whose disease does not  sufficiently respond, interleukin-1 inhibition and/or cyclosporine A is  recommended. In familial hemophagocytic lymphohistiocytosis and severe,  persistent, or relapsing secondary macrophage activation syndrome, the addition  of prompt individualized, age-adjusted etoposide treatment is recommended.  

CONCLUSIONS: Further studies are needed to determine optimal treatment for  patients with hemophagocytic lymphohistiocytosis in ICUs, including the use of  novel and adjunct therapies.

## 危重病儿童和成人中噬血细胞性淋巴组织细胞增生症的识别、诊断和管理的基于共识的指南。

目的：噬血细胞性淋巴组织细胞增生症是一种高炎性综合征，通常需要重症监护支持，仍然难以诊断。这些指南旨在帮助ICU中噬血细胞性淋巴组织细胞增生症患者的早期识别、诊断、支持治疗和治疗。

资料来源：应用PubMed(MEDLINE)进行文献检索。

研究选择：用于文献检索的关键词和医学主题词包括“巨噬细胞活化综合征”、“嗜血细胞性淋巴组织细胞增生症”和“嗜血细胞综合征”。

数据提取：组织细胞学会根据已发表的报告和专家意见制定这些共识建议，并提供每项建议的证据水平。他们得到了重症医学协会的支持。

资料综合：所有入住ICU的炎症反应无法解释或不成比例的患者，尤其是临床症状迅速恶化的患者，应及时开始噬血细胞性淋巴组织细胞增生症的检测。满足2004年8项噬血细胞性淋巴组织细胞增生症中的5项或5项以上诊断标准，可作为噬血细胞性淋巴组织细胞增生症的一种有价值的诊断工具。通常需要早期积极的重症监护干预来管理与噬血细胞性淋巴组织细胞增生症相关的多系统器官衰竭。必须彻底调查噬血细胞性淋巴组织细胞增生症的潜在触发因素，包括感染、恶性肿瘤和自身免疫性/自身炎症性疾病。早期类固醇治疗适用于家族性噬血细胞性淋巴组织细胞增生症患者，在获得性噬血细胞性淋巴组织细胞增生症（即，继发性噬血细胞性淋巴组织细胞增生症），既往未接受过治疗，包括巨噬细胞活化综合征（继发于自身免疫/自身炎症性疾病的噬血细胞性淋巴组织细胞增生症），无持续性或复发性疾病。类固醇治疗不应延迟，尤其是存在器官功能障碍时。在疾病疗效不充分的巨噬细胞活化综合征患者中，推荐使用白细胞介素-1抑制剂和/或环孢素A。在家族性噬血细胞性淋巴组织细胞增生症和重度、持续性或复发性继发性巨噬细胞活化综合征中，建议增加及时的个体化、年龄调整的依托泊苷治疗。

结论：需要进一步的研究来确定ICU中噬血细胞性淋巴组织细胞增生症患者的最佳治疗，包括使用新型和辅助疗法。
关键词：Humans; Adult; Child; Consensus; Critical Illness/therapy; Steroids; *Lymphohistiocytosis, Hemophagocytic/diagnosis/therapy; *Macrophage Activation Syndrome/diagnosis/etiology/therapy; Neoplasm Recurrence, Local/complications

--------
--------

## Extended Lung Ultrasound to Differentiate Between Pneumonia and Atelectasis in Critically Ill Patients: A Diagnostic Accuracy Study.

5:750-759. DOI:10.1097/CCM.0000000000005303

Abstract: 

OBJECTIVES: To determine the diagnostic accuracy of extended lung ultrasonographic assessment, including evaluation of dynamic air bronchograms and  color Doppler imaging to differentiate pneumonia and atelectasis in patients with  consolidation on chest radiograph. Compare this approach to the Simplified  Clinical Pulmonary Infection Score, Lung Ultrasound Clinical Pulmonary Infection  Score, and the Bedside Lung Ultrasound in Emergency protocol. 

DESIGN: Prospective  diagnostic accuracy study. 

SETTING: Adult ICU applying selective digestive  decontamination. 

PATIENTS: Adult patients that underwent a chest radiograph for  any indication at any time during admission. Patients with acute respiratory  distress syndrome, coronavirus disease 2019, severe thoracic trauma, and  infectious isolation measures were excluded. 

INTERVENTIONS: None. 

MEASUREMENTS  AND MAIN RESULTS: Lung ultrasound was performed within 24 hours of chest  radiograph. Consolidated tissue was assessed for presence of dynamic air  bronchograms and with color Doppler imaging for presence of flow. Clinical data  were recorded after ultrasonographic assessment. The primary outcome was  diagnostic accuracy of dynamic air bronchogram and color Doppler imaging alone  and within a decision tree to differentiate pneumonia from atelectasis. Of 120  patients included, 51 (42.5%) were diagnosed with pneumonia. The dynamic air  bronchogram had a 45% (95% CI, 31-60%) sensitivity and 99% (95% CI, 92-100%)  specificity. Color Doppler imaging had a 90% (95% CI, 79-97%) sensitivity and 68%  (95% CI, 56-79%) specificity. The combined decision tree had an 86% (95% CI,  74-94%) sensitivity and an 86% (95% CI, 75-93%) specificity. The Bedside Lung  Ultrasound in Emergency protocol had a 100% (95% CI, 93-100%) sensitivity and 0%  (95% CI, 0-5%) specificity, while the Simplified Clinical Pulmonary Infection  Score and Lung Ultrasound Clinical Pulmonary Infection Score had a 41% (95% CI,  28-56%) sensitivity, 84% (95% CI, 73-92%) specificity and 68% (95% CI, 54-81%)  sensitivity, 81% (95% CI, 70-90%) specificity, respectively. 

CONCLUSIONS: In  critically ill patients with pulmonary consolidation on chest radiograph, an  extended lung ultrasound protocol is an accurate and directly bedside available  tool to differentiate pneumonia from atelectasis. It outperforms standard lung  ultrasound and clinical scores.

## 扩展肺部超声鉴别危重患者肺炎和肺不张：一项诊断准确性研究。

目的：确定扩展的肺部超声评估的诊断准确性，包括评价动态空气支气管造影和彩色多普勒成像，以鉴别胸片上实变患者的肺炎和肺不张。将此方法与紧急情况下的简化临床肺部感染评分、肺部超声临床肺部感染评分和床旁肺部超声进行比较。

设计：前瞻性诊断准确性研究。

背景：成人ICU应用选择性消化道净化。

患者：在入院期间任何时间因任何指征接受胸部x线检查的成人患者。排除急性呼吸窘迫综合征、2019冠状病毒病、严重胸外伤、感染性隔离措施患者。

干预：无。

测量值和主要结果：在胸片检查后24小时内进行肺部超声检查。对合并组织进行动态空气支气管造影评估，并使用彩色多普勒成像评估是否存在血流。超声评估后记录临床数据。主要结局是动态空气支气管造影和彩色多普勒成像单独和在决策树内鉴别肺炎和肺不张的诊断准确性。在纳入的120例患者中，51例(42.5%)被诊断为肺炎。动态空气支气管造影的灵敏度为45%(95%CI，31-60%)，特异性为99%(95%CI，92-100%)。彩色多普勒成像的敏感性为90%(95%CI，79-97%)，特异性为68%(95%CI，56-79%)。联合决策树的灵敏度为86%(95%CI，74-94%)，特异性为86%(95%CI，75-93%)。急诊方案中的床旁肺部超声的灵敏度为100%(95%CI，93-100%)，特异性为0%(95%CI，0-5%)，而简化临床肺部感染评分和肺部超声临床肺部感染评分的灵敏度为41%(95%CI，28-56%)，特异性为84%(95%CI，73-92%)，特异性为68%（95%CI，54-81%）的灵敏度，81%(95%CI，70-90%)的特异性。

结论：在胸部x线片显示肺实变的重症患者中，扩展的肺部超声方案是鉴别肺炎与肺不张的一种准确、直接床旁可用的工具。其优于标准肺部超声和临床评分。
关键词：Humans; Prospective Studies; Critical Illness; Adult; Sensitivity and Specificity; *COVID-19; Lung/diagnostic imaging; *Pneumonia/diagnostic imaging; *Pulmonary Atelectasis/diagnostic imaging; Ultrasonography/methods

--------
--------

## Clinical Benefit of Extubation in Patients on Venoarterial Extracorporeal Membrane Oxygenation., Massart, Nicolas

5:760-769. DOI:10.1097/CCM.0000000000005304

Abstract: 

OBJECTIVES: Although patients on venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock are usually supported with mechanical  ventilation, it is not clear whether sedation cessation and extubation might  improve outcomes. 

DESIGN: Retrospective cohort study with propensity score  overlap weighting analysis. 

SETTING: Three ICUs in a 1,500-bed tertiary  university hospital. 

PATIENTS: From an overall cohort of 641 patients with  venoarterial-extracorporeal membrane oxygenation support, the primary analysis  was performed in 344 patients who had been successfully decannulated in order to  reduce immortal time bias. 

MEASUREMENTS AND MAIN RESULTS: Seventy-five patients  (22%) were extubated during extracorporeal membrane oxygenation support and were  subsequently decannulated alive. Forty-nine percent received noninvasive  ventilation, and 25% had emergency reintubation for respiratory, neurologic, or  hemodynamic reasons. Higher Simplified Acute Physiology Score II at admission  (odds ratio, 0.97; 95% CI [0.95-0.99]; p = 0.008) was associated with a lower  probability of extubation, whereas cannulation in cardiac surgery ICU (odds  ratio, 3.14; 95% CI [1.21-8.14]; p = 0.018) was associated with an increased  probability. Baseline characteristics were well balanced after propensity score  overlap weighting. The number of ICU-free days within 30 days of extracorporeal  membrane oxygenation decannulation was significantly higher among extubated  patients compared with nonextubated patients (22 d [11-26 d] vs 18 d [7-25 d],  respectively; p = 0.036). There were no differences in other outcomes including  ventilator-associated pneumonia (odds ratio, 0.96; 95% CI [0.51-1.82]; p = 0.90)  and all-cause mortality within 30 days of extracorporeal membrane oxygenation  decannulation (5% vs 17%; hazard ratio, 0.54; 95% CI [0.19-1.59]; p = 0.27).As a  secondary analysis, outcomes were compared in the overall cohort of 641  venoarterial extracorporeal membrane oxygenation-supported patients. Results were  consistent with the primary analysis as extubated patients had a higher number of  ICU-free days (18 d [0-24 d] vs 0 d [0-18 d], respectively; < 0.001) and a lower  risk of death within 30 days of extracorporeal membrane oxygenation cannulation  (hazard ratio, 0.45; 95% CI [0.29-0.71]; p = 0.001). 

CONCLUSIONS: Extubation  during venoarterial-extracorporeal membrane oxygenation support is safe,  feasible, and associated with greater ICU-free days.

## 静脉动脉体外膜肺氧合患者拔管的临床获益。

目的：虽然接受静脉动脉体外膜肺氧合治疗难治性心源性休克的患者通常接受机械通气支持，但尚不清楚停止镇静和拔管是否可改善结局。

设计：采用倾向评分重叠加权分析的回顾性队列研究。

单位：1500张床位的一所三级大学医院的3间ICU。

患者：在641例接受静脉-动脉-体外膜肺氧合支持的患者组成的整体队列中，对344例成功拔管的患者进行了主要分析，以减少永久时间偏倚。

测量结果和主要结果：75例患者(22%)在体外膜肺氧合支持期间拔管，随后存活拔管。49%接受无创通气，25%因呼吸、神经或血流动力学原因紧急重新插管。入院时较高的简化急性生理学评分II（比值比，0.97；95%CI[0.95-0.99]；p = 0.008）与拔管概率较低相关，而在心脏手术ICU插管（比值比，3.14；95%CI[1.21-8.14]；p = 0.018）与概率增加相关。倾向评分重叠加权后基线特征平衡良好。与非拔管患者相比，拔管患者体外膜氧合拔管30天内无ICU的天数显著更高（分别为22天[11-26天]与18天[7-25天]；p = 0.036）。其他结局无差异，包括呼吸机相关性肺炎（比值比，0.96；95%CI[0.51-1.82]；p = 0.90）和体外膜氧合拔管后30天内的全因死亡率（5%vs 17%；风险比，0.54；95%CI[0.19-1.59]；p = 0.27）。As次要分析，比较了641例静脉-动脉体外膜氧合支持患者的总体队列的结局。结果与主要分析一致，因为拔管患者的无ICU天数较多（分别为18天[0-24天]与0天[0-18天]；< 0.001），体外膜氧合插管30天内的死亡风险较低（风险比，0.45；95%CI[0.29-0.71]；p = 0.001）。

结论：静脉动脉-体外膜肺氧合支持期间拔管安全、可行，并与更长的无ICU天数相关。
关键词：Humans; Retrospective Studies; *Cardiac Surgical Procedures/adverse effects; *Extracorporeal Membrane Oxygenation/methods; Airway Extubation/adverse effects; Shock, Cardiogenic/etiology/therapy

--------
--------

## The Impact of a Machine Learning Early Warning Score on Hospital Mortality: A Multicenter Clinical Intervention Trial.

4:e413-e414. DOI:10.1097/CCM.0000000000005492

Abstract: 

OBJECTIVES: To determine the impact of a machine learning early warning risk score, electronic Cardiac Arrest Risk Triage (eCART), on mortality for  elevated-risk adult inpatients. 

DESIGN: A pragmatic pre- and post-intervention  study conducted over the same 10-month period in 2 consecutive years. 

SETTING:  Four-hospital community-academic health system. 

PATIENTS: All adult patients  admitted to a medical-surgical ward. 

INTERVENTIONS: During the baseline period,  clinicians were blinded to eCART scores. During the intervention period, scores  were presented to providers. Scores greater than or equal to 95th percentile were  designated high risk prompting a physician assessment for ICU admission. Scores  between the 89th and 95th percentiles were designated intermediate risk,  triggering a nurse-directed workflow that included measuring vital signs every 2  hours and contacting a physician to review the treatment plan. 

MEASUREMENTS AND  MAIN RESULTS: The primary outcome was all-cause inhospital mortality. Secondary  measures included vital sign assessment within 2 hours, ICU transfer rate, and  time to ICU transfer. A total of 60,261 patients were admitted during the study  period, of which 6,681 (11.1%) met inclusion criteria (baseline period n = 3,191,  intervention period n = 3,490). The intervention period was associated with a  significant decrease in hospital mortality for the main cohort (8.8% vs 13.9%; p  < 0.0001; adjusted odds ratio [OR], 0.60 [95% CI, 0.52-0.71]). A significant  decrease in mortality was also seen for the average-risk cohort not subject to  the intervention (0.49% vs 0.26%; p < 0.05; adjusted OR, 0.53 [95% CI,  0.41-0.74]). In subgroup analysis, the benefit was seen in both high- (17.9% vs  23.9%; p = 0.001) and intermediate-risk (2.0% vs 4.0 %; p = 0.005) patients. The  intervention period was also associated with a significant increase in ICU  transfers, decrease in time to ICU transfer, and increase in vital sign  reassessment within 2 hours. 

CONCLUSIONS: Implementation of a machine learning  early warning score-driven protocol was associated with reduced inhospital  mortality, likely driven by earlier and more frequent ICU transfer.

## 机器学习早期警告评分对医院死亡率的影响：一项多中心临床干预试验。

目的：确定机器学习早期预警风险评分，电子心脏骤停风险分级(eCART)对高危成人住院患者死亡率的影响。

设计：在连续2年的相同10个月期间进行的实用干预前和干预后研究。

单位：四医院社区-医疗卫生系统。

患者：所有入住内外科病房的成年患者。

干预：基线期间，临床医生对eCART评分不知情。在干预期间，将评分提供给提供者。评分大于或等于第95百分位数被指定为高风险，提示医生进行ICU入院评估。第89百分位数和第95百分位数之间的评分被指定为中等风险，触发了护士指导的工作流程，包括每2小时测量一次生命体征，并联系医生审查治疗计划。

测量和主要结果：主要结局为全因住院死亡率。次要指标包括2小时内生命体征评估、转ICU率和转ICU时间。研究期间共有60,261例患者入院，其中6,681例(11.1%)符合入选标准（基线期n = 3,191，干预期n = 3,490）。对于主要队列，介入期与住院死亡率的显著降低相关（8.8%vs 13.9%；p < 0.0001；校正比值比[OR]，0.60[95%CI，0.52-0.71]）。在未接受干预的平均风险队列中也观察到死亡率显著降低（0.49%vs 0.26%；p < 0.05；校正OR，0.53[95%CI，0.41-0.74]）。在亚组分析中，高危(17.9%vs 23.9%；p = 0.001)和中危(2.0%vs 4.0%；p = 0.005)患者均可见获益。干预期间也与ICU转诊显著增加、至ICU转诊时间减少和2小时内生命体征再评估增加相关。

结论：实施机器学习早期预警评分驱动方案与住院死亡率降低相关，这可能是由于早期和更频繁的ICU转移所致。

--------
--------

## Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021: Erratum.

4:e409-e410. DOI:10.1097/CCM.0000000000005457

DOI: 10.1097/CCM.0000000000005513

--------
--------

## The authors reply., Spinella, Philip C.

## Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021: Erratum.

--------
--------

## The authors reply.

4:e413-e414. DOI:10.1097/CCM.0000000000005513

--------
--------

## The authors reply.

4:e407-e408. DOI:10.1097/CCM.0000000000005421

--------
--------

## Bringing Hidden Biases Into Light: Comments on an Observational Study on the Use of Antifibrinolytics for Pediatric Patients With Life-Threatening Hemorrhage.

## 揭示隐藏的偏倚：关于对危及生命的出血儿科患者使用抗纤溶药物的观察性研究的评论。
关键词：Humans; Child; *Antifibrinolytic Agents/therapeutic use; Bias; Hemorrhage/chemically induced; Platelet Transfusion

--------
--------

## The authors reply., Domecq, Juan Pablo

4:e406-e407. DOI:10.1097/CCM.0000000000005456

## 作者回复。

--------
--------

## Optimal Evidence Grading of Simultaneous Use of Hypertonic Saline and Furosemide for Fluid Overload.

4:e405-e406. DOI:10.1097/CCM.0000000000005419

关键词：Humans; *Heart Failure; *Water-Electrolyte Imbalance; Diuretics/therapeutic use; Furosemide/therapeutic use; Saline Solution, Hypertonic/therapeutic use

--------
--------

## The authors reply.

4:e403-e404. DOI:10.1097/CCM.0000000000005455

## 作者回复。

--------
--------

## Early Vasopressor Initiation Increases Mortality in Patients With Septic Shock: Less Intensive Intervention or More Critically Ill Patients?

4:e402-e403. DOI:10.1097/CCM.0000000000005418

## 早期血管加压药治疗增加感染性休克患者的死亡率：强化干预较少或危重患者更多？
关键词：Humans; Intensive Care Units; Critical Illness/therapy; Vasoconstrictor Agents/therapeutic use; *Shock, Septic/drug therapy/mortality

--------
--------

## The authors reply., Lee, Hong Yeul

4:e400-e402. DOI:10.1097/CCM.0000000000005454

## 作者回复。

--------
--------

## How Should We Use Frailty Evaluation for Patients With Sepsis in the Clinical Practice?

4:e399-e400. DOI:10.1097/CCM.0000000000005417

## 在临床实践中，我们应该如何对败血症患者进行虚弱评估？
关键词：Humans; Hospital Mortality; *Frailty/diagnosis; *Sepsis/diagnosis/therapy

--------
--------

## Stand Alone Renal Doppler to Assess the Risk of Acute Kidney Injury Is Dead: Maybe It Is Time to Consider a Triumvirate?

4:719-721. DOI:10.1097/CCM.0000000000005438

## 独立的肾脏多普勒超声评估急性肾损伤的风险是死亡：也许是时候考虑三联疗法了？
关键词：Humans; Female; Male; Ultrasonography, Doppler; *Acute Kidney Injury/diagnostic imaging/etiology; Kidney/diagnostic imaging

--------
--------

## Vasopressor Therapy Early, or Vasopressors Later? Still an Important Question in Septic Shock., Chalfin, Donald B.

4:717-718. DOI:10.1097/CCM.0000000000005449

## 早期血管加压素治疗或后期血管加压素治疗？仍是感染性休克的重要问题。
关键词：Humans; Norepinephrine; *Shock, Septic/drug therapy; Vasoconstrictor Agents/therapeutic use

--------
--------

## New Movement in Sepsis Immunotherapeutics-A Role for Prokineticin 2?

4:714-716. DOI:10.1097/CCM.0000000000005375

## 败血症免疫治疗的新趋势-促动力药2的作用？
关键词：Humans; Signal Transduction; *Sepsis/therapy; *Neuropeptides

--------
--------

## Vasopressin: The Impact of Predatory Patents on a Captive ICU Marketplace., Peterson, Lars-Kristofer N.

4:711-714. DOI:10.1097/CCM.0000000000005348

## 血管加压素：捕食性专利对ICU捕捉市场的影响。
关键词：*Intensive Care Units; *Vasopressins/therapeutic use

--------
--------

## Early Multimodal Vasopressors-Are We Ready for It?, Wieruszewski, Patrick M.

4:705-708. DOI:10.1097/CCM.0000000000005344

## 早期多模式血管加压药-我们准备好了吗？
关键词：*Vasoconstrictor Agents/therapeutic use

--------
--------

## Is the Pao2/Fio2 Ratio in Acute Respiratory Distress Syndrome Another Source of Heterogeneity?, Rachoin, Jean-Sebastien

4:703-705. DOI:10.1097/CCM.0000000000005378

## Pao2/Fio2比值在急性呼吸窘迫综合征中是否是异质性的另一个来源？
关键词：Humans; Oximetry; *Respiratory Distress Syndrome/therapy

--------
--------

## A Ventilator Mode Cannot Set Itself, Nor Can It Be Solely Responsible for Outcomes.

4:695-699. DOI:10.1097/CCM.0000000000005403

## 呼吸机模式无法自行设置，也无法完全应对结果负责。
关键词：Tidal Volume; *Ventilators, Mechanical

--------
--------

## To Withdraw or to Continue ICU Care: When Is it a Premature Question?

4:693-695. DOI:10.1097/CCM.0000000000005349

## 撤回或继续ICU治疗：何时为早产问题？
关键词：Humans; *Intensive Care Units; *Life Support Care

--------
--------

## Inflamed., Nyquist, Paul

4:691-693. DOI:10.1097/CCM.0000000000005293

## 炎症。

--------
--------

## Sepsis: The Gift That Keeps Giving.

4:689-691. DOI:10.1097/CCM.0000000000005381

## 败血症：给予患者的礼物。
关键词：Humans; Cognition; *Sepsis/therapy

--------
--------

## The Many Faces of Prediction Modeling in Critical Care.

4:687-689. DOI:10.1097/CCM.0000000000005409

## 重症监护中的多种预测模型。
关键词：Humans; *Critical Care

--------
--------

## Shining a Light on Diversity in Team Science.

4:685-687. DOI:10.1097/CCM.0000000000005292

## 为团队科学的多样性亮起一盏明灯。
关键词：*Interdisciplinary Research

--------
--------

## The authors reply.

4:e398-e399. DOI:10.1097/CCM.0000000000005453

## 作者回复。

--------
--------

## The authors reply., Chotalia, Minesh

4:e395-e396. DOI:10.1097/CCM.0000000000005452

## 作者回复。

--------
--------

## The authors reply.

4:e411-e412. DOI:10.1097/CCM.0000000000005458

## 作者回复。

--------
--------

## Use of Extracorporeal Membrane Oxygenation in Acutely Poisoned Pediatric Patients in United States: A Retrospective Analysis of the Extracorporeal Life Support  Registry From 2003 to 2019.

4:655-664. DOI:10.1097/CCM.0000000000005436

Abstract: 

OBJECTIVES: To describe the use of extracorporeal membrane oxygenation (ECMO) in the management of pediatric poisoning in the United States and to identify  predictors of mortality. 

DESIGN: Retrospective cohort study. 

SETTING: Data  reported to the Extracorporeal Life Support Organization by 76 U.S. ECMO centers  from 2003 to 2019. 

PATIENTS: Pediatric patients (0-18 yr) receiving ECMO for  poisoning. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: During our study  period, 86 cases of acute poisoning were identified and included in the analysis.  The median age was 12.0 year and 52.9% were female. The most commonly reported  substance exposures were hydrocarbon (n = 17; 19.8%), followed by chemical  asphyxiants (n = 14; 16.3%), neuroactive agents (n = 14; 16.3%),  opioid/analgesics (n = 13; 15.1%), and cardiovascular agents (n = 12; 14.0%).  Single substance exposures were reported in 83.7% of the cases. The intention of  the exposure was unknown in 65.1%, self-harm in 20.9% and 10.5% was unintentional  exposure. Fifty-six patients (65.1%) survived. Venoarterial ECMO was used more  frequently than venovenous ECMO, and its use increased significantly during the  study period (p < 0.01). 

A bimodal distribution of ECMO support was observed  among two age groups: less than or equal to 3 years (n = 34) and 13-17 years (n =  41). Hemodynamic and metabolic parameters improved for all patients with ECMO.  Persistent systolic hypotension, acidemia/metabolic acidosis, and elevated Pao2)  after 24 hours of ECMO support were associated with mortality. Time from PICU  admission to ECMO cannulation was not significantly different between survivors  (24.0 hr; interquartile range [IQR], 11.0-58.0 hr) and nonsurvivors (30.5 hr;  IQR, 10.0-60.2 hr; p = 0.58). ECMO duration and PICU length of stay were  significantly longer in survivors than in nonsurvivors (139.5 vs 70.5 hr; p =  0.007 and 25.0 vs 4.0 d; p = 0.002, respectively). 

CONCLUSIONS: ECMO may improve  the hemodynamic and metabolic status of poisoned pediatric patients. Persistent  hypotension, acidemia/acidosis, and elevated Pao2 after 24 hours of ECMO were  associated with mortality.

## 体外膜肺氧合在美国急性中毒儿科患者中的应用：体外生命支持的回顾性分析  登记研究（2003年至2019年）。

目的：描述体外膜肺氧合(ECMO)在美国儿科中毒管理中的应用，并确定  死亡率预测因素。

设计：回顾性队列研究。

设置：数据  由76家美国ECMO中心报告给体外生命支持组织  2003年至2019年。

患者：接受ECMO治疗的儿科患者（0-18岁）  中毒。

干预：无。

测量和主要结果：在我们的研究期间  期间，确定了86例急性中毒病例并纳入分析中。中位年龄为12.0岁，52.9%为女性。最常报告  物质暴露是碳氢化合物(n = 17；19.8%)，其次是化学品  窒息药(n = 14；16.3%)，神经活性药物(n = 14；16.3%)，  阿片类/镇痛药(n = 13；15.1%)和心血管药物(n = 12；14.0%)。83.7%的病例报告了单一物质暴露。目的  65.1%的暴露未知，20.9%的自我伤害和10.5%的意外伤害  暴露量。56例患者(65.1%)存活。更多使用静脉动脉ECMO  经常高于静脉-静脉ECMO，并且在  研究阶段(p < 0.01)。观察到ECMO支持的双峰分布  两个年龄组中：小于或等于3岁(n = 34)和13-17岁（n =  41).所有ECMO患者的血液动力学和代谢参数均有所改善。持续性收缩性低血压、酸血症/代谢性酸中毒和Pao2）升高  ECMO支持24小时后与死亡率相关。距离PICU的时间  存活者之间的ECMO插管住院时间无显著差异  （24.0 h；四分位距[IQR]，11.0-58.0 h）和非存活者（30.5 h；  IQR，10.0-60.2 h；p = 0.58）。ECMO持续时间和PICU住院时间为  存活者显著长于非存活者（139.5 vs 70.5 h；p =  0.007和25.0 vs 4.0 d；p = 0.002）。

结论：ECMO可能改善  中毒儿童患者的血液动力学和代谢状态。持续  ECMO 24小时后出现低血压、酸血症/酸中毒和Pao2升高  与死亡率相关。
关键词：Humans; Female; Male; Oxygen; Retrospective Studies; Child; Registries; United States/epidemiology; *Extracorporeal Membrane Oxygenation/adverse effects; *Hypotension/epidemiology/etiology/therapy; *Poisons

--------
--------

## Concise Definitive Review for Reinitiation of Antidepressants, Antipsychotics, and Gabapentinoids in ICU Patients., Cucci, Michaelia D.

4:665-673. DOI:10.1097/CCM.0000000000005415

Abstract: 

OBJECTIVE: Concise definitive review of the reinitiation of prior-to-admission neuropsychiatric medications (NPMs) in ICU patients. 

DATA SOURCES: Available  literature on PubMed and MEDLINE databases. 

STUDY SELECTION: Available clinical  trials and observational studies addressing the reinitiation of select NPMs  (antidepressants, antipsychotics, and gabapentinoids) on various outcomes were  included. 

DATA EXTRACTION: Eligible studies were identified by authors, and  recommendations were summarized. 

DATA SYNTHESIS: Agitation and delirium are  recognized as common complications of patients in the ICU. While there is  literature that suggests patients can acutely withdraw from opioids, less data  are known about withdrawal from NPM such as antidepressants, antipsychotics, and  gabapentinoids. However, there is some literature that suggests reinitiating some  NPMs may lead to reductions in agitation, delirium, and hospital and ICU length  of stay. 

CONCLUSIONS: Additional larger studies are needed to evaluate the safety  and efficacy of reinitiation of select prior-to-admission NPM to prevent  agitation and delirium in ICU patients. Multiple factors for NPM reinitiation  should be considered, such as reason for admission, organ dysfunction, available  route of administration to provide prior-to-admission NPM, concomitant additional  medications for agitation and delirium, and safety of these medications for  patients in the ICU.

## 对ICU患者重新开始抗抑郁药、抗精神病药和加巴喷丁治疗的简要确定性审查。

目的：对ICU患者重新开始使用入院前神经精神病药物(NPM)进行明确的简要审查。

数据来源：可用  PubMed和MEDLINE数据库相关文献。

研究选择：可用的临床  针对重新开始选定NPM的试验和观察性研究  （抗抑郁药、抗精神病药和加巴喷丁类）对各种结局的影响为  包括。

数据提取：由作者确定合格的研究，和  总结了建议。

资料综合：躁动和谵妄是  被公认为ICU患者的常见并发症。而有  提示患者可紧急停用阿片类药物的文献，较少数据  已知从NPM撤药，如抗抑郁药、抗精神病药和  加巴喷丁类药物。然而，一些文献建议重新开始一些  NPM可减少激越、谵妄以及住院和ICU时长  的停留。

结论：需要更多的大型研究来评价安全性  和重新开始特定的入院前NPM的有效性，以预防  ICU患者的激越和谵妄。NPM重新开始的多种因素  应考虑，如入院原因、器官功能障碍、可用  提供入院前NPM的给药途径，其他伴随治疗  治疗激越和谵妄的药物，以及这些药物的安全性  ICU患者。
关键词：Humans; Intensive Care Units; Hospitalization; *Antipsychotic Agents/adverse effects; *Delirium/prevention & control; Antidepressive Agents/adverse effects

--------
--------

## Etiopathogenetic Particularities and Prognostic Impact of Right Ventricular Involvement in COVID-19-Related Acute Respiratory Distress Syndrome.

4:e396-e397. DOI:10.1097/CCM.0000000000005420

## COVID-19相关急性呼吸窘迫综合征中右心室受累的病因特异性和预后影响。
关键词：Humans; Prognosis; *COVID-19/complications; *Respiratory Distress Syndrome/etiology; Heart Ventricles

--------
--------

## Proning Responder or Not? This Is the Question., Cinnella, Gilda

4:708-711. DOI:10.1097/CCM.0000000000005400

## 是否剪毛应答者？此为问题。
关键词：Prone Position; *Respiration, Artificial

--------
--------

## Phenotypic Characterization of Right Ventricular Dysfunction and Prognostication in COVID-19-Induced Acute Respiratory Distress Syndrome., Jha, Ajay Kumar

4:e393-e394. DOI:10.1097/CCM.0000000000005416

## COVID-19诱导的急性呼吸窘迫综合征中右心室功能障碍和预后的表型特征。
关键词：Humans; *COVID-19/complications; *Respiratory Distress Syndrome/etiology; *Ventricular Dysfunction, Right/diagnostic imaging/etiology/physiopathology; Ventricular Function, Right

--------
--------

## Airway Pressure Release Ventilation in Acute Respiratory Failure Due to COVID-19: When One Door Closes., Ghosh, Auyon J.

4:e410-e411. DOI:10.1097/CCM.0000000000005422

## COVID-19急性呼吸衰竭的气道压力释放通气：当单门关闭。
关键词：Humans; *COVID-19/complications; *Respiratory Insufficiency/etiology/therapy; *Respiratory Distress Syndrome/etiology/therapy; Continuous Positive Airway Pressure

--------
--------

## Performance of Doppler-Based Resistive Index and Semiquantitative Renal Perfusion in Predicting Persistent Acute Kidney Injury According to Operator Experience:  Post Hoc Analysis of a Prospective Multicenter Study.

4:e361-e369. DOI:10.1097/CCM.0000000000005372

Abstract: 

OBJECTIVES: The Doppler-based resistive index and semiquantitative evaluation of renal perfusion using color Doppler failed to discriminate renal recovery  patterns in a recent study. The influence of operator experience on resistive  index and semiquantitative evaluation of renal perfusion performances is however  unknown. This study aimed at evaluating the performance of resistive index and  semiquantitative evaluation of renal perfusion according to the operator  experience to predict short-term renal prognosis in critically ill patients.  

DESIGN: Preplanned ancillary analysis of a prospective multicenter cohort study.  

SETTING: Seven ICUs. 

PATIENTS: Unselected ICU patients. 

INTERVENTION: Renal  Doppler was performed at admission to the ICU. The diagnostic performance of  resistive index and semiquantitative evaluation of renal perfusion to predict  persistent acute kidney injury at day 3 was evaluated. 

MAIN RESULTS: Overall, 371  patients were included, of whom 351 could be assessed for short-term renal  recovery. Two thirds of the included patients had acute kidney injury (n = 233;  66.3%), of whom 136 had persistent acute kidney injury (58.4%). Overall  performance in discriminating persistent acute kidney injury was however null  with an area under the receiver operating characteristic curve less than 0.6 for  both resistive index and semiquantitative evaluation of renal perfusion, and no  difference across operator experience. A multivariate analysis using logistic  regression with the center as a random effect adjusted on the operator experience  showed no association between resistive index (odds ratio, 0.02 per international  units (95% CI, 0.00-18.60 international units]) or semiquantitative evaluation of  renal perfusion (odds ratio, 0.96 per international units [95% CI, 0.43-2.11  international units]) and persistent acute kidney injury. Similar results were  obtained within subgroups of expert and nonexpert operators. 

CONCLUSIONS:  Doppler-based measurements performed by an expert or a nonexpert operator did not  discriminate renal recovery patterns and neither modified the risk stratification  of acute kidney injury persistence.

## 根据术者经验，多普勒阻力指数和半定量肾灌注在预测持续性急性肾损伤中的性能：前瞻性多中心研究的事后分析。

目的：在最近的一项研究中，使用彩色多普勒对肾脏灌注进行的多普勒阻力指数和半定量评价未能区分肾脏恢复模式。然而，操作人员经验对阻力指数和肾脏灌注性能半定量评估的影响未知。本研究旨在根据操作者经验评价阻力指数和肾脏灌注半定量评价预测重症患者短期肾脏预后的性能。

设计：前瞻性多中心队列研究的预先计划的辅助分析。

设置：7个ICU。

患者：未选择的ICU患者。

干预：入住ICU时进行肾脏多普勒超声。评价了阻力指数和肾脏灌注半定量评价预测第3天持续性急性肾损伤的诊断性能。

主要结果：总体而言，共纳入371例患者，其中351例可评估短期肾功能恢复。三分之二的纳入患者患有急性肾损伤(n = 233；66.3%)，其中136例患有持续性急性肾损伤(58.4%)。然而，鉴别持续性急性肾损伤的总体性能是无效的，对于阻力指数和肾脏灌注的半定量评估，受试者工作特征曲线下面积均小于0.6，并且操作人员经验之间没有差异。使用logistic回归进行多变量分析，中心作为对操作人员经验进行调整的随机效应，结果显示阻力指数（比值比，0.02/国际单位（95%CI，0.00-18.60国际单位））或肾脏灌注半定量评价（比值比，0.96/国际单位[95%CI，0.43-2.11国际单位]）和持续性急性肾损伤。在专家和非专家操作员亚组中获得了相似的结果。

结论：由专家或非专家操作人员进行的基于多普勒的测量没有区分肾脏恢复模式，也没有改变急性肾损伤持续性的风险分层。
关键词：Humans; Perfusion; Female; Male; Prospective Studies; Cohort Studies; Vascular Resistance; Kidney/diagnostic imaging; *Acute Kidney Injury/diagnostic imaging

--------
--------

## Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study.

4:e382-e392. DOI:10.1097/CCM.0000000000005383

Abstract: 

OBJECTIVES: To assess the impact of antifibrinolytics in children with life-threatening hemorrhage. 

DESIGN: Secondary analysis of the MAssive  Transfusion epidemiology and outcomes In Children study dataset, a prospective  observational study of children with life-threatening bleeding events. 

SETTING:  Twenty-four children's hospitals in the United States, Canada, and Italy.  

PATIENTS: Children 0-17 years old who received greater than 40 mL/kg of total  blood products over 6 hours or were transfused under activation of massive  transfusion protocol. INTERVENTION/EXPOSURE: Children were compared according to  receipt of antifibrinolytic medication (tranexamic acid or aminocaproic acid)  during the bleeding event. 

MEASUREMENTS AND MAIN RESULTS: Patient  characteristics, medications administered, and clinical outcomes were analyzed  using Cox proportional hazard and Kaplan-Meier survival analysis. The primary  outcome was 24-hour mortality. Of 449 patients analyzed, median age was 7 years  (2-15 yr), and 55% were male. The etiology of bleeding was 46% traumatic, 34%  operative, and 20% medical. Twelve percent received antifibrinolytic medication  during the bleeding event (n = 54 unique subjects; n = 18 epsilon aminocaproic  acid, n = 35 tranexamic acid, and n = 1 both). The antifibrinolytic group was  comparable with the nonantifibrinolytic group on baseline demographic and  physiologic parameters; the antifibrinolytic group had longer massive transfusion  protocol duration, received greater volume blood products, and received factor  VII more frequently. In the antifibrinolytic group, there was significantly less  6-hour mortality overall (6% vs 17%; p = 0.04) and less 6-hour mortality due to  hemorrhage (4% vs 14%; p = 0.04). After adjusting for age, bleeding etiology,  Pediatric Risk of Mortality score, and plasma deficit, the antifibrinolytic group  had decreased mortality at 6- and 24-hour postbleed (adjusted odds ratio, 0.29  [95% CI, 0.09-0.93]; p = 0.04 and adjusted odds ratio, 0.45 [95% CI, 0.21-0.98];  p = 0.04, respectively). 

CONCLUSIONS: Administration of antifibrinolytic  medications during the life-threatening event was independently associated with  improved 6- and 24-hour survivals in bleeding children. Consideration should be  given to use of antifibrinolytics in pediatric patients with life-threatening  hemorrhage.

## 抗纤溶药物在危及生命的儿科出血中的应用：一项前瞻性、观察性、多中心研究。

目的：评估抗纤溶剂治疗危及生命的出血儿童的影响。

设计：MAssive输血流行病学和结局的次要分析在儿童研究数据集中，对发生危及生命的出血事件的儿童进行的一项前瞻性观察性研究。

地点：美国、加拿大和意大利的24家儿童医院。

患者：接受大于40 mL/kg的总血制品超过6小时或在大量输血方案激活下进行输血的0-17岁儿童。干预/暴露：根据出血事件期间抗纤维蛋白溶解药物（氨甲环酸或氨基己酸）的使用情况，对儿童进行比较。

测量和主要结果：使用Cox比例风险和Kaplan-Meier生存分析对患者特征、给药和临床结局进行分析。主要结局为24小时死亡率。在分析的449例患者中，中位年龄为7岁（2-15岁），55%为男性。出血的病因包括46%创伤性出血、34%手术性出血和20%药物性出血。12%的患者在出血事件期间接受了抗纤维蛋白溶解药物（n = 54例独特受试者；n = 18例ε-氨基己酸，n = 35例氨甲环酸，n = 1例两者）。抗纤溶组的基线人口统计学和生理参数与非抗纤溶组相当；抗纤溶组的大量输血方案持续时间更长，接受的血液制品量更大，接受凝血因子VII的频率更高。在抗纤溶组，总体6小时死亡率显著降低(6%vs 17%；p = 0.04)，出血导致的6小时死亡率降低(4%vs 14%；p = 0.04)。校正年龄、出血病因、儿科死亡风险评分和血浆缺陷后，抗纤溶组出血后6和24小时的死亡率下降（校正比值比，0.29[95%CI，0.09-0.93]；p = 0.04）。和调整后的比值比，0.45[95%CI，0.21-0.98]；p = 0.04）。

结论：在危及生命的事件中给予抗纤溶药物与出血儿童6小时和24小时生存率的改善独立相关。在有危及生命出血的儿科患者中，应考虑使用抗纤溶剂。
关键词：Humans; Female; Male; Prospective Studies; Adolescent; Child; Infant; Infant, Newborn; Child, Preschool; *Antifibrinolytic Agents/therapeutic use; *Tranexamic Acid/therapeutic use; Aminocaproic Acid/therapeutic use; Hemorrhage/drug therapy/epidemiology/etiology

--------
--------

## Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis., Tran, Alexandre

4:e370-e381. DOI:10.1097/CCM.0000000000005382

Abstract: 

OBJECTIVE: To identify prognostic factors for the development of venous thromboembolism in the ICU. 

DATA SOURCES: We searched MEDLINE, EMBASE, and  Cochrane CENTRAL from inception to March 1, 2021. 

STUDY SELECTION: We included  English-language studies describing prognostic factors associated with the  development of venous thromboembolism among critically ill patients. 

DATA  EXTRACTION: Two authors performed data extraction and risk-of-bias assessment. We  pooled adjusted odds ratios and adjusted hazard ratios for prognostic factors  using random-effects model. We assessed risk of bias using the Quality in  Prognosis Studies tool and certainty of evidence using the Grading of  Recommendations, Assessment, Development and Evaluations approach. 

DATA  SYNTHESIS: We included 39 observational cohort studies involving 729,477  patients. Patient factors with high or moderate certainty of association with  increased odds of venous thromboembolism include older age (adjusted odds ratio,  1.15; 95% CI, 1.02-1.29 per 10 yr), obesity (adjusted odds ratio, 1.25; 95% CI,  1.18-1.32), active malignancy (adjusted odds ratio, 1.70; 95% CI, 1.18-2.44),  history of venous thromboembolism (adjusted odds ratio, 4.77; 95% CI, 3.42-6.65),  and history of recent surgery (adjusted odds ratio, 1.77; 95% CI, 1.26-2.47).  ICU-specific factors with high or moderate certainty of association with  increased risk of venous thromboembolism include sepsis (adjusted odds ratio,  1.41; 95% CI, 1.12-1.78), lack of pharmacologic venous thromboembolism  prophylaxis (adjusted odds ratio, 1.80; 95% CI, 1.14-2.84), central venous  catheter (adjusted odds ratio, 2.93; 95% CI, 1.98-4.34), invasive mechanical  ventilation (adjusted odds ratio, 1.74; 95% CI, 1.36-2.24), and use of vasoactive  medication (adjusted odds ratio, 1.86; 95% CI, 1.23-2.81). 

CONCLUSIONS: This  meta-analysis provides quantitative summaries of the association between  patient-specific and ICU-related prognostic factors and the risk of venous  thromboembolism in the ICU. These findings provide the foundation for the  development of a venous thromboembolism risk stratification tool for critically  ill patients.

## 危重患者静脉血栓栓塞预后相关因素的系统评价和荟萃分析。

目的：确定ICU中发生静脉血栓栓塞的预后因素。

数据来源：我们检索了MEDLINE、EMBASE和Cochrane CENTRAL，检索日期从开始至2021年3月1日。

研究选择：我们纳入了描述与重症患者发生静脉血栓栓塞相关的预后因素的英文研究。

数据提取：两位作者进行了数据提取和偏倚风险评估。我们使用随机效应模型汇总了预后因素的校正比值比和校正风险比。我们使用预后质量研究工具评估偏倚风险，使用推荐、评估、开发和评价方法分级评估证据的确定性。

资料综合：我们纳入了39项观察性队列研究，涉及729,477例患者。静脉血栓栓塞比值比升高相关的高度或中度确定的患者因素包括年龄较大（校正比值比，1.15；95%CI，1.02-1.29/10岁）、肥胖（校正比值比，1.25；95%CI，1.18-1.32）、活动性恶性肿瘤（校正比值比，1.70；95%CI，1.18-2.44），静脉血栓栓塞病史（校正比值比，4.77；95%CI，3.42-6.65）和近期手术史（校正比值比，1.77；95%CI，1.26-2.47）。与静脉血栓栓塞风险增加有高度或中度相关性的ICU特异性因素包括脓毒症（调整后比值比，1.41；95%CI，1.12-1.78）、缺乏药物预防静脉血栓栓塞（调整后比值比，1.80；95%CI，1.14-2.84）、中心静脉导管（调整后比值比，2.93；95%CI，1.98-4.34），有创机械通气（校正比值比，1.74；95%CI，1.36-2.24）和血管活性药物的使用（校正比值比，1.86；95%CI，1.23-2.81）。

结论：本荟萃分析定量总结了患者特异性和ICU相关预后因素与ICU静脉血栓栓塞风险的相关性。这些结果为重症患者静脉血栓栓塞风险分层工具的开发提供了基础。
关键词：Humans; Prognosis; Critical Illness; Anticoagulants/therapeutic use; *Central Venous Catheters/adverse effects; *Venous Thromboembolism/drug therapy/epidemiology/etiology

--------
--------

## The Influence of Hypercapnia and Atmospheric Pressure on the Pao2/Fio2 Ratio-Pathophysiologic Considerations, a Case Series, and Introduction of a  Clinical Tool.

4:607-613. DOI:10.1097/CCM.0000000000005316

Abstract: 

OBJECTIVES: The ratio between Pao2 and Fio2 is used as a marker for impaired oxygenation and acute respiratory distress syndrome classification. However, any  discrepancy between Fio2 and o2 fraction in the alveolus affects the Pao2/Fio2  ratio. Correcting the Pao2/Fio2 ratios using the alveolar gas equation may result  in an improved reflection of the pulmonary situation. This study investigates the  difference between standard and corrected Pao2/Fio2 in magnitude, its correlation  with the mortality of acute respiratory distress syndrome classification, and  trends over time. 

DESIGN: A register and a retrospective study combined with the  development of a mathematical model to determine the difference between standard  and corrected Pao2/Fio2 ratio for various levels of Paco2 and atmospheric  pressure. 

SETTING: ICU in a secondary hospital in The Netherlands. 

PATIENTS:  Patients admitted to the ICU for pneumonia or acute respiratory distress  syndrome. 

Register cohort: January 1, 2010, till March 1, 2020 (n = 1008).  

Retrospective cohort: March 1, 2020, till June 1, 2020 (n = 34). 

MEASUREMENTS AND  MAIN RESULTS: The register was used to determine the 7-day ICU mortality per  acute respiratory distress syndrome classification based on the standard and  corrected Pao2/Fio2 ratio. The retrospective dataset correlated the Paco2 with  Pao2/Fio2 ratio over time in patients with assumed stable oxygenation. The model  demonstrated an increased difference between the standard and corrected Pao2/Fio2  ratios by a lower Fio2 and atmospheric pressure and higher Pao2 and Paco2.  Reclassification of severe acute respiratory distress syndrome resulted in an  increase in mortality from 28.1% for standard Pao2/Fio2 to 30.6% for corrected  Pao2/Fio2 ratios. Acute Physiology and Chronic Health Evaluation scores  correlated better with 7-day ICU-mortality when corrected Pao2/Fio2 ratio was  used for classification. For patients with Fio2 less than 50% (n = 55), change in  Paco2 correlated with change in Pao2/Fio2 ratio (r = -0.388; p = 0.003).  

INTERVENTIONS: A corrected Pao2/Fio2 ratio was calculated. 

CONCLUSIONS:  Correcting the Pao2/Fio2 ratio for the alveolar gas equation predominantly  affects patients with high ratios between Pao2 and Fio2 and Paco2 and at low  atmospheric pressure. Using the corrected Pao2/Fio2 ratio for acute respiratory  distress syndrome classification results in improved correlation with the 7-day  ICU mortality and increases generalization among acute respiratory distress  syndrome studies. The authors provide a free, web-based tool.

## 高碳酸血症和大气压对Pao2/Fio2比值的影响-病理生理学考量，病例系列，并引入临床工具。

目的：Pao2和Fio2的比值用作氧合受损和急性呼吸窘迫综合征分类的标志物。但是，肺泡中Fio2和o2分数的任何差异都会影响Pao2/Fio2比值。使用肺泡气体方程校正Pao2/Fio2比值可能会改善肺部情况的反映。本研究调查了标准和校正Pao2/Fio2的幅度差异、其与急性呼吸窘迫综合征分类的死亡率的相关性以及随时间的趋势。

设计：注册研究和回顾性研究结合数学模型的开发，确定不同Paco2和大气压水平的标准和校正Pao2/Fio2比值之间的差异。

背景：荷兰一家二级医院的ICU。

患者：因肺炎或急性呼吸窘迫综合征入住ICU的患者。

注册队列：2010年1月1日至2020年3月1日(n = 1008)。

回顾性队列：2020年3月1日至2020年6月1日(n = 34)。

测量和主要结果：根据标准和校正的Pao2/Fio2比值，通过登记确定每个急性呼吸窘迫综合征分类的7天ICU死亡率。回顾性数据集在假定氧合稳定的患者中关联了Paco2与Pao2/Fio2比值随时间的变化。该模型显示，通过较低的Fio2和大气压以及较高的Pao2和Paco2，标准和校正的Pao2/Fio2比率之间的差异增加。对严重急性呼吸窘迫综合征重新分类导致死亡率从标准Pao2/Fio2的28.1%增加至校正Pao2/Fio2比值的30.6%。当使用校正的Pao2/Fio2比值进行分类时，急性生理学和慢性健康状况评分与7天ICU死亡率的相关性更好。对于Fio2小于50%的患者(n = 55)，Paco2变化与Pao2/Fio2比值变化相关(r =-0.388；p = 0.003)。

干预：计算校正的Pao2/Fio2比值。

结论：针对肺泡气体方程校正Pao2/Fio2比值主要影响Pao2与Fio2和Paco2比值较高以及低气压的患者。在急性呼吸窘迫综合征研究中，使用校正的Pao2/Fio2比值进行急性呼吸窘迫综合征分类，结果改善了与7天ICU死亡率的相关性，并增加了普遍性。作者提供了一个免费的、基于网络的工具。
关键词：Humans; Oxygen; Retrospective Studies; *Respiratory Distress Syndrome/therapy; *Hypercapnia; Atmospheric Pressure

--------
--------

## Differences and Similarities Among COVID-19 Patients Treated in Seven ICUs in Three Countries Within One Region: An Observational Cohort Study., Mesotten, Dieter

4:595-606. DOI:10.1097/CCM.0000000000005314

Abstract: 

OBJECTIVES: To investigate healthcare system-driven variation in general characteristics, interventions, and outcomes in coronavirus disease 2019  (COVID-19) patients admitted to the ICU within one Western European region across  three countries. 

DESIGN: Multicenter observational cohort study. 

SETTING: Seven  ICUs in the Euregio Meuse-Rhine, one region across Belgium, The Netherlands, and  Germany. 

PATIENTS: Consecutive COVID-19 patients supported in the ICU during the  first pandemic wave. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Baseline  demographic and clinical characteristics, laboratory values, and outcome data  were retrieved after ethical approval and data-sharing agreements. Descriptive  statistics were performed to investigate country-related practice variation. From  March 2, 2020, to August 12, 2020, 551 patients were admitted. Mean age was 65.4  ?± 11.2 years, and 29% were female. At admission, Acute Physiology and Chronic  Health Evaluation II scores were 15.0 ?± 5.5, 16.8 ?± 5.5, and 15.8 ?± 5.3 (p =  0.002), and Sequential Organ Failure Assessment scores were 4.4 ?± 2.7, 7.4 ?± 2.2,  and 7.7 ?± 3.2 (p < 0.001) in the Belgian, Dutch, and German parts of Euregio,  respectively. The ICU mortality rate was 22%, 42%, and 44%, respectively (p <  0.001). Large differences were observed in the frequency of organ support,  antimicrobial/inflammatory therapy application, and ICU capacity.  Mixed-multivariable logistic regression analyses showed that differences in ICU  mortality were independent of age, sex, disease severity, comorbidities, support  strategies, therapies, and complications. 

CONCLUSIONS: COVID-19 patients admitted  to ICUs within one region, the Euregio Meuse-Rhine, differed significantly in  general characteristics, applied interventions, and outcomes despite presumed  genetic and socioeconomic background, admission diagnosis, access to  international literature, and data collection are similar. Variances in  healthcare systems' organization, particularly ICU capacity and admission  criteria, combined with a rapidly spreading pandemic might be important drivers  for the observed differences. Heterogeneity between patient groups but also  healthcare systems should be presumed to interfere with outcomes in coronavirus  disease 2019.

## 一个地区内三个国家中7个ICU治疗的COVID-19患者的差异和相似性：一项观察性队列研究。

目的：研究西欧地区三个国家2019年(COVID-19)期间入住ICU的冠状病毒病患者的卫生保健系统驱动的一般特征、干预措施和结局的变化。

设计：多中心观察性队列研究。

设置：Euregio Meuse-Rhine的7间ICU，比利时、荷兰和德国的一个地区。

患者：在第一次大流行期间，ICU连续支持19例患者。

干预：无。

测量和主要结果：在伦理批准和数据共享协议后，检索基线人口统计学和临床特征、实验室检查值和结局数据。进行描述性统计以研究国家相关实践变化。2020年3月2日至2020年8月12日，共收治551例患者。平均年龄为65.4±11.2岁，29%为女性。入院时，比利时、荷兰和德国部分Euregio的急性生理学和慢性健康状况评分II评分分别为15.0?±5.5、16.8?±5.5和15.8?±5.3(p = 0.002)，序贯器官衰竭评估评分分别为4.4?±2.7、7.4?±2.2和7.7?±3.2(p < 0.001)。ICU死亡率分别为22%、42%和44%(p < 0.001)。观察到器官支持频率、抗微生物/炎症治疗应用和ICU容量有较大差异。混合多变量logistic回归分析显示，ICU死亡率的差异与年龄、性别、疾病严重程度、合并症、支持策略、治疗和并发症无关。

结论：尽管假定遗传和社会经济背景、入院诊断、查阅国际文献和数据收集相似，但在一个地区(Euregio Meuse-Rhine)内入住ICU的COVID-19患者在一般特征、应用的干预措施和结局方面存在显著差异。卫生保健系统组织的差异，特别是ICU能力和入院标准，以及迅速蔓延的大流行可能是观察到差异的重要驱动因素。应假定患者组之间以及医疗保健系统之间的异质性干扰2019年冠状病毒疾病的结局。
关键词：Humans; Treatment Outcome; Female; Male; Middle Aged; Aged; APACHE; Cohort Studies; Critical Care/*methods; Logistic Models; *Intensive Care Units/organization & administration/statistics & numerical data; COVID-19/mortality/*therapy; Europe/epidemiology; Patient Acuity; Patient Transfer

--------
--------

## Vasopressor Initiation Within 1 Hour of Fluid Loading Is Associated With Increased Mortality in Septic Shock Patients: Analysis of National Registry Data.

4:e351-e360. DOI:10.1097/CCM.0000000000005363

Abstract: 

OBJECTIVES: To investigate whether administration of a vasopressor within 1 hour of first fluid loading affected mortality and organ dysfunction in septic shock  patients. 

DESIGN: Prospective, multicenter, observational study. 

SETTING: Sixteen  tertiary or university hospitals in the Republic of Korea. 

PATIENTS: Patients  with septic shock (n = 415) were classified into early and late groups according  to whether the vasopressor was initiated within 1 hour of the first resuscitative  fluid load. Early (n = 149) patients were 1:1 propensity matched to late (n =  149) patients. 

INTERVENTIONS: None. 

MEASUREMENT AND MAIN RESULTS: The median time  from the initial fluid bolus to vasopressor was shorter in the early group (0.3  vs 2.3 hr). There was no significant difference in the fluid bolus volume within  6 hours (33.2 vs 35.9 mL/kg) between the groups. The Sequential Organ Failure  Assessment score and lactate level on day 3 in the ICU were significantly higher  in the early group than that in the late group (Sequential Organ Failure  Assessment, 9.2 vs 7.7; lactate level, 2.8 vs 1.7 mmol/L). In multivariate Cox  regression analyses, early vasopressor use was associated with a significant  increase in the risk of 28-day mortality (hazard ratio, 1.83; 95% CI, 1.26-2.65).  

CONCLUSIONS: Vasopressor initiation within 1 hour of fluid loading was associated  with higher 28-day mortality in patients with septic shock.

## 在脓毒性休克患者中，液体负荷1小时内开始血管加压药治疗与死亡率增加相关：国家登记数据的分析。

目的：研究在首次液体负荷1小时内给予血管加压药是否影响感染性休克患者的死亡率和器官功能障碍。

设计：前瞻性、多中心、观察性研究。

单位：韩国的16家三级或大学医院。

患者：根据首次复苏液体负荷1小时内是否启动血管加压药，将感染性休克患者(n = 415)分为早期组和晚期组。早期(n = 149)患者与晚期(n = 149)患者的1:1倾向匹配。

干预：无。

测量和主要结果：早期组从初始液体推注至血管加压药的中位时间较短(0.3 vs 2.3 h)。各组之间6小时内的液体推注量无显著差异(33.2 vs 35.9 mL/kg)。ICU第3天序贯器官衰竭评估评分和乳酸盐水平，早期组显著高于晚期组（序贯器官衰竭评估，9.2 vs 7.7；乳酸盐水平，2.8 vs 1.7 mmol/L）。在多变量Cox回归分析中，早期使用血管加压素与28天死亡风险显著增加相关（风险比，1.83；95%CI，1.26-2.65）。

结论：在脓毒性休克患者中，液体负荷1小时内启动血管加压药与28天死亡率较高相关。
关键词：Humans; Prospective Studies; Registries; *Shock, Septic; Vasoconstrictor Agents/therapeutic use; Lactic Acid

--------
--------

## Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock., Sacha, Gretchen L.

4:644-654. DOI:10.1097/CCM.0000000000005305

Abstract: 

OBJECTIVES: Vasopressin is suggested as an adjunct to norepinephrine in patients with septic shock. However, after vasopressin was rebranded in November 2014, its  cost exponentially increased. Utilization patterns of vasopressin after its  rebranding are unclear. The objective of this study was to determine if there is  an association between the rebranding of vasopressin in November 2014 and its  utilization in vasopressor-dependent patients with severe sepsis or septic shock.  

DESIGN: Retrospective, multicenter, database study between January 2010 and March  2017. 

SETTING: Premier Healthcare Database hospitals. 

PATIENTS: Adult patients  admitted to an ICU with severe sepsis or septic shock, who received at least one  vasoactive agent for two or more calendar days were included. 

INTERVENTIONS: The  proportion of patients who received vasopressin and vasopressin cost was assessed  before and after rebranding, and evaluated with segmented regression.  

MEASUREMENTS AND MAIN RESULTS: Among 294,733 patients (mean age, 66 ?± 15 yr),  27.8% received vasopressin, and ICU mortality was 26.5%. The proportion of  patients receiving vasopressin was higher after rebranding (31.2% postrebranding  vs 25.8% prerebranding). Before vasopressin rebranding, the quarterly proportion  of patients who received vasopressin had an increasing slope (prerebranding slope  0.41% [95% CI, 0.35-0.46%]), with no difference in slope detected after  vasopressin rebranding (postrebranding slope, 0.47% [95% CI, 0.29-0.64%]). After  vasopressin rebranding, mean vasopressin cost per patient was higher ($527 ?±  1,130 vs $77 ?± 160), and the quarterly slope of vasopressin cost was higher  (change in slope $77.18 [95% CI, $75.73-78.61]). Total vasopressin billed cost  postrebranding continually increased by ~$294,276 per quarter from less than  $500,000 in Q4 2014 to over $3,000,000 in Q1 2017. 

CONCLUSIONS: After vasopressin  rebranding, utilization continued to increase quarterly despite a significant  increase in vasopressin cost. Vasopressin appeared to have price inelastic demand  in septic shock.

## 在感染性休克患者中血管加压素重塑和使用的相关性。

目的：血管加压素被建议用作脓毒性休克患者去甲肾上腺素的辅助治疗。然而，在2014年11月血管加压素被更名后，其成本呈指数增长。加压素品牌重塑后的使用模式尚不清楚。本研究的目的是确定2014年11月血管加压素重塑与其在伴有重度败血症或感染性休克的血管加压素依赖性患者中的使用是否相关。

设计：回顾性、多中心、数据库研究，2010年1月至2017年3月。

设置：Premier Healthcare数据库医院。

患者：因重度败血症或感染性休克入住ICU的成人患者，至少接受一种血管活性药物2天或以上。

干预：评估重塑品牌前后使用血管加压素和血管加压素费用的患者比例，并用分段回归进行评价。

测量值和主要结果：294,733例患者（平均年龄，66 μm±15岁）中，27.8%接受血管加压素治疗，ICU死亡率为26.5%。重塑品牌后，接受血管加压素的患者比例较高（重塑品牌后31.2%vs重塑品牌前25.8%）。在血管加压素重塑前，每季度接受血管加压素的患者比例斜率增加（重塑前斜率0.41%[95%CI，0.35-0.46%]），血管加压素重塑后检测到斜率无差异（重塑后斜率0.47%[95%CI，0.29-0.64%]）。血管加压素重塑后，每例患者的平均血管加压素成本较高（分别为527美元±1,130和77美元±160），且血管加压素成本的季度斜率较高（斜率变化为77.18美元[95%CI，75.73-78.61美元]）。贴标后的血管加压素总成本每季度增加约294,276美元，从2014年第4季度的不足500,000美元增加至2017年第1季度的超过3,000,000美元。

结论：加压素重塑品牌后，尽管加压素成本显著增加，但每季度使用率仍持续增加。在脓毒性休克中，血管加压素似乎具有价格无弹性需求。
关键词：Humans; Middle Aged; Aged; Aged, 80 and over; Retrospective Studies; *Shock, Septic; Vasoconstrictor Agents/therapeutic use; Norepinephrine/therapeutic use; Vasopressins/therapeutic use

--------
--------

## Influence of Geopolitics on Severity and Outcome in COVID-19.

4:700-702. DOI:10.1097/CCM.0000000000005325

## COVID-19中地缘政治对严重程度和结局的影响。
关键词：Humans; *COVID-19

--------
--------

## Use of Airway Pressure Release Ventilation in Patients With Acute Respiratory Failure Due to COVID-19: Results of a Single-Center Randomized Controlled Trial., Ibarra-Estrada, Miguel ??

4:586-594. DOI:10.1097/CCM.0000000000005312

Abstract: 

OBJECTIVES: Airway pressure release ventilation is a ventilatory mode characterized by a mandatory inverse inspiratory:expiratory ratio with a very  short expiratory phase, aimed to avoid derecruitment and allow spontaneous  breathing. Recent basic and clinical evidence suggests that this mode could be  associated with improved outcomes in patients with acute respiratory distress  syndrome. The aim of this study was to compare the outcomes between airway  pressure release ventilation and traditional ventilation targeting low tidal  volume, in patients with severe coronavirus disease 2019. 

DESIGN: Single-center  randomized controlled trial. 

SETTING: ICU of a Mexican referral center dedicated  to care of patients with confirmed diagnosis of coronavirus disease 2019.  

PATIENTS: Ninety adult intubated patients with acute respiratory distress  syndrome associated with severe coronavirus disease 2019. 

INTERVENTIONS: Within  48 hours after intubation, patients were randomized to either receive ventilatory  management with airway pressure release ventilation or continue low tidal volume  ventilation. 

MEASUREMENTS AND MAIN RESULTS: Forty-five patients in airway  pressure release ventilation group and 45 in the low tidal volume group were  included. Ventilator-free days were 3.7 (0-15) and 5.2 (0-19) in the airway  pressure release ventilation and low tidal volume groups, respectively (p =  0.28). During the first 7 days, patients in airway pressure release ventilation  had a higher Pao2/Fio2 (mean difference, 26 [95%CI, 13-38]; p < 0.001) and static  compliance (mean difference, 3.7 mL/cm H2O [95% CI, 0.2-7.2]; p = 0.03), higher  mean airway pressure (mean difference, 3.1 cm H2O [95% CI, 2.1-4.1]; p < 0.001),  and higher tidal volume (mean difference, 0.76 mL/kg/predicted body weight [95%  CI, 0.5-1.0]; p < 0.001). More patients in airway pressure release ventilation  had transient severe hypercapnia, defined as an elevation of Pco2 at greater than  or equal to 55 along with a pH less than 7.15 (42% vs 15%; p = 0.009); other  outcomes were similar. Overall mortality was 69%, with no difference between the  groups (78% in airway pressure release ventilation vs 60% in low tidal volume; p  = 0.07). 

CONCLUSIONS: In conclusion, when compared with low tidal volume, airway  pressure release ventilation was not associated with more ventilator-free days or  improvement in other relevant outcomes in patients with severe coronavirus  disease 2019.

## COVID-19急性呼吸衰竭患者中气道压力释放通气的使用：一项单中心随机对照试验的结果。

目的：气道压力释放通气是一种通气模式，其特征为强制的反向吸气：呼气比，呼气相极短，旨在避免去整流和允许自主呼吸。近期的基础和临床证据表明，这种模式可能与急性呼吸窘迫综合征患者的结局改善相关。本研究旨在比较2019年重症冠状病毒病患者中气道压力释放通气与传统低潮气量靶向通气的结局。

设计：单中心随机对照试验。

背景：2019年墨西哥转诊中心ICU，专门护理确诊为冠状病毒病的患者。

患者：2019年90例严重冠状病毒疾病相关急性呼吸窘迫综合征成人插管患者。

干预：插管后48小时内，患者随机接受气道压力释放通气的通气管理或继续低潮气量通气。

测量和主要结果：气道压力释放通气组45例，低潮气量组45例。气道压力释放通气组和低潮气量组的无通气天数分别为3.7(0-15)和5.2(0-19)天(p = 0.28)。在前7天，气道压力释放通气患者的Pao2/Fio2（平均差异，26[95%CI，13-38]；p < 0.001）和静态顺应性（平均差异，3.7 mL/cm H2O[95%CI，0.2-7.2]；p = 0.03）更高，平均气道压力（平均差异，3.1 cm H2O[95%CI，2.1-4.1]；p < 0.001）更高，潮气量较高（平均差异，0.76 mL/kg/预测体重[95%CI，0.5-1.0]；p < 0.001）。气道压力释放通气组中有更多患者发生了一过性重度高碳酸血症，定义为Pco2升高≥55，且pH值 < 7.15(42%vs 15%；p = 0.009)；其他结局相似。总体死亡率为69%，组间无差异（气道压力释放通气为78%，低潮气量为60%；p = 0.07）。

结论：总之，与低潮气量相比，在2019年重度冠状病毒病患者中，气道压力释放通气与无呼吸机天数增加或其他相关结局改善无关。
关键词：Humans; Female; Male; Middle Aged; Aged; Adult; Tidal Volume; Mexico; *Continuous Positive Airway Pressure; COVID-19/*complications/mortality; Respiration, Artificial/*methods; Respiratory Distress Syndrome/etiology/mortality/*therapy

--------
--------

## The Return on Investment of a Province-Wide Quality Improvement Initiative for Reducing In-Hospital Sepsis Rates and Mortality in British Columbia, Canada., Khowaja, Asif Raza

4:e340-e350. DOI:10.1097/CCM.0000000000005353

Abstract: 

OBJECTIVES: Sepsis is a life-threatening medical emergency. There is a paucity of information on whether quality improvement approaches reduce the in-hospital  sepsis caseload or save lives and decrease the healthcare system and society's  cost at the provincial/national levels. This study aimed to assess the outcomes  and economic impact of a province-wide quality improvement initiative in Canada.  

DESIGN: Retrospective population-based study with interrupted time series and  return on investment analyses. 

SETTING: The sepsis cases and deaths averted over  time for British Columbia were calculated and compared with the rest of Canada  (excluding Quebec and three territories). 

PATIENTS: Aggregate data were obtained  from the Canadian Institute for Health Information on risk-adjusted in-hospital  sepsis rates and sepsis mortality in acute care sites across Canada.  

INTERVENTIONS: In 2012, the British Columbia Sepsis Network was formed to reduce  sepsis occurrence and mortality through education, knowledge translation, and  quality improvement. 

MEASUREMENTS AND MAIN RESULTS: A return on investment  analysis compared the financial investment for the British Columbia Sepsis  Network with the savings from averted sepsis occurrence and mortality. An  estimated 981 sepsis cases and 172 deaths were averted in the post-British  Columbia Sepsis Network period (2014-2018). The total cost, including the  development and implementation of British Columbia Sepsis Network, was $449,962.  Net savings due to cases averted after program costs were considered were $50.6  million in 2018. This translates into a return of $112.5 for every dollar  invested. 

CONCLUSIONS: British Columbia Sepsis Network appears to have averted a  greater number of sepsis cases and deaths in British Columbia than the national  average and yielded a positive return on investment. Our findings strengthen the  policy argument for targeted quality improvement initiatives for sepsis care and  provide a model of care for other provinces in Canada and elsewhere globally.

## 加拿大不列颠哥伦比亚省降低院内败血症率和死亡率的省级质量改进倡议的投资回报。

目的：败血症是一种危及生命的医学急症。关于质量改进方法是否可减少院内败血症病例负荷或挽救生命，以及降低省级/国家级医疗保健系统和社会成本的信息很少。本研究旨在评估加拿大省级质量改进倡议的结果和经济影响。

设计：回顾性人群研究，中断时间序列和投资回报分析。

设置：计算了不列颠哥伦比亚随时间推移避免的败血症病例和死亡，并与加拿大其他地区（不包括魁北克和三个地区）进行比较。

患者：从加拿大卫生信息研究所获得了加拿大急性护理中心经风险调整的院内败血症发生率和败血症死亡率的汇总数据。

干预：2012年成立不列颠哥伦比亚败血症网络，通过教育、知识翻译和质量改进，减少败血症发生和死亡。

测量值和主要结果：投资回报分析比较了不列颠哥伦比亚败血症网络的财政投入与避免败血症发生和死亡产生的节约。在不列颠哥伦比亚败血症网络后期（2014-2018年），估计避免了981例败血症病例和172例死亡。包括开发和实施不列颠哥伦比亚败血症网络在内的总费用为449,962美元。在2018年，考虑到项目费用后避免的病例净节省额为5060万美元。这意味着每投资一美元，回报就达到112.5美元。

结论：不列颠哥伦比亚省败血症网络在不列颠哥伦比亚省似乎避免了比全国平均水平更多的败血症病例和死亡，并产生了积极的投资回报率。我们的发现加强了败血症护理目标质量改进措施的政策论据，并为加拿大其他省份和全球其他地方提供了护理模式。
关键词：Humans; Retrospective Studies; *Sepsis/therapy; *Quality Improvement; Hospitals; British Columbia/epidemiology

--------
--------

## Prone Position in COVID-19 and -COVID-19 Acute Respiratory Distress Syndrome: An International Multicenter Observational Comparative Study., Camporota, Luigi

4:633-643. DOI:10.1097/CCM.0000000000005354

Abstract: 

OBJECTIVES: Prone position is used in acute respiratory distress syndrome and in coronavirus disease 2019 acute respiratory distress syndrome. However, it is  unclear how responders may be identified and whether an oxygenation response  improves outcome. The objective of this study was to quantify the response to  prone position, describe the differences between coronavirus disease 2019 acute  respiratory distress syndrome and acute respiratory distress syndrome, and  explore variables associated with survival. 

DESIGN: Retrospective, observational,  multicenter, international cohort study. 

SETTING: Seven ICUs in Italy, United  Kingdom, and France. 

PATIENTS: Three hundred seventy-six adults (220 coronavirus  disease 2019 acute respiratory distress syndrome and 156 acute respiratory  distress syndrome). 

INTERVENTION: None. 

MEASUREMENTS AND MAIN RESULTS:  Preproning, a greater proportion of coronavirus disease 2019 acute respiratory  distress syndrome patients had severe disease (53% vs 40%), worse Pao2/Fio2 (13.0  kPa [interquartile range, 10.5-15.5 kPa] vs 14.1 kPa [interquartile range,  10.5-18.6 kPa]; p = 0.017) but greater compliance (38 mL/cm H2O [interquartile  range, 27-53 mL/cm H2O] vs 31 mL/cm H2O [interquartile range, 21-37 mL/cm H2O]; p  < 0.001). Patients with coronavirus disease 2019 acute respiratory distress  syndrome had a longer median time from intubation to prone position (2.0 d  [interquartile range, 0.7-5.0 d] vs 1.0 d [interquartile range, 0.5-2.9 d]; p =  0.03). The proportion of responders, defined by an increase in Pao2/Fio2 greater  than or equal to 2.67 kPa (20 mm Hg), upon proning, was similar between acute  respiratory distress syndrome and coronavirus disease 2019 acute respiratory  distress syndrome (79% vs 76%; p = 0.5). Responders had earlier prone position  (1.4 d [interquartile range, 0.7-4.2 d] vs 2.5 d [interquartile range, 0.8-6.2  d]; p = 0.06)]. Prone position less than 24 hours from intubation achieved  greater improvement in oxygenation (11 kPa [interquartile range, 4-21 kPa] vs 7  kPa [interquartile range, 2-13 kPa]; p = 0.002). The variables independently  associated with the "responder" category were Pao2/Fio2 preproning (odds ratio,  0.89 kPa-1 [95% CI, 0.85-0.93 kPa-1]; p < 0.001) and interval between intubation  and proning (odds ratio, 0.94 d-1 [95% CI, 0.89-0.99 d-1]; p = 0.019). The  overall mortality was 45%, with no significant difference observed between acute  respiratory distress syndrome and coronavirus disease 2019 acute respiratory  distress syndrome. Variables independently associated with mortality included age  (odds ratio, 1.03 yr-1 [95% CI, 1.01-1.05 yr-1]; p < 0.001); interval between  hospital admission and proning (odds ratio, 1.04 d-1 [95% CI, 1.002-1.084 d-1]; p  = 0.047); and change in Pao2/Fio2 on proning (odds ratio, 0.97 kPa-1 [95% CI,  0.95-0.99 kPa-1]; p = 0.002). 

CONCLUSIONS: Prone position, particularly when  delivered early, achieved a significant oxygenation response in ~80% of  coronavirus disease 2019 acute respiratory distress syndrome, similar to acute  respiratory distress syndrome. This response was independently associated with  improved survival.

## COVID-19和-COVID-19急性呼吸窘迫综合征的俯卧位：一项国际多中心观察性比较研究。

目的：仰卧位用于急性呼吸窘迫综合征和冠状病毒病2019年急性呼吸窘迫综合征。但是，尚不清楚如何识别应答者以及氧合反应是否改善结局。本研究的目的是量化俯卧位时的反应，描述2019年冠状病毒病急性呼吸窘迫综合征和急性呼吸窘迫综合征之间的差异，并探索与生存期相关的变量。

设计：回顾性、观察性、多中心、国际队列研究。

设置：意大利、英国和法国的7个ICU。

患者：376例成人（220例冠状病毒病2019例急性呼吸窘迫综合征和156例急性呼吸窘迫综合征）。

干预：无。

测量值和主要结果：预测，更大比例的冠状病毒病2019急性呼吸窘迫综合征患者患有重度疾病(53%vs 40%)，Pao2/Fio2较差（13.0 kPa[四分位距，10.5-15.5 kPa]vs 14.1 kPa[四分位距，10.5-18.6 kPa]；p = 0.017），但依从性较高（38 mL/cm H2O[四分位距，27-53 mL/cm H2O]对比31 mL/cm H2O[四分位距，21-37 mL/cm H2O]；p < 0.001）。2019年，冠状病毒疾病急性呼吸窘迫综合征患者从插管至俯卧位的中位时间较长（2.0天[四分位距，0.7-5.0天]vs 1.0天[四分位距，0.5-2.9天]；p = 0.03）。急性呼吸窘迫综合征和冠状病毒病2019年急性呼吸窘迫综合征之间应答者的比例相似(79%vs 76%；p = 0.5)，应答者定义为减少时Pao2/Fio2升高≥2.67 kPa(20 mmHg)。应答者的俯卧位时间更早（1.4天[四分位距，0.7-4.2天]vs 2.5天[四分位距，0.8-6.2天]；p = 0.06）]。插管后不到24小时的俯卧位实现了更大的氧合改善（11 kPa[四分位距，4-21 kPa]vs 7kPa[四分位距，2-13 kPa]；p = 0.002）。与“应答者”类别独立相关的变量为Pao2/Fio2预扩增（比值比，0.89 kPa-1[95%CI，0.85-0.93 kPa-1]；p < 0.001）和插管与预扩增之间的间隔（比值比，0.94 d-1[95%CI，0.89-0.99 d-1]；p = 0.019）。总体死亡率为45%，急性呼吸窘迫综合征与冠状病毒病2019急性呼吸窘迫综合征无显著差异。与死亡率独立相关的变量包括年龄（比值比，1.03-1岁[95%CI，1.01-1.05-1岁]；p < 0.001）；入院与去毛时间间隔（比值比，1.04-1岁-1[95%CI，1.002-1.084-1岁]；p = 0.047）；去毛时间Pao2/Fio2的变化（比值比，0.97 kPa-1[95%CI，0.95-0.99 kPa-1]；p = 0.002）。

结论：仰卧位，尤其是早期分娩时，在2019年急性呼吸窘迫综合征（类似于急性呼吸窘迫综合征）中约80%的冠状病毒疾病患者获得了显著的氧合反应。该缓解与生存期改善独立相关。
关键词：Humans; Female; Male; Middle Aged; Aged; Intensive Care Units; Retrospective Studies; Europe; Odds Ratio; Lung/physiopathology; Patient Positioning; Respiration, Artificial/*methods; *Prone Position; COVID-19/complications/physiopathology/*therapy; Respiratory Distress Syndrome/etiology/physiopathology/*therapy; Respiratory Function Tests

--------
--------

## Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.

4:614-623. DOI:10.1097/CCM.0000000000005317

Abstract: 

OBJECTIVES: To determine the association of catecholamine dose, lactate concentration, and timing from shock onset at vasopressin initiation with  in-hospital mortality. 

DESIGN: Retrospective, observational study using segmented  and multivariable logistic regression to evaluate the associations of  catecholamine dose, lactate concentration, and timing from shock onset at  vasopressin initiation with in-hospital mortality. 

SETTING: Multiple hospitals  within the Cleveland Clinic Health System. 

PATIENTS: Adult patients who met  criteria for septic shock based on the U.S. Centers for Disease Control and  Prevention Adult Sepsis Event definition. 

INTERVENTIONS: All patients received  continuous infusion vasopressin as an adjunct to catecholamine vasopressors.  

MEASUREMENTS AND MAIN RESULTS: In total, 1,610 patients were included with a mean  Acute Physiology and Chronic Health Evaluation III 109.0 ?± 35.1 and Sequential  Organ Failure Assessment 14.0 ?± 3.5; 41% of patients survived the hospital  admission. At the time of vasopressin initiation, patients had median  (interquartile range) lactate concentration 3.9 mmol/L (2.3-7.2 mmol/L),  norepinephrine-equivalent dose 25 ??g/min (18-40 ??g/min), and 5.3 hours  (2.1-12.2 hr) elapsed since shock onset. The odds of in-hospital mortality  increased 20.7% for every 10 ??g/min increase in norepinephrine-equivalent dose up  to 60 ??g/min at the time of vasopressin initiation (adjusted odds ratio, 1.21  [95% CI, 1.09-1.34]), but no association was detected when the  norepinephrine-equivalent dose exceeded 60 ??g/min (adjusted odds ratio, 0.96 [95%  CI, 0.84-1.10]). There was a significant interaction between timing of  vasopressin initiation and lactate concentration (p = 0.02) for the association  with in-hospital mortality. A linear association between increasing in-hospital  mortality was detected for increasing lactate concentration at the time of  vasopressin initiation, but no association was detected for time elapsed from  shock onset. 

CONCLUSIONS: Higher norepinephrine-equivalent dose at vasopressin  initiation and higher lactate concentration at vasopressin initiation were each  associated higher in-hospital mortality in patients with septic shock who  received vasopressin.

## 在感染性休克患者中，血管加压素开始治疗时儿茶酚胺剂量、乳酸盐和休克持续时间与死亡率的相关性。Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.

目的：确定儿茶酚胺剂量、乳酸盐浓度和血管加压素启动时休克发作时间与住院死亡率的相关性。

设计：采用分段和多变量逻辑回归的回顾性、观察性研究，以评价儿茶酚胺剂量、乳酸盐浓度和血管加压素启动时自休克开始的时间与住院死亡率的相关性。

单位：克利夫兰诊所卫生系统内的多家医院。

患者：根据美国疾病控制和预防中心成人败血症事件定义，符合感染性休克标准的成人患者。

干预：所有患者均接受血管加压素持续输注，作为儿茶酚胺类血管加压素的辅助治疗。

测量值和主要结果：共纳入1610例患者，平均急性生理学和慢性健康状况评分III为109.0 μm±35.1，序贯器官衰竭评估为14.0 μm±3.5；41%的患者住院期间存活。在开始血管加压素治疗时，患者的中位（四分位距）乳酸盐浓度为3.9 mmol/L(2.3-7.2 mmol/L)，去甲肾上腺素当量剂量为25 μg/min(18-40 μg/min)，自休克发生后持续5.3h(2.1-12.2 h)。血管加压素开始治疗时，去甲肾上腺素当量剂量每增加10 μg/min，至60 μg/min，住院死亡率增加20.7%（调整后比值比，1.21[95%CI，1.09-1.34]），但当去甲肾上腺素当量剂量超过60 μg/min时，未检测到相关性（调整后比值比，0.96[95%CI，1.09-1.34]）。0.84-1.10]).血管加压素启动时间和乳酸盐浓度之间有显著相互作用(p = 0.02)，与住院死亡率相关。在血管加压素治疗开始时，发现乳酸盐浓度升高与住院死亡率增加之间存在线性关系，但未发现与休克发作时间相关。

结论：在血管加压素开始治疗时，较高的去甲肾上腺素等效剂量和血管加压素开始治疗时较高的乳酸盐浓度均与接受血管加压素治疗的感染性休克患者中较高的住院死亡率相关。
关键词：Humans; Adult; Retrospective Studies; *Shock, Septic/drug therapy; Vasoconstrictor Agents/therapeutic use; Lactic Acid; Norepinephrine/therapeutic use; Vasopressins/therapeutic use; Catecholamines/therapeutic use

--------
--------

## Benchmarking Inpatient Mortality Using Electronic Medical Record Data: A Retrospective, Multicenter Analytical Observational Study.

4:543-553. DOI:10.1097/CCM.0000000000005301

Abstract: 

OBJECTIVES: To develop a model to benchmark mortality in hospitalized patients using accessible electronic medical record data. 

DESIGN: Univariate analysis and  multivariable logistic regression were used to identify variables collected  during the first 24 hours following admission to test for risk factors associated  with the end point of hospital mortality. Models were built using specific  diagnosis (International Classification of Diseases, 9th Edition or International  Classification of Diseases, 10th Edition) captured at discharge, rather than  admission diagnosis, which may be discordant. Variables were selected based, in  part, on prior the Acute Physiology and Chronic Health Evaluation methodology and  included primary diagnosis information plus three aggregated indices (physiology,  comorbidity, and support). A Physiology Index was created using parsimonious  nonlinear modeling of heart rate, mean arterial pressure, temperature,  respiratory rate, hematocrit, platelet counts, and serum sodium. A Comorbidity  Index incorporates new or ongoing diagnoses captured by the electronic medical  record during the preceding year. A Support Index considered 10 interventions  such as mechanical ventilation, selected IV drugs, and hemodialysis. Accuracy was  determined using area under the receiver operating curve for discrimination,  calibration curves, and modified Brier score for calibration. 

SETTING AND  PATIENTS: We used deidentified electronic medical record data from 74,434 adult  inpatients (ICU and ward) at 15 hospitals from 2010 to 2013 to develop the  mortality model and validated using data for additional 49,752 patients from the  same 15 hospitals. A second revalidation was accomplished using data on 83,684  patients receiving care at six hospitals between 2014 and 2016. The model was  also validated on a subset of patients with an ICU stay on day 1. 

INTERVENTIONS:  None. 

MEASUREMENTS AND MAIN RESULTS: This model uses physiology, comorbidity, and  support indices, primary diagnosis, age, lowest Glasgow Coma Score, and elapsed  time since hospital admission to predict hospital mortality. In the initial  validation cohort, observed mortality was 4.04% versus predicted mortality 4.12%  (Student t test, p = 0.37). In the revalidation using a different set of  hospitals, predicted and observed mortality were 2.66% and 2.99%, respectively.  Area under the receiver operating curve were 0.902 (0.895-0.909) and 0.884  (0.877-0.891), respectively, and calibration curves show a close relationship of  observed and predicted mortalities. In the evaluation of the subset of ICU  patients on day1, the area under the receiver operating curve was 0.87, with an  observed mortality of 8.78% versus predicted mortality of 8.93% (Student t test,  p = 0.52) and a standardized mortality ratio of 0.98 (0.932-1.034). 

CONCLUSIONS:  Variables considered by traditional ICU prognostic models accurately benchmark  patient mortality for patients receiving care in multiple hospital locations, not  only the ICU. Unlike Acute Physiology and Chronic Health Evaluation, this model  relies on electronic medical record data alone and does not require personnel to  collect the independent predictor variables. Assessing the model's utility for  benchmarking hospital performance will require prospective testing in a larger  representative sample of hospitals.

## 使用电子病历数据建立住院患者死亡率基准：一项回顾性、多中心、分析性观察性研究。

目的：使用可访问的电子病历数据开发一个以住院患者死亡率为基准的模型。

设计：使用单变量分析和多变量logistic回归来确定入院后最初24小时收集的变量，以检验与医院死亡率终点相关的风险因素。使用出院时采集的具体诊断（国际疾病分类第9版或国际疾病分类第10版）而不是入院诊断（可能不一致）建立模型。选择的变量部分基于之前的急性生理学和慢性健康状况评价方法，包括主要诊断信息加三个综合指数（生理学、合并症和支持）。使用心率、平均动脉压、体温、呼吸率、红细胞压积、血小板计数和血清钠的简约非线性模型创建生理学指数。合并症指数包括前一年通过电子病历采集的新的或正在进行的诊断。支持指数考虑了10种干预措施，如机械通气、选定IV药物和血液透析。使用受试者工作曲线下面积（用于鉴别）、校准曲线和改良Brier评分（用于校准）确定准确度。

设置和患者：我们使用了2010-2013年15家医院74,434例成人住院患者（ICU和病房）的去身份识别电子病历数据，以开发死亡率模型，并使用来自相同15家医院的额外49,752例患者的数据进行验证。使用2014年至2016年在6家医院接受治疗的83,684例患者的数据完成了第二次再验证。该模型也在第1天留住ICU的患者子集中进行了验证。

干预：无。

测量和主要结果：该模型使用生理学、合并症和支持指数、初步诊断、年龄、最低Glasgow昏迷评分和自入院后经过的时间预测住院死亡率。在初始验证队列中，观察到的死亡率为4.04%，预测死亡率为4.12%（Student t检验，p = 0.37）。在使用不同医院的再验证中，预测和观察死亡率分别为2.66%和2.99%。受试者工作曲线下面积分别为0.902(0.895-0.909)和0.884(0.877-0.891)，校准曲线显示观察到的和预测的死亡率之间存在密切的关系。在评估ICU患者亚组的第1天，受试者工作曲线下面积为0.87，观察到的死亡率为8.78%，而预测的死亡率为8.93%（Student t检验，p = 0.52），标准化死亡率比为0.98(0.932-1.034)。

结论：通过传统ICU预后模型考虑的变量准确地标定了在多个医院位置接受护理的患者的死亡率，而不仅仅是ICU。与急性生理学和慢性健康评估不同，该模型仅依赖于电子病历数据，不需要人员收集独立预测变量。评估该模型对医院绩效的效用将需要在更大的代表性医院样本中进行前瞻性检验。
关键词：Humans; Prospective Studies; Intensive Care Units; Adult; Retrospective Studies; Hospital Mortality; Inpatients; *Benchmarking; *Electronic Health Records

--------
--------

## Vascular Thrombosis in Severe COVID-19 Requiring Extracorporeal Membrane Oxygenation: A Multicenter Study.

4:624-632. DOI:10.1097/CCM.0000000000005322

Abstract: 

OBJECTIVES: Coronavirus disease 2019 has been reported to be a prothrombotic condition; however, multicenter data comparing this with other viral pneumonias  in those requiring extracorporeal membrane oxygenation are lacking. We conducted  a multicenter study using whole-body CT to examine the prevalence, severity, and  nature of vascular complications in coronavirus disease 2019 in comparison with  patients with other viral pneumonias. 

DESIGN: We analyzed whole-body CT scans for  the presence of vascular thrombosis (defined as pulmonary artery thrombus, venous  thrombus, systemic arterial thrombus, or end-organ infarct). The severity,  distribution, and morphology of pulmonary artery thrombus were characterized.  Competing risk cumulative incidence analysis was used to compare survival with  discharge. 

SETTING: Three centers of the English national extracorporeal membrane  oxygenation service. 

PATIENTS: Consecutive patients admitted with either  coronavirus disease 2019 or noncoronavirus disease 2019 viral pneumonia admitted  from January 2019. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS:  One-hundred thirty-six patients (45.2 ?± 10.6 yr old, 39/146 [27%] female)  requiring extracorporeal membrane oxygenation support underwent whole-body CT  scans at admission. Of these, 86 had coronavirus disease 2019 pneumonia, and 50  had noncoronavirus disease 2019 viral pneumonia. Vascular thrombosis was seen  more often in patients with coronavirus disease 2019 (odds ratio, 12.9 [95% CI  4.5-36.8]). In those with coronavirus disease 2019, 57 (73%) demonstrated  pulmonary artery thrombus or pulmonary perfusion defects. Eighty-two percent of  thrombus exhibited emboli-like morphology. The location of pulmonary artery  thrombus and parenchymal perfusion defects was only concordant in 30% of cases.  The risk of mortality was higher in those with coronavirus disease 2019 compared  with noncoronavirus disease 2019 pneumonia (??2 = 3.94; p = 0.047). Mortality was  no different in coronavirus disease 2019 patients with or without vascular  thrombosis (??2 = 0.44; p = 0.51). 

CONCLUSIONS: In patients who received  extracorporeal membrane oxygenation, coronavirus disease 2019 is associated with  a higher prevalence of vascular thrombosis compared with noncoronavirus disease  viral pneumonias. The pattern of pulmonary vascular changes suggests concurrent  embolic disease and small vessel disease. Despite this, vascular thrombosis was  not linked to poorer short-term prognosis in those with coronavirus disease 2019.

## 需要体外膜肺氧合的重度COVID-19中的血管血栓形成：一项多中心研究。Vascular Thrombosis in Severe COVID-19 Requiring Extracorporeal Membrane Oxygenation: A Multicenter Study.

目的：据报告，2019年的冠状病毒病是一种血栓前疾病；然而，缺乏在需要体外膜肺氧合的患者中比较该疾病与其他病毒性肺炎的多中心数据。我们进行了一项多中心研究，使用全身CT检查2019年冠状病毒病中血管并发症的患病率、严重程度和性质，并与其他病毒性肺炎患者进行比较。

设计：我们分析了全身CT扫描是否存在血管血栓（定义为肺动脉血栓、静脉血栓、体循环动脉血栓或终末器官梗死）。描述肺动脉血栓的严重程度、分布和形态。使用竞争风险累积发生率分析比较出院时的生存率。

单位：英国国家体外膜肺氧合服务中心3家。

患者：2019年1月至2019年1月期间，连续收治的冠状病毒病或非冠状病毒病2019病毒性肺炎患者。

干预：无。

测量值和主要结果：136例（45.2 μm±10.6岁，39/146[27%]例女性）需要体外膜肺氧合支持的患者在入院时接受了全身CT扫描。其中，2019年有86例冠状病毒病肺炎，2019年有50例非冠状病毒病病毒性肺炎。2019年，在冠状病毒疾病患者中更常观察到血管血栓形成（比值比，12.9[95%CI 4.5-36.8]）。2019年，在冠状病毒疾病患者中，57例(73%)表现出肺动脉血栓或肺灌注缺陷。82%的血栓呈现栓子样形态。30%的病例肺动脉血栓和实质灌注缺损的位置一致。2019年，冠状病毒疾病患者的死亡风险高于2019年非冠状病毒疾病患者的肺炎风险(<unk>?2=3.94；p=0.047)。死亡率为  2019例有或无血管疾病的冠状病毒病患者无差异  血栓形成(<unk>?2=0.44；p=0.51)。

结论：在接受  体外膜肺氧合，冠状病毒病2019相关  与非冠状病毒病相比，血管血栓形成的患病率更高  病毒性肺炎。肺血管改变的模式提示同时发生  栓塞性疾病和小血管疾病。尽管如此，血管血栓形成仍  2019年，与冠状病毒病患者较差的短期预后无关。
关键词：Humans; Female; Male; Middle Aged; Prognosis; Adult; Tomography, X-Ray Computed; *Extracorporeal Membrane Oxygenation; COVID-19/*complications/therapy; Pneumonia, Viral/*complications/therapy; Thrombosis/diagnostic imaging/*etiology

--------
--------

## Identifying Prokineticin2 as a Novel Immunomodulatory Factor in Diagnosis and Treatment of Sepsis., Yu, Xiaoyan

4:674-684. DOI:10.1097/CCM.0000000000005335

Abstract: 

OBJECTIVES: Sepsis remains a highly lethal disease, whereas the precise reasons for death remain poorly understood. Prokineticin2 is a secreted protein that  regulates diverse biological processes. Whether prokineticin2 is beneficial or  deleterious to sepsis and the underlying mechanisms remain unknown. 

DESIGN:  Prospective randomized animal investigation and in vitro studies. 

SETTING:  Research laboratory at a medical university hospital. 

SUBJECTS: Prokineticin2  deficiency and wild-type C57BL/6 mice were used for in vivo studies; sepsis  patients by Sepsis-3 definitions, patient controls, and healthy controls were  used to obtain blood for in vitro studies. 

INTERVENTIONS: Prokineticin2  concentrations were measured and analyzed in human septic patients, patient  controls, and healthy individuals. The effects of prokineticin2 on sepsis-related  survival, bacterial burden, organ injury, and inflammation were assessed in an  animal model of cecal ligation and puncture-induced polymicrobial sepsis. In  vitro cell models were also used to study the role of prokineticin2 on  antibacterial response of macrophages. 

MEASUREMENTS AND MAIN RESULTS:  Prokineticin2 concentration is dramatically decreased in the patients with sepsis  and septic shock compared with those of patient controls and healthy controls.  Furthermore, the prokineticin2 concentration in these patients died of sepsis or  septic shock is significantly lower than those survival patients with sepsis or  septic shock, indicating the potential value of prokineticin2 in the diagnosis of  sepsis and septic shock, as well as the potential value in predicting mortality  in adult patients with sepsis and septic shock. In animal model, recombinant  prokineticin2 administration protected against sepsis-related deaths in both  heterozygous prokineticin2 deficient mice and wild-type mice and alleviated  sepsis-induced multiple organ damage. In in vitro cell models, prokineticin2  enhanced the phagocytic and bactericidal functions of macrophage through signal  transducers and activators of transcription 3 pathway which could be abolished by  signal transducers and activators of transcription 3 inhibitors S3I-201.  Depletion of macrophages reversed prokineticin2-mediated protection against  polymicrobial sepsis. 

CONCLUSIONS: This study elucidated a previously  unrecognized role of prokineticin2 in clinical diagnosis and treatment of sepsis.  The proof-of-concept study determined a central role of prokineticin2 in  alleviating sepsis-induced death by regulation of macrophage function, which  presents a new strategy for sepsis immunotherapy.

## 在脓毒症的诊断和治疗中确定Prokineticin2是一种新型的免疫调节因子。

目的：败血症仍是一种高度致死性疾病，而对死亡的确切原因仍知之甚少。Prokineticin2是一种分泌蛋白，  调节多种生物过程。prokineticin2是否有益或  对败血症有害，其潜在机制仍不清楚。

设计：  前瞻性随机动物研究和体外研究。

设置：  在医科大学医院的研究实验室。

受试者：趋化因子2  体内研究使用缺陷型和野生型C57BL/6小鼠；败血症  按照脓毒血症-3定义的患者、患者对照和健康对照为  用于获取血液以进行体外研究。

干预：促凝血酶原激酶2  测定并分析了人类败血症患者中的浓度，患者  对照组和健康个体。胃泌素2在脓毒症相关疾病中的作用  在一项  盲肠结扎和穿刺诱导多微生物败血症动物模型。In  体外细胞模型也被用于研究促凝血酶原激酶2对  巨噬细胞的抗菌反应。

测量和主要结果：  脓毒血症患者的胃泌素2浓度显著降低  感染性休克与患者对照和健康对照相比。此外，这些患者的胃泌素2浓度死于败血症或  感染性休克显著低于脓毒症生存患者或  感染性休克，表明促胃动素2在以下疾病诊断中的潜在价值  败血症和感染性休克，以及预测死亡率的潜在价值  脓毒症和脓毒性休克成人患者。在动物模型中，重组  在两项研究中，给予促凝血酶原激酶2均可预防败血症相关死亡  杂合子prokineticin2缺陷小鼠和野生型小鼠，并减轻  脓毒症引起的多器官损害。体外细胞模型，促动力药2  通过信号增强巨噬细胞的吞噬和杀菌功能  转录3通路的转导因子和激活子，可被  信号转导因子和转录激活子3抑制剂S3I-201。巨噬细胞的耗竭逆转了促凝血酶原激酶2介导的保护作用  多微生物败血症。

结论：本研究阐明了之前  在败血症的临床诊断和治疗中未认识到促胃动素2的作用。概念验证研究确定了prokineticin2在  通过调节巨噬细胞功能减轻败血症诱导的死亡，  提出了脓毒症免疫治疗的新策略。
关键词：Humans; Prospective Studies; Animals; Disease Models, Animal; Mice, Inbred C57BL; Mice; *Sepsis; *Shock, Septic; Macrophages

--------
--------

## Immune Profiling Demonstrates a Common Immune Signature of Delayed Acquired Immunodeficiency in Patients With Various Etiologies of Severe Injury.

4:565-575. DOI:10.1097/CCM.0000000000005270

Abstract: 

OBJECTIVES: The host response plays a central role in the pathophysiology of sepsis and severe injuries. So far, no study has comprehensively described the  overtime changes of the injury-induced immune profile in a large cohort of  critically ill patients with different etiologies. 

DESIGN: Prospective  observational cohort study. 

SETTING: Adult ICU in a University Hospital in Lyon,  France. 

PATIENTS: Three hundred fifty-three septic, trauma, and surgical patients  and 175 healthy volunteers were included in the REAnimation Low Immune Status  Marker study. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Extensive  immune profiling was performed by assessing cellular phenotypes and functions,  protein, and messenger RNA levels at days 1-2, 3-4, and 5-7 after inclusion using  a panel of 30 standardized immune markers. Using this immunomonitoring panel, no  specificity in the immune profile was observed among septic, trauma, and surgical  patients. This common injury-induced immune response was characterized by an  initial adaptive (i.e., physiologic) response engaging all constituents of the  immune system (pro- and anti-inflammatory cytokine releases, and innate and  adaptive immune responses) but not associated with increased risk of secondary  infections. In contrary, the persistence in a subgroup of patients of profound  immune alterations at the end of the first week after admission was associated  with increased risk of secondary infections independently of exposure to invasive  devices. The combined monitoring of markers of pro-/anti-inflammatory, innate,  and adaptive immune responses allowed a better enrichment of patients with risk  of secondary infections in the selected population. 

CONCLUSIONS: Using  REAnimation Low Immune Status Marker immunomonitoring panel, we detected delayed  injury-acquired immunodeficiency in a subgroup of severely injured patients  independently of primary disease. Critically ill patients' immune status could be  captured through the combined monitoring of a common panel of complementary  markers of pro-/anti-inflammatory, innate, and adaptive immune responses. Such  immune monitoring needs to be incorporated in larger study cohorts with more  extensive immune surveillance to develop specific hypothesis allowing for  identification of biological systems affecting altered immune function related to  late infection in the setting of acute systemic injury.

## 免疫分析显示，在各种严重损伤病因的患者中，迟发性获得性免疫缺陷的常见免疫特征。

目的：宿主反应在败血症和重度损伤的病理生理学中发挥重要作用。到目前为止，尚无研究对  一项大型队列研究中损伤诱导的免疫特征随时间的变化  不同病因的重症患者。

设计：前瞻性  观察性队列研究。

地点：里昂大学医院的成人ICU，  法国。

患者：353例败血症、创伤和手术患者  和175名健康志愿者被纳入REAnimation Low Immune Status  标记物研究。

干预：无。

测量和主要结果：广泛  通过评估细胞表型和功能进行免疫分析，  入组后第1-2、3-4和5-7天的蛋白和信使RNA水平  一组30种标准化免疫标志物。使用该免疫监测组合，否  观察到败血症、创伤和外科手术之间免疫特征的特异性  患者。这种常见损伤诱导的免疫反应的特征为  初始适应性（即，生理学）反应包含所有的  免疫系统（促炎和抗炎细胞因子释放，以及先天和  适应性免疫应答），但与继发性风险增加无关  感染。相反，在显著患者亚组中的持续性  入院后第一周结束时的免疫改变与  独立于侵袭性暴露的继发性感染风险增加  器械。先天性免疫/抗炎标志物的联合监测，  和适应性免疫应答使得有风险的患者得到更好的富集  的选择人群中继发感染。

结论：使用  REAnimation Low Immune Status Marker免疫监测panel，我们检测到延迟  重度损伤患者亚组中的损伤获得性免疫缺陷  与原发疾病无关。重症患者的免疫状态可能为  通过共同补充小组的联合监测采集  促炎/抗炎、固有和适应性免疫应答的标志物。此类  免疫监测需要纳入更大的研究队列和更多的  广泛的免疫监视以产生允许以下情况的特定假设  识别影响以下相关免疫功能改变的生物系统  急性全身损伤背景下的晚期感染。
关键词：Humans; Prospective Studies; Critical Illness; Biomarkers; *Coinfection/complications; *Sepsis/complications

--------
--------

## Diversity of Authors of Publications From the Canadian Critical Care Trials Group.

4:535-542. DOI:10.1097/CCM.0000000000005284

Abstract: 

OBJECTIVES: Diverse perspectives improve the quality of scholarly initiatives. The demographic and professional diversity of scientists who contribute to  critical care research and publications has not been described for the Canadian  Critical Care Trials Group. Our objective was to describe the diversity of  authors of publications from the Canadian Critical Care Trials Group. 

DESIGN: We  conducted a quantitative content analysis of peer-reviewed articles published on  behalf of the Canadian Critical Care Trials Group. 

SETTING: All peer-reviewed  articles that were published on behalf of the Canadian Critical Care Trials Group  between 1994 and October 2020. 

SUBJECTS: For each publication, we recorded the  study design, the number of authors, and national or international collaboration.  For the lead author, the senior author, and each coauthor, we recorded the  following facets of diversity: gender, professional role, medical discipline,  geographic location, academic stage, and visible minority status. 

INTERVENTIONS:  None. 

MEASUREMENTS AND MAIN RESULTS: We identified 354 eligible publications; 74%  (263/354) reported observational cohort studies, randomized trials, and surveys.  Of 4,246 authors, 1,205 were unique individuals. The mean (sd) number of authors  per publication was 12 (7.1). Of all 4,246 authors, 37% were women, and 13.7%  were members of a visible minority group. Of all lead or senior authors, 40% and  34% respectively were women; 15% of lead and 10% of senior authors were members  of a visible minority group. Three-quarters (73%) of publications listed authors  from more than one profession, and more than half (54%) listed authors from more  than one medical discipline. Nearly half of publications (45%) listed authors who  were early career faculty, 33% listed authors who were trainees, and 67% listed  authors who were from visible minority groups. Authors from different provinces  and from different countries were listed in 67% and 40% of publications,  respectively. 

CONCLUSIONS: Authors of Canadian Critical Care Trials Group  publications are diverse with regard to demographic and professional  characteristics.

## 来自加拿大重症监护试验组的出版物作者的多样性。

目的：多角度可提高学术倡议的质量。贡献于以下领域的科学家的人口统计学和专业多样性  尚未描述加拿大的重症监护研究和出版物  重症监护试验组。我们的目的是描述  来自加拿大关键治疗试验组的出版物作者。

设计：我们  对发表于  代表加拿大重症医学试验组。

设置：所有同行评审  代表加拿大重症医学试验组发表的文章  1994年至2020年10月。

受试者：对于每份出版物，我们记录了  研究设计、作者数量以及国家或国际合作。对于主要作者、资深作者和每名共同作者，我们记录了  多样性的以下方面：性别、专业角色、医学学科，  地理位置、学术阶段和明显的少数民族地位。

干预：  无。

测量和主要结果：我们确定了354篇合格出版物；74%  (263/354)报告了观察性队列研究、随机试验和调查。在4,246位作者中，1,205位是独特的个体。平均(sd)作者人数  每个出版物为12(7.1)。在4,246名作者中，37%为女性，13.7%为  是可见的少数群体的成员。在所有主要或资深作者中，40%和  34%为女性；15%的主要作者和10%的资深作者为成员  的可见少数群体。四分之三(73%)的出版物列出了作者  来自一个以上职业，超过一半(54%)的上市作者来自更多职业  超过医学学科。近半数的出版物(45%)列出了作者  早期教员职业，33%列出作者为培训者，67%列出作者  来自明显少数群体的作者。67%和40%的出版物分别列出了来自不同省份和不同国家的作者。

结论：加拿大重症护理试验组出版物的作者在人口统计学和专业特征方面存在差异。
关键词：Humans; Female; Male; Canada; Research Design; *Critical Care; *Authorship; Professional Role; Publications

--------
--------

## Risk of Dementia and Structural Brain Changes Following Nonneurological Infections During 9-Year Follow-Up.

4:554-564. DOI:10.1097/CCM.0000000000005313

Abstract: 

OBJECTIVES: Given the strong association between systemic inflammation and cognitive decline, we aimed to determine whether nonneurologic infections are  associated with accelerated cognitive decline and structural changes in the brain  using pre- and post-infection neuropsychologic assessments and repeated brain MR  images. 

DESIGN: Additional analysis of the prospective observational Radboud  University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort study.  

SETTING: Single-center study at the Radboud university medical center, Nijmegen,  The Netherlands, between January 2006 and September 2015. 

PATIENTS: Five-hundred  three participants (50-85 yr old) with cerebral small vessel disease were  included and followed for 9 years. 

MEASUREMENTS AND MAIN RESULTS: Participants  underwent repeated cognitive measurements and brain MRI. Infectious events were  collected. Sepsis episodes were analyzed, and additionally, patients were  stratified in three groups: having had a severe infectious episode (e.g., sepsis  or hospitalization for infection), a mild, or no infectious episode. Development  of dementia, trajectories of cognition, and structural brain changes on MRI in  the subsequent follow-up periods were compared between the groups. Complete  infectious data were available from 331 patients (mean age 64 ?± 8 yr, 57% males).  Twenty-nine participants (9%) suffered from a sepsis episode, 69 (21%) from a  severe, 201 (61%) from a mild, and 61 (18%) had no infectious episode during  follow-up. After correction for age, baseline cognition, and brain volume, each  sepsis episode remained associated with an 82% increased risk to develop dementia  within the follow-up period (hazard ratio, 1.82; 95% CI, 1.07-3.10; p = 0.027).  Infections had no effect on the trajectory of structural changes to the brain  after correction for baseline differences. 

CONCLUSIONS: In this 9-year  observational follow-up study, sepsis episodes were associated with subsequent  development of dementia. Nonneurologic infections had no effect on the trajectory  of structural cerebral changes.

## 9年随访期间非神经系统感染后痴呆和脑结构性变化的风险。

目的：考虑到系统性炎症与认知衰退之间的强相关性，我们旨在使用感染前和感染后神经心理学评估和重复脑部MR成像来确定非神经系统感染是否与认知衰退加速和大脑结构变化相关。

设计：对前瞻性观察性Radboud University Nijmegen扩散张量和磁共振队列研究进行附加分析。

设置：2006年1月至2015年9月在荷兰奈梅亨Radboud大学医学中心进行的单中心研究。

患者：纳入503例脑小血管疾病参与者（50-85岁），并随访9年。

测量和主要结果：受试者接受重复认知测量和脑MRI。收集感染事件。分析了败血症发作，此外，将患者分为3组：发生重度感染发作（例如，败血症或因感染住院）、轻度或无感染发作。比较了两组在后续随访期间痴呆的发生、认知轨迹和MRI显示的结构性大脑变化。获得了331例患者（平均年龄64岁±8岁，57%为男性）的完整感染数据。随访期间，29例受试者(9%)发生脓毒症，69例(21%)发生重度脓毒症，201例(61%)发生轻度脓毒症，61例(18%)未发生感染。校正年龄、基线认知和脑容量后，在随访期间，每一次脓毒症发作均与发生痴呆的风险增加82%相关（风险比，1.82；95%CI，1.07-3.10；p = 0.027）。校正基线差异后，感染对大脑结构变化轨迹无影响。

结论：在这项为期9年的观察随访研究中，败血症发作与随后发生的痴呆相关。非神经系统感染对大脑结构变化的轨迹没有影响。
关键词：Humans; Female; Male; Middle Aged; Aged; Cohort Studies; Follow-Up Studies; *Sepsis/complications; *Cognitive Dysfunction/complications/etiology; *Dementia/epidemiology/etiology; Brain/diagnostic imaging/pathology; Magnetic Resonance Imaging/adverse effects

--------
--------

## The Association Between the Decision to Withdraw Life-Sustaining Therapy and Patient Mortality in U.K. ICUs.

4:576-585. DOI:10.1097/CCM.0000000000005306

Abstract: 

OBJECTIVES: Differences in decisions to limit life-sustaining therapy are often supported by perceptions that patients receive unnecessary and expensive  treatment which provide negligible survival benefit. However, the assumption  behind those beliefs-that is, that life-sustaining therapy provides no  significant marginal survival benefit-remains unproven. Our objective was to  quantify the effects of variations in decisions to withdraw or withhold  life-sustaining treatment on 180-day mortality in critically ill patients.  

DESIGN: Retrospective observational cohort study of a national clinical database.  

SETTING: Adult ICUs participating in the Intensive Care National Audit and  Research Center Case Mix Program in the United Kingdom. 

PATIENTS: Adult patients  admitted to general ICUs between April 1, 2009, and March 31, 2016. 

MEASUREMENTS  AND MAIN RESULTS: During the study period, 795,721 patients were admitted to 247  ICUs across the United Kingdom. A decision to withdraw or withhold  life-sustaining treatment was made for 92,327 patients (11.6%). A multilevel  model approach was used to estimate ICU-level practice variation. The ICU-level  practice variation was then used as an instrument to measure the effects of  decision to withdraw or withhold life-sustaining treatment on 180-day mortality.  The marginal population was estimated to be 5.9% of the total cohort. A decision  to withdraw or withhold life-sustaining treatment was associated with a marginal  increase in 180-day mortality of 25.6% (95% CI, 23.2-27.9%). 

CONCLUSIONS:  Decision to withdraw or withhold life-sustaining treatment in critically ill  adults in the United Kingdom was associated with increased 180-day mortality in  the marginal patients. The increased mortality from a decision to withdraw or  withhold life-sustaining treatment in the marginal patient may be informative  when establishing patients' preferences and evaluating the cost-effectiveness of  intensive treatments.

## 英国ICU中停止维持生命治疗的决定与患者死亡率之间的相关性。

目的：限制维持生命治疗决策的差异通常得到以下观念的支持：患者接受不必要和昂贵的治疗，而这些治疗提供的生存获益可忽略不计。然而，这些信念背后的假设-即维持生命的治疗不能提供显著的边际生存获益-仍未证实。我们的目的是量化不同决定撤回或暂停维持生命治疗对重症患者180天死亡率的影响。

设计：国家临床数据库回顾性观察性队列研究。

设置：英国国家审计和研究中心重症监护病例混合项目的成人ICU。

患者：2009年4月1日至2016年3月31日期间入住普通ICU的成人患者。

测量和主要结果：在研究期间，英国共有795,721例患者入住247间ICU。92,327例患者(11.6%)决定停止或暂停维持生命治疗。使用多水平模型方法估计ICU水平实践变化。然后，将ICU-水平实践变化用作测量决定停止或暂停维持生命治疗对180天死亡率影响的工具。估计边缘人群占总队列的5.9%。决定停止或暂停维持生命治疗与180天死亡率小幅增加25.6%(95%CI，23.2-27.9%)相关。

结论：在英国的危重成人中，决定停止或暂停维持生命的治疗与边缘患者中增加的180天死亡率相关。在确定患者的偏好和评估强化治疗的成本效益时，边缘患者决定停止或暂停维持生命治疗可能会增加死亡率。
关键词：Humans; Adult; Retrospective Studies; *Intensive Care Units; *Critical Illness/therapy; Decision Making; Life Support Care; Withholding Treatment

--------
--------

## Hysteresis and Lung Recruitment in Acute Respiratory Distress Syndrome Patients: A CT Scan Study: Erratum.

3:e339. DOI:10.1097/CCM.0000000000005448

--------
--------

## The authors reply., Marshall, John C.

3:e337-e338. DOI:10.1097/CCM.0000000000005413

## Hysteresis and Lung Recruitment in Acute Respiratory Distress Syndrome Patients: A CT Scan Study: Erratum.

--------
--------

## The authors reply.

3:e339. DOI:10.1097/CCM.0000000000005448

--------
--------

## The authors reply.

3:e336-e337. DOI:10.1097/CCM.0000000000005370

--------
--------

## Altered Metabolic Resource Allocation May Play Important Role in Multiple Organ Dysfunction Syndrome., Qu, Hong Ping

## 代谢资源分配改变可能在多器官功能障碍综合征中发挥重要作用。
关键词：Humans; *Multiple Organ Failure/physiopathology; *Resource Allocation

--------
--------

## The authors reply.

3:e335-e336. DOI:10.1097/CCM.0000000000005406

## 作者回复。

--------
--------

## Look Back, Look Forward, but Use a Fresh Look.

3:e334. DOI:10.1097/CCM.0000000000005369

## 回顾、向前看，但是请使用新鲜的回顾。

--------
--------

## The author replies., Oh, Tak Kyu

3:e333. DOI:10.1097/CCM.0000000000005387

## 作者回复。

--------
--------

## How to Preserve Quality of Life Following Extracorporeal Membrane Oxygenation Explantation.

3:e332-e333. DOI:10.1097/CCM.0000000000005368

## 如何维持体外膜肺氧合移植后的生活质量。
关键词：Quality of Life; *Extracorporeal Membrane Oxygenation

--------
--------

## The authors reply., Rass, Verena

3:e331-e332. DOI:10.1097/CCM.0000000000005402

## 作者回复。

--------
--------

## The RAISE Score: A Possible Tool to Better Identify Subarachnoid Hemorrhage Patients Who Might Benefit From Early Tracheostomy?

3:e329-e330. DOI:10.1097/CCM.0000000000005367

## RAISE评分：一种可能的工具，可更好地识别从早期气管造口术中获益的蛛网膜下腔出血患者？
关键词：Humans; Critical Care; Respiration, Artificial; *Tracheostomy; *Subarachnoid Hemorrhage/surgery

--------
--------

## The authors reply.

3:e328-e329. DOI:10.1097/CCM.0000000000005407

## 作者回复。

--------
--------

## Mischaracterizing the Data Regarding Hypertonic Saline., Lapham, David A.

3:e327-e328. DOI:10.1097/CCM.0000000000005366

## 对高渗盐水相关数据的错误描述。
关键词：*Saline Solution; Hypertonic/therapeutic use

--------
--------

## The authors reply.

3:e325-e326. DOI:10.1097/CCM.0000000000005410

## 作者回复。

--------
--------

## Assessing Risk Factors and Associated Adverse Outcomes of Acute Kidney Injury After Neonatal Cardiac Surgery.

3:e324-e325. DOI:10.1097/CCM.0000000000005365

## 评估新生儿心脏手术后急性肾损伤的风险因素和相关不良结局。
关键词：Humans; Risk Factors; Infant, Newborn; *Cardiac Surgical Procedures/adverse effects; *Acute Kidney Injury/epidemiology/etiology

--------
--------

## The authors reply., Duprey, Matthew S.

3:e323-e324. DOI:10.1097/CCM.0000000000005405

## 作者回复。

--------
--------

## Concerns With Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.

3:e322-e323. DOI:10.1097/CCM.0000000000005358

## 危重病成人中氟哌啶醇治疗谵妄事件与死亡率之间相关性的担忧。
关键词：Humans; Intensive Care Units; Adult; *Delirium/drug therapy/mortality; *Haloperidol/therapeutic use; Critical Illness/mortality/therapy

--------
--------

## The authors reply.

3:e321-e322. DOI:10.1097/CCM.0000000000005412

## 作者回复。

--------
--------

## Why Clinicians Should Adopt Routine Neuroimaging After Extracorporeal Membrane Oxygenation.

3:528-531. DOI:10.1097/CCM.0000000000005401

## 为什么临床医生应在体外膜肺氧合术后采用常规神经影像学检查。
关键词：Neuroimaging; *Extracorporeal Membrane Oxygenation/methods

--------
--------

## The IMPACT of Transitional Care Management in Sepsis., Chatterjee, Arjun B.

3:525-527. DOI:10.1097/CCM.0000000000005336

## 败血症过渡期护理管理的影响。
关键词：Humans; *Sepsis/therapy; *Transitional Care; Health Services

--------
--------

## Taking a New SLANT on Postcardiac Arrest Prognostication?

3:519-522. DOI:10.1097/CCM.0000000000005341

## 是否在心脏骤停后预后中使用新的SLANT？
关键词：Humans; *Cardiopulmonary Resuscitation; *Out-of-Hospital Cardiac Arrest/therapy

--------
--------

## Improving Sepsis Care: Is It Research? Promoting Clarity in a Zone of Confusion.

3:516-519. DOI:10.1097/CCM.0000000000005279

## 改善败血症治疗：是否为研究？促进意识模糊区域的清晰度。
关键词：Humans; *Sepsis/diagnosis/therapy; *Confusion

--------
--------

## Panacea or Perplexing?

3:513-516. DOI:10.1097/CCM.0000000000005278

## 万能药还是困扰？

--------
--------

## Tocilizumab: A Role for Biomarker-Directed Therapy?, Strich, Jeffrey R.

3:510-513. DOI:10.1097/CCM.0000000000005281

## 托珠单抗：生物标记物导向治疗的作用？
关键词：Biomarkers; *Antibodies, Monoclonal, Humanized/therapeutic use

--------
--------

## Time Out: More Observation Time to Allow for Stronger Science, Sharper Prognostic Tools, and Better Outcomes in Cardiac Arrest Survivors., Duarte, Siena

3:507-510. DOI:10.1097/CCM.0000000000005330

## 结束时间：留出更多的观察时间，以便更有力的科学、更清晰的预后工具和更好的心搏骤停幸存者结局。
关键词：Humans; Prognosis; Survivors; *Out-of-Hospital Cardiac Arrest/therapy

--------
--------

## Physical Rehabilitation in the ICU: Is It Worth the Effort?, Laghi, Franco

3:504-507. DOI:10.1097/CCM.0000000000005289

## ICU中的身体康复：是否值得努力？
关键词：*Intensive Care Units; *Quality of Life

--------
--------

## Pediatric Acute Respiratory Distress Syndrome-Will We Be Able to Predict It and Eventually Prevent It?, Ciomartan, Tatiana C.

3:501-504. DOI:10.1097/CCM.0000000000005324

## 小儿急性呼吸窘迫综合征??我们是否能够对其进行预测并最终预防？
关键词：Humans; Child; Infant, Newborn; *Respiratory Distress Syndrome, Newborn; *Respiratory Distress Syndrome/prevention & control

--------
--------

## Is Ventilator-Associated Pneumonia More Frequent in Patients With Coronavirus Disease 2019?

3:522-524. DOI:10.1097/CCM.0000000000005389

## 2019年冠状病毒病患者的呼吸机相关性肺炎是否更常见？
关键词：Humans; Intensive Care Units; *COVID-19; SARS-CoV-2; Respiration, Artificial/adverse effects; *Pneumonia, Ventilator-Associated/epidemiology

--------
--------

## Tranexamic Acid in Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

3:e313-e319. DOI:10.1097/CCM.0000000000005362

Abstract: 

OBJECTIVES: Tranexamic acid is proposed as a treatment for gastrointestinal bleeding. The Haemorrhage Alleviation with Tranexamic Acid-Intestinal System  trial evaluated extended-use (24 hr) high-dose tranexamic acid, prompting a  reappraisal for tranexamic acid in gastrointestinal bleeding. 

DATA SOURCES: We  conducted a systematic review and meta-analysis of randomized controlled trials  comparing tranexamic acid with usual care or placebo in adults with  gastrointestinal bleeding. We searched MEDLINE, EMBASE, and CENTRAL (inception to  September 2019). 

DATA SELECTION: Two reviewers independently screened citations,  extracted data, and assessed the risk of bias using the Cochrane risk of bias  tool in duplicate. The main outcomes were mortality, bleeding, and adverse  events. 

DATA EXTRACTION: Studies were analyzed as high-dose IV tranexamic acid  versus all other dosing strategies for tranexamic acid using fixed-effects  models. We assessed certainty of evidence using the Grading of Recommendations  Assessment, Development, and Evaluation approach. 

DATA SYNTHESIS: Five randomized  controlled trials evaluated extended-use high-dose IV tranexamic acid, seven  evaluating low-dose IV or enteral tranexamic acid. Extended-use high-dose IV  tranexamic acid did not reduce mortality (relative risk, 0.98%; 95% CI,  0.88-1.09; I2 = 63%; high certainty) or bleeding (relative risk, 0.92; 95% CI,  0.82-1.04; p = 0.17 and absolute risk differences, -0.7%; 95% CI, -1.5 to 0.3;  high certainty) but resulted in a small increase in deep venous thrombosis  (relative risk, 2.01; 95% CI, 1.08-3.72; I2 = 0%), pulmonary embolism (relative  risk, 1.78; 95% CI, 1.06-3.0; I2 = 0%), and seizure (relative risk, 1.73; 95% CI,  1.03-2.93) with high certainty. Low-dose IV/enteral tranexamic acid did not  reduce mortality (relative risk, 0.62; 95% CI, 0.36-1.09; I2 = 0%) but did reduce  risk of rebleeding (relative risk, 0.5; 95% CI, 0.33-0.75; I2 = 9%) and need for  surgery (relative risk, 0.58; 95% CI, 0.38-0.88; I2 = 11%), with moderate  certainty. 

CONCLUSIONS: Extended-use high-dose IV tranexamic acid does not  improve mortality or bleeding outcomes and increases adverse events.  Low-dose/enteral tranexamic acid may be effective in reducing hemorrhage; more  evidence is required to demonstrate its safety.

## 氨甲环酸在胃肠道出血中的应用：一项系统回顾和荟萃分析。

目的：氨甲环酸拟用于治疗胃肠道出血。使用氨甲环酸-肠系统缓解出血的试验评价了延长使用(24 h)高剂量氨甲环酸，促使对胃肠道出血中氨甲环酸进行重新评价。

资料来源：我们对比较氨甲环酸与常规护理或安慰剂治疗成人胃肠道出血的随机对照试验进行了系统回顾和荟萃分析。检索MEDLINE、EMBASE和CENTRAL（开始至2019年9月）。

数据选择：两名审查员独立筛选引文、提取数据，并使用Cochrane偏倚风险工具重复评估偏倚风险。主要结局为死亡率、出血和不良事件。

数据提取：使用固定效应模型分析高剂量IV氨甲环酸与氨甲环酸所有其他给药策略的研究。我们使用推荐评估、开发和评价方法分级评估证据的确定性。

资料综合：5项随机对照试验评价了扩大使用的高剂量IV氨甲环酸，7项评价了低剂量IV或肠内氨甲环酸。延长使用大剂量IV氨甲环酸没有降低死亡率（相对风险，0.98%；95%CI，0.88-1.09；I2 = 63%；高度确定性）或出血率（相对风险，0.92；95%CI，0.82-1.04；p = 0.17和绝对风险差异，-0.7%；95%CI，-1.5至0.3；高确定性），但导致深静脉血栓形成（相对风险，2.01；95%CI，1.08-3.72；I2 = 0%）、肺栓塞（相对风险，1.78；95%CI，1.06-3.0；I2 = 0%）和癫痫发作（相对风险，1.73；95%CI，1.03-2.93）小幅增加，具有高确定性。低剂量IV/肠内氨甲环酸没有降低死亡率（相对风险，0.62；95%CI，0.36-1.09；I2 = 0%），但是降低了再出血风险（相对风险，0.5；95%CI，0.33-0.75；I2 = 9%）和需要手术的风险（相对风险，0.58；95%CI，0.38-0.88；I2 = 11%），具有中度确定性。

结论：延长使用大剂量IV氨甲环酸不能改善死亡率或出血结局，并增加不良事件。低剂量/肠内氨甲环酸可能有效减少出血；需要更多证据证明其安全性。
关键词：Humans; Antifibrinolytic Agents/*therapeutic use; Gastrointestinal Hemorrhage/*drug therapy/mortality; Length of Stay/statistics & numerical data; Secondary Prevention/statistics & numerical data; Tranexamic Acid/*therapeutic use

--------
--------

## The Coronavirus Disease 2019 Pandemic Impacts Burnout Syndrome Differently Among Multiprofessional Critical Care Clinicians-A Longitudinal Survey Study., Moll, Vanessa

3:440-448. DOI:10.1097/CCM.0000000000005265

Abstract: 

OBJECTIVES: To determine the impact of coronavirus disease 2019 on burnout syndrome in the multiprofessional ICU team and to identify factors associated  with burnout syndrome. 

DESIGN: Longitudinal, cross-sectional survey. 

SETTING: All  adult ICUs within an academic health system. 

SUBJECTS: Critical care nurses,  advanced practice providers, physicians, respiratory therapists, pharmacists,  social workers, and spiritual health workers were surveyed on burnout in 2017 and  during the coronavirus disease 2019 pandemic in 2020. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: Burnout syndrome and contributing factors were  measured using the Maslach Burnout Inventory of Health and Human Service and  Areas of Worklife Survey. Response rates were 46.5% (572 respondents) in 2017 and  49.9% (710 respondents) in 2020. The prevalence of burnout increased from 59% to  69% (p < 0.001). Nurses were disproportionately impacted, with the highest  increase during the pandemic (58-72%; p < 0.0001) with increases in emotional  exhaustion and depersonalization, and personal achievement decreases. In  contrast, although burnout was high before and during coronavirus disease 2019 in  all specialties, most professions had similar or lower burnout in 2020 as they  had in 2017. Physicians had the lowest rates of burnout, measured at 51% and 58%,  respectively. There was no difference in burnout between clinicians working in  ICUs who treated coronavirus disease 2019 than those who did not (71% vs 67%; p =  0.26). Burnout significantly increased in females (71% vs 60%; p = 0.001) and was  higher than in males during the pandemic (71% vs 60%; p = 0.01). 

CONCLUSIONS:  Burnout syndrome was common in all multiprofessional ICU team members prior to  and increased substantially during the pandemic, independent of whether one  treated coronavirus disease 2019 patients. Nurses had the highest prevalence of  burnout during coronavirus disease 2019 and had the highest increase in burnout  from the prepandemic baseline. Female clinicians were significantly more impacted  by burnout than males. Different susceptibility to burnout syndrome may require  profession-specific interventions as well as work system improvements.

## 2019年冠状病毒病对多专业重症临床医生中倦怠综合征不同影响的纵向调查研究。

目的：确定2019年冠状病毒病对多专业ICU团队中倦怠综合征的影响，并确定与倦怠综合征相关的因素。

设计：纵向横断面调查。

设置：学术卫生系统内的所有成人ICU。

受试者：2017年和2020年冠状病毒病2019年大流行期间，调查了重症护士、高级执业医师、医生、呼吸治疗师、药剂师、社会工作者和精神卫生工作者的倦怠情况。

干预：无。

测量和主要结果：使用Maslach健康与人类服务部倦怠量表和工作生活调查领域对倦怠综合征和影响因素进行测量。2017年应答率为46.5%（572名应答者），2020年为49.9%（710名应答者）。倦怠的患病率从59%增加至69%(p < 0.001)。护士受到不成比例的影响，在大流行期间增幅最高(58-72%；p < 0.0001)，情绪衰竭和人格解体增加，个人成就降低。相比之下，虽然2019年之前和期间冠状病毒病在所有专业中倦怠程度均很高，但2020年大部分职业的倦怠程度与2017年相似或更低。医生的倦怠率最低，分别为51%和58%。2019年治疗冠状病毒病的ICU临床医生的倦怠与未治疗的临床医生无差异(71%vs 67%；p = 0.26)。女性倦怠显著增加(71%vs 60%；p = 0.001)，在大流行期间高于男性(71%vs 60%；p = 0.01)。

结论：在流行之前，Burnout综合征在所有多专业ICU团队成员中很常见，并在流行期间大幅增加，与是否治疗2019例冠状病毒病无关。2019年，护士在冠状病毒疾病期间的倦怠患病率最高，且倦怠相对于大流行前基线的增幅最高。女性临床医生受倦怠的影响显著高于男性。对倦怠综合征的不同易感性可能需要职业特异性干预以及工作系统改进。
关键词：Humans; Female; Male; Middle Aged; Adult; Longitudinal Studies; Prevalence; Pandemics; Cross-Sectional Studies; SARS-CoV-2; COVID-19/*epidemiology; Burnout, Professional/*epidemiology; Critical Care Nursing/statistics & numerical data; Critical Care/*statistics & numerical data; Intensive Care Units/*statistics & numerical data; Patient Care Team/statistics & numerical data; Personnel, Hospital/*psychology

--------
--------

## Association Between Urine Output and Mortality in Critically Ill Patients: A Machine Learning Approach., Heffernan, Aaron J.

3:e263-e271. DOI:10.1097/CCM.0000000000005310

Abstract: 

OBJECTIVES: Current definitions of acute kidney injury use a urine output threshold of less than 0.5 mL/kg/hr, which have not been validated in the modern  era. We aimed to determine the prognostic importance of urine output within the  first 24 hours of admission to the ICU and to evaluate for variance between  different admission diagnoses. 

DESIGN: Retrospective cohort study. 

SETTING:  One-hundred eighty-three ICUs throughout Australia and New Zealand from 2006 to  2016. 

PATIENTS: Patients greater than or equal to 16 years old who were admitted  with curative intent who did not regularly receive dialysis. ICU readmissions  during the same hospital admission and patients transferred from an external ICU  were excluded. 

MEASUREMENTS AND MAIN RESULTS: One hundred and sixty-one thousand  nine hundred forty patients were included with a mean urine output of  1.05 mL/kg/hr and an overall in-hospital mortality of 7.8%. A urine output less  than 0.47 mL/kg/hr was associated with increased unadjusted in-hospital  mortality, which varied with admission diagnosis. A machine learning model  (extreme gradient boosting) was trained to predict in-hospital mortality and  examine interactions between urine output and survival. Low urine output was most  strongly associated with mortality in postoperative cardiovascular patients,  nonoperative gastrointestinal admissions, nonoperative renal/genitourinary  admissions, and patients with sepsis. 

CONCLUSIONS: Consistent with current  definitions of acute kidney injury, a urine output threshold of less than  0.5 mL/kg/hr is modestly predictive of mortality in patients admitted to the ICU.  The relative importance of urine output for predicting survival varies with  admission diagnosis.

## 危重患者中尿量与死亡率之间的相关性：机器学习方法。

目的：急性肾损伤的当前定义采用小于0.5 mL/kg/hr的尿量阈值，这在现代尚未得到验证。我们旨在确定入ICU后最初24小时内尿量的预后重要性，并评估不同入院诊断之间的差异。

设计：回顾性队列研究。

设置：2006年至2016年，澳大利亚和新西兰的183间ICU。

患者：大于等于16岁，以治愈为目的入院，未定期接受透析的患者。排除在同一医院住院期间再次入住ICU和从外部ICU转出的患者。

测量值和主要结果：1611940例患者的平均尿量为1.05 mL/kg/hr，总体住院死亡率为7.8%。尿量低于0.47 mL/kg/hr与未经调整的住院死亡率增加相关，住院诊断不同。培训了机器学习模型（极端梯度增强），以预测住院死亡率，并检查尿量和生存率之间的相互作用。在术后心血管疾病患者、非手术胃肠道疾病患者、非手术肾脏/泌尿生殖系统疾病患者和脓毒症患者中，尿量减少与死亡率的相关性最强。

结论：与当前急性肾损伤的定义一致，小于0.5 mL/kg/hr的尿排出量阈值可中度预测ICU住院患者的死亡率。尿量预测生存率的相对重要性因入院诊断而异。
关键词：Humans; Female; Male; Middle Aged; Prognosis; Aged; Adult; Young Adult; Retrospective Studies; Australia; New Zealand; Hospital Mortality; *Intensive Care Units; Acute Kidney Injury/diagnosis/*mortality/*urine; Critical Illness/*mortality; Machine Learning

--------
--------

## Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study.

3:449-459. DOI:10.1097/CCM.0000000000005297

Abstract: 

OBJECTIVES: Little is known about the epidemiology of ventilator-acquired pneumonia among coronavirus disease 2019 patients such as incidence or  etiological agents. Some studies suggest a higher risk of ventilator-associated  pneumonia in this specific population. 

DESIGN: Cohort exposed/nonexposed study  among the REA-REZO surveillance network. 

SETTING: Multicentric; ICUs in France.  

PATIENTS: The coronavirus disease 2019 patients at admission were matched on the  age, sex, center of inclusion, presence of antimicrobial therapy at admission,  patient provenance, time from ICU admission to mechanical ventilation, and  Simplified Acute Physiology Score II at admission to the patients included  between 2016 and 2019 within the same surveillance network (1:1). 

INTERVENTIONS:  None. 

MEASUREMENTS AND MAIN RESULTS: The overall incidence of  ventilator-associated pneumonia, the cumulative incidence, and hazard rate of the  first and the second ventilator-associated pneumonia were estimated. In addition,  the ventilator-associated pneumonia microbiological ecology and specific  resistant pattern in coronavirus disease 2019 exposed and nonexposed patients  were compared. Medication data were not collected. A total of 1,879 patients were  included in each group. The overall incidence of ventilator-associated pneumonia  was higher among coronavirus disease 2019 exposed patients (25.5; 95% CI  [23.7-27.45] vs 15.4; 95% CI [13.7-17.3] ventilator-associated pneumonia per  1,000 ventilation days). The cumulative incidence was higher for the first and  the second ventilator-associated pneumonia among the coronavirus disease 2019  exposed patients (respective Gray test p < 0.0001 and 0.0167). The  microbiological ecology and resistance were comparable between groups with a  predominance of Enterobacterales and nonfermenting Gram-negative bacteria. The  documented resistance pattern was similar between groups, except for a lower rate  of methicillin-resistant Staphylococcus aureus in the coronavirus disease 2019  exposed patient (6% vs 23%; p = 0.013). 

CONCLUSIONS: There was a higher incidence  of ventilator-associated pneumonia occurring among coronavirus disease 2019  patient compared with the general ICU population, with a similar microbiological  ecology and resistance pattern.

## 2019年冠状病毒疾病患者中呼吸机获得性肺炎的发病率增加：一项多中心队列研究。

目的：关于2019例冠状病毒疾病患者中呼吸机获得性肺炎的流行病学情况，如发病率或病原体，我们知之甚少。一些研究表明，在这一特定人群中，呼吸机相关性肺炎的风险较高。

设计：REA-REZO监测网络中队列暴露/非暴露研究。

设置：多中心；法国的ICU。

患者：2019例患者入院时的冠状病毒病在年龄、性别、入选中心、入院时是否进行抗微生物治疗、患者来源、从ICU入院至机械通气的时间、和2016年至2019年期间同一监测网络内纳入的患者入院时的简化急性生理学评分II(1:1)。

干预：无。

测量和主要结果：对呼吸机相关性肺炎的总发病率、第一和第二呼吸机相关性肺炎的累积发病率和危害率进行了估计。此外，比较了2019年暴露和未暴露患者中冠状病毒病的呼吸机相关性肺炎微生物学生态和特定耐药模式。未收集用药数据。每组共纳入1879例患者。2019年暴露于冠状病毒病的患者中，呼吸机相关性肺炎的总发生率较高（25.5；95%CI[23.7-27.45]vs 15.4；95%CI[13.7-17.3]，呼吸机相关性肺炎/1000个通气日）。2019年暴露于冠状病毒病的患者中，首次和第二次呼吸机相关性肺炎的累积发生率较高（相应Gray检验p < 0.0001和0.0167）。以肠杆菌科细菌和非发酵革兰氏阴性菌为主的治疗组之间的微生物学生态和耐药性相当。除了2019年暴露于冠状病毒疾病的患者中耐甲氧西林金黄色葡萄球菌的发生率较低(6%vs 23%；p = 0.013)外，记录的组间耐药模式相似。

结论：2019例冠状病毒病患者发生呼吸机相关性肺炎的发生率高于普通ICU人群，具有相似的微生物学生态和耐药模式。
关键词：Humans; Female; Male; Middle Aged; Prospective Studies; Aged; SARS-CoV-2; Drug Resistance, Bacterial; COVID-19/*epidemiology; Intensive Care Units/*statistics & numerical data; France/epidemiology; Pneumonia, Ventilator-Associated/*epidemiology/microbiology; Respiration, Artificial/*adverse effects; Simplified Acute Physiology Score

--------
--------

## Barotrauma in Coronavirus Disease 2019 Patients Undergoing Invasive Mechanical Ventilation: A Systematic Literature Review., Belletti, Alessandro

3:491-500. DOI:10.1097/CCM.0000000000005283

Abstract: 

OBJECTIVE: There are concerns of a high barotrauma rate in coronavirus disease 2019 patients with acute respiratory distress syndrome receiving invasive  mechanical ventilation. However, a few studies were published, and reported rates  were highly variable. We performed a systematic literature review to identify  rates of barotrauma, pneumothorax, and pneumomediastinum in coronavirus disease  2019 acute respiratory distress syndrome patients receiving invasive mechanical  ventilation. 

DATA SOURCE: PubMed and Scopus were searched for studies reporting  barotrauma event rate in adult coronavirus disease 2019 patients receiving  invasive mechanical ventilation. 

STUDY SELECTION: We included all studies  investigating adult patients with coronavirus disease 2019 acute respiratory  distress syndrome requiring mechanical ventilation. Case reports, studies  performed outside ICU setting, and pediatric studies were excluded. Two  investigators independently screened and selected studies for inclusion. 

DATA  EXTRACTION: Two investigators abstracted data on study characteristics, rate of  pneumothorax, pneumomediastinum and overall barotrauma events, and mortality.  When available, data from noncoronavirus disease 2019 acute respiratory distress  syndrome patients were also collected. Pooled estimates for barotrauma,  pneumothorax, and pneumomediastinum were calculated. 

DATA SYNTHESIS: A total of  13 studies with 1,814 invasively ventilated coronavirus disease 2019 patients and  493 noncoronavirus disease 2019 patients were included. A total of 266/1,814  patients (14.7%) had at least one barotrauma event (pooled estimates, 16.1% [95%  CI, 11.8-20.4%]). Pneumothorax occurred in 132/1,435 patients (pooled estimates,  10.7%; 95% CI, 6.7-14.7%), whereas pneumomediastinum occurred in 162/1,432  patients (pooled estimates, 11.2%; 95% CI, 8.0-14.3%). Mortality in coronavirus  disease 2019 patients who developed barotrauma was 111/198 patients (pooled  estimates, 61.6%; 95% CI, 50.2-73.0%). In noncoronavirus disease 2019 acute  respiratory distress syndrome patients, barotrauma occurred in 31/493 patients  (6.3%; pooled estimates, 5.7%; 95% CI, -2.1% to 13.5%). 

CONCLUSIONS: Barotrauma  occurs in one out of six coronavirus disease 2019 acute respiratory distress  syndrome patients receiving invasive mechanical ventilation and is associated  with a mortality rate of about 60%. Barotrauma rate may be higher than  noncoronavirus disease 2019 controls.

## 2019例接受侵入性机械通气的冠状病毒疾病患者中的气压伤：一项系统性文献综述。

目的：在2019例接受有创机械通气的急性呼吸窘迫综合征患者中，存在冠状病毒疾病患者气压伤率较高的问题。但是，发表了几项研究，报告的发生率具有高度变异性。我们进行了系统性文献综述，以确定2019年接受有创机械通气的急性呼吸窘迫综合征患者中冠状病毒病的气压伤、气胸和纵隔气肿的发生率。

资料来源：检索PubMed和Scopus中2019例接受有创机械通气的成人冠状病毒病患者报告气压伤事件发生率的研究。

研究选择：我们纳入了所有研究冠状病毒病2019年急性呼吸窘迫综合征需要机械通气的成人患者的研究。排除了病例报告、在ICU外进行的研究和儿科研究。两名研究者独立筛选和选择研究纳入。

数据提取：两名研究者提取了关于研究特征、气胸、纵隔气肿和总体气压伤事件发生率以及死亡率的数据。当可用时，还收集了非冠状病毒病2019例急性呼吸窘迫综合征患者的数据。计算了气压伤、气胸和纵隔气肿的合并估计值。

资料综合：共纳入13项研究，1814例侵入性通气的冠状病毒病2019例患者，493例非冠状病毒病2019例患者。总计266/1,814例患者(14.7%)至少发生1起气压伤事件（汇总估计值，16.1%[95%CI，11.8-20.4%]）。132/1,435例患者发生气胸（汇总估计值，10.7%；95%CI，6.7-14.7%），而162/1,432例患者发生纵隔气肿（汇总估计值，11.2%；95%CI，8.0-14.3%）。2019年发生气压伤的冠状病毒疾病患者的死亡率为111/198例（合并估计值，61.6%；95%CI，50.2%）-73.0%).在非冠状病毒病2019例急性呼吸窘迫综合征患者中，31/493例患者发生气压伤（6.3%；汇总估计值，5.7%；95%CI，-2.1%至13.5%）。

结论：在2019例接受有创机械通气的急性呼吸窘迫综合征患者中，6例冠状病毒病中1例发生气压伤，死亡率约为60%。气压伤发生率可能高于非冠状病毒病2019对照组。
关键词：Humans; SARS-CoV-2; COVID-19/mortality/*therapy; Respiration, Artificial/*adverse effects; Barotrauma/*etiology/mortality; Mediastinal Emphysema/*etiology/mortality; Pneumothorax/*etiology/mortality

--------
--------

## IV Vitamin C in Critically Ill Patients: A Systematic Review and Meta-Analysis.

3:e304-e312. DOI:10.1097/CCM.0000000000005320

Abstract: 

OBJECTIVES: To conduct a systematic review and meta-analysis to evaluate the impact of IV vitamin C on outcomes in critically ill patients. 

DATA SOURCES:  Systematic search of MEDLINE, EMBASE, CINAHL, and the Cochrane Register of  Controlled Trials. 

STUDY SELECTION: Randomized controlled trials testing IV  vitamin C in critically ill patients. 

DATA ABSTRACTION: Two independent reviewers  abstracted patient characteristics, treatment details, and clinical outcomes.  

DATA SYNTHESIS: Fifteen studies involving 2,490 patients were identified.  Compared with placebo, IV vitamin C administration is associated with a trend  toward reduced overall mortality (relative risk, 0.87; 95% CI, 0.75-1.00; p =  0.06; test for heterogeneity I2 = 6%). High-dose IV vitamin C was associated with  a significant reduction in overall mortality (relative risk, 0.70; 95% CI,  0.52-0.96; p = 0.03), whereas low-dose IV vitamin C had no effect (relative risk,  0.94; 95% CI, 0.79-1.07; p = 0.46; test for subgroup differences, p = 0.14). IV  vitamin C monotherapy was associated with a significant reduction in overall  mortality (relative risk, 0.64; 95% CI, 0.49-0.83; p = 0.006), whereas there was  no effect with IV vitamin C combined therapy. No trial reported an increase in  adverse events related to IV vitamin C. 

CONCLUSIONS: IV vitamin C administration  appears safe and may be associated with a trend toward reduction in overall  mortality. High-dose IV vitamin C monotherapy may be associated with improved  overall mortality, and further randomized controlled trials are warranted.

## 危重病患者静脉注射维生素C：一项系统回顾和荟萃分析。

目的：实施一项系统性审查和荟萃分析，以评价IV维生素C对重症患者结局的影响。

数据来源：系统检索MEDLINE、EMBASE、CINAHL和Cochrane临床对照试验注册数据库。

研究选择：在重症患者中检验IV维生素C的随机对照试验。

数据摘要：两名独立的审查员摘录了患者特征、治疗细节和临床结局。

数据综合：确定了涉及2490例患者的15项研究。与安慰剂相比，IV维生素C给药与总死亡率降低的趋势相关（相对风险，0.87；95%CI，0.75-1.00；p = 0.06；异质性检验I2 = 6%）。高剂量IV维生素C与总死亡率显著降低相关（相对风险，0.70；95%CI，0.52-0.96；p = 0.03），而低剂量IV维生素C无影响（相对风险，0.94；95%CI，0.79-1.07；p = 0.46；亚组差异检验，p = 0.14）。IV维生素C单药治疗与总死亡率显著降低相关（相对风险，0.64；95%CI，0.49-0.83；p = 0.006），而IV维生素C联合治疗无影响。没有试验报告与IV维生素C相关的不良事件增加。

结论：IV维生素C给药似乎是安全的，并且可能与总死亡率降低的趋势有关。高剂量IV维生素C单药治疗可能与总死亡率改善相关，还需要进一步的随机对照试验。
关键词：Humans; Treatment Outcome; Dose-Response Relationship, Drug; Critical Illness/*therapy; Antioxidants/*therapeutic use; Ascorbic Acid/*therapeutic use; Sepsis/*drug therapy/mortality

--------
--------

## The Effectiveness of High-Flow Nasal Cannula in Coronavirus Disease 2019 Pneumonia: A Retrospective Cohort Study.

3:e253-e262. DOI:10.1097/CCM.0000000000005309

Abstract: 

OBJECTIVES: High-flow nasal cannula is widely used in acute hypoxemic respiratory failure due to coronavirus disease 2019, yet data regarding its effectiveness is  lacking. More evidence is needed to guide patient selection, timing of high-flow  nasal cannula initiation, and resource allocation. We aimed to assess time to  discharge and time to death in severe coronavirus disease 2019 in patients  treated with high-flow nasal cannula compared with matched controls. We also  evaluated the ability of the respiratory rate-oxygenation ratio to predict  progression to invasive mechanical ventilation. 

DESIGN: Time-dependent propensity  score matching was used to create pairs of individuals who were then analyzed in  a Cox proportional-hazards regression model to estimate high-flow nasal cannula's  effect on time to discharge and time to death. A secondary analysis excluded  high-flow nasal cannula patients intubated within 6 hours of admission. A Cox  proportional-hazards regression model was used to assess risk of invasive  mechanical ventilation among high-flow nasal cannula patients stratified by  respiratory rate-oxygenation. 

SETTING: The five hospitals of the Johns Hopkins  Health System. 

PATIENTS: All patients who were admitted with a  laboratory-confirmed diagnosis of coronavirus disease 2019 were eligible for  inclusion. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: High-flow nasal  cannula was associated with longer median time to discharge: 10.6 days  (interquartile range, 7.1-15.8 d) versus 7.8 days (interquartile range, 4.9-12.1  d). Respiratory rate-oxygenation index performed poorly in predicting ventilation  or death. In the primary analysis, there was no significant association between  high-flow nasal cannula and hazard of death (adjusted hazard ratio, 0.79; 95% CI,  0.57-1.09). Excluding patients intubated within 6 hours of admission, high-flow  nasal cannula was associated with reduced hazard of death (adjusted hazard ratio,  0.67; 95% CI, 0.45-0.99). 

CONCLUSIONS: Among unselected patients with severe  coronavirus disease 2019 pneumonia, high-flow nasal cannula was not associated  with a statistically significant reduction in hazard of death. However, in  patients not mechanically ventilated within 6 hours of admission, high-flow nasal  cannula was associated with a significantly reduced hazard of death.

## 高流量鼻导管在2019年冠状病毒病肺炎治疗中的有效性：一项回顾性队列研究。

目的：高流量鼻导管广泛用于2019年冠状病毒病引起的急性低氧性呼吸衰竭，但缺乏其有效性相关数据。需要更多的证据来指导患者选择、高流量鼻插管开始的时机和资源分配。我们旨在评估与匹配的对照组相比，接受高流量鼻插管治疗的患者在2019年重度冠状病毒疾病的出院时间和至死亡时间。我们还评估了呼吸频率-氧合比预测有创机械通气进展的能力。

设计：使用时间依赖性倾向评分匹配创建成对个体，然后在Cox比例风险回归模型中进行分析，以估计高流量鼻插管对出院时间和至死亡时间的影响。次要分析排除了入院6小时内接受插管的高流量鼻插管患者。使用Cox比例风险回归模型评估高流量鼻插管患者中有创机械通气的风险，患者按呼吸频率-氧合进行分层。

单位：约翰霍普金斯卫生系统的5家医院。

患者：所有2019年经实验室确诊为冠状病毒病的患者均有资格入选。

干预：无。

测量值和主要结果：高流量鼻插管与较长的中位出院时间相关：10.6天（四分位距，7.1-15.8天）对比7.8天（四分位距，4.9-12.1天）。呼吸频率-氧合指数在预测通气或死亡方面表现不佳。在主要分析中，高流量鼻插管与死亡风险之间无显著相关性（校正的风险比，0.79；95%CI，0.57-1.09）。排除入院6小时内接受插管的患者，高流量鼻插管与死亡风险降低相关（调整后风险比，0.67；95%CI，0.45-0）。99).结论：在未选择的2019年重症冠状病毒病肺炎患者中，高流量鼻插管与死亡风险统计学显著降低无关。但是，在入院6小时内未接受机械通气的患者中，高流量鼻插管与死亡风险显著降低相关。
关键词：Humans; Female; Male; Middle Aged; Time Factors; Aged; Length of Stay; Retrospective Studies; Equipment Design; SARS-CoV-2; Patient Selection; Proportional Hazards Models; Respiratory Rate; COVID-19/mortality/*therapy; Cannula/*classification

--------
--------

## Routine Neuroimaging: Understanding Brain Injury in Pediatric Extracorporeal Membrane Oxygenation.

3:480-490. DOI:10.1097/CCM.0000000000005308

Abstract: 

OBJECTIVES: This project aims to describe brain injuries on routine neuroimaging in a large single-center neonatal and pediatric cohort supported by  extracorporeal membrane oxygenation. The study also aims to examine the  association of these injuries with neurocognitive outcomes in survivors and  identify laboratory findings associated with neurologic injury. 

DESIGN:  Retrospective observational single-center cohort study. 

SETTING: Tertiary care  PICU. 

PATIENTS: Pediatric patients with noncardiac indications for extracorporeal  membrane oxygenation supported by venoarterial or venovenous extracorporeal  membrane oxygenation, with on-extracorporeal membrane oxygenation brain CT or  postextracorporeal membrane oxygenation brain CT/MRI. 

INTERVENTIONS:  Extracorporeal membrane oxygenation support. 

MEASUREMENTS AND MAIN RESULTS:  Occurrence of brain injury on CT and MRI was reviewed; injuries were scored.  Clinical and laboratory results associated with injury were identified. Survivor  neurocognitive outcomes were obtained using the Pediatric Overall Performance  Category scale and Pediatric Cerebral Performance Category scale. Of 132 imaged  patients, 98 (74%) had radiological evidence of brain injury. Mean injury score  was 6.5 (?± 3.8). Head ultrasounds and clinician suspicion performed poorly in  suspecting the presence of injury. Of 104 respondents to neurodevelopmental  assessments, 61 (59%) had normal scores; 12.5%, 17%, and 11.5% had mild,  moderate, or severe disability. A neuroimaging score greater than 10 was  associated with an unfavorable outcome on the Pediatric Cerebral Performance  Category (odds ratio, 3.4; p < 0.01) and Pediatric Overall Performance Category  (odds ratio, 1.7; p < 0.05). Ischemic injury correlated with worse  neurodevelopmental outcome. Preextracorporeal membrane oxygenation lactate,  Vasoactive-Inotropic Scores, transaminitis, elevated bilirubin and creatinine  levels, and thrombocytopenia were associated with injury occurrence. 

CONCLUSIONS:  Brain injury is frequent in extracorporeal membrane oxygenation patients,  although the majority of survivors have favorable neurocognitive outcomes. More  research is needed in order to understand the etiology of such injuries. Head  ultrasound and clinician suspicion are not sensitive in detecting extracorporeal  membrane oxygenation-related brain injuries. Protocolizing postextracorporeal  membrane oxygenation imaging with brain MRI allows the identification of injuries  and provision of timely neurocognitive intervention.

## 常规神经影像学：了解儿童体外膜肺氧合中的脑损伤。

目的：本项目旨在描述由体外膜肺氧合支持的大型单中心新生儿和儿科队列中常规神经影像学的脑损伤。本研究的目的还包括检查这些损伤与幸存者神经认知结果的相关性，并确定与神经损伤相关的实验室结果。

设计：回顾性观察性单中心队列研究。

单位：三级监护PICU。

患者：采用静脉-动脉或静脉-静脉体外膜氧合支持进行体外膜氧合的非心脏适应症儿科患者，进行体外膜氧合脑部CT或体外膜氧合后脑部CT/MRI。

干预：体外膜肺氧合支持。

测量和主要结果：审查CT和MRI的脑损伤发生率；对损伤进行评分。确定了与损伤相关的临床和实验室结果。使用儿科整体性能分类量表和儿科大脑性能分类量表获得存活者神经认知结局。在132例成像患者中，98例(74%)有脑损伤的放射学证据。平均损伤评分为6.5(?±3.8)。头部超声和临床医生怀疑其表现不佳，怀疑存在损伤。在104名神经发育评估的应答者中，61名(59%)评分正常；12.5%、17%和11.5%有轻度、中度或重度残疾。神经影像学评分大于10与儿童大脑功能分类（比值比，3.4；p < 0.01）和儿童整体功能分类（比值比，1.7；p < 0.05）的不良结局相关。缺血性损伤与较差的神经发育结局相关。体外膜氧合乳酸、血管活性药物评分、转氨酶、胆红素和肌酐水平升高以及血小板减少与损伤发生相关。

结论：虽然大多数存活者有良好的神经认知结局，但脑损伤在体外膜肺氧合患者中较为常见。需要更多的研究来了解这种损伤的病因。头部超声和临床医生怀疑对检测体外膜氧合相关脑损伤不敏感。脑MRI的程序化体外膜氧合后成像允许识别损伤并提供及时的神经认知干预。
关键词：Humans; Female; Male; Prognosis; Cohort Studies; Adolescent; Retrospective Studies; Child; Infant, Newborn; *Intensive Care Units, Pediatric; *Severity of Illness Index; Brain Injuries/*diagnosis/*etiology; Extracorporeal Membrane Oxygenation/*adverse effects; Intracranial Hemorrhages/diagnosis/etiology

--------
--------

## Coronavirus Disease 2019 Tracheostomy Candidacy, Ceteris Paribus Assumptions, and Tracking Survivorship Data.

3:e320-e321. DOI:10.1097/CCM.0000000000005338

## Coronavirus Disease 2019气管造口术候选资格、Ceteris Paribus假设和追踪生存率数据。
关键词：Humans; *COVID-19; SARS-CoV-2; *Tracheostomy; Survivorship

--------
--------

## Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial., Tom, Jennifer

3:398-409. DOI:10.1097/CCM.0000000000005229

Abstract: 

OBJECTIVES: To explore candidate prognostic and predictive biomarkers identified in retrospective observational studies (interleukin-6, C-reactive protein,  lactate dehydrogenase, ferritin, lymphocytes, monocytes, neutrophils, d-dimer,  and platelets) in patients with coronavirus disease 2019 pneumonia after  treatment with tocilizumab, an anti-interleukin-6 receptor antibody, using data  from the COVACTA trial in patients hospitalized with severe coronavirus disease  2019 pneumonia. 

DESIGN: Exploratory analysis from a multicenter, randomized,  double-blind, placebo-controlled, phase 3 trial. 

SETTING: Hospitals in North  America and Europe. 

PATIENTS: Adults hospitalized with severe coronavirus disease  2019 pneumonia receiving standard care. 

INTERVENTION: Randomly assigned 2:1 to IV  tocilizumab 8 mg/kg or placebo. 

MEASUREMENTS AND MAIN RESULTS: Candidate  biomarkers were measured in 295 patients in the tocilizumab arm and 142 patients  in the placebo arm. Efficacy outcomes assessed were clinical status on a  seven-category ordinal scale (1, discharge; 7, death), mortality, time to  hospital discharge, and mechanical ventilation (if not receiving it at  randomization) through day 28. Prognostic and predictive biomarkers were  evaluated continuously with proportional odds, binomial or Fine-Gray models, and  additional sensitivity analyses. Modeling in the placebo arm showed all candidate  biomarkers except lactate dehydrogenase and d-dimer were strongly prognostic for  day 28 clinical outcomes of mortality, mechanical ventilation, clinical status,  and time to hospital discharge. Modeling in the tocilizumab arm showed a  predictive value of ferritin for day 28 clinical outcomes of mortality  (predictive interaction, p = 0.03), mechanical ventilation (predictive  interaction, p = 0.01), and clinical status (predictive interaction, p = 0.02)  compared with placebo. 

CONCLUSIONS: Multiple biomarkers prognostic for clinical  outcomes were confirmed in COVACTA. Ferritin was identified as a predictive  biomarker for the effects of tocilizumab in the COVACTA patient population; high  ferritin levels were associated with better clinical outcomes for tocilizumab  compared with placebo at day 28.

## 2019年在一项随机对照试验中接受托珠单抗治疗的冠状病毒疾病患者的预后和预测生物标志物。

目的：探索在回顾性观察性研究（白细胞介素-6、C-反应蛋白、乳酸脱氢酶、铁蛋白、淋巴细胞、单核细胞、中性粒细胞、d-二聚体和血小板）中鉴别的冠状病毒病2019年肺炎患者在接受抗白细胞介素-6受体抗体托珠单抗治疗后的候选预后和预测性生物标志物，使用在2019年因重症冠状病毒病肺炎住院的患者中进行的COVACTA试验的数据。

设计：一项多中心、随机化、双盲、安慰剂对照、iii期试验的探索性分析。

设置：北美和欧洲的医院。

患者：2019年住院治疗重症冠状病毒病的肺炎成人患者，接受标准治疗。

干预：以2:1的比例随机分配至托珠单抗8 mg/kg IV组或安慰剂组。

测量和主要结果：在tocilizumab组295例患者和安慰剂组142例患者中测量了候选生物标志物。评估的有效性结局为7类序数量表（1，出院；7，死亡）上的临床状态、死亡率、出院时间和机械通气（如果随机化时未接受）至第28天。使用比例优势、二项式或Fine-Gray模型以及额外的敏感性分析，对预后和预测性生物标志物进行连续评估。安慰剂组建模显示，除乳酸脱氢酶和d-二聚体外，所有候选生物标志物对第28天死亡率、机械通气、临床状态和出院时间等临床结局具有强预后性。与安慰剂相比，托珠单抗组的建模显示铁蛋白对第28天死亡率（预测性相互作用，p = 0.03）、机械通气（预测性相互作用，p = 0.01）和临床状态（预测性相互作用，p = 0.02）的临床结局具有预测价值。

结论：COVACTA研究证实了多个临床结局预后生物标志物。铁蛋白被确定为COVACTA患者人群中托珠单抗作用的预测性生物标志物；在第28天，与安慰剂相比，铁蛋白水平较高与托珠单抗更好的临床结局相关。
关键词：Humans; Female; Male; Prognosis; Double-Blind Method; Length of Stay; Respiration, Artificial; Biomarkers; SARS-CoV-2; Inflammation Mediators/metabolism; Patient Discharge; Antibodies, Monoclonal, Humanized/administration & dosage/adverse effects/*therapeutic use; COVID-19/*drug therapy/*epidemiology/mortality

--------
--------

## Single Nucleotide Variant in FAS Associates With Organ Failure and Soluble Fas Cell Surface Death Receptor in Critical Illness.

3:e284-e293. DOI:10.1097/CCM.0000000000005333

Abstract: 

OBJECTIVES: Multiple organ failure in critically ill patients is associated with poor prognosis, but biomarkers contributory to pathogenesis are unknown. Previous  studies support a role for Fas cell surface death receptor (Fas)-mediated  apoptosis in organ dysfunction. Our objectives were to test for associations  between soluble Fas and multiple organ failure, identify protein quantitative  trait loci, and determine associations between genetic variants and multiple  organ failure. 

DESIGN: Retrospective observational cohort study. 

SETTING: Four  academic ICUs at U.S. hospitals. 

PATIENTS: Genetic analyses were completed in a  discovery (n = 1,589) and validation set (n = 863). Fas gene expression and flow  cytometry studies were completed in outpatient research participants (n = 250).  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: In discovery and validation  sets of critically ill patients, we tested for associations between enrollment  plasma soluble Fas concentrations and Sequential Organ Failure Assessment score  on day 3. We conducted a genome-wide association study of plasma soluble Fas  (discovery n = 1,042) and carried forward a single nucleotide variant in the FAS  gene, rs982764, for validation (n = 863). We further tested whether the single  nucleotide variant in FAS (rs982764) was associated with Sequential Organ Failure  Assessment score, FAS transcriptional isoforms, and Fas cell surface expression.  Higher plasma soluble Fas was associated with higher day 3 Sequential Organ  Failure Assessment scores in both the discovery (?? = 4.07; p < 0.001) and  validation (?? = 6.96; p < 0.001) sets. A single nucleotide variant in FAS  (rs982764G) was associated with lower plasma soluble Fas concentrations and lower  day 3 Sequential Organ Failure Assessment score in meta-analysis (-0.21; p =  0.02). Single nucleotide variant rs982764G was also associated with a lower  relative expression of the transcript for soluble as opposed to transmembrane Fas  and higher cell surface expression of Fas on CD4+ T cells. 

CONCLUSIONS: We found  that single nucleotide variant rs982764G was associated with lower plasma soluble  Fas concentrations in a discovery and validation population, and single  nucleotide variant rs982764G was also associated with lower organ dysfunction on  day 3. These findings support further study of the Fas pathway as a potential  mediator of organ dysfunction in critically ill patients.

## 危重症患者中与器官衰竭和可溶性FAS细胞表面死亡受体相关的FAS中的单核苷酸变异。

目的：重症患者的多器官功能衰竭与预后不良相关，但发病机制的生物标志物未知。既往研究支持Fas细胞表面死亡受体(Fas)介导的细胞凋亡在器官功能障碍中的作用。我们的目的是检测可溶性Fas与多器官衰竭之间的相关性，确定蛋白质数量性状位点，并确定遗传变异体与多器官衰竭之间的相关性。

设计：回顾性观察性队列研究。

单位：美国医院4间学术ICU。

患者：在一个发现(n = 1,589)和验证集(n = 863)中完成了遗传分析。在门诊研究参与者(n = 250)中完成了Fas基因表达和流式细胞术研究。

干预：无。

测量和主要结果：在危重患者的发现和验证组中，我们在第3天检测了入组血浆可溶性Fas浓度和序贯器官衰竭评估评分之间的相关性。我们进行了血浆可溶性Fas的全基因组关联研究（发现n = 1，042），并在FAS基因中结转一个单核苷酸变异体rs982764进行验证(n = 863)。我们进一步检测了FAS(rs982764)中的单核苷酸变异是否与序贯器官衰竭评估评分、FAS转录亚型和FAS细胞表面表达相关。血浆可溶性Fas水平较高与第3天序贯器官衰竭评估评分较高相关，无论是发现组(?? = 4.07；p < 0.001)还是验证组(?? = 6.96；p < 0.001)。在荟萃分析中，FAS中的单核苷酸变异体(rs982764G)与血浆可溶性FAS浓度降低和第3天序贯器官衰竭评估评分降低相关(-0.21；p = 0.02)。单核苷酸变异体rs982764G也与可溶性转录本相对表达较低（与跨膜Fas相反）和CD4 + T细胞上Fas的细胞表面表达较高相关。

结论：我们发现单核苷酸变异体rs982764G与发现和验证人群中较低的血浆可溶性Fas浓度相关，并且单核苷酸变异体rs982764G也与第3天的下器官功能障碍有关。这些发现支持进一步研究Fas通路作为危重患者器官功能障碍的潜在介质。
关键词：Humans; Female; Male; Middle Aged; Aged; Intensive Care Units; Adult; Biomarkers; Apoptosis; Genotype; Critical Illness/*epidemiology; fas Receptor/blood/*genetics; Genome-Wide Association Study; Multiple Organ Failure/blood/*epidemiology; Organ Dysfunction Scores; Polymorphism, Single Nucleotide

--------
--------

## Neuromuscular Blocker Use in Critically Ill Children: Assessing Mortality Risk by Propensity Score-Weighted Analysis.

3:e294-e303. DOI:10.1097/CCM.0000000000005334

Abstract: 

OBJECTIVES: We aim to describe the use of continuous infusion of neuromuscular blocking agents in mechanically ventilated critically ill children and to test  its association with in-hospital mortality. 

DESIGN: Multicenter, registry-based,  observational, two-cohort-comparison retrospective study using prospectively  collected data from a web-based national registry. 

SETTING: Seventeen PICUs in  Italy. 

PATIENTS: We included children less than 18 years who received mechanical  ventilation and a neuromuscular blocking agent infusion from January 2010 to  October 2017. A propensity score-weighted Cox regression analysis was used to  assess the relationship between the use of neuromuscular blocking agents and  in-hospital mortality. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Of the  23,227 patients admitted to the PICUs during the study period, 3,823 patients  were included. Patients who received a continuous infusion of neuromuscular  blocking agent were more likely to be younger (p < 0.001), ex-premature (p <  0.001), and presenting with less chronic respiratory insufficiency requiring home  mechanical ventilation (p < 0.001). Reasons for mechanical ventilation  significantly differed between patients who received a continuous infusion of  neuromuscular blocking agent and patients who did not receive a continuous  infusion of neuromuscular blocking agent, with a higher frequency of respiratory  and cardiac diagnosis among patients who received neuromuscular blocking agents  compared with other diagnoses (all p < 0.001). The covariates were well balanced  in the propensity-weighted cohort. The mortality rate significantly differed  among the two cohorts (patients who received a continuous infusion of  neuromuscular blocking agent 21% vs patients who did not receive a continuous  infusion of neuromuscular blocking agent 11%; p < 0.001 by weighted logistic  regression). Patients who received a continuous infusion of neuromuscular  blocking agent experienced longer mechanical ventilation and PICU stay (both p <  0.001 by weighted logistic regression). A weighted Cox regression analysis found  the use of neuromuscular blocking agents to be a significant predictor of  in-hospital mortality both in the unadjusted analysis (hazard ratio, 1.7; 95% CI,  1.3-2.2) and in the adjusted one (hazard ratio, 1.6; 95% CI, 1.2-2.1).  

CONCLUSIONS: Thirteen percent of mechanically ventilated children in PICUs  received neuromuscular blocking agents. When adjusting for selection bias with a  propensity score approach, the use of neuromuscular blocking agent was found to  be a significant predictor of in-hospital mortality.

## 神经肌肉阻滞剂在危重病儿童中的使用：通过倾向评分加权分析评估死亡风险。

目的：我们的目的是描述在机械通气的重症儿童中持续输注神经肌肉阻滞剂的使用，并检测其与住院死亡率的相关性。

设计：采用基于网络的国家登记研究中前瞻性收集的数据进行的多中心、基于登记研究、观察性、两队列比较回顾性研究。

设置：意大利17家PICU。

患者：我们纳入了2010年1月至2017年10月接受机械通气和神经肌肉阻滞剂输注的18岁以下儿童。倾向评分加权Cox回归分析用于评估神经肌肉阻滞剂的使用与住院死亡率之间的关系。

干预：无。

测量和主要结果：在研究期间入住PICU的23,227例患者中，3,823例患者入组。接受神经肌肉阻滞剂连续输注的患者更可能更年轻(p < 0.001)、早早(p < 0.001)，并且表现出需要家庭机械通气的慢性呼吸功能不全更少(p < 0.001)。接受神经肌肉阻滞剂连续输注的患者与未接受神经肌肉阻滞剂连续输注的患者之间，机械通气的原因显著不同，与其他诊断相比，接受神经肌肉阻滞剂的患者中呼吸和心脏诊断的频率更高（所有p < 0.001）。倾向加权队列中的协变量平衡良好。两个队列的死亡率显著不同（持续输注神经肌肉阻滞剂的患者是21%，没有持续输注神经肌肉阻滞剂的患者是11%；加权logistic回归分析p < 0.001）。持续输注神经肌肉阻滞剂的患者经历了更长的机械通气和PICU停留时间（加权logistic回归均为p < 0.001）。加权Cox回归分析发现，在未调整的分析（风险比1.7；95%CI 1.3-2.2）和调整的分析（风险比1.6；95%CI 1.2-2.1）中，神经肌肉阻滞剂的使用是住院死亡率的显著预测因素。

结论：PICU中13%的机械通气儿童接受了神经肌肉阻滞剂。当用倾向评分方法调整选择偏倚时，发现使用神经肌肉阻滞剂是住院死亡率的显著预测因素。
关键词：Hemodynamics; Humans; Male; Cohort Studies; Propensity Score; Adolescent; Retrospective Studies; Child; Child, Preschool; Critical Illness/*therapy; Italy; Respiration, Artificial/*methods; Neuromuscular Blocking Agents/*therapeutic use; Respiratory Distress Syndrome/*drug therapy/mortality

--------
--------

## Electrical Impedance Tomography Monitoring of Bronchoalveolar Lavage in Patients With Acute Respiratory Distress Syndrome., Franchineau, Guillaume

3:e231-e240. DOI:10.1097/CCM.0000000000005302

Abstract: 

OBJECTIVES: The impact of bronchoalveolar lavage on regional ventilation in mechanically ventilated patients with acute respiratory distress syndrome has  rarely been described. Our objectives were use electrical impedance tomography to  describe lung impedance variation post bronchoalveolar lavage and identify  morphologic patterns according to respiratory failure severity. 

DESIGN:  Monocenter physiologic study on mechanically ventilated patients. 

SETTING:  University medical ICU. 

INTERVENTIONS: After a recruitment maneuver, tidal  impedance variation distributions (a surrogate for impact of bronchoalveolar  lavage on tidal volume distribution), end-expiratory lung impedance (correlated  with end-expiratory lung volume and used to quantify postbronchoalveolar lavage  derecruitment), respiratory mechanics, and blood gases were recorded before and  over 6 hours post bronchoalveolar lavage with Pao2 to the Fio2 ratio. Patients  were grouped according to their prebronchoalveolar lavage, that is, Pao2 to the  Fio2 ratio less than 200 or greater than or equal to 200. 

RESULTS: Twenty-one  patients (median [interquartile range] age 55 yr [50-58 yr]; 13 males), 13 with  Pao2 to the Fio2 ratio less than 200, were included. Unlike that latter group,  bronchoalveolar lavage significantly impacted tidal impedance variation  distribution in patients with Pao2 to the Fio2 ratio greater than or equal to  200, with a ventilation shift to the contralateral lung (from 54% to 42% in the  bronchoalveolar lavage side), which persisted up to 6 hours post bronchoalveolar  lavage. Similarly, end-expiratory lung impedance was less distributed in the  bronchoalveolar lavage side post procedure of patients with Pao2 to the Fio2  ratio greater than or equal to 200, but the difference did not reach statistical  significance (p = 0.09). As reported for tidal impedance variation,  end-expiratory lung impedance distribution in patients with severe or moderate  acute respiratory distress syndrome did not change significantly during the 6  hours post bronchoalveolar lavage. Although bronchoalveolar lavage effects on gas  exchanges were minor in all patients, static compliance in patients with Pao2 to  the Fio2 ratio greater than or equal to 200 was significantly lower post  bronchoalveolar lavage (p = 0.04). 

CONCLUSIONS: The negative impact of  bronchoalveolar lavage on regional ventilation, which persisted at least 6 hours,  appeared to be more profound in patients with normal lung function or mild acute  respiratory distress syndrome. In contrast, regional ventilation, lung  recruitment, respiratory mechanics, and gas exchanges were modestly impacted by  the bronchoalveolar lavage in patients with severe or moderate acute respiratory  distress syndrome. That finding is reassuring and supports not summarily  proscribing bronchoalveolar lavage for the most severely ill with acute  respiratory distress syndrome.

## 电阻抗断层成像监测急性呼吸窘迫综合征患者的支气管肺泡灌洗。

目的：在急性呼吸窘迫综合征的机械通气患者中，很少描述支气管肺泡灌洗对局部通气的影响。我们的目的是使用电阻抗断层扫描来描述支气管肺泡灌洗后的肺阻抗变化，并根据呼吸衰竭的严重程度确定形态学模式。

设计：机械通气患者的单中心生理学研究。

单位：大学医学中心。

干预：复张操作后，潮气阻抗变化分布（支气管肺泡灌洗对潮气量分布影响的替代指标），呼气末肺阻抗（与呼气末肺容量相关，并用于定量支气管肺泡灌洗后呼吸力学），在使用Pao2/Fio2比率进行支气管肺泡灌洗之前和之后6小时，记录血气。根据患者的支气管肺泡灌洗术前情况进行分组，即Pao2与Fio2的比值小于200或大于等于200。

结果：纳入21例患者（中位[四分位距]年龄55岁[50-58岁]；13例男性），13例Pao2与Fio2比值小于200。与后一组不同，支气管肺泡灌洗显著影响Pao2与Fio2比值大于或等于200的患者的潮气阻抗变化分布，通气转移至对侧肺（支气管肺泡灌洗侧从54%至42%），其持续至支气管肺泡灌洗后6小时。同样，在Pao2与Fio2比率大于或等于200的患者中，呼气末肺阻抗在术后支气管肺泡灌洗侧的分布较少，但差异未达到统计学显著性(p = 0.09)。根据潮气阻抗变化的报告，重度或中度急性呼吸窘迫综合征患者的呼气末肺阻抗分布在支气管肺泡灌洗后6小时期间无显著变化。尽管在所有患者中，支气管肺泡灌洗对气体交换的影响较小，但在支气管肺泡灌洗后，Pao2与Fio2比率大于或等于200的患者的静态依从性显著较低(p = 0.04)。

结论：在肺功能正常或轻度急性呼吸窘迫综合征患者中，至少持续6小时的支气管肺泡灌洗对局部通气的负面影响似乎更明显。相比之下，在重度或中度急性呼吸窘迫综合征患者中，支气管肺泡灌洗中度影响了局部通气、肺复张、呼吸力学和气体交换。该结果是可靠的，并支持对急性呼吸窘迫综合征最严重的患者不立即禁止支气管肺泡灌洗。
关键词：Humans; Male; Middle Aged; Monitoring, Physiologic/methods; Respiratory Function Tests; *Electric Impedance; Bronchoalveolar Lavage/*methods; Respiratory Distress Syndrome/*diagnostic imaging/*therapy; Respiratory Mechanics

--------
--------

## Epidemiology and Outcomes of Critically Ill Children at Risk for Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome  Incidence and Epidemiology Study.

3:363-374. DOI:10.1097/CCM.0000000000005287

Abstract: 

OBJECTIVES: Interventional trials aimed at pediatric acute respiratory distress syndrome prevention require accurate identification of high-risk patients. In  this study, we aimed to characterize the frequency and outcomes of children  meeting "at risk for pediatric acute respiratory distress syndrome" criteria as  defined by the Pediatric Acute Lung Injury Consensus Conference. 

DESIGN: Planned  substudy of the prospective multicenter, international Pediatric Acute  Respiratory Distress Syndrome Incidence and Epidemiology study conducted during  10 nonconsecutive weeks (May 2016-June 2017). 

SETTING: Thirty-seven international  PICUs. 

PATIENTS: Three-hundred ten critically ill children meeting Pediatric  Acute Lung Injury Consensus Conference "at-risk for pediatric acute respiratory  distress syndrome" criteria. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS:  We evaluated the frequency of children at risk for pediatric acute respiratory  distress syndrome and rate of subsequent pediatric acute respiratory distress  syndrome diagnosis and used multivariable logistic regression to identify factors  associated with subsequent pediatric acute respiratory distress syndrome.  Frequency of at risk for pediatric acute respiratory distress syndrome was 3.8%  (95% CI, 3.4-5.2%) among the 8,122 critically ill children who were screened and  5.8% (95% CI, 5.2-6.4%) among the 5,334 screened children on positive pressure  ventilation or high-flow oxygen. Among the 310 at-risk children, median age was  2.1 years (interquartile range, 0.5-7.3 yr). Sixty-six children (21.3%) were  subsequently diagnosed with pediatric acute respiratory distress syndrome, a  median of 22.6 hours (interquartile range, 9.8-41.0 hr) later. Subsequent  pediatric acute respiratory distress syndrome was associated with increased  mortality (21.2% vs 3.3%; p < 0.001) and longer durations of invasive ventilation  and PICU care. Subsequent pediatric acute respiratory distress syndrome rate did  not differ by respiratory support modality at the time of meeting at risk  criteria but was independently associated with lower initial saturation:Fio2  ratio, progressive tachycardia, and early diuretic administration. 

CONCLUSIONS:  The Pediatric Acute Lung Injury Consensus Conference "at-risk for pediatric acute  respiratory distress syndrome" criteria identify critically ill children at high  risk of pediatric acute respiratory distress syndrome and poor outcomes.  Interventional trials aimed at pediatric acute respiratory distress syndrome  prevention should target patients early in their illness course and include  patients on high-flow oxygen and positive pressure ventilation.

## 具有儿科急性呼吸窘迫综合征风险的危重患儿的流行病学和结局：一项儿科急性呼吸窘迫综合征发病率和流行病学研究。

目的：旨在预防儿科急性呼吸窘迫综合征的干预性试验需要准确识别高危患者。在本研究中，我们旨在描述符合儿科急性肺损伤共识会议定义的“儿科急性呼吸窘迫综合征风险”标准的儿童的频率和结局。

设计：前瞻性、多中心、国际儿科急性呼吸窘迫综合征发病率和流行病学研究的计划子研究，在非连续10周内进行（2016年5月2017年6月）。

设置：37个国际PICU。

患者：符合儿科急性肺损伤共识会议“儿科急性呼吸窘迫综合征高危”标准的310例重症儿童。

干预：无。

测量和主要结果：我们评估了有急性呼吸窘迫综合征风险的儿童的频率和随后的儿科急性呼吸窘迫综合征的确诊率，并使用多变量logistic回归来确定与随后的儿科急性呼吸窘迫综合征相关的因素。在接受筛选的8,122例重症儿童中，发生急性呼吸窘迫综合征风险的频率为3.8%(95%CI,3.4-5.2%)，在接受正压通气或高流量氧治疗的5,334例接受筛选的儿童中，发生急性呼吸窘迫综合征风险的频率为5.8%(95%CI,5.2-6.4%)。310例高危儿童的中位年龄为2.1岁（四分位距：0.5-7.3岁）。66名儿童(21.3%)随后被诊断为急性呼吸窘迫综合征，中位时间22.6h（四分位距9.8-41.0 h）。后续的儿科急性呼吸窘迫综合征与死亡率增加（21.2%与3.3%；p < 0.001）以及有创通气和PICU护理的持续时间更长相关。随后的儿科急性呼吸窘迫综合征发生率在符合风险标准时通过呼吸支持方式无差异，但与较低的初始饱和度独立相关：Fio2比率、进展性心动过速和早期利尿剂给药。

结论：儿科急性肺损伤共识会议“儿科急性呼吸窘迫综合征高危”标准确定了儿科急性呼吸窘迫综合征高风险和不良结局的危重儿童。旨在预防儿科急性呼吸窘迫综合征的干预性试验应针对病程早期的患者，并纳入接受高流量氧气和正压通气的患者。
关键词：Humans; Female; Male; Prospective Studies; Time Factors; Adolescent; Child; Outcome Assessment, Health Care; Child, Preschool; *Intensive Care Units, Pediatric; Acute Lung Injury/epidemiology/therapy; Critical Illness/mortality/*therapy; Respiration, Artificial/statistics & numerical data; Respiratory Distress Syndrome/*epidemiology/*therapy

--------
--------

## Effect of a Multicomponent Sepsis Transition and Recovery Program on Mortality and Readmissions After Sepsis: The Improving Morbidity During Post-Acute Care  Transitions for Sepsis Randomized Clinical Trial., Taylor, Stephanie Parks

3:469-479. DOI:10.1097/CCM.0000000000005300

Abstract: 

OBJECTIVES: To evaluate whether a nurse navigator-led, multicomponent Sepsis Transition And Recovery program improves 30-day mortality and readmission  outcomes after sepsis hospitalization. 

DESIG: n: Multisite pragmatic randomized  clinical trial. 

SETTING: Three hospitals in North Carolina from January 2019 to  March 2020. 

PATIENTS: Eligible patients hospitalized for suspected sepsis and  deemed high-risk for mortality or readmission by validated internal risk models.  

INTERVENTIONS: Patients were randomized to receive usual care alone (i.e.,  routine transition support, outpatient care; n = 342) or additional Sepsis  Transition And Recovery support (n = 349). The 30-day intervention involved a  multicomponent transition service led by a nurse navigator through telephone and  electronic health record communication to facilitate best practice postsepsis  care strategies during and after hospitalization including: postdischarge  medication review, evaluation for new impairments or symptoms, monitoring  comorbidities, and palliative care approach when appropriate. Clinical oversight  was provided by a Hospital Medicine Transition Services team. 

MEASUREMENTS AND  MAIN RESULTS: The primary outcome was a composite of mortality or hospital  readmission at 30 days. Logistic regression models were constructed to evaluate  marginal and conditional odds ratios (adjusted for prognostic covariates: age,  comorbidity, and organ dysfunction at enrollment). Among 691 randomized patients  (mean age = 63.7 ?± 15.1 yr; 52% female), a lower percentage of patients in the  Sepsis Transition And Recovery group experienced the primary outcome compared  with the usual care group (28.7% vs 33.3%; risk difference, 4.7%; odds ratio,  0.80; 95% CI, 0.58-1.11; adjusted odds ratio, 0.80; 95% CI, 0.64-0.98). There  were 74 deaths (Sepsis Transition And Recovery: 33 [9.5%] vs usual care: 41  [12.0%]) and 155 rehospitalizations (Sepsis Transition And Recovery: 71 [20.3%]  vs usual care: 84 [24.6%]). 

CONCLUSIONS: In a multisite randomized clinical trial  of patients hospitalized with sepsis, patients provided with a 30-day program  using a nurse navigator to provide best practices for postsepsis care experienced  a lower proportion of either mortality or rehospitalization within 30 days after  discharge. Further research is needed to understand the contextual factors  associated with successful implementation.

## 多组分败血症转换和恢复项目对败血症后死亡率和再入院的影响：败血症急性治疗后转换期间发病率的改善：随机临床试验。

目的：评估护士导航员主导的多组分脓毒症转换和恢复项目是否改善脓毒症住院后30天死亡率和再入院结局。

设计：n：多中心实用随机临床试验。

地点：2019年1月至2020年3月，北卡罗莱纳州的三家医院。

患者：因疑似败血症住院的合格患者，通过验证的内部风险模型确定为死亡或再入院的高风险。

干预：患者随机接受单独常规护理（即，常规过渡支持，门诊护理；n = 342）或额外的败血症过渡和恢复支持(n = 349)。30天干预涉及由护士领航员通过电话和电子健康记录通信进行的多组分转换服务，以促进住院期间和住院后最佳实践败血症后护理策略，包括：出院后药物审查，新损伤或症状评价，监测合并症，以及适当的姑息治疗方法。由医院医学过渡服务团队进行临床监督。

测量和主要结果：主要结局是30天时死亡率或再入院率的复合终点。构建Logistic回归模型，评价边际和条件比值比（根据预后协变量调整：入组时年龄、合并症和器官功能障碍）。691例随机化患者（平均年龄为63.7±15.1岁；52%为女性）中，与常规治疗组相比，败血症转化和恢复组出现主要结局的患者百分比较低（28.7%vs 33.3%；风险差异，4.7%；比值比，0.80；95%CI，0.58-1.11；调整后比值比，0.80；95%CI，0.64-0.98）。有74例死亡（败血症转化和恢复：33例[9.5%]与常规护理：41例[12.0%]）和155例再次住院（败血症转化和恢复：71例[20.3%]与常规护理：84例[24.6%]）.结论：在一项对因败血症住院患者进行的多中心随机临床试验中，为败血症后护理提供最佳实践的患者提供30天程序，患者出院后30天内死亡或再次住院的比例较低。需要进一步研究以了解与成功实施相关的背景因素。
关键词：Humans; Female; Male; Middle Aged; Aged; Emergency Service, Hospital; Risk Factors; Outcome Assessment, Health Care; Aftercare/*statistics & numerical data; Patient Discharge/*statistics & numerical data; Patient Readmission/*statistics & numerical data; Sepsis/*nursing/*rehabilitation; Transitional Care/*statistics & numerical data

--------
--------

## Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in  the United States, 2012-2019.

3:460-468. DOI:10.1097/CCM.0000000000005298

Abstract: 

OBJECTIVES: Multiple randomized controlled trials exploring the outcomes of patients with ventilator-associated bacterial pneumonia and hospital-acquired  bacterial pneumonia have noted that hospital-acquired bacterial pneumonia  patients who require subsequent ventilated hospital-acquired bacterial pneumonia  suffered higher mortality than either those who did not (nonventilated  hospital-acquired bacterial pneumonia) or had ventilator-associated bacterial  pneumonia. We examined the epidemiology and outcomes of all three conditions in a  large U.S. database. 

DESIGN: Retrospective cohort. 

SETTING: Two hundred  fifty-three acute-care hospitals, United States, contributing data (including  microbiology) to Premier database, 2012-2019. 

PATIENTS: Patients with  hospital-acquired bacterial pneumonia or ventilator-associated bacterial  pneumonia identified based on a slightly modified previously published  International Classification of Diseases, 9th Edition/International  Classification of Diseases, 10th Edition-Clinical Modification algorithm.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Among 17,819 patients who met  enrollment criteria, 26.5% had nonventilated hospital-acquired bacterial  pneumonia, 25.6% vHAPB, and 47.9% ventilator-associated bacterial pneumonia.  Ventilator-associated bacterial pneumonia predominated in the Northeastern United  States and in large urban teaching hospitals. Patients with nonventilated  hospital-acquired bacterial pneumonia were oldest (mean 66.7 ?± 15.1 yr) and most  likely White (76.9%), whereas those with ventilator-associated bacterial  pneumonia were youngest (59.7 ?± 16.6 yr) and least likely White (70.3%).  Ventilated hospital-acquired bacterial pneumonia was associated with the highest  comorbidity burden (mean Charlson score 4.1 ?± 2.8) and ventilator-associated  bacterial pneumonia with the lowest (3.2 ?± 2.5). Similarly, hospital mortality  was highest among patients with ventilated hospital-acquired bacterial pneumonia  (29.2%) and lowest in nonventilated hospital-acquired bacterial pneumonia  (11.7%), with ventilator-associated bacterial pneumonia in-between (21.3%). Among  survivors, 24.5% of nonventilated hospital-acquired bacterial pneumonia required  a rehospitalization within 30 days of discharge, compared with 22.5% among  ventilated hospital-acquired bacterial pneumonia and 18.8% ventilator-associated  bacterial pneumonia. Unadjusted hospital length of stay after infection onset was  longest among ventilator-associated bacterial pneumonia and shortest among  nonventilated hospital-acquired bacterial pneumonia patients. 

Median total  hospital costs mirrored length of stay: ventilator-associated bacterial pneumonia  $77,657, ventilated hospital-acquired bacterial pneumonia $62,464, and  nonventilated hospital-acquired bacterial pneumonia $39,911. 

CONCLUSIONS: Both  hospital-acquired bacterial pneumonia and ventilator-associated bacterial  pneumonia remain associated with significant mortality and cost in the United  States. Our analyses confirm that of all three conditions, ventilated  hospital-acquired bacterial pneumonia carries the highest risk of death. In  contrast, ventilator-associated bacterial pneumonia remains most costly.  Nonventilated hospital-acquired bacterial pneumonia survivors were most likely to  require a readmission within 30 days of discharge.

## 美国非通气性医院获得性、通气性医院获得性和呼吸机相关细菌性肺炎的描述性流行病学和结局，2012-2019。

目的：探索呼吸机相关细菌性肺炎和医院获得性细菌性肺炎患者结局的多项随机对照试验表明，需要后续通气的医院获得性细菌性肺炎患者的死亡率高于未接受后续通气的患者（非通气）。住院获得性细菌性肺炎）或患有呼吸机相关细菌性肺炎。我们在一个大型美国数据库中检查了所有三种疾病的流行病学和结局。

设计：回顾性队列研究。

设置：253家美国急症医院，为Premier数据库提供数据（包括微生物学），2012-2019。

患者：根据先前发表的国际疾病分类第9版/国际疾病分类第10版-临床修订算法略微修订的标准确定的医院获得性细菌性肺炎或呼吸机相关细菌性肺炎患者。

干预：无。

测量值和主要结果：在符合入组标准的17819例患者中，26.5%患有非通气型医院获得性细菌性肺炎，25.6%患有vHAPB，47.9%患有呼吸机相关细菌性肺炎。在美国东北部和大型城市教学医院，呼吸机相关细菌性肺炎占主导地位。非通气型医院获得性细菌性肺炎患者年龄最大（平均66.7?15.1岁），最可能为白人(76.9%)，而呼吸机相关细菌性肺炎患者年龄最小（59.7?16.6岁），不太可能为白人(70.3%)。通气性医院获得性细菌性肺炎与最高的合并症负担相关（平均Charlson评分4.1±2.8），与呼吸机相关细菌性肺炎相关的合并症负担最低(3.2?±2.5)。同样，呼吸机治疗的医院获得性细菌性肺炎患者的住院死亡率最高(29.2%)，非呼吸机治疗的医院获得性细菌性肺炎患者的住院死亡率最低(11.7%)，呼吸机相关细菌性肺炎患者的住院死亡率为(21.3%)。在存活者中，24.5%的非通气医院获得性细菌性肺炎患者在出院后30天内需要再次住院治疗，而通气医院获得性细菌性肺炎患者中为22.5%，呼吸机相关细菌性肺炎患者中为18.8%。在呼吸机相关细菌性肺炎中，感染发生后未经调整的住院时间最长，在非通气的医院获得性细菌性肺炎患者中最短。

中位总住院费用反映了住院时间：呼吸机相关细菌性肺炎$77,657，通气医院获得性细菌性肺炎$62,464，非通气医院获得性细菌性肺炎$39,911。

结论：在美国，医院获得性细菌性肺炎和呼吸机相关细菌性肺炎均与显著的死亡率和费用相关。我们的分析证实，在所有三种情况中，通气型医院获得性细菌性肺炎的死亡风险最高。相比之下，呼吸机相关细菌性肺炎的治疗费用仍然最高。非通气的医院获得性细菌性肺炎生存者在出院后30天内最可能需要再次入院。
关键词：Humans; Female; Male; Middle Aged; Time Factors; Adult; Young Adult; Retrospective Studies; Outcome Assessment, Health Care; Hospital Mortality; United States; *Severity of Illness Index; Cost of Illness; Cross Infection/economics/*epidemiology; Healthcare-Associated Pneumonia/economics/*epidemiology; Pneumonia, Bacterial/economics/*epidemiology; Pneumonia, Ventilator-Associated/economics/*epidemiology

--------
--------

## A Simple Risk Score for Predicting Neurologic Outcome in Out-of-Hospital Cardiac Arrest Patients After Targeted Temperature Management.

3:428-439. DOI:10.1097/CCM.0000000000005266

Abstract: 

OBJECTIVES: Although several risk factors for outcomes of out-of-hospital cardiac arrest patients have been identified, the cumulative risk of their combinations  is not thoroughly clear, especially after targeted temperature management.  Therefore, we aimed to develop a risk score to evaluate individual  out-of-hospital cardiac arrest patient risk at early admission after targeted  temperature management regarding poor neurologic status at discharge. 

DESIGN:  Retrospective observational cohort study. 

SETTING: Two large academic medical  networks in the United States. 

PATIENTS: Out-of-hospital cardiac arrest survivors  treated with targeted temperature management with age of 18 years old or older.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Based on the odds ratios,  five identified variables (initial nonShockable rhythm, Leucocyte count < 4 or >  12 K/??L after targeted temperature management, total Adrenalin [epinephrine] ?‰? 5  mg, lack of oNlooker cardiopulmonary resuscitation, and Time duration of  resuscitation ?‰? 20 min) were assigned weighted points. The sum of the points was  the total risk score known as the SLANT score (range 0-21 points) for each  patient. Based on our risk prediction scores, patients were divided into three  risk categories as moderate-risk group (0-7), high-risk group (8-14), and very  high-risk group (15-21). Both the ability of our risk score to predict the rates  of poor neurologic outcomes at discharge and in-hospital mortality were  significant under the Cochran-Armitage trend test (p < 0.001 and p < 0.001,  respectively). 

CONCLUSIONS: The risk of poor neurologic outcomes and in-hospital  mortality of out-of-hospital cardiac arrest survivors after targeted temperature  management is easily assessed using a risk score model derived using the readily  available information. Its clinical utility needed further investigation.

## 一种预测靶向温度管理后院外心脏骤停患者神经结局的简单风险评分。

目的：虽然已经确定了院外心脏骤停患者结局的几个风险因素，但其联合治疗的累积风险尚不完全清楚，特别是在进行针对性温度管理后。因此，我们旨在开发一个风险评分来评价个体院外心脏骤停患者在出院时神经功能状态较差的针对性温度管理后早期入院时的风险。

设计：回顾性观察性队列研究。

单位：美国两个大型学术医疗网络。

患者：院外心脏骤停幸存者接受针对性温度管理，年龄在18岁或以上。

干预：无。

测量值和主要结果：基于比值比，5个确定的变量（初始不可休克节律、目标温度管理后白细胞计数<4或>12 K/?L、总肾上腺素[肾上腺素] ≥ 5 mg、无oNlooker心肺复苏、和复苏持续时间 ≥ 20 min）指定加权点。评分之和是被称为每例患者的SLANT评分（范围0-21分）的总风险评分。根据我们的风险预测评分，将患者分为3个风险类别，中度风险组(0-7)、高风险组(8-14)和极高风险组(15-21)。在Cochran-Armitage趋势检验中，我们的风险评分预测出院时较差神经学结局发生率和住院死亡率的能力均显著（分别为p < 0.001和p < 0.001）。

结论：采用现有信息得出的风险评分模型，易于评估靶向温度管理后院外心脏骤停存活者的不良神经系统结局和院内死亡率风险。其临床实用性需要进一步研究。
关键词：Humans; Treatment Outcome; Female; Male; Middle Aged; Prognosis; Time Factors; Aged; Adult; Cohort Studies; Risk Factors; Retrospective Studies; *Cardiopulmonary Resuscitation; Hypothermia, Induced/*mortality; Out-of-Hospital Cardiac Arrest/mortality/*therapy; Survivors/*statistics & numerical data

--------
--------

## Association Between Pandemic Coronavirus Disease 2019 Public Health Measures and Reduction in Critical Care Utilization Across ICUs in Alberta, Canada.

3:353-362. DOI:10.1097/CCM.0000000000005275

Abstract: 

OBJECTIVES: The coronavirus disease 2019 pandemic has disrupted critical care services across the world. In anticipation of surges in the need for critical  care services, governments implemented "lockdown" measures to preserve and create  added critical care capacity. Herein, we describe the impact of lockdown measures  on the utilization of critical care services and patient outcomes compared with  nonlockdown epochs in a large integrated health region. 

DESIGN: This was a  population-based retrospective cohort study. 

SETTING: Seventeen adult ICUs across  14 acute care hospitals in Alberta, Canada. 

PATIENTS: All adult (age ?‰? 15 yr)  patients admitted to any study ICU. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN  RESULTS: The main exposure was ICU admission during "lockdown" occurring between  March 16, 2020, and June 30, 2020. 

This period was compared with two nonpandemic  control periods: "year prior" (March 16, 2019, to June 30, 2019) and "pre  lockdown" immediately prior (November 30, 2019, to March 15, 2020). The primary  outcome was the number of ICU admissions. 

Secondary outcomes included the  following: daily measures of ICU utilization, ICU duration of stay, avoidable  delay in ICU discharge, and occupancy; and patient outcomes. Mixed multilevel  negative binomial regression and interrupted time series regression were used to  compare rates of ICU admissions between periods. Multivariable regressions were  used to compare patient outcomes between periods. During the lockdown, there were  3,649 ICU admissions (34.1 [8.0] ICU admissions/d), compared with 4,125 (38.6  [9.3]) during the prelockdown period and 3,919 (36.6 [8.7]) during the year  prior. Mean bed occupancy declined significantly during the lockdown compared  with the nonpandemic periods (78.7%, 95.9%, and 96.4%; p < 0.001). Avoidable ICU  discharge delay also decreased significantly (42.0%, 53.2%, and 58.3%; p <  0.001). During the lockdown, patients were younger, had fewer comorbid diseases,  had higher acuity, and were more likely to be medical admissions compared with  the nonpandemic periods. Adjusted ICU and hospital mortality and ICU and hospital  lengths of stay were significantly lower during the lockdown compared with  nonpandemic periods. 

CONCLUSIONS: The coronavirus disease 2019 lockdown resulted  in substantial changes to ICU utilization, including a reduction in admissions,  occupancy, patient lengths of stay, and mortality.

## 2019年加拿大艾伯塔省ICU中流行冠状病毒病公共卫生措施与减少重症监护利用之间的相关性。

目的：2019年的冠状病毒病大流行扰乱了全球的重症监护服务。预期危重症护理服务需求激增，各国政府实施了“封锁”措施，以保持和创造额外的危重症护理能力。在此，我们描述了在一个大型综合健康地区，与非封锁时期相比，封锁措施对重症监护服务利用和患者结局的影响。

设计：这是一项基于人群的回顾性队列研究。

设置：加拿大艾伯塔省14家急症护理医院的17个成人ICU。

患者：所有入住任何研究ICU的成人（年龄 ≥ 15岁）患者。

干预：无。

测量和主要结果：主要暴露是2020年3月16日至2020年6月30日期间发生的“封锁”期间入住ICU。

将这一时期与两个非大流行控制时期进行比较：“前一年”（2019年3月16日至2019年6月30日）和紧邻的“预锁定”（2019年11月30日至2020年3月15日）。主要结局是ICU住院次数。

次要结局包括以下指标：ICU每日利用率、ICU住院时间、ICU出院可避免的延迟和占用时间；以及患者结局。使用混合多级负二项回归和中断时间序列回归来比较不同时期的ICU入院率。使用多变量回归比较不同时期的患者结局。在封锁期间，共有3,649次ICU入院（34.1[8.0]次ICU入院/天），相比之下，封锁前期有4,125次（38.6[9.3]次），前一年有3,919次（36.6[8.7]次）。与无大流行期相比，封锁期间平均床位使用率显著下降（78.7%、95.9%和96.4%；p < 0.001）。可避免的ICU出院延迟也显著减少（42.0%、53.2%和58.3%；p < 0.001）。在封锁期间，与非大流行期相比，患者更年轻，合并症更少，急性程度更高，更可能是内科入院。在封锁期间，调整后的ICU和住院死亡率以及ICU和住院时间显著低于非大流行期间。

结论：2019年冠状病毒病的封锁导致了ICU利用率的实质性改变，包括入院率、占用率、患者住院时间和死亡率的降低。
关键词：Humans; Female; Male; Middle Aged; Aged; APACHE; Adult; Critical Care; Retrospective Studies; Pandemics; Hospital Mortality; Age Factors; Sex Factors; Comorbidity; SARS-CoV-2; COVID-19/*epidemiology; Patient Discharge; Alberta/epidemiology; Intensive Care Units/*statistics & numerical data; Bed Occupancy; Communicable Disease Control/*statistics & numerical data; Hospitalization/statistics & numerical data; Public Health

--------
--------

## Improving Timeliness of Antibiotic Administration Using a Provider and Pharmacist Facing Sepsis Early Warning System in the Emergency Department Setting: A  Randomized Controlled Quality Improvement Initiative., Tarabichi, Yasir

3:418-427. DOI:10.1097/CCM.0000000000005267

Abstract: 

OBJECTIVES: Results of pre-post intervention studies of sepsis early warning systems have been mixed, and randomized clinical trials showing efficacy in the  emergency department setting are lacking. Additionally, early warning systems can  be resource-intensive and may cause unintended consequences such as antibiotic or  IV fluid overuse. We assessed the impact of a pharmacist and provider facing  sepsis early warning systems on timeliness of antibiotic administration and  sepsis-related clinical outcomes in our setting. 

DESIGN: A randomized, controlled  quality improvement initiative. 

SETTING: The main emergency department of an  academic, safety-net healthcare system from August to December 2019. 

PATIENTS:  Adults presenting to the emergency department. 

INTERVENTION: Patients were  randomized to standard sepsis care or standard care augmented by the display of a  sepsis early warning system-triggered flag in the electronic health record  combined with electronic health record-based emergency department pharmacist  notification. 

MEASUREMENTS AND MAIN RESULTS: The primary process measure was time  to antibiotic administration from arrival. A total of 598 patients were included  in the study over a 5-month period (285 in the intervention group and 313 in the  standard care group). Time to antibiotic administration from emergency department  arrival was shorter in the augmented care group than that in the standard care  group (median, 2.3 hr [interquartile range, 1.4-4.7 hr] vs 3.0 hr [interquartile  range, 1.6-5.5 hr]; p = 0.039). The hierarchical composite clinical outcome  measure of days alive and out of hospital at 28 days was greater in the augmented  care group than that in the standard care group (median, 24.1 vs 22.5 d; p =  0.011). Rates of fluid resuscitation and antibiotic utilization did not differ.  

CONCLUSIONS: In this single-center randomized quality improvement initiative, the  display of an electronic health record-based sepsis early warning  system-triggered flag combined with electronic health record-based pharmacist  notification was associated with shorter time to antibiotic administration  without an increase in undesirable or potentially harmful clinical interventions.

## 在急诊室使用提供者和药剂师应对败血症预警系统来提高抗生素给药的时效性：一项随机对照质量改进倡议。

目的：败血症预警系统的干预前-干预后研究结果好坏参半，缺乏显示在急诊科环境中疗效的随机临床试验。此外，早期预警系统可能是资源密集的，可能导致意外后果，如抗生素或静脉输液过量。我们评估了药剂师和面对败血症预警系统的提供者对抗生素给药时效性和我们环境中败血症相关临床结局的影响。

设计：一项随机化、对照质量改进倡议。

背景：2019年8月至12月，学术级安全网医疗保健系统的主要急诊科。

患者：前往急诊科就诊的成人。

干预：将患者随机分配至标准败血症治疗组或标准治疗组，通过在电子健康记录中显示败血症早期预警系统触发的标志并结合基于电子健康记录的急诊科药剂师通知进行强化。

测量和主要结果：主要过程测量是从到达开始抗生素给药的时间。在5个月期间，共有598例患者被纳入研究（干预组285例，标准治疗组313例）。增强护理组从到达急诊室至抗生素给药时间比标准护理组短（中位数2.3 h[四分位距，1.4-4.7 h]vs 3.0 h[四分位距，1.6-5.5 h]；p = 0.039）。增强护理组第28天的存活和出院天数的分层复合临床结局指标大于标准护理组（中位数，24.1 vs 22.5天；p = 0.011）。液体复苏率和抗生素使用率没有差异。

结论：在该单中心随机质量改善计划中，显示基于电子健康记录的败血症预警系统触发的标志结合基于电子健康记录的药剂师通知与抗生素给药时间更短相关，而不良或潜在有害临床干预的增加。
关键词：Humans; Algorithms; Anti-Bacterial Agents/*therapeutic use; Sepsis/*drug therapy; *Clinical Protocols; Emergency Service, Hospital/*organization & administration; Process Assessment, Health Care; Quality Improvement/*organization & administration; Time-to-Treatment/*statistics & numerical data

--------
--------

## Peripheral Oxygen Saturation Facilitates Assessment of Respiratory Dysfunction in the Sequential Organ Failure Assessment Score With Implications for the Sepsis-3  Criteria.

3:e272-e283. DOI:10.1097/CCM.0000000000005318

Abstract: 

OBJECTIVES: Sequential Organ Failure Assessment score is the basis of the Sepsis-3 criteria and requires arterial blood gas analysis to assess respiratory  function. Peripheral oxygen saturation is a noninvasive alternative but is not  included in neither Sequential Organ Failure Assessment score nor Sepsis-3. We  aimed to assess the association between worst peripheral oxygen saturation during  onset of suspected infection and mortality. 

DESIGN: Cohort study of hospital  admissions from a main cohort and emergency department visits from four external  validation cohorts between year 2011 and 2018. Data were collected from  electronic health records and prospectively by study investigators. 

SETTING:  Eight academic and community hospitals in Sweden and Canada. 

PATIENTS: Adult  patients with suspected infection episodes. 

INTERVENTIONS: None. 

MEASUREMENTS AND  MAIN RESULTS: The main cohort included 19,396 episodes (median age, 67.0  [53.0-77.0]; 9,007 [46.4%] women; 1,044 [5.4%] died). The validation cohorts  included 10,586 episodes (range of median age, 61.0-76.0; women 42.1-50.2%;  mortality 2.3-13.3%). Peripheral oxygen saturation levels 96-95% were not  significantly associated with increased mortality in the main or pooled  validation cohorts. At peripheral oxygen saturation 94%, the adjusted odds ratio  of death was 1.56 (95% CI, 1.10-2.23) in the main cohort and 1.36 (95% CI,  1.00-1.85) in the pooled validation cohorts and increased gradually below this  level. Respiratory assessment using peripheral oxygen saturation 94-91% and less  than 91% to generate 1 and 2 Sequential Organ Failure Assessment points,  respectively, improved the discrimination of the Sequential Organ Failure  Assessment score from area under the receiver operating characteristics 0.75 (95%  CI, 0.74-0.77) to 0.78 (95% CI, 0.77-0.80; p < 0.001). Peripheral oxygen  saturation/Fio2 ratio had slightly better predictive performance compared with  peripheral oxygen saturation alone, but the clinical impact was minor.  

CONCLUSIONS: These findings provide evidence for assessing respiratory function  with peripheral oxygen saturation in the Sequential Organ Failure Assessment  score and the Sepsis-3 criteria. Our data support using peripheral oxygen  saturation thresholds 94% and 90% to get 1 and 2 Sequential Organ Failure  Assessment respiratory points, respectively. This has important implications  primarily for emergency practice, rapid response teams, surveillance, research,  and resource-limited settings.

## 周围血氧饱和度有助于在序贯器官衰竭评估评分中评估呼吸功能障碍，具有脓毒血症-3标准的意义。

目的：序贯器官衰竭评估评分是脓毒血症-3标准的基础，需要动脉血气分析评估呼吸功能。外周血氧饱和度是一种非侵入性的替代指标，但在序贯器官衰竭评估评分和脓毒血症-3评分中均未纳入。我们旨在评估疑似感染发作期间最差外周血氧饱和度与死亡率之间的相关性。

设计：2011年至2018年间，对主要队列的入院情况和4个外部验证队列的急诊科就诊情况进行队列研究。数据收集自电子健康记录，由研究者前瞻性收集。

单位：瑞典和加拿大的8家学术和社区医院。

患者：具有疑似感染发作的成人患者。

干预：无。

测量和主要结果：主要队列包括19,396起事件（中位年龄，67.0[53.0-77.0]；9,007[46.4%]例女性；1,044[5.4%]例死亡）。验证队列包括10586起发作（中位年龄范围61.0-76.0岁；女性42.1-50.2%；死亡率2.3-13.3%）。在主要队列或合并验证队列中，外周血氧饱和度水平96-95%与死亡率增加无显著相关性。在外周血氧饱和度为94%时，主要队列和合并验证队列的死亡校正比值比分别为1.56(95%CI，1.10-2.23)和1.36(95%CI，1.00-1.85)，并逐渐低于该水平。使用外周血氧饱和度94-91%和小于91%分别生成1个和2个序贯器官衰竭评估点的呼吸评估，提高了序贯器官衰竭评估评分从接收者操作特征下面积0.75(95%CI，0.74-0.77)到0.78（95%CI，0.77-0.80；p < 0.001).与单独外周血氧饱和度相比，外周血氧饱和度/Fio2比值具有略好的预测性能，但临床影响较小。

结论：这些结果提供了在序贯器官衰竭评估评分和败血症-3标准中使用外周血氧饱和度评估呼吸功能的证据。我们的数据支持使用外周血氧饱和度阈值94%和90%分别获得1个和2个序贯器官衰竭评估呼吸点。这对急救实践、快速响应团队、监测、研究和资源有限的环境具有重要影响。
关键词：Humans; Female; Male; Middle Aged; Aged; Cohort Studies; Retrospective Studies; Hospital Mortality; Systemic Inflammatory Response Syndrome; Oxygen Consumption/*physiology; Oxygen/blood; *Intensive Care Units; *Organ Dysfunction Scores; Oxygen Saturation/*physiology; Sepsis/*blood/*mortality

--------
--------

## Physical Rehabilitation in the ICU: A Systematic Review and Meta-Analysis.

3:375-388. DOI:10.1097/CCM.0000000000005285

Abstract: 

OBJECTIVES: Significant variability exists in physical rehabilitation modalities and dosage used in the ICU. Our objective was to investigate the effect of  physical rehabilitation in ICU on patient outcomes, the impact of task-specific  training, and the dose-response profile. 

DATA SOURCES: A systematic search of  Ovid MEDLINE, Cochrane Library, EMBASE, and CINAHL plus databases was undertaken  on the May 28, 2020. 

STUDY SELECTION: Randomized controlled trials and controlled  clinical trials investigating physical rehabilitation commencing in the ICU in  adults were included. Outcomes included muscle strength, physical function,  duration of mechanical ventilation, ICU and hospital length of stay, mortality,  and health-related quality of life. Two independent reviewers assessed titles,  abstracts, and full texts against eligibility criteria. 

DATA EXTRACTION: Details  on intervention for all groups were extracted using the template for intervention  description and replication checklist. 

DATA SYNTHESIS: Sixty trials were  included, with a total of 5,352 participants. Random-effects pooled analysis  showed that physical rehabilitation improved physical function at hospital  discharge (standardized mean difference, 0.22; 95% CI, 0.00-0.44), reduced ICU  length of stay by 0.8 days (mean difference, -0.80 d; 95% CI, -1.37 to -0.23 d),  and hospital length of stay by 1.75 days (mean difference, -1.75 d; 95% CI, -3.03  to -0.48 d). Physical rehabilitation had no impact on the other outcomes. The  intervention was more effective in trials where the control group received  low-dose physical rehabilitation and in trials that investigated functional  exercises. 

CONCLUSIONS: Physical rehabilitation in the ICU improves physical  function and reduces ICU and hospital length of stay. However, it does not appear  to impact other outcomes.

## ICU中的身体康复：一项系统回顾和荟萃分析。

目的：ICU中的身体康复模式和使用剂量存在显著差异。我们的目的是研究ICU中身体康复对患者结局的影响、任务特定训练的影响和剂量-反应特征。

资料来源：于2020年5月28日系统检索Ovid MEDLINE、Cochrane Library、EMBASE和CINAHL plus数据库。

研究选择：纳入从ICU开始的成人肢体康复的随机对照试验和对照临床试验。结局包括肌力、身体功能、机械通气持续时间、ICU和住院时间、死亡率和健康相关生活质量。两名独立的审查员根据合格性标准评估标题、摘要和全文。

数据提取：使用干预描述和复制检查表模板提取所有组的干预详情。

数据综合：共纳入60项试验，共计5352例参与者。随机效应合并分析显示，身体康复改善了出院时的身体功能（标准化平均差异，0.22；95%CI，0.00-0.44），ICU住院时间缩短了0.8天（平均差异，-0.80天；95%CI，-1.37至-0.23天），住院时间缩短了1.75天（平均差异，-1.75天；95%CI，-3.03至-0.48天）。身体康复对其他结局无影响。在对照组接受低剂量身体康复治疗的试验和研究功能锻炼的试验中，这种干预更有效。

结论：ICU的身体康复改善了身体功能，减少了ICU和住院时间。但是，它似乎不会影响其他结局。
关键词：Humans; *Muscle Strength; *Intensive Care Units; Length of Stay/statistics & numerical data; Critical Illness/*rehabilitation; Exercise Therapy/statistics & numerical data; Patient Discharge/statistics & numerical data; Physical Therapy Modalities/*statistics & numerical data; Respiration, Artificial/nursing

--------
--------

## Postmortem Evidence of Brain Inflammatory Markers and Injury in Septic Patients: A Systematic Review., Barichello, Tatiana

3:e241-e252. DOI:10.1097/CCM.0000000000005307

Abstract: 

OBJECTIVES: Sepsis is a life-threatening organ dysfunction caused by a host's unregulated immune response to eliminate the infection. After hospitalization,  sepsis survivors often suffer from long-term impairments in memory, attention,  verbal fluency, and executive functioning. To understand the effects of sepsis  and the exacerbated peripheral inflammatory response in the brain, we asked the  question: What are the findings and inflammatory markers in the brains of  deceased sepsis patients? To answer this question, we conducted this systematic  review by the recommendations of Preferred Reporting Items for Systematic Reviews  and Meta-Analyses. 

DATA SOURCES: Relevant studies were identified by searching  the PubMed/National Library of Medicine, PsycINFO, EMBASE, Bibliographical Index  in Spanish in Health Sciences, Latin American and Caribbean Health Sciences  Literature, and Web of Science databases for peer-reviewed journal articles  published on April 05, 2021. 

STUDY SELECTION: A total of 3,745 articles were  included in the primary screening; after omitting duplicate articles, animal  models, and reviews, 2,896 articles were selected for the study. These studies  were selected based on the title and abstract, and 2,772 articles were still  omitted based on the exclusion criteria. 

DATA EXTRACTION: The complete texts of  the remaining 124 articles were obtained and thoroughly evaluated for the final  screening, and 104 articles were included. 

DATA SYNTHESIS: The postmortem brain  had edema, abscess, hemorrhagic and ischemic injuries, infarction, hypoxia,  atrophy, hypoplasia, neuronal loss, axonal injuries, demyelination, and necrosis.  

CONCLUSIONS: The mechanisms by which sepsis induces brain dysfunction are likely  to include vascular and neuronal lesions, followed by the activation of glial  cells and the presence of peripheral immune cells in the brain.

## 脓毒血症患者脑部炎症标志物和损伤的尸检证据：一项系统回顾。

目的：败血症是一种危及生命的器官功能障碍，由宿主为消除感染而产生的不受调节的免疫应答所致。住院后，败血症幸存者通常会出现记忆、注意力、语言流畅性和执行功能的长期损害。为了了解败血症和大脑外周炎症反应加剧的影响，我们提出了以下问题：在死亡的败血症患者的大脑中有哪些发现和炎症标志物？为了回答这个问题，我们通过推荐的系统评价和荟萃分析首选报告项目进行了这项系统评价。

资料来源：通过检索PubMed/美国国家医学图书馆、PsycINFO、EMBASE、西班牙健康科学参考书目索引、拉丁美洲和加勒比海健康科学文献和Web of Science数据库中2021年4月5日发表的同行评议期刊文章，查找相关研究。

研究选择：初筛共纳入3745篇文献，省略重复文献、动物模型和综述后，选择2896篇文献进行研究。根据标题和摘要选择这些研究，根据排除标准仍遗漏2772篇文献。

资料提炼：获取其余124篇文献的完整正文，全面评价后进行最终筛选，纳入104篇文献。

资料综合：尸检后脑出现水肿、脓肿、出血和缺血性损伤、梗死、缺氧、萎缩、发育不全、神经元缺失、轴突损伤、脱髓鞘和坏死。

结论：脓毒症诱导脑功能障碍的机制很可能包括血管和神经元病变，其次是胶质细胞的活化和脑内外周免疫细胞的存在。
关键词：Humans; Magnetic Resonance Imaging; Biomarkers; Atrophy/pathology; Autopsy; Brain/*diagnostic imaging/*metabolism/pathology; Inflammation/*diagnostic imaging/*metabolism/pathology; Sepsis/diagnostic imaging/*metabolism/*pathology

--------
--------

## Bursting at the Seams: Barotrauma in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients., Hossain, Saamia

3:531-534. DOI:10.1097/CCM.0000000000005291

## 伤口破裂：冠状病毒病2019年急性呼吸窘迫综合征患者的气压伤。
关键词：Humans; *COVID-19; SARS-CoV-2; *Respiratory Distress Syndrome/therapy; *Barotrauma

--------
--------

## Should We Prolong the Observation Period for Neurological Recovery After Cardiac Arrest?, Tsai, Min-Shan

3:389-397. DOI:10.1097/CCM.0000000000005264

Abstract: 

OBJECTIVES: To evaluate whether the recommended observation period of 7 days for cardiac arrest survivors is sufficient for conscious recovery and to identify the  variables associated with eventual neurologic recovery among patients with  delayed awakening. 

DESIGN: A retrospective cohort study. 

SETTING: A single  tertiary medical center. 

PATIENTS: Five-hundred twenty-nine nontraumatic adult  cardiac arrest survivors with prearrest favorable neurologic function (Cerebral  Performance Category 1-2) who survived to hospital discharge during 2011-2019.  

INTERVENTIONS: The enrolled patients were classified into favorable (Cerebral  Performance Category 1-2) and poor (Cerebral Performance Category 3-4) neurologic  recovery according to their neurologic function at hospital discharge. Among  patients with favorable neurologic recovery, those who recovered within 7 days  were assigned to the early recovery group or after 7 days as the late recovery  group. 

MEASUREMENTS AND MAIN RESULTS: There were 395 patients exhibiting  favorable neurologic recovery (n = 357 in the early group, n = 38 in late group)  and 134 patients exhibiting poor neurologic recovery (poor recovery group). Among  patients who remained unconscious on day 7, delayed awakening was associated with  male sex (odds ratio [OR], 3.905; 95% CI, 1.153-13.221), prehospital return of  spontaneous circulation (OR, 7.628; 95% CI, 2.084-27.922), therapeutic  hypothermia (OR, 4.320; 95% CI, 1.624-11.488), and extracorporeal cardiopulmonary  resuscitation (OR, 4.508; 95% CI, 1.414-14.371). Being transferred from another  hospital, however, was less likely to be associated with delayed awakening (OR,  0.061; 95% CI, 0.009-0.431). The median duration for patients to regain clear  consciousness in the late recovery group was 12.12 days. No patient who recovered  consciousness had an unfavorable electroencephalography pattern, however, in  patients with poor recovery, the 7-day electroencephalography showed 45 patients  with generalized suppression (33.6%), two with burst suppression (1.5%), 14 with  seizure/epileptic discharge (10.5%), and one with status epilepticus (0.7%).  

CONCLUSIONS: Up to 9.6% of cardiac arrest patients with favorable outcomes  recover consciousness after the recommended 7 days of observation, indicating the  observation time of 7 days seems justified but longer duration may be needed. The  results of the culturally and clinically isolated population may limit the  application to other population.

## 我们是否应该延长心脏骤停后神经功能恢复的观察期？

目的：评价心脏骤停幸存者推荐的7天观察期是否足以使意识恢复，并确定与延迟觉醒患者最终神经功能恢复相关的变量。

设计：回顾性队列研究。

地点：一家三级医疗中心。

患者：在2011-2019年期间存活至出院的529例非创伤性成人心脏骤停生存者，其停前神经功能良好（脑功能1-2类）。

干预：根据出院时的神经功能，将入组患者分类为良好（脑功能1-2类）和不良（脑功能3-4类）神经功能恢复。在神经功能恢复良好的患者中，7天内恢复的患者归为早期恢复组，7天后恢复的患者归为晚期恢复组。

测量和主要结果：395例患者神经功能恢复良好（早期组n = 357，晚期组n = 38），134例患者神经功能恢复较差（恢复较差组）。在第7天保持无意识的患者中，苏醒延迟与男性（比值比[OR]，3.905；95%CI，1.153-13.221）、院前自主循环恢复(OR，7.628；95%CI，2.084-27.922)、治疗性低体温(OR，4.320；95%CI，1.624-11.488)和体外心肺复苏（OR，4.508；95%CI，1.414-14.371).但是，从另一家医院转诊的患者不太可能与觉醒延迟相关(OR，0.061；95%CI，0.009-0.431)。后期恢复组患者恢复意识的中位时间为12.12天。意识恢复的患者均无不良脑电图模式，然而，在恢复不良的患者中，7天脑电图显示45例患者出现了全身性抑制(33.6%)，2例出现了爆发抑制(1.5%)，14例出现了癫痫发作/癫痫性放电(10.5%)，1例出现了癫痫持续状态(0.7%)。

结论：高达9.6%结局良好的心脏骤停患者在推荐的7天观察后恢复意识，表明7天的观察时间似乎是合理的，但可能需要更长的持续时间。文化和临床上孤立的人群的结果可能限制了其他人群的应用。
关键词：Humans; Treatment Outcome; Female; Male; Middle Aged; Time Factors; Aged; Adult; Retrospective Studies; Patient Discharge/*statistics & numerical data; Survivors/*statistics & numerical data; Cardiopulmonary Resuscitation/*statistics & numerical data; Heart Arrest/*rehabilitation; Neurologic Examination/*statistics & numerical data

--------
--------

## Race Does Not Impact Sepsis Outcomes When Considering Socioeconomic Factors in Multilevel Modeling.

3:410-417. DOI:10.1097/CCM.0000000000005217

Abstract: 

OBJECTIVES: To determine whether race is a major determinant of sepsis outcomes when controlling for socioeconomic factors. 

DESIGN: Retrospective cohort study.  

SETTING: Barnes-Jewish Hospital a 1,350 bed academic medical center. 

PATIENTS:  Eleven-thousand four-hundred thirty-two patients hospitalized between January  2010 and April 2017 with sepsis and septic shock. 

INTERVENTIONS: Multilevel  random effects modeling was employed whereby patients were nested within ZIP  codes. Individual patient characteristics and socioeconomic variables aggregated  at the ZIP code level (education, employment status, income, poverty level,  access to healthcare) were included in the model. 

MEASUREMENTS AND MAIN RESULTS:  In hospital mortality, length of stay, need for vasopressors, and mechanical  ventilation were the main endpoints. Black patients had more comorbidities than  White patients except for cirrhosis and malignancy. In unadjusted comparisons,  White individuals were more likely to require mechanical ventilation and had  higher mortality rates and longer hospital stays for both low- and high-income  groups. When nesting within ZIP codes and accounting for socioeconomic variables,  race did not have a significant effect on mortality. Non-White races had lower  odds ratio for mechanical ventilation. 

CONCLUSIONS: Our study demonstrates that  race is not an independent risk factor for sepsis mortality, as well as  sepsis-related length of stay. We should expand our inquiry into determinants of  sepsis outcomes by including socioeconomic variables.

## 在多级建模中考虑社会经济因素时，人种不会影响败血症结局。

目的：在控制社会经济因素时，确定人种是否为败血症结局的主要决定因素。

设计：回顾性队列研究。

单位：Barnes-Jewish Hospital a 1,350 bed academic medical center。

患者：2010年1月至2017年4月间有11432名败血症和感染性休克患者住院。

干预：采用多级随机效应模型，将患者嵌套在ZIP编码内。该模型纳入了ZIP编码水平（教育、就业状况、收入、贫困水平、获得医疗保健）汇总的个体患者特征和社会经济学变量。

测量和主要结果：住院死亡率、住院时间、血管加压素需求和机械通气是主要终点。除肝硬化和恶性肿瘤外，黑人患者的合并症多于白人患者。在未校正的比较中，白人个体更可能需要机械通气，低收入组和高收入组的死亡率更高，住院时间更长。当在ZIP编码下嵌套并考虑社会经济学变量时，人种对死亡率无显著影响。非白人种族的机械通气比值比较低。

结论：我们的研究表明，人种不是败血症死亡率以及败血症相关住院时间的独立风险因素。我们应通过纳入社会经济变量来扩大对败血症结局决定因素的调查。
关键词：Humans; Retrospective Studies; Outcome Assessment, Health Care; Hospital Mortality; Socioeconomic Factors; *Severity of Illness Index; *Health Status Disparities; Racial Groups/*statistics & numerical data; Sepsis/ethnology/*mortality; Shock, Septic/mortality

--------
--------

## Pathophysiologic Signature of Impending ICU Hypoglycemia in Bedside Monitoring and Electronic Health Record Data: Model Development and External Validation., Horton, William B.

3:e221-e230. DOI:10.1097/CCM.0000000000005171

Abstract: 

OBJECTIVES: We tested the hypothesis that routine monitoring data could describe a detailed and distinct pathophysiologic phenotype of impending hypoglycemia in  adult ICU patients. 

DESIGN: Retrospective analysis leading to model development  and validation. 

SETTING: All ICU admissions wherein patients received insulin  therapy during a 4-year period at the University of Virginia Medical Center. Each  ICU was equipped with continuous physiologic monitoring systems whose signals  were archived in an electronic data warehouse along with the entire medical  record. 

PATIENTS: Eleven thousand eight hundred forty-seven ICU patient  admissions. 

INTERVENTIONS: The primary outcome was hypoglycemia, defined as any  episode of blood glucose less than 70 mg/dL where 50% dextrose injection was  administered within 1 hour. We used 61 physiologic markers (including vital  signs, laboratory values, demographics, and continuous cardiorespiratory  monitoring variables) to inform the model. 

MEASUREMENTS AND MAIN RESULTS: Our  dataset consisted of 11,847 ICU patient admissions, 721 (6.1%) of which had one  or more hypoglycemic episodes. Multivariable logistic regression analysis  revealed a pathophysiologic signature of 41 independent variables that best  characterized ICU hypoglycemia. The final model had a cross-validated area under  the receiver operating characteristic curve of 0.83 (95% CI, 0.78-0.87) for  prediction of impending ICU hypoglycemia. We externally validated the model in  the Medical Information Mart for Intensive Care III critical care dataset, where  it also demonstrated good performance with an area under the receiver operating  characteristic curve of 0.79 (95% CI, 0.77-0.81). 

CONCLUSIONS: We used data from  a large number of critically ill inpatients to develop and externally validate a  predictive model of impending ICU hypoglycemia. Future steps include  incorporating this model into a clinical decision support system and testing its  effects in a multicenter randomized controlled clinical trial.

## 床旁监测和电子病历数据中ICU即将发生低血糖的病理生理学特征：模型开发和外部验证。

目的：我们检验了以下假设：常规监测数据可以描述ICU成人患者即将发生低血糖的详细和独特的病理生理表型。

设计：通过回顾性分析开发和验证模型。

设置：弗吉尼亚大学医学中心所有4年内患者接受胰岛素治疗的ICU入院。每间ICU均配备了连续生理监测系统，其信号与整个病历一起存档在电子数据仓库中。

患者：1847例ICU患者入院。

干预：主要结局为低血糖，定义为血糖低于70 mg/dL的任何发作，在1小时内注射50%葡萄糖。我们使用61个生理标志物（包括生命体征、实验室检查值、人口统计学和连续心肺监测变量）来告知模型。

测量值和主要结果：我们的数据集包括11847例ICU患者，其中721例(6.1%)发生一次或多次低血糖发作。多变量逻辑回归分析显示病理生理学特征的41个独立变量最能描述ICU低血糖。最终模型在预测即将发生ICU低血糖的受试者工作特征曲线下面积为0.83(95%CI，0.78-0.87)。我们在Medical Information Mart for Intensive Care III急救护理数据集中对该模型进行了外部验证，其还表现出良好的性能，受试者操作特征曲线下面积为0.79(95%CI，0.77-0.81)。

结论：我们使用大量危重住院患者的数据来开发和外部验证即将发生ICU低血糖的预测模型。未来的步骤包括将该模型纳入临床决策支持系统，并在多中心随机对照临床试验中检验其效果。
关键词：Humans; Monitoring, Physiologic; Male; Middle Aged; Retrospective Studies; ROC Curve; *Intensive Care Units; Critical Illness/epidemiology; Critical Care/*statistics & numerical data; Machine Learning; Electronic Health Records/*statistics & numerical data; Hypoglycemia/*diagnosis; Point-of-Care Testing/*statistics & numerical data

--------
--------

## Tidal Volume-Dependent Activation of the Renin-Angiotensin System in Experimental Ventilator-Induced Lung Injury.

2:e220. DOI:10.1097/CCM.0000000000005495

Abstract: 

OBJECTIVES: Ventilator-induced lung injury (VILI) is a major contributor to morbidity and mortality in critically ill patients. Mechanical damage to the  lungs is potentially aggravated by the activation of the renin-angiotensin system  (RAS). This article describes RAS activation profiles in VILI and discusses the  effects of angiotensin (Ang) 1-7 supplementation or angiotensin-converting enzyme  (ACE) inhibition with captopril as protective strategies. 

DESIGN: Animal study.  

SETTING: University research laboratory. 

SUBJECTS: C57BL/6 mice. 

INTERVENTIONS:  Anesthetized mice (n = 12-18 per group) were mechanically ventilated with low  tidal volume (LVT, 6 mL/kg), high tidal volume (HVT, 15 mL/kg), or very high  tidal volume (VHVT, 30 mL/kg) for 4 hours, or killed after 3 minutes (sham).  Additional VHVT groups received infusions of 60 ??g/kg/hr Ang 1-7 or a single dose  of 100 mg/kg captopril. 

MEASUREMENTS AND MAIN RESULTS: VILI was characterized by  increased bronchoalveolar lavage fluid levels of interleukin (IL)-6,  keratinocyte-derived cytokine, and macrophage inflammatory protein-2 (MIP2). The  Ang metabolites in plasma measured with liquid chromatography tandem mass  spectrometry showed a strong activation of the classical (Ang I, Ang II) and  alternative RAS (Ang 1-7, Ang 1-5), with highest concentrations found in the HVT  group. Although the lung-tissue ACE messenger RNA expression was unchanged, its  protein expression showed a dose-dependent increase under mechanical ventilation.  The ACE2 messenger RNA expression decreased in all ventilated groups, whereas  ACE2 protein levels remained unchanged. Both captopril and Ang 1-7 led to  markedly increased Ang 1-7 plasma levels, decreased Ang II levels, and ACE  activity (Ang II/Ang I ratio), and effectively prevented VILI. 

CONCLUSIONS: VILI  is accompanied by a strong activation of the RAS. Based on circulating Ang  metabolite levels and tissue expression of RAS enzymes, classical ACE-dependent  and alternative RAS cascades were activated in the HVT group, whereas classical  RAS activation prevailed with VHVT ventilation. Ang 1-7 or captopril protected  from VILI primarily by modifying the systemic RAS profile.

## 实验性呼吸机诱导肺损伤中肾素-血管紧张素系统的潮气量依赖性激活。

目的：呼吸机诱导肺损伤(VILI)是重症患者发病和死亡的主要原因。肾素-血管紧张素系统(RAS)的激活可能会加重肺脏的机械损伤。本文描述了VILI中的RAS激活特征，并讨论了血管紧张素(Ang)1-7补充或卡托普利作为保护策略的血管紧张素转换酶(ACE)抑制的影响。

设计：动物研究。

单位：大学研究室。

受试者：C57BL/6小鼠。

干预：麻醉小鼠（n = 12-18/组）接受低潮气量(LVT，6 mL/kg)、高潮气量(HVT，15 mL/kg)或极高潮气量(VHVT，30 mL/kg)机械通气4小时，或3 min后处死（假手术）。其他VHVT组接受60?g/kg/hr Ang 1-7输注或100 mg/kg卡托普利单次给药。

测量和主要结果：VILI的特征为支气管肺泡灌洗液中白细胞介素(IL)-6、角质形成细胞衍生的细胞因子和巨噬细胞炎性蛋白-2(MIP2)水平升高。采用液相色谱串联质谱法测定的血浆中的Ang代谢物显示经典(Ang I、Ang II)和替代RAS(Ang 1-7、Ang 1-5)强烈激活，HVT组浓度最高。尽管肺组织ACE信使RNA表达没有变化，但其蛋白表达在机械通气下呈剂量依赖性增加。所有通气组的ACE2信使RNA表达均下降，而ACE2蛋白水平保持不变。卡托普利和Ang 1-7均导致Ang 1-7血浆水平显著升高，降低Ang II水平和ACE活性（Ang II/Ang I比值），并有效预防VILI。

结论：VILI伴有RAS的强烈激活。基于循环中的Ang代谢产物水平和RAS酶的组织表达，HVT组中经典的ACE依赖性和替代性RAS级联被激活，而VHVT通气中经典的RAS激活占优势。血管紧张素1-7或卡托普利主要通过改变系统性RAS谱来保护VILI。

--------
--------

## The ??1-Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory Function.

2:e220. DOI:10.1097/CCM.0000000000005444

Abstract: 

OBJECTIVES: Although cardiovascular benefits of??1-adrenergic receptor blockade have been described in sepsis, little is known about its impact on the adaptive  immune response, specifically CD4 T cells. Herein, we study the effects of  ??1-adrenergic receptor modulation on CD4 T-cell function in a murine model of  sepsis. 

DESIGN: Experimental study. 

SETTING: University laboratory. 

SUBJECTS:  C57BL/6 mice. 

INTERVENTIONS: High-grade sepsis was induced by cecal ligation and  puncture in wild-type mice (??1+/+) with or without esmolol (a selective  ??1-adrenergic receptor blocker) or in ??1-adrenergic receptor knockout mice  (??1-/-). At 18 hours after surgery, echocardiography was performed with blood and  spleen collected to analyze lymphocyte function. 

MEASUREMENTS AND MAIN RESULTS:  At 18 hours, ??1+/+ cecal ligation and puncture mice exhibited characteristics of  high-grade sepsis and three surrogate markers of immunosuppression, namely  decreased splenic CD4 T cells, reduced CD4 T-cell proliferation, and increased  regulatory T lymphocyte cell proportions. Pharmacologic and genetic ??1-adrenergic  receptor blockade reversed the impact of sepsis on CD4 T and regulatory T  lymphocyte proportions and maintained CD4 T-cell proliferative capacity.  ??1-adrenergic receptor blocked cecal ligation and puncture mice also exhibited a  global decrease in both pro- and anti-inflammatory mediators and improved in vivo  cardiovascular efficiency with maintained cardiac power index despite the  expected decrease in heart rate. 

CONCLUSIONS: ??1-adrenergic receptor activation  enhances regulatory T lymphocyte inhibitory function and thus contributes to  sepsis-induced immunosuppression. This can be attenuated by ??1-adrenergic  receptor blockade, suggesting a potential immunoregulatory role for this therapy  in the management of sepsis.

DOI: 10.1097/CCM.0000000000005503

## ?1-肾上腺素能受体通过调节调节性T细胞抑制功能参与败血症诱导的免疫抑制。

目的：尽管已有人描述败血症患者接受??1-肾上腺素能受体阻断的心血管获益，但对于其对适应性免疫应答尤其是CD4 T细胞的影响知之甚少。在此，我们在败血症的小鼠模型中，研究?1-肾上腺素能受体调节对cd4t细胞功能的影响。

设计：实验研究。

单位：大学实验室。

受试者：C57BL/6小鼠。

干预：在有或无艾司洛尔（选择性Ι?1-肾上腺素能受体阻滞剂）的野生型小鼠(Ι?1 +/+)或Ι?1-肾上腺素能受体基因敲除小鼠(Ι?1-/-)中，通过盲肠结扎和穿刺诱导高级别脓毒症。术后18小时，采集血液和脾脏进行超声心动图检查，分析淋巴细胞功能。

测量值和主要结果：18小时时，??1 +/+ 盲肠结扎和穿刺小鼠表现出高度败血症特征和3种免疫抑制替代标志物，即脾脏CD4 T细胞减少、CD4 T细胞增殖减少和调节性T淋巴细胞比例增加。药理学和遗传学的?1-肾上腺素能受体阻断逆转了败血症对CD4 T和调节性T淋巴细胞比例的影响，并维持了CD4 T细胞的增殖能力。nct014?1-肾上腺素能受体阻断盲肠结扎和穿刺的小鼠也表现出促炎和抗炎介质的整体减少，体内心血管效率改善，尽管预期心率下降，但心脏功率指数保持不变。

结论：rec?1-肾上腺素能受体活化增强了调节性T淋巴细胞的抑制功能，从而有助于败血症诱导的免疫抑制。这一效应可通过钙通道阻滞剂和肾上腺素能受体的阻断而减弱，提示这种治疗在败血症管理中具有潜在的免疫调节作用。

--------
--------

## Standardized Care Is Better Than Individualized Care for the Majority of Critically Ill Patients: Erratum.

DOI: 10.1097/CCM.0000000000005445

--------
--------

## Orange You Wishing There Were Definitive Randomized Controlled Trials Already?: Erratum.

--------
--------

## 21st Century Evidence: Randomized Controlled Trials Versus Systematic Reviews and Meta-Analyses: Erratum.

2:e220. DOI:10.1097/CCM.0000000000005442

--------
--------

## The authors reply.

2:e218-e219. DOI:10.1097/CCM.0000000000005386

## Standardized Care Is Better Than Individualized Care for the Majority of Critically Ill Patients: Erratum.

--------
--------

## Orange You Wishing There Were Definitive Randomized Controlled Trials Already?: Erratum.

2:e220. DOI:10.1097/CCM.0000000000005444

--------
--------

## 21st Century Evidence: Randomized Controlled Trials Versus Systematic Reviews and Meta-Analyses: Erratum.

2:e220. DOI:10.1097/CCM.0000000000005442

--------
--------

## The authors reply.

2:e220. DOI:10.1097/CCM.0000000000005445

--------
--------

## Orange You Wishing There Were Definitive Randomized Controlled Trials Already?: Erratum.

2:e220. DOI:10.1097/CCM.0000000000005444

--------
--------

## 21st Century Evidence: Randomized Controlled Trials Versus Systematic Reviews and Meta-Analyses: Erratum.

2:e220. DOI:10.1097/CCM.0000000000005442

--------
--------

## The authors reply.

2:e217-e218. DOI:10.1097/CCM.0000000000005326

关键词：Humans; *Heart Arrest; Adrenal Cortex Hormones

--------
--------

## Efficacy and Safety of Corticosteroid Therapy in Patients With Cardiac Arrest.

## 心脏骤停患者中皮质类固醇治疗的疗效和安全性。
关键词：Humans; *Cardiopulmonary Resuscitation; *Heart Arrest/chemically induced/drug therapy; Adrenal Cortex Hormones/adverse effects

--------
--------

## The authors reply., Acosta, Juli??n N.

2:e215-e216. DOI:10.1097/CCM.0000000000005388

## 作者回复。

--------
--------

## Hemoglobin Level at Admission Is Less Important., Ye, Tian

2:e214-e215. DOI:10.1097/CCM.0000000000005323

## 入院时血红蛋白水平不太重要。
关键词：Humans; *Hemoglobins/analysis; *Hospitalization

--------
--------

## Online Editorial Board Acknowledgment.

2:e103-e108. DOI:10.1097/CCM.0000000000005446

--------
--------

## Pediatric Delirium: We Have Come a Long Way, and We Have Only Just Begun., Traube, Chani

2:350-352. DOI:10.1097/CCM.0000000000005277

## Online Editorial Board Acknowledgment.

--------
--------

## Pediatric Delirium: We Have Come a Long Way, and We Have Only Just Begun.

2:e103-e108. DOI:10.1097/CCM.0000000000005446

--------
--------

## Pediatric Delirium: We Have Come a Long Way, and We Have Only Just Begun.

2:349-350. DOI:10.1097/CCM.0000000000005257

关键词：Humans; Child; *Delirium; Intensive Care Units, Pediatric

--------
--------

## How Much Fluid Should I Give to My Patient on a Ventilator?

## 使用呼吸机给患者输注多少液体？
关键词：Humans; Ventilators, Mechanical; *Home Care Services; *Pneumonia, Ventilator-Associated

--------
--------

## Further Exploration of MARS.

2:346-348. DOI:10.1097/CCM.0000000000005202

## MARS的进一步探索。

--------
--------

## Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation.

2:343-345. DOI:10.1097/CCM.0000000000005342

## 静脉-静脉体外膜氧合期间的俯卧位。
关键词：Humans; Prone Position; *Respiratory Distress Syndrome/therapy; *Extracorporeal Membrane Oxygenation; Patient Positioning

--------
--------

## Are We Still Withdrawing Too Soon?-Predictors of Late Awakening After Cardiac Arrest.

2:338-340. DOI:10.1097/CCM.0000000000005379

## 我们是否还在很快退出？-心脏骤停后晚醒的预测因素。
关键词：Humans; *Hypothermia, Induced; *Heart Arrest/therapy

--------
--------

## The Big Consequences of Small Discrepancies: Why Racial Differences in Pulse Oximetry Errors Matter., Holder, Andre L.

2:335-337. DOI:10.1097/CCM.0000000000005447

## 小偏差的重大后果：为什么脉搏血氧测量错误存在人种差异。
关键词：*Oximetry; *Oxygen; Race Factors

--------
--------

## RBC Transfusion in Venovenous Extracorporeal Membrane Oxygenation: A Multicenter Cohort Study., Raasveld, Senta Jorinde

2:224-234. DOI:10.1097/CCM.0000000000005398

Abstract: 

OBJECTIVES: In the general critical care patient population, restrictive transfusion regimen of RBCs has been shown to be safe and is yet implemented  worldwide. However, in patients on venovenous extracorporeal membrane  oxygenation, guidelines suggest liberal thresholds, and a clear overview of RBC  transfusion practice is lacking. This study aims to create an overview of RBC  transfusion in venovenous extracorporeal membrane oxygenation. 

DESIGN: Mixed  method approach combining multicenter retrospective study and survey. 

SETTING:  Sixteen ICUs worldwide. 

PATIENTS: Patients receiving venovenous extracorporeal  membrane oxygenation between January 2018 and July 2019. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: The primary outcome was the proportion receiving  RBC, the amount of RBC units given daily and in total. Furthermore, the course of  hemoglobin over time during extracorporeal membrane oxygenation was assessed.  Demographics, extracorporeal membrane oxygenation characteristics, and patient  outcome were collected. Two-hundred eight patients received venovenous  extracorporeal membrane oxygenation, 63% male, with an age of 55 years (45-62  yr), mainly for acute respiratory distress syndrome. Extracorporeal membrane  oxygenation duration was 9 days (5-14 d). Prior to extracorporeal membrane  oxygenation, hemoglobin was 10.8 g/dL (8.9-13.0 g/dL), decreasing to 8.7 g/dL  (7.7-9.8 g/dL) during extracorporeal membrane oxygenation. Nadir hemoglobin was  lower on days when a transfusion was administered (8.1 g/dL [7.4-9.3 g/dL]). A  vast majority of 88% patients received greater than or equal to 1 RBC  transfusion, consisting of 1.6 U (1.3-2.3 U) on transfusion days. This high  transfusion occurrence rate was also found in nonbleeding patients (81%).  Patients with a liberal transfusion threshold (hemoglobin > 9 g/dL) received more  RBC in total per transfusion day and extracorporeal membrane oxygenation day. No  differences in survival, hemorrhagic and thrombotic complication rates were found  between different transfusion thresholds. Also, 28-day mortality was equal in  transfused and nontransfused patients. 

CONCLUSIONS: Transfusion of RBC has a high  occurrence rate in patients on venovenous extracorporeal membrane oxygenation,  even in nonbleeding patients. There is a need for future studies to find optimal  transfusion thresholds and triggers in patients on extracorporeal membrane  oxygenation.

## 静脉-静脉体外膜氧合中的RBC输血：一项多中心队列研究。

目的：在一般重症监护患者人群中，已证实RBC的限制性输血方案是安全的，且尚未实施  全球。但是，在接受静脉-静脉体外膜的患者中  指南建议自由的阈值和对RBC的清晰概述  缺乏输血实践。本研究旨在创建RBC概述  静脉-静脉体外膜肺氧合中的输血。

设计：混合  多中心回顾性研究与调查相结合的方法。

设置：  全球16间ICU。

患者：接受静脉-静脉体外治疗的患者  2018年1月至2019年7月期间的膜氧合。

干预：无。

测量和主要结果：主要结局是接受  RBC，每日给予的RBC单位数量和总数量。此外，病程  评估了体外膜氧合期间血红蛋白随时间的变化。人口统计学、体外膜肺氧合特征和患者  收集结局。208例患者接受了静脉-静脉输注  体外膜肺氧合，63%男性，年龄55岁（45-62岁）  yr），主要用于急性呼吸窘迫综合征。体外膜  氧合持续时间为9天（5-14天）。体外膜之前  氧合，血红蛋白为10.8 g/dL(8.9-13.0 g/dL)，降低至8.7 g/dL  (7.7-9.8 g/dL)。血红蛋白最低值  输血天数减少(8.1 g/dL[7.4-9.3 g/dL])。A  绝大多数88%的患者接受了大于或等于1个RBC  输血，输血日1.6 U(1.3-2.3 U)。如此之高  在非出血患者中也发现输血发生率(81%)。输血阈值较宽（血红蛋白 > 9 g/dL）的患者接受更多的  每个输血日和体外膜氧合日的总RBC。No  发现生存率、出血和血栓并发症发生率存在差异  不同输血阈值之间。此外，28天死亡率与  输血和非输血患者。

结论：RBC输血具有高  接受静脉-静脉体外膜氧合的患者的发生率，  即使在非出血患者中。未来的研究需要找到最优的  体外膜患者的输血阈值和触发因素  氧合作用。
关键词：Humans; Treatment Outcome; Female; Male; Middle Aged; Adult; Cohort Studies; Retrospective Studies; Australia; Netherlands; Intensive Care Units/organization & administration/statistics & numerical data; Italy; Belgium; Croatia; Erythrocyte Transfusion/methods/*standards/statistics & numerical data; Extracorporeal Membrane Oxygenation/methods/*statistics & numerical data; Sweden

--------
--------

## Coronavirus Disease 2019 Temperature Trajectories Correlate With Hyperinflammatory and Hypercoagulable Subphenotypes.

2:212-223. DOI:10.1097/CCM.0000000000005397

Abstract: 

OBJECTIVES: Body temperature trajectories of infected patients are associated with specific immune profiles and survival. We determined the association between  temperature trajectories and distinct manifestations of coronavirus disease 2019.  

DESIGN: Retrospective observational study. 

SETTING: Four hospitals within an  academic healthcare system from March 2020 to February 2021. 

PATIENTS: All adult  patients hospitalized with coronavirus disease 2019. 

INTERVENTIONS: Using a  validated group-based trajectory model, we classified patients into four  previously defined temperature trajectory subphenotypes using oral temperature  measurements from the first 72 hours of hospitalization. Clinical  characteristics, biomarkers, and outcomes were compared between subphenotypes.  

MEASUREMENTS AND MAIN RESULTS: The 5,903 hospitalized coronavirus disease 2019  patients were classified into four subphenotypes: hyperthermic slow resolvers (n  = 1,452, 25%), hyperthermic fast resolvers (1,469, 25%), normothermics (2,126,  36%), and hypothermics (856, 15%). Hypothermics had abnormal coagulation markers,  with the highest d-dimer and fibrin monomers (p < 0.001) and the highest  prevalence of cerebrovascular accidents (10%, p = 0.001). The prevalence of  venous thromboembolism was significantly different between subphenotypes (p =  0.005), with the highest rate in hypothermics (8.5%) and lowest in hyperthermic  slow resolvers (5.1%). Hyperthermic slow resolvers had abnormal inflammatory  markers, with the highest C-reactive protein, ferritin, and interleukin-6 (p <  0.001). Hyperthermic slow resolvers had increased odds of mechanical ventilation,  vasopressors, and 30-day inpatient mortality (odds ratio, 1.58; 95% CI,  1.13-2.19) compared with hyperthermic fast resolvers. Over the course of the  pandemic, we observed a drastic decrease in the prevalence of hyperthermic slow  resolvers, from representing 53% of admissions in March 2020 to less than 15% by  2021. We found that dexamethasone use was associated with significant reduction  in probability of hyperthermic slow resolvers membership (27% reduction; 95% CI,  23-31%; p < 0.001). 

CONCLUSIONS: Hypothermics had abnormal coagulation markers,  suggesting a hypercoagulable subphenotype. Hyperthermic slow resolvers had  elevated inflammatory markers and the highest odds of mortality, suggesting a  hyperinflammatory subphenotype. Future work should investigate whether  temperature subphenotypes benefit from targeted antithrombotic and  anti-inflammatory strategies.

## 冠状病毒病2019温度轨迹与高炎性和高凝性亚表型相关。

目的：感染患者的体温曲线与特定免疫特征和生存期相关。我们确定了  2019年冠状病毒病的温度轨迹和不同表现。

设计：回顾性观察性研究。

单位：一家内四家医院  2020年3月至2021年2月期间的学术医疗系统。

患者：所有成人  2019年冠状病毒病住院患者。

干预：使用  经验证的基于小组的轨迹模型，我们将患者分为四组  之前定义的使用口腔温度的温度轨迹亚表型  住院前72小时的测量值。临床  比较亚表型之间的特征、生物标志物和结局。

测量和主要结果：2019年5,903例住院冠状病毒病  患者分为4个亚表型：高温慢消退型（n  = 1,452，25%）、高温快速解决者(1,469，25%)、常温（2,126，  36%）和低体温(856，15%)。体温过低导致凝血标志物异常，  d-二聚体和纤维蛋白单体最高(p < 0.001)，纤维蛋白单体最高  脑血管意外的患病率(10%，p = 0.001)。以下疾病的患病率  静脉血栓栓塞在亚表型之间有显著差异（p =  0.005），其中低温最高(8.5%)，高温最低  缓慢消退者(5.1%)。体温过高缓慢消退者有异常炎症  具有最高C反应蛋白、铁蛋白和白细胞介素-6的标志物（p <  0.001).体温过高的缓慢恢复者增加了机械通气的几率，  血管加压药和30天住院死亡率（比值比，1.58；95%CI，  1.13-2.19）与高温快速解毒器相比。整个过程  大流行期间，我们观察到高温缓慢型流感的患病率急剧下降  缓解者，从2020年3月占入院的53%降至2020年3月的15%以下  2021.我们发现使用地塞米松与显著减少  体温过高缓慢消退者的比例（降低27%；95%CI，  23-31%; p < 0.001).结论：低体温患者存在凝血标志物异常，  提示高凝亚表型。体温过高缓慢消退者  炎症标志物升高和死亡率最高，表明  高炎性亚表型。未来的工作应该调查是否  温度亚表型获益于靶向抗血栓形成和  抗炎策略。
关键词：Humans; Female; Male; Middle Aged; Aged; Cohort Studies; Retrospective Studies; Academic Medical Centers; Biomarkers/blood; Inflammation; SARS-CoV-2; Blood Coagulation; *Phenotype; Anti-Inflammatory Agents/therapeutic use; Organ Dysfunction Scores; *Body Temperature; COVID-19/*pathology; Dexamethasone/therapeutic use; Hyperthermia/*pathology; Hypothermia/*pathology

--------
--------

## Disparities in Hypoxemia Detection by Pulse Oximetry Across Self-Identified Racial Groups and Associations With Clinical Outcomes.

2:204-211. DOI:10.1097/CCM.0000000000005394

Abstract: 

OBJECTIVES: To assess disparities in hypoxemia detection by pulse oximetry across self-identified racial groups and associations with clinical outcomes. 

DESIGN:  Observational cohort study from May 5, 2018, to December 31, 2020. 

SETTING: Three  academic medical centers in the United States. 

PATIENTS: Adults greater than or  equal to 18 years who self-identified as White, Black, Asian, or American Indian  admitted to the ICU or undergoing surgery during inpatient hospitalization with  simultaneous measurements of pulse oximetry-estimated oxygen saturation and  arterial blood gas-derived oxygen saturation. 

INTERVENTIONS: None. 

MEASUREMENTS  AND MAIN RESULTS: Multivariable models were employed to assess the relationships  between race, occult hypoxemia (i.e., arterial blood gas-derived oxygen  saturation < 88% despite pulse oximetry-estimated oxygen saturation ?‰? 92%), and  clinical outcomes of hospital mortality and hospital-free days. One-hundred  twenty-eight-thousand two-hundred eighty-five paired pulse oximetry-estimated  oxygen saturation-arterial blood gas-derived oxygen saturation measurements were  included from 26,603 patients. Pulse oximetry-estimated oxygen saturation on  average overestimated arterial blood gas-derived oxygen saturation by 1.57%  (1.54-1.61%). Black, Asian, and American Indian patients were more likely to  experience occult hypoxemia during hospitalization (estimated probability 6.2%  [5.1-7.6%], 6.6% [4.9-8.8%], and 6.6% [4.4-10.0%], respectively) compared with  White patients (3.6% [3.4-3.8%]). Black patients had increased odds of occult  hypoxemia compared with White patients after adjustment (odds ratio, 1.65;  1.28-2.14; p < 0.001). Differences in occult hypoxemia between Asian and American  Indian patients compared with White patients were not significant after  adjustment (odds ratio, 1.53; 0.95-2.47; p = 0.077 and odds ratio, 1.31;  0.80-2.16; p = 0.288, respectively). Occult hypoxemia was associated with  increased odds of mortality in surgical (odds ratio, 2.96; 1.20-7.28; p = 0.019)  and ICU patients (1.36; 1.03-1.80; p = 0.033). Occult hypoxemia was associated  with fewer hospital-free days in surgical (-2.5 d [-3.9 to -1.2 d]; p < 0.001)  but not ICU patients (0.4 d [-0.7 to 1.4 d]; p = 0.500). 

CONCLUSIONS: Occult  hypoxemia is more common in Black patients compared with White patients and is  associated with increased mortality, suggesting potentially important outcome  implications for undetected hypoxemia. It is imperative to validate pulse  oximetry with expanded racial inclusion.

## 通过脉搏血氧测定法检测自我识别的人种组中低氧血症的差异以及与临床结局的相关性。

目的：在自我确认的人种组中，通过脉搏血氧定量法评估低氧血症检测的差异，以及与临床结局的相关性。

设计：  2018年5月5日至2020年12月31日的观察性队列研究。

设置：3个  美国学术医学中心。

患者：大于或等于  自称为白人、黑人、亚洲人或美国印第安人的18岁以下儿童  入住ICU或在住院期间接受手术  同时测量脉搏血氧饱和度-估计血氧饱和度和  动脉血气氧饱和度。

干预：无。测量  和主要结果：采用多变量模型评估关系  人种之间，隐匿性低氧血症（即，动脉血气衍生的氧气  脉搏血氧仪估计的氧饱和度???92%，饱和度 < 88%），以及  住院死亡率和无住院天数的临床结局。100  估计的2,800,285对脉搏血氧饱和度  氧饱和度-动脉血气衍生的氧饱和度测量值为  纳入了26,603例患者。脉搏血氧饱和度-估计血氧饱和度  平均高估动脉血气衍生氧饱和度1.57%  (1.54-1.61%).黑人、亚洲人和美洲印第安人患者更可能  住院期间出现隐匿性低氧血症（估计概率6.2%）  分别为[5.1-7.6%]、6.6%[4.9-8.8%]和6.6%[4.4-10.0%]）  白人患者(3.6%[3.4-3.8%])。黑人患者的隐匿性几率增加  校正后低氧血症与白人患者相比（比值比，1.65；  1.28-2.14; p < 0.001).亚裔和美国人之间隐匿性低氧血症的差异  之后，印度患者与白人患者相比无显著性  校正（比值比，1.53；0.95-2.47；p = 0.077和比值比，1.31；  分别为0.80-2.16；p = 0.288）。隐匿性低氧血症与  手术死亡率增加（比值比，2.96；1.20-7.28；p = 0.019）  和ICU患者(1.36；1.03-1.80；p = 0.033)。隐匿性低氧血症相关  手术期间无住院天数更少（-2.5天[-3.9至-1.2天]；p < 0.001）  但不是ICU患者（0.4天[-0.7至1.4天]；p = 0.500）。

结论：隐性  与白人患者相比，低氧血症在黑人患者中更常见，  与死亡率增加相关，提示潜在重要结局  对未检测到的低氧血症的影响。必须验证脉冲  血氧定量法，包含扩大的人种。
关键词：Humans; Female; Male; Middle Aged; Aged; Cohort Studies; Academic Medical Centers/organization & administration/statistics & numerical data; Arizona; Florida; Hypoxia/*diagnosis/ethnology; Minnesota; Outcome Assessment, Health Care/methods/*statistics & numerical data; Oximetry/instrumentation/methods/*standards; Oxygen/analysis/blood; Racial Groups/ethnology/*statistics & numerical data; Self Report/statistics & numerical data; Skin Pigmentation/*physiology

--------
--------

## Lung- and Diaphragm-Protective Ventilation by Titrating Inspiratory Support to Diaphragm Effort: A Randomized Clinical Trial., de Vries, Heder J.

2:192-203. DOI:10.1097/CCM.0000000000005395

Abstract: 

OBJECTIVES: Lung- and diaphragm-protective ventilation is a novel concept that aims to limit the detrimental effects of mechanical ventilation on the diaphragm  while remaining within limits of lung-protective ventilation. The premise is that  low breathing effort under mechanical ventilation causes diaphragm atrophy,  whereas excessive breathing effort induces diaphragm and lung injury. In a  proof-of-concept study, we aimed to assess whether titration of inspiratory  support based on diaphragm effort increases the time that patients have effort in  a predefined "diaphragm-protective" range, without compromising lung-protective  ventilation. 

DESIGN: Randomized clinical trial. 

SETTING: Mixed medical-surgical  ICU in a tertiary academic hospital in the Netherlands. 

PATIENTS: Patients (n =  40) with respiratory failure ventilated in a partially-supported mode.  

INTERVENTIONS: In the intervention group, inspiratory support was titrated hourly  to obtain transdiaphragmatic pressure swings in the predefined  "diaphragm-protective" range (3-12 cm H2O). The control group received  standard-of-care. 

MEASUREMENTS AND MAIN RESULTS: Transdiaphragmatic pressure,  transpulmonary pressure, and tidal volume were monitored continuously for 24  hours in both groups. In the intervention group, more breaths were within  "diaphragm-protective" range compared with the control group (median 81%;  interquartile range [64-86%] vs 35% [16-60%], respectively; p < 0.001). Dynamic  transpulmonary pressures (20.5 ?± 7.1 vs 18.5 ?± 7.0 cm H2O; p = 0.321) and tidal  volumes (7.56 ?± 1.47 vs 7.54 ?± 1.22 mL/kg; p = 0.961) were not different in the  intervention and control group, respectively. 

CONCLUSIONS: Titration of  inspiratory support based on patient breathing effort greatly increased the time  that patients had diaphragm effort in the predefined "diaphragm-protective" range  without compromising tidal volumes and transpulmonary pressures. This study  provides a strong rationale for further studies powered on patient-centered  outcomes.

## 通过滴定吸气支持对膈肌用力的肺和膈肌保护性通气：一项随机化临床试验。

目的：肺和隔膜保护性通气是一个新概念，旨在限制机械通气对隔膜的有害作用  同时保持在肺保护通气的限值内。前提是  机械通气时呼吸费力小，导致膈肌萎缩，  而过度的呼吸用力会导致膈肌和肺损伤。在a中  概念验证研究，我们旨在评估吸气滴定是否  基于膈肌做功的支持增加了患者做功的时间  预定义的“隔膜保护”范围，不影响肺保护  通风。

设计：随机临床试验。

设置：混合内科-外科  荷兰一家三级学术医院的ICU。

患者：患者（n =  40）患有呼吸衰竭，在部分支持模式下通气。

干预：在干预组中，每小时调整一次吸气支持  以获得预定义的经膈肌压力波动  “隔膜-保护”范围(3-12 cm H2O)。对照组接受  标准治疗。

测量和主要结果：经膈肌压力，  连续监测24小时的跨肺压和潮气量  两组的小时数。在干预组中，更多的呼吸在  “隔膜保护”范围与对照组相比（中位数81%；  四分位距[64-86%]vs 35%[16-60%]；p < 0.001）。动态  跨肺压(20.5?7.1 vs 18.5?±7.0 cm H2O；p = 0.321)和潮气量  注射体积（分别为7.56±1.47和7.54±1.22 mL/kg；p = 0.961）在  干预组和对照组。

结论：滴定  基于患者呼吸努力的吸气支持大大增加了时间  患者的膈肌用力在预定的“膈肌保护”范围内  不影响潮气量和跨肺压。本研究  为以患者为中心的进一步研究提供了强有力的依据  结局。
关键词：Humans; Female; Male; Middle Aged; Intensive Care Units/organization & administration/statistics & numerical data; Netherlands/epidemiology; Diaphragm/*metabolism/physiopathology; Lung/*metabolism/physiopathology; Respiration, Artificial/methods/*standards/statistics & numerical data; Respiratory Insufficiency/epidemiology/prevention & control/therapy; Work of Breathing/drug effects/*physiology

--------
--------

## Optimal Cerebral Perfusion Pressure During Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage., Weiss, Miriam

2:183-191. DOI:10.1097/CCM.0000000000005396

Abstract: 

OBJECTIVES: The recommendation of induced hypertension for delayed cerebral ischemia treatment after aneurysmal subarachnoid hemorrhage has been challenged  recently and ideal pressure targets are missing. A new concept advocates an  individual cerebral perfusion pressure where cerebral autoregulation functions  best to ensure optimal global perfusion. We characterized optimal cerebral  perfusion pressure at time of delayed cerebral ischemia and tested the conformity  of induced hypertension with this target value. 

DESIGN: Retrospective analysis of  prospectively collected data. 

SETTING: University hospital neurocritical care  unit. 

PATIENTS: Thirty-nine aneurysmal subarachnoid hemorrhage patients with  invasive neuromonitoring (20 with delayed cerebral ischemia, 19 without delayed  cerebral ischemia). 

INTERVENTIONS: Induced hypertension greater than 180 mm Hg  systolic blood pressure. 

MEASUREMENTS AND MAIN RESULTS: Changepoint analysis was  used to calculate significant changes in cerebral perfusion pressure, optimal  cerebral perfusion pressure, and the difference of cerebral perfusion pressure  and optimal cerebral perfusion pressure 48 hours before delayed cerebral ischemia  diagnosis. Optimal cerebral perfusion pressure increased 30 hours before the  onset of delayed cerebral ischemia from 82.8 ?± 12.5 to 86.3 ?± 11.4 mm Hg (p <  0.05). Three hours before delayed cerebral ischemia, a changepoint was also found  in the difference of cerebral perfusion pressure and optimal cerebral perfusion  pressure (decrease from -0.2 ?± 11.2 to -7.7 ?± 7.6 mm Hg; p < 0.05) with a  corresponding increase in pressure reactivity index (0.09 ?± 0.33 to 0.19 ?± 0.37;  p < 0.05). Cerebral perfusion pressure at time of delayed cerebral ischemia was  lower than in patients without delayed cerebral ischemia in a comparable time  frame (cerebral perfusion pressure delayed cerebral ischemia 81.4 ?± 8.3 mm Hg, no  delayed cerebral ischemia 90.4 ?± 10.5 mm Hg; p < 0.05). Inducing hypertension  resulted in a cerebral perfusion pressure above optimal cerebral perfusion  pressure (+12.4 ?± 8.3 mm Hg; p < 0.0001). Treatment response (improvement of  delayed cerebral ischemia: induced hypertension+ [n = 15] or progression of  delayed cerebral ischemia: induced hypertension- [n = 5]) did not correlate to  either absolute values of cerebral perfusion pressure or optimal cerebral  perfusion pressure, nor the resulting difference (cerebral perfusion pressure [p  = 0.69]; optimal cerebral perfusion pressure [p = 0.97]; and the difference of  cerebral perfusion pressure and optimal cerebral perfusion pressure [p = 0.51]).  

CONCLUSIONS: At the time of delayed cerebral ischemia occurrence, there is a  significant discrepancy between cerebral perfusion pressure and optimal cerebral  perfusion pressure with worsening of autoregulation, implying inadequate but  identifiable individual perfusion. Standardized induction of hypertension  resulted in cerebral perfusion pressures that exceeded individual optimal  cerebral perfusion pressure in delayed cerebral ischemia patients. The potential  benefit of individual blood pressure management guided by autoregulation-based  optimal cerebral perfusion pressure should be explored in future intervention  studies.

## 动脉瘤性蛛网膜下腔出血后迟发性脑缺血期间的最佳脑灌注压。

目的：对动脉瘤性蛛网膜下腔出血后诱导高血压用于迟发性脑缺血治疗的建议提出质疑  近期和理想的压力目标缺失。新概念支持  脑自动调节功能的个体脑灌注压  确保最佳整体灌注。我们描述了最佳脑功能  迟发型脑缺血时灌注压及一致性检验  的诱导高血压以该目标值。

设计：回顾性分析  前瞻性收集的数据。

单位：大学医院神经重症监护  单位。

患者：39例动脉瘤性蛛网膜下腔出血患者  侵入性神经监测（20例有延迟脑缺血，19例无延迟  脑缺血）。

干预：诱导的高血压大于180 mmHg  收缩压。

测量和主要结果：变更点分析为  用于计算脑灌注压的显著变化，最佳  脑灌注压，以及脑灌注压的差值  延迟性脑缺血前48小时的最佳脑灌注压  诊断。最佳脑灌注压在以下前30小时升高  迟发性脑缺血发作，从82.8±12.5到86.3±11.4 mmHg（p <  0.05).迟发性脑缺血前3小时也发现变点  在脑灌注压的差异和最佳脑灌注  压力（从-0.2Ι±11.2降至-7.7Ι±7.6 mmHg；p < 0.05），其中  压力反应性指数相应增加（0.09 μm±0.33至0.19 μm±0.37；p < 0.05).延迟性脑缺血时的脑灌注压为  在相当时间内低于无迟发性脑缺血的患者  脑灌注压延迟脑缺血81.4 μm±8.3 mmHg，无  迟发性脑缺血90.4 μm±10.5 mmHg；p < 0.05）。诱发高血压  导致脑灌注压高于最佳脑灌注  压力(+ 12.4?8.3 mmHg；p < 0.0001)。治疗缓解（改善  迟发性脑缺血：诱发高血压 +[n = 15]或进展  迟发性脑缺血：诱导的高血压-[n = 5]）与以下症状无关  脑灌注压绝对值或最佳脑灌注压  灌注压，也未得到相应的差异（脑灌注压[p  = 0.69]；最佳脑灌注压[p = 0.97]；以及  脑灌注压和最佳脑灌注压[p = 0.51]）。

结论：在迟发性脑缺血发生时，存在  脑灌注压与最佳脑灌注压之间存在显著差异  灌注压伴随自动调节恶化，提示不充分但  可识别的个体灌注。高血压规范化诱导  导致脑灌注压超过个体最佳灌注压  迟发性脑缺血患者的脑灌注压。电位  基于自动调节指导的个体血压管理获益  在将来的干预中应探索最佳的脑灌注压  研究。
关键词：Humans; Female; Male; Middle Aged; Adult; Retrospective Studies; Cerebrovascular Circulation/*physiology; *Time Factors; Brain Ischemia/*etiology/physiopathology; Subarachnoid Hemorrhage/*complications/physiopathology; Tertiary Care Centers/organization & administration/statistics & numerical data

--------
--------

## Transfusion-Associated Delirium in Children: No Difference Between Short Storage Versus Standard Issue RBCs.

2:173-182. DOI:10.1097/CCM.0000000000005393

Abstract: 

OBJECTIVES: Primary objective is to determine if transfusion of short storage RBCs compared with standard issue RBCs reduced risk of delirium/coma in  critically ill children. Secondary objective is to assess if RBC transfusion was  independently associated with delirium/coma. 

DESIGN: This study was performed in  two stages. First, we compared patients receiving either short storage or  standard RBCs in a multi-institutional prospective randomized controlled trial.  Then, we compared all transfused patients in the randomized controlled trial with  a single-center cohort of nontransfused patients matched for confounders of  delirium/coma. 

SETTING: Twenty academic PICUs who participated in the Age of  Transfused Blood in Critically Ill Children trial. 

PATIENTS: Children 3 days to  16 years old who were transfused RBCs within the first 7 days of admission.  

INTERVENTIONS: Subjects were randomized to either short storage RBC study arm  (defined as RBCs stored for up to seven days) or standard issue RBC study arm. In  addition, subjects were screened for delirium prior to transfusion and every 12  hours after transfusion for up to 3 days. 

MEASUREMENTS AND MAIN RESULTS: Primary  outcome measure was development of delirium/coma within 3 days of initial  transfusion. Additional outcome measures were dose-response relationship between  volume of RBCs transfused and delirium/coma, and comparison of delirium/coma  rates between transfused patients and individually matched nontransfused  patients. We included 146 subjects in the stage I analysis; 69 were randomized to  short storage RBCs and 77 to standard issue. There was no significant difference  in delirium/coma development between study arms (79.5% vs 70.1%; p = 0.184). In  the stage II analysis, adjusted odds for delirium in the transfused cohort was  more than eight-fold higher than in the nontransfused matched cohort, even after  controlling for hemoglobin (adjusted odds ratio, 8.9; CI, 2.8-28.4; p < 0.001).  

CONCLUSIONS: RBC transfusions (and not anemia) are independently associated with  increased odds of subsequent delirium/coma. However, storage age of RBCs does not  affect delirium risk.

## 儿童输血相关性谵妄：短期储存与标准发放RBC之间无差异。

目的：主要目的是确定与标准输注RBC相比，输注短储存RBC是否可降低下列患者的谵妄/昏迷风险  重症儿童。次要目的是评估RBC输血是否  与谵妄/昏迷独立相关。

设计：本研究在  两个阶段。首先，我们比较了接受短期储存或  多机构前瞻性随机对照试验中的标准RBC。然后，我们将随机对照试验中的所有输血患者与  单个中心队列的非输血患者匹配混杂因素  谵妄/昏迷。

单位：20位年龄在  危重病儿童输血试验。

患者：儿童3天至  16岁，入院前7天内输注RBC。

干预：受试者随机分配至短期储存RBC研究组  （定义为RBC储存长达7天）或标准问题RBC研究组。In  此外，受试者在输血前和每12小时一次接受谵妄筛查  输注后数小时，最长持续3天。

测量和主要结果：主要  结局指标为初始治疗3天内发生谵妄/昏迷  输血。其他结局指标为剂量-效应关系  RBC输血量和谵妄/昏迷，以及谵妄/昏迷比较  输血患者与个体匹配的非输血患者之间的比率  患者。我们在I期分析中纳入了146例受试者；其中69例被随机分配至  短期储存RBC和77至标准问题。无显著性差异  研究组之间谵妄/昏迷的发生率(79.5%vs 70.1%；p = 0.184)。In  II期分析，输血队列中谵妄的校正比值比为  比非输血匹配队列高8倍以上，即使在  控制血红蛋白（校正比值比，8.9；CI，2.8-28.4；p < 0.001）。

结论：红细胞输注（而不是贫血）与以下独立相关  增加继发谵妄/昏迷的几率。但是，RBC的储存时间不  影响谵妄风险。
关键词：Humans; Female; Male; Prospective Studies; Animals; Child; Disease Models, Animal; Rats, Sprague-Dawley; Rats; Odds Ratio; Surveys and Questionnaires; *Time Factors; Blood Banks/methods/*statistics & numerical data; Blood Transfusion/methods/*statistics & numerical data; Delirium/*etiology/therapy; Erythrocytes/metabolism/*physiology

--------
--------

## Ake Grenvik, MD, PhD, MCCM., Pinsky, Michael R.

2:171-172. DOI:10.1097/CCM.0000000000005408

## Ake Grenvik，MD，PhD，MCCM。

--------
--------

## The authors reply.

2:e210-e211. DOI:10.1097/CCM.0000000000005391

## 作者回复。
关键词：Humans; Biomarkers; *COVID-19; SARS-CoV-2; *Respiratory Distress Syndrome; *Ventricular Dysfunction, Right

--------
--------

## The authors reply., Chotalia, Minesh

2:e213-e214. DOI:10.1097/CCM.0000000000005390

## 作者回复。

--------
--------

## Rapid Development and Deployment of an Intensivist-Led Venovenous Extracorporeal Membrane Oxygenation Cannulation Program.

2:e154-e161. DOI:10.1097/CCM.0000000000005282

Abstract: 

OBJECTIVES: To determine the safety and efficacy of a rapidly deployed intensivist-led venovenous extracorporeal membrane oxygenation cannulation  program in a preexisting extracorporeal membrane oxygenation program. 

DESIGN: A  retrospective observational before-and-after study of 40 patients undergoing  percutaneous cannulation for venovenous extracorporeal membrane oxygenation in an  established cannulation program by cardiothoracic surgeons versus a rapidly  deployed medical intensivist cannulation program. 

SETTING: An adult ICU in a  tertiary academic medical center in Camden, NJ. 

PATIENTS: Critically ill adult  subjects with severe respiratory failure undergoing percutaneous cannulation for  venovenous extracorporeal membrane oxygenation. 

INTERVENTIONS: Percutaneous  cannulation for venovenous extracorporeal membrane oxygenation performed by  cardiothoracic surgeons compared with cannulations performed by medical  intensivists. 

MEASUREMENTS AND MAIN RESULTS: Venovenous extracorporeal membrane  oxygenation cannulation site attempts were retrospectively reviewed. Subject  demographics, specialty of physician performing cannulation, type of support,  cannulation configuration, cannula size, imaging guidance, success rate, and  complications were recorded and summarized. Twenty-two cannulations were  performed by three cardiothoracic surgeons in 11 subjects between September 2019  and February 2020. The cannulation program rapidly transitioned to an  intensivist-led and performed program in March 2020. Fifty-seven cannulations  were performed by eight intensivists in 29 subjects between March 2020 and  December 2020. Mean body mass index for subjects did not differ between groups  (33.86 vs 35.89; p = 0.775). There was no difference in days on mechanical  ventilation prior to cannulation, configuration, cannula size, or discharge  condition. There was no difference in success rate of cannulation on first  attempt per cannulation site (95.5 vs 96.7; p = 0.483) or major complication rate  per cannulation site (4.5 vs 3.5; p = 1). 

CONCLUSIONS: There is no difference  between success and complication rates of percutaneous venovenous extracorporeal  membrane oxygenation canulation when performed by cardiothoracic surgeons versus  medical intensivist in an already established extracorporeal membrane oxygenation  program. A rapidly deployed cannulation program by intensivists for venovenous  extracorporeal membrane oxygenation can be performed with high success and low  complication rates.

## 强化静脉-静脉体外膜氧合插管项目的快速开发和部署。

目的：确定快速展开的重症监护-主导的静脉-静脉体外膜肺氧合插管的安全性和疗效  预存体外膜肺氧合项目中的项目。

设计：A  对40名接受  经皮插管行静脉-静脉体外膜肺氧合  由心胸外科医生与快速导管插入术确定的插管方案  部署了内科重症监护插管项目。

背景：成人ICU  新泽西州卡姆登第三学术医学中心。

患者：重症成人  接受经皮插管治疗的重度呼吸衰竭受试者  静脉-静脉体外膜肺氧合。

干预：经皮  静脉-静脉体外膜肺氧合插管  心胸外科医生与内科插管的比较  重症监护医生。

测量和主要结果：静脉-静脉体外膜  对氧合插管部位尝试进行了回顾性审查。受试者  人口统计学、行插管术的医生的专业、支持类型，  插管结构、插管尺寸、成像引导、成功率，以及  记录并总结并发症。22例插管  2019年9月由3名心胸外科医生在11名受试者中进行  和2020年2月。插管程序快速转变为  重症监护医师主导并于2020年3月开展的项目。57例插管  在2020年3月至  2020年12月。治疗组间受试者的平均体重指数无差异  (33.86 vs 35.89；p = 0.775)。机械通气天数无差异  插管、配置、插管尺寸或排出前通气  条件。首次插管成功率无差异  尝试通过插管部位(95.5 vs 96.7；p = 0.483)或重大并发症发生率  每个插管部位(4.5 vs 3.5；p = 1)。

结论：无差异  介于经皮静脉-静脉体外的成功率和并发症发生率之间  由心胸外科医生与  已确立的体外膜肺氧合的内科重症监护医生  程序。重症监护医生开展的静脉-静脉快速置入术项目  体外膜肺氧合成功率高，成功率低  并发症发生率。
关键词：Humans; Female; Male; Middle Aged; Aged; Retrospective Studies; Extracorporeal Membrane Oxygenation/methods/*statistics & numerical data; Academic Medical Centers/organization & administration/statistics & numerical data; *Time Factors; Catheterization/methods/*statistics & numerical data; Health Services/statistics & numerical data/supply & distribution/*trends; Intensive Care Units/organization & administration/*statistics & numerical data; Internal Medicine/methods/statistics & numerical data; New Jersey

--------
--------

## Evaluating the Balance Between Privacy and Access in Digital Information Sharing.

2:e109-e116. DOI:10.1097/CCM.0000000000005234

Abstract: 

OBJECTIVES: Access to personal health records in an ICU by persons involved in the patient's care (referred to broadly as "family members" below) has the  potential to increase engagement and reduce the negative psychologic sequelae of  such hospitalizations. Currently, little is known about patient preferences for  information sharing with a designated family member in the ICU. We sought to  understand the information-sharing preferences of former ICU patients and their  family members and to identify predictors of information-sharing preferences.  

DESIGN: We performed an internet survey that was developed by a broad,  multidisciplinary team of stakeholders. Formal pilot testing of the survey was  conducted prior to internet survey administration to study subjects. 

SETTING:  Internet survey. 

SUBJECTS: Subjects included English-speaking adults who had an  ICU experience or a family member with ICU experience between 2013 and 2016. We  used panel sampling to ensure an ethnically representative sample of the U.S.  population. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: One thousand five  hundred twenty surveys were submitted, and 1,470 were included in analysis. The  majority of respondents (93.6%) stated that they would want to share present and  past medical history, either all or that related to their ICU stay, with a  designated family member of their choosing. The majority (79%) would also want  their designated family member to be able to access that information from a home  computer. Although most respondents preferred to share all types of information,  they indicated varying levels of willingness to share specific types of more  sensitive information. Information-sharing preferences did not differ by age,  sex, ethnicity, or type of prior experience in the ICU (i.e., patient or family  member). 

CONCLUSIONS: In the context of an ICU admission, sharing personal health  information with a person of the patient's choosing appears desirable for most  patients and family members. Policies and implementation of regulations should  take this into consideration.

## 数字信息共享中隐私与访问的平衡评估。

目的：参与患者护理的人员（下文统称为“家庭成员”）在ICU中查阅个人健康记录具有  可能增加参与并减少下列不良心理后遗症  此类住院。目前，关于患者的偏好知之甚少  与ICU指定的家庭成员共享信息。我们试图  了解既往ICU患者及其信息分享偏好  家庭成员和识别信息共享偏好的预测因素。

设计：我们进行了一项互联网调查，该调查由一个广泛的，  利益相关者多学科团队。调查的正式试点试验是  在对研究受试者进行网络调查之前进行。

设置：  网络调查。

受试者：受试者包括说英语的成年人，  2013年至2016年有ICU经验或家庭成员有ICU经验。We  使用样本组采样，以确保美国的种族代表性样本。  人群。

干预：无。

测量和主要结果：1505  提交了120份调查，其中1470份被纳入分析。事件  大多数回答者(93.6%)表示他们希望分享现在和  既往病史，包括所有或与其ICU住院相关病史，且  指定其选择的家庭成员。大多数(79%)也希望  其指定的家庭成员能够从家中访问该信息  计算机。尽管大多数受访者倾向于分享所有类型的信息，  他们表示不同程度的愿意分享特定类型的更多  敏感信息。不同年龄的信息共享偏好无差异，  性别、种族或ICU既往经验类型（即患者或家人）  成员）。

结论：在入住ICU的背景下，共享个人健康  大多数人希望获得患者选择的信息  患者和家属。法规的政策与执行应  考虑到这一点。
关键词：Humans; Female; Male; Middle Aged; Adult; Surveys and Questionnaires; Confidentiality/*standards/trends; Health Services Accessibility/*standards/trends; Information Dissemination/*methods; Patient Preference/psychology/statistics & numerical data

--------
--------

## Anisocoria and Poor Pupil Reactivity by Quantitative Pupillometry in Patients With Intracranial Pathology., Prescott, Brenton R.

2:e143-e153. DOI:10.1097/CCM.0000000000005272

Abstract: 

OBJECTIVES: To describe the prevalence and associated risk factors of new onset anisocoria (new pupil size difference of at least 1 mm) and its subtypes: new  onset anisocoria accompanied by abnormal and normal pupil reactivities in  patients with acute neurologic injuries. 

DESIGN: We tested the association of  patients who experienced new onset anisocoria subtypes with degree of midline  shift using linear regression. We further explored differences between  quantitative pupil characteristics associated with first-time new onset  anisocoria and nonnew onset anisocoria at preceding observations using mixed  effects logistic regression, adjusting for possible confounders. 

SETTING: All  quantitative pupil observations were collected at two neuro-ICUs by nursing staff  as standard of care. 

PATIENTS: We conducted a retrospective two-center study of  adult patients with intracranial pathology in the ICU with at least a 24-hour  stay and three or more quantitative pupil measurements between 2016 and 2018.  

MEASUREMENTS AND MAIN RESULTS: We studied 221 patients (mean age 58, 41% women).  Sixty-three percent experienced new onset anisocoria. New onset anisocoria  accompanied by objective evidence of abnormal pupil reactivity occurring at any  point during hospitalization was significantly associated with maximum midline  shift (?? = 2.27 per mm; p = 0.01). The occurrence of new onset anisocoria  accompanied by objective evidence of normal pupil reactivity was inversely  associated with death (odds ratio, 0.34; 95% CI, 0.16-0.71; p = 0.01) in adjusted  analyses. Subclinical continuous pupil size difference distinguished first-time  new onset anisocoria from nonnew onset anisocoria in up to four preceding pupil  observations (or up to 8 hr prior). Minimum pupil reactivity between eyes also  distinguished new onset anisocoria accompanied by objective evidence of abnormal  pupil reactivity from new onset anisocoria accompanied by objective evidence of  normal pupil reactivity prior to first-time new onset anisocoria occurrence.  

CONCLUSIONS: New onset anisocoria occurs in over 60% of patients with neurologic  emergencies. Pupil reactivity may be an important distinguishing characteristic  of clinically relevant new onset anisocoria phenotypes. New onset anisocoria  accompanied by objective evidence of abnormal pupil reactivity was associated  with midline shift, and new onset anisocoria accompanied by objective evidence of  normal pupil reactivity had an inverse relationship with death. Distinct  quantitative pupil characteristics precede new onset anisocoria occurrence and  may allow for earlier prediction of neurologic decline. Further work is needed to  determine whether quantitative pupillometry sensitively/specifically predicts  clinically relevant anisocoria, enabling possible earlier treatments.

## 颅内病变患者瞳孔不等大和瞳孔反应不良（定量瞳孔测量）。

目的：描述新发瞳孔不等大（新瞳孔大小差异至少1 mm）及其亚型的患病率和相关风险因素：新  起始瞳孔不等大伴瞳孔反应异常和正常  急性神经损伤患者。

设计：我们检测了  出现新发瞳孔不等亚型伴中线程度的患者  使用线性回归进行偏移。我们进一步探索了  与首次新发相关的定量瞳孔特征  使用混合显微镜在先前观察时观察到的瞳孔不等和非新发瞳孔不等  logistic回归效应，校正可能的混杂因素。

设置：全部  由护理人员在两间神经-ICU收集定量瞳孔观察结果  作为标准治疗。

患者：我们进行了一项回顾性两中心研究  ICU中至少24小时内有颅内病变的成人患者  2016年至2018年期间停留和三次或三次以上定量瞳孔测量。

测量和主要结果：我们研究了221例患者（平均年龄58岁，41%为女性）。63%的患者出现新发瞳孔不等大。新发瞳孔不等大  伴有在任何时间发生的瞳孔反应异常的客观证据  住院期间，最大中线显著相关  偏移(Δ? = 2.27/mm；p = 0.01)。新发瞳孔不等大的发生  伴有正常瞳孔反应性的客观证据为反  校正后与死亡相关（比值比，0.34；95%CI，0.16-0.71；p = 0.01）  分析。首次区分亚临床连续瞳孔大小差异  在之前多达4个瞳孔中，非新发瞳孔不等大导致新发瞳孔不等大  观察（或8 h前）。双眼之间的最低瞳孔反应性也  区分新发瞳孔不等伴异常的客观证据  新发瞳孔大小不等引起的瞳孔反应性伴客观证据  首次新发瞳孔不等大发生前瞳孔反应正常。

结论：超过60%的神经科患者出现新发瞳孔不等  紧急情况。瞳孔反应可能是一个重要的鉴别特征  临床相关的新发瞳孔不等表型。新发瞳孔不等大  伴随瞳孔反应性异常的客观证据与  伴有中线移位和新发瞳孔不等大，伴有客观证据  正常瞳孔反应性与死亡呈负相关。显著  定量瞳孔特征先于新发瞳孔不等大发生，且  可能允许更早预测神经功能衰退。需要进一步的工作  确定定量瞳孔测量是否可灵敏/特异地预测  临床相关的瞳孔大小不等，能够进行早期治疗。
关键词：Humans; Female; Male; Middle Aged; Adult; Cohort Studies; Retrospective Studies; Intensive Care Units/organization & administration/statistics & numerical data; Anisocoria/*complications/epidemiology; Brain/*pathology/physiopathology; Reflex, Pupillary/*physiology

--------
--------

## Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm: A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest  Trial.

2:e129-e142. DOI:10.1097/CCM.0000000000005271

Abstract: 

OBJECTIVES: The optimal targeted temperature in patients with shockable rhythm is unclear, and current guidelines recommend targeted temperature management with a  correspondingly wide range between 32?°C and 36?°C. Our aim was to study survival  and neurologic outcome associated with targeted temperature management strategy  in postarrest patients with initial shockable rhythm. 

DESIGN: Observational  substudy of the Coronary Angiography after Cardiac Arrest without ST-segment  Elevation trial. 

SETTING: Nineteen hospitals in The Netherlands. 

PATIENTS: The  Coronary Angiography after Cardiac Arrest trial randomized successfully  resuscitated patients with shockable rhythm and absence of ST-segment elevation  to a strategy of immediate or delayed coronary angiography. In this substudy, 459  patients treated with mild therapeutic hypothermia (32.0-34.0?°C) or targeted  normothermia (36.0-37.0?°C) were included. Allocation to targeted temperature  management strategy was at the discretion of the physician. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: After 90 days, 171 patients (63.6%) in the mild  therapeutic hypothermia group and 129 (67.9%) in the targeted normothermia group  were alive (hazard ratio, 0.86 [95% CI, 0.62-1.18]; log-rank p = 0.35; adjusted  odds ratio, 0.89; 95% CI, 0.45-1.72). Patients in the mild therapeutic  hypothermia group had longer ICU stay (4 d [3-7 d] vs 3 d [2-5 d]; ratio of  geometric means, 1.32; 95% CI, 1.15-1.51), lower blood pressures, higher lactate  levels, and increased need for inotropic support. Cerebral Performance Category  scores at ICU discharge and 90-day follow-up and patient-reported Mental and  Physical Health Scores at 1 year were similar in the two groups. 

CONCLUSIONS: In  the context of out-of-hospital cardiac arrest with shockable rhythm and no  ST-elevation, treatment with mild therapeutic hypothermia was not associated with  improved 90-day survival compared with targeted normothermia. Neurologic outcomes  at 90 days as well as patient-reported Mental and Physical Health Scores at 1  year did not differ between the groups.

## 院外心脏骤停伴可电击节律的目标温度管理：心脏骤停后冠状动脉造影的事后分析  试验。

目的：伴有可电击节律的患者的最佳目标温度尚不清楚，现行指南推荐采用  相应地，温度范围在32 ℃至36 ℃之间。我们的目的是研究生存期  与目标温度管理策略相关的神经系统结局  初始可电击节律的停搏后患者。

设计：观察性  无ST段的心搏骤停后冠状动脉造影亚组研究  升高试验。

单位：荷兰的19家医院。

患者：  心搏骤停试验后冠状动脉造影成功随机化  对伴有可电击心律和无ST段抬高的患者进行复苏  立即或延迟冠状动脉造影策略。在该子研究中，459  接受轻度治疗性低体温(32.0-34.0 ℃)或靶向治疗的患者  包括正常体温(36.0 ℃-37.0 ℃)。分配至目标温度  管理策略由医生决定。

干预：无。

测量和主要结果：90天后，171例(63.6%)轻度  治疗性低温组129例(67.9%)，靶向常温组129例  存活（风险比，0.86[95%CI，0.62-1.18]；对数秩检验p = 0.35；校正  比值比，0.89；95%CI，0.45-1.72）。轻度治疗的患者  低温组ICU停留时间较长（4 d[3-7 d]vs 3d[2-5 d];  几何均值，1.32；95%CI，1.15-1.51），较低血压，较高乳酸盐  对正性肌力支持的需求增加。大脑功能分类  ICU出院和90天随访时的评分以及患者报告的精神和  两组1年时的身体健康评分相似。

结论：在  院外心脏骤停，伴有可电击节律，无  ST段抬高，轻度治疗性低体温治疗与  与目标体温正常相比，90天生存率改善。神经系统结局  第90天时以及第1天时患者报告的心理和身体健康评分  治疗组之间的年份没有差异。
关键词：Humans; Treatment Outcome; Female; Male; Middle Aged; Aged; Netherlands; Coronary Angiography/*methods/statistics & numerical data; Electric Countershock/*statistics & numerical data; Hypothermia, Induced/methods/*standards/statistics & numerical data; Out-of-Hospital Cardiac Arrest/epidemiology/*therapy; Resuscitation/methods/statistics & numerical data

--------
--------

## Exogenous Nicotinamide Adenine Dinucleotide Attenuates Postresuscitation Myocardial and Neurologic Dysfunction in a Rat Model of Cardiac Arrest., Su, Chenglei

2:e189-e198. DOI:10.1097/CCM.0000000000005268

Abstract: 

OBJECTIVES: To investigate the therapeutic potential and underlying mechanisms of exogenous nicotinamide adenine dinucleotide+ on postresuscitation myocardial and  neurologic dysfunction in a rat model of cardiac arrest. 

DESIGN: Thirty-eight  rats were randomized into three groups: 1) Sham, 2) Control, and 3) NAD. Except  for the sham group, untreated ventricular fibrillation for 6 minutes followed by  cardiopulmonary resuscitation was performed in the control and NAD groups.  Nicotinamide adenine dinucleotide+ (20 mg/kg) was IV administered at the onset of  return of spontaneous circulation. 

SETTING: University-affiliated research  laboratory. 

SUBJECTS: Sprague-Dawley rats. 

INTERVENTIONS: Nicotinamide adenine  dinucleotide+. 

MEASUREMENTS AND MAIN RESULTS: Hemodynamic and myocardial function  were measured at baseline and within 4 hours following return of spontaneous  circulation. Survival analysis and Neurologic Deficit Score were performed up to  72 hours after return of spontaneous circulation. Adenosine triphosphate  (adenosine triphosphate) level was measured in both brain and heart tissue.  Mitochondrial respiratory chain function, acetylation level, and expression of  Sirtuin3 and NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (NDUFA9) in  isolated mitochondrial protein from both brain and heart tissue were evaluated at  4 hours following return of spontaneous circulation. The results demonstrated  that nicotinamide adenine dinucleotide+ treatment improved mean arterial pressure  (at 1 hr following return of spontaneous circulation, 94.69 ?± 4.25 mm Hg vs 89.57  ?± 7.71 mm Hg; p < 0.05), ejection fraction (at 1 hr following return of  spontaneous circulation, 62.67% ?± 6.71% vs 52.96% ?± 9.37%; p < 0.05), Neurologic  Deficit Score (at 24 hr following return of spontaneous circulation, 449.50 ?±  82.58 vs 339.50 ?± 90.66; p < 0.05), and survival rate compared with that of the  control group. The adenosine triphosphate level and complex I respiratory were  significantly restored in the NAD group compared with those of the control group.  In addition, nicotinamide adenine dinucleotide+ treatment activated the Sirtuin3  pathway, down-regulating acetylated-NDUFA9 in the isolated mitochondria protein.  

CONCLUSIONS: Exogenous nicotinamide adenine dinucleotide+ treatment attenuated  postresuscitation myocardial and neurologic dysfunction. The responsible  mechanisms may involve the preservation of mitochondrial complex I respiratory  capacity and adenosine triphosphate production, which involves the  Sirtuin3-NDUFA9 deacetylation.

## 外源性烟酰胺腺嘌呤二核苷酸减轻心脏骤停大鼠模型复苏后心肌和神经功能障碍。

目的：研究外源性烟酰胺腺嘌呤二核苷酸 + 对复苏后心肌和  心脏骤停大鼠模型中的神经功能障碍。

设计：38  大鼠随机分为3组：1）假手术组，2）对照组和3）NAD组。除外  对于假手术组，未处理心室颤动6 min，然后  对照组和NAD组进行心肺复苏。在以下时间点IV给予烟酰胺腺嘌呤二核苷酸 +(20 mg/kg)  自主循环恢复。

单位：大学附属研究  实验室。

受试者：Sprague-Dawley大鼠。

干预：烟酰胺腺嘌呤  二核苷酸 +。

测量和主要结果：血流动力学和心肌功能  在基线和自发恢复后4小时内进行测量  循环。进行生存期分析和神经功能缺损评分，直至  自主循环恢复后72小时。三磷酸腺苷  在大脑和心脏组织中测量（三磷酸腺苷）水平。线粒体呼吸链功能、乙酰化水平和  Sirtuin3和NADH脱氢酶（泛醌）1α亚复合物，9(NDUFA9)在  在以下时间点评估了脑和心脏组织中分离的线粒体蛋白  自主循环恢复后4小时。结果证明  烟酰胺腺嘌呤二核苷酸 + 治疗改善平均动脉压  （自主循环恢复后1 h，94.69 μm±4.25 mmHg vs 89.57 μm）  ?±7.71 mmHg；p < 0.05），射血分数（恢复至基线后1 h）  自发循环，62.67%?6.71%vs 52.96%?9.37%；p < 0.05），神经系统  缺陷评分（自主循环恢复后24 h，449.50 μm±  82.58 vs 339.50?±90.66；p < 0.05），生存率与  对照组。三磷酸腺苷水平和复合物I呼吸  与对照组相比，NAD组显著恢复。此外，烟酰胺腺嘌呤二核苷酸 + 治疗激活Sirtuin3  通路，下调分离线粒体蛋白中的乙酰化-NDUFA9。

结论：外源性烟酰胺腺嘌呤二核苷酸 + 治疗减弱  复苏后心肌和神经功能障碍。负责人  机制可能涉及线粒体复合物I呼吸功能的保存  能力和三磷酸腺苷的生成，其中涉及  Sirtuin3-NDUFA9去乙酰化。
关键词：Animals; Disease Models, Animal; Rats; Heart Arrest/*complications/drug therapy; Heart Failure/*drug therapy/prevention & control; NAD/*pharmacology/therapeutic use; Nervous System Diseases/*drug therapy/prevention & control; Rats, Sprague-Dawley/injuries/metabolism; Resuscitation/methods/*standards/statistics & numerical data

--------
--------

## Continuous Versus Routine Standardized Electroencephalogram for Outcome Prediction in Critically Ill Adults: Analysis From a Randomized Trial., Beuchat, Isabelle

2:329-334. DOI:10.1097/CCM.0000000000005311

Abstract: 

OBJECTIVES: To investigate electroencephalogram (EEG) features' relation with mortality or functional outcome after disorder of consciousness, stratifying  patients between continuous EEG and routine EEG. 

DESIGN: Retrospective analysis  of data from a randomized controlled trial. 

SETTING: Multiple adult ICUs.  

PATIENTS: Data from 364 adults with acute disorder of consciousness, randomized  to continuous EEG (30-48 hr; n = 182) or repeated 20-minute routine  electroencephalogram (n = 182). 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN  RESULTS: Correlations between electrographic features and mortality and modified  Rankin scale at 6 months (good 0-2) were assessed. Background continuity, higher  frequency, and reactivity correlated with survival and good modified Rankin  scale. 

Rhythmic and periodic patterns carried dual prognostic information:  lateralized periodic discharges were associated with mortality and bad modified  Rankin scale. Generalized rhythmic delta activity correlated with survival, good  modified Rankin scale, and lower occurrence of status epilepticus. Presence of  sleep-spindles and continuous EEG background was associated with good outcome in  the continuous EEG subgroup. In the routine EEG group, a model combining  background frequency, continuity, reactivity, sleep-spindles, and lateralized  periodic discharges was associated with mortality at 70.91% (95% CI,  59.62-80.10%) positive predictive value and 63.93% (95% CI, 58.67-68.89%)  negative predictive value. In the continuous EEG group, a model combining  background continuity, reactivity, generalized rhythmic delta activity, and  lateralized periodic discharges was associated with mortality at 84.62% (95%CI,  75.02-90.97) positive predictive value and 74.77% (95% CI, 68.50-80.16) negative  predictive value. 

CONCLUSIONS: Standardized EEG interpretation provides reliable  prognostic information. Continuous EEG provides more information than routine  EEG.

## 在危重成人中比较连续与常规标准化脑电图用于结局预测：一项随机试验的分析。

目的：研究意识障碍后脑电图(EEG)特征与死亡率或功能结局的关系，分层  连续EEG和常规EEG之间的患者。

设计：回顾性分析  的数据来自一项随机对照试验。

设置：多个成人ICU。

患者：数据来自364例急性意识障碍成人患者，随机分配  至连续EEG(30-48 h；n = 182)或重复20 min常规  脑电图(n = 182)。

干预：无。测量和主要  结果：电波图特征与死亡率之间的相关性和改良  评估了6个月时的Rankin量表（良好0-2分）。背景连续性，较高  与生存期和良好改良Rankin评分相关的频率和反应性  刻度。

节律和周期模式具有双重预后信息：  偏侧周期性放电与死亡率和不良改良相关  Rankin量表。全身节律性δ活动与生存率相关，良好  改良Rankin量表，癫痫持续状态发生率较低。存在  睡眠-纺锤波和连续EEG背景与良好的结局相关  连续EEG亚组。在常规EEG组，模型结合  背景频率、连续性、反应性、睡眠-纺锤波和单侧化  周期性放电与死亡率相关，为70.91%（95%CI，  59.62-80.10%）的阳性预测值和63.93%(95%CI，58.67-68.89%)  阴性预测值。在连续脑电图组，模型结合  背景连续性、反应性、全身节律性δ活动，以及  单侧周期性放电与死亡率相关，为84.62%（95%CI，  75.02-90.97）阳性预测值和74.77%(95%CI，68.50-80.16)阴性  预测值。

结论：标准化脑电图解读提供了可靠的  预后信息。连续EEG提供的信息比常规更多  脑电图。
关键词：Humans; Female; Male; Middle Aged; Prognosis; Adult; Retrospective Studies; ROC Curve; Critical Illness/therapy; Intensive Care Units/organization & administration/statistics & numerical data; Outcome Assessment, Health Care/methods/*statistics & numerical data; *Time Factors; Area Under Curve; Electroencephalography/*methods/standards/statistics & numerical data; Seizures/*diagnosis/epidemiology/physiopathology

--------
--------

## Beneficial Effect of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019., Zaaqoq, Akram M.

2:275-285. DOI:10.1097/CCM.0000000000005296

Abstract: 

OBJECTIVES: The study investigated the impact of prone positioning during venovenous extracorporeal membrane oxygenation support for coronavirus disease  2019 acute respiratory failure on the patient outcome. 

DESIGN: An observational  study of venovenous extracorporeal membrane oxygenation patients. We used a  multistate survival model to compare the outcomes of patients treated with or  without prone positioning during extracorporeal membrane oxygenation, which  incorporates the dynamic nature of prone positioning and adjusts for potential  confounders. 

SETTING: Seventy-two international institutions participating in the  Coronavirus Disease 2019 Critical Care Consortium international registry.  

PATIENTS: Coronavirus disease 2019 patients who were supported by venovenous  extracorporeal membrane oxygenation during the study period. 

INTERVENTION: None.  

MEASUREMENTS AND MAIN RESULTS: There were 232 coronavirus disease 2019 patients  at 72 participating institutions who were supported with venovenous  extracorporeal membrane oxygenation during the study period from February 16,  2020, to October 31, 2020. Proning was used in 176 patients (76%) before  initiation of extracorporeal membrane oxygenation and in 67 patients (29%) during  extracorporeal membrane oxygenation. Survival to hospital discharge was 33% in  the extracorporeal membrane oxygenation prone group versus 22% in the  extracorporeal membrane oxygenation supine group. Prone positioning during  extracorporeal membrane oxygenation support was associated with reduced mortality  (hazard ratio, 0.31; 95% CI, 0.14-0.68). 

CONCLUSIONS: Our study highlights that  prone positioning during venovenous extracorporeal membrane oxygenation support  for refractory coronavirus disease 2019-related acute respiratory distress  syndrome is associated with reduced mortality. Given the observational nature of  the study, a randomized controlled trial of prone positioning on venovenous  extracorporeal membrane oxygenation is needed to confirm these findings.

## 2019年冠状病毒病静脉-静脉体外膜氧合期间俯卧位的有益作用。

目的：本研究调查了在冠状病毒病的静脉-静脉体外膜肺氧合支持过程中俯卧位的影响  2019年急性呼吸衰竭对患者结局的影响。

设计：观察性研究  对静脉-静脉体外膜肺氧合患者的研究。我们使用了  多状态生存模型，比较接受或  体外膜肺氧合过程中无俯卧位，  结合了俯卧位的动态特性，并调整了潜在体位  混杂因素。

背景：72家国际机构参与  2019年冠状病毒病重症监护联盟国际登记。

患者：冠状病毒病2019例静脉-静脉支持患者  研究期间的体外膜肺氧合。

干预：无。

测量值和主要结果：有232例冠状病毒病2019例患者  在72家静脉-静脉支持的参与机构  2月16日研究期间的体外膜肺氧合，  2020年，至2020年10月31日。之前176例患者(76%)使用过剪毛术  67例患者(29%)开始体外膜肺氧合治疗  体外膜肺氧合。患者的出院生存率为33%  体外膜肺氧合倾向组vs. 22%  体外膜肺氧合仰卧位组。术中俯卧位  体外膜肺氧合支持与死亡率降低相关  （风险比，0.31；95%CI，0.14-0.68）。

结论：我们的研究强调  静脉-静脉体外膜肺氧合支持期间的俯卧位  难治性冠状病毒病2019相关急性呼吸窘迫  综合征与死亡率降低相关。鉴于以下观察性质  静脉-静脉俯卧位的随机对照研究  需要体外膜肺氧合来证实这些结果。
关键词：Humans; Female; Male; Middle Aged; Adult; Hospital Mortality; *SARS-CoV-2; Patient Discharge; *Extracorporeal Membrane Oxygenation; *Prone Position; COVID-19/complications/*therapy; Patient Positioning/*methods; Probability; Respiratory Distress Syndrome/etiology/*therapy

--------
--------

## Late Awakening Is Common in Settings Without Withdrawal of Life-Sustaining Therapy in Out-of-Hospital Cardiac Arrest Survivors Who Undergo Targeted  Temperature Management.

2:235-244. DOI:10.1097/CCM.0000000000005274

Abstract: 

OBJECTIVES: We investigated awakening time and characteristics of awakening compared nonawakening and factors contributing to poor neurologic outcomes in  out-of-hospital cardiac arrest survivors in no withdrawal of life-sustaining  therapy settings. 

DESIGN: Retrospective analysis of the Korean Hypothermia  Network Pro registry. 

SETTING: Multicenter ICU. 

PATIENTS: Adult (?‰? 18 yr)  comatose out-of-hospital cardiac arrest survivors who underwent targeted  temperature management at 33-36?°C between October 2015 and December 2018.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: We measured the time from the  end of rewarming to awakening, defined as a total Glasgow Coma Scale score  greater than or equal to 9 or Glasgow Coma Scale motor score equals to 6. The  primary outcome was awakening time. The secondary outcome was 6-month neurologic  outcomes (poor outcome: Cerebral Performance Category 3-5). Among 1,145  out-of-hospital cardiac arrest survivors, 477 patients (41.7%) regained  consciousness 30 hours (6-71 hr) later, and 116 patients (24.3%) awakened late  (72 hr after the end of rewarming). Young age, witnessed arrest, shockable  rhythm, cardiac etiology, shorter time to return of spontaneous circulation,  lower serum lactate level, absence of seizures, and multisedative requirement  were associated with awakening. Of the 477 who woke up, 74 (15.5%) had poor  neurologic outcomes. Older age, liver cirrhosis, nonshockable rhythm, noncardiac  etiology, a higher Sequential Organ Failure Assessment score, and higher serum  lactate levels were associated with poor neurologic outcomes. Late awakeners were  more common in the poor than in the good neurologic outcome group (38/74 [51.4%]  vs 78/403 [19.4%]; p < 0.001). The awakening time (odds ratio, 1.005; 95% CIs,  1.003-1.008) and late awakening (odds ratio, 3.194; 95% CIs, 1.776-5.746) were  independently associated with poor neurologic outcomes. 

CONCLUSIONS: Late  awakening after out-of-hospital cardiac arrest was common in no withdrawal of  life-sustaining therapy settings and the probability of awakening decreased over  time.

## 在接受靶向治疗的院外心脏骤停幸存者中，在未停止生命维持治疗的情况下，延迟觉醒很常见  温度管理。

目的：我们研究了觉醒时间和觉醒特征，比较了觉醒前和导致较差神经系统结局的因素  未撤除生命维持治疗的院外心脏骤停幸存者  治疗设置。

设计：韩国低体温回顾性分析  Network Pro注册表。

设置：多中心ICU。

患者：成人（ ≥ 18岁）  接受靶向疗法的院外心脏骤停幸存者  2015年10月至2018年12月期间，在33-36 ℃下进行温度管理。

干预：无。

测量和主要结果：我们测量了从  复温结束至觉醒，定义为总Glasgow昏迷量表评分  大于等于9分或格拉斯哥昏迷量表运动评分等于6分。  主要结局是觉醒时间。次要结局是6个月时的神经系统结局  结局（不良结局：脑功能3-5级）。1,145例患者中  院外心脏骤停幸存者，477例患者(41.7%)重新获得  30h(6-71 h)后意识清醒，116例患者(24.3%)苏醒较晚  （复温结束后72 h）。年幼，有目击者，令人震惊  心律，心脏病因，自主循环恢复时间较短，  血清乳酸水平降低、无癫痫发作和需要多种镇静剂  与觉醒相关。在477名醒来的患者中，74名(15.5%)较差  神经系统结局。高龄、肝硬化、无电击节律、非心源性  病因学，序贯器官衰竭评估评分较高，血清  乳酸盐水平与较差的神经系统结局相关。晚醒者为  较差组比良好神经学结局组更常见(38/74)[51.4%]  对比78/403[19.4%]；p < 0.001）。觉醒时间（比值比，1.005；95%CI，  1.003-1.008）和晚期苏醒（比值比，3.194；95%CI，1.776-5.746）  与较差的神经系统结局独立相关。

结论：晚期  院外心脏骤停后觉醒常见于无撤药  维持生命的治疗环境和苏醒的概率降低  时间。
关键词：Humans; Female; Male; Middle Aged; Aged; Cohort Studies; Retrospective Studies; Statistics, Nonparametric; Intensive Care Units/organization & administration/statistics & numerical data; *Time Factors; Hypothermia, Induced/methods/*standards/statistics & numerical data; Out-of-Hospital Cardiac Arrest/*complications/epidemiology/mortality; Republic of Korea/epidemiology; Survivors/statistics & numerical data; Withholding Treatment/*statistics & numerical data

--------
--------

## Extracorporeal Life Support for Respiratory Failure in Patients With Electronic Cigarette or Vaping Product Use-Associated Lung Injury.

2:e173-e182. DOI:10.1097/CCM.0000000000005299

Abstract: 

OBJECTIVES: Electronic cigarette or vaping product use-associated lung injury is a clinical entity that can lead to respiratory failure and death. Despite the  severity of electronic cigarette or vaping product use-associated lung injury,  the role of extracorporeal life support in its management remains unclear. Our  objective was to describe the clinical characteristics and outcomes of patients  with electronic cigarette or vaping product use-associated lung injury who  received extracorporeal life support. 

DESIGN: We performed a retrospective review  of records of electronic cigarette or vaping product use-associated lung injury  patients who received extracorporeal life support. Standardized data were  collected via direct contact with extracorporeal life support centers. Data  regarding presentation, ventilatory management, extracorporeal life support  details, and outcome were analyzed. 

SETTING: This was a multi-institutional,  international case series with patients from 10 different institutions in three  different countries. 

PATIENTS: Patients who met criteria for confirmed electronic  cigarette or vaping product use-associated lung injury (based on previously  reported diagnostic criteria) and were placed on extracorporeal life support were  included. Patients were identified via literature review and by direct contact  with extracorporeal life support centers. 

MEASUREMENTS AND MAIN RESULTS: Data  were collected for 14 patients ranging from 16 to 45 years old. All had confirmed  vape use within 3 months of presentation. Nicotine was the most commonly used  vaping product. All patients had respiratory symptoms and radiographic evidence  of bilateral pulmonary opacities. IV antibiotics and corticosteroids were  universally initiated. Patients were intubated for 1.9 days (range, 0-6) prior to  extracorporeal life support initiation. Poor oxygenation and ventilation were the  most common indications for extracorporeal life support. Five patients showed  evidence of ventricular dysfunction on echocardiography. Thirteen patients (93%)  were placed on venovenous extracorporeal life support, and one patient required  multiple rounds of extracorporeal life support. Total extracorporeal life support  duration ranged from 2 to 37 days. Thirteen patients survived to hospital  discharge; one patient died of septic shock. 

CONCLUSIONS: Electronic cigarette or  vaping product use-associated lung injury can cause refractory respiratory  failure and hypoxemia. These data suggest that venovenous extracorporeal life  support can be an effective treatment option for profound, refractory respiratory  failure secondary to electronic cigarette or vaping product use-associated lung  injury.

## 电子香烟或挥发产品使用相关肺损伤患者呼吸衰竭的体外生命支持。

目的：电子香烟或挥发产品使用相关的肺损伤是一种可导致呼吸衰竭和死亡的临床疾病。尽管  电子香烟或挥发产品使用相关的肺损伤的严重程度，  尚不清楚体外生命支持在其管理中的作用。我们的  目的是描述患者的临床特征和结局  电子香烟或蒸汽产品使用相关的肺损伤，  接受体外生命支持。

设计：我们进行了一项回顾性审查  电子香烟或挥发产品使用相关肺损伤记录  接受体外生命支持的患者。标准化数据为  通过直接联系体外生命支持中心收集。数据  关于表现、通气管理、体外生命支持  对详细信息和结局进行了分析。

背景：这是一家多机构，  10家不同机构的患者组成的3个国际病例系列  不同国家。

患者：符合确认的电子  吸烟或挥发产品使用相关的肺损伤（基于既往信息）  报告诊断标准），并接受体外生命支持  包括。通过文献综述和直接联系识别患者  体外生命支持中心。

测量和主要结果：数据  收集了年龄范围为16至45岁的14例患者。均已确认  就诊后3个月内使用vape。尼古丁是最常用的  挥发产物。所有患者均有呼吸系统症状和放射学证据  双侧肺部阴影。IV抗生素和皮质类固醇  普遍启动。术前患者插管1.9天（范围0-6）  开始体外生命支持。氧合和通气不良是  最常见的体外生命支持适应症。5例患者显示  超声心动图显示心室功能不全的证据。13例患者(93%)  接受静脉-静脉体外生命支持，1例患者需要  多轮体外生命支持。完全体外生命支持  持续时间范围为2-37天。13例患者存活至医院  出院；1例患者死于感染性休克。

结论：电子香烟或  挥发性产品使用相关肺损伤可导致难治性呼吸系统疾病  衰竭和低氧血症。这些数据表明，静脉-静脉体外  支持可作为严重、难治性呼吸系统疾病的有效治疗选择  电子香烟或蒸汽产品使用相关肺继发失效  损伤。
关键词：Humans; Female; Male; Middle Aged; Adult; Adolescent; Retrospective Studies; Extracorporeal Membrane Oxygenation/methods/*statistics & numerical data; Electronic Nicotine Delivery Systems/*statistics & numerical data; Lung Injury/complications/epidemiology/*etiology; Lung/abnormalities/physiopathology; Respiratory Insufficiency/epidemiology/*etiology; Vaping/*adverse effects/epidemiology

--------
--------

## Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Do Not Focus on Not Reliable  Markers!, Petit, Matthieu

2:e209-e210. DOI:10.1097/CCM.0000000000005328

## 冠状病毒病2019年急性呼吸窘迫综合征中右心室功能障碍及其与死亡率的相关性：不关注不可靠  标记！
关键词：Humans; *COVID-19; SARS-CoV-2; *Respiratory Distress Syndrome; Ventricular Function, Right; *Ventricular Dysfunction, Right

--------
--------

## Association of Socioeconomic Status With Postdischarge Pediatric Resource Use and Quality of Life., Kachmar, Alicia G.

2:e117-e128. DOI:10.1097/CCM.0000000000005261

Abstract: 

OBJECTIVES: Socioeconomic factors may impact healthcare resource use and health-related quality of life, but their association with postcritical illness  outcomes is unknown. This study examines the associations between socioeconomic  status, resource use, and health-related quality of life in a cohort of children  recovering from acute respiratory failure. 

DESIGN: Secondary analysis of data  from the Randomized Evaluation of Sedation Titration for Respiratory Failure  clinical trial. 

SETTING: Thirty-one PICUs. 

PATIENTS: Children with acute  respiratory failure enrolled whose parent/guardians consented for follow-up.  

MEASUREMENTS AND MAIN RESULTS: Resource use included in-home care, number of  healthcare providers, prescribed medications, home medical equipment, emergency  department visits, and hospital readmission. Socioeconomic status was estimated  by matching residential address to census tract-based median income.  Health-related quality of life was measured using age-based parent-report  instruments. Resource use interviews with matched census tract data (n = 958) and  health-related quality of life questionnaires (n = 750/958) were assessed.  Compared with high-income children, low-income children received care from fewer  types of healthcare providers (?? = -0.4; p = 0.004), used less newly prescribed  medical equipment (odds ratio = 0.4; p < 0.001), and had more emergency  department visits (43% vs 33%; p = 0.04). In the youngest cohort (< 2 yr old),  low-income children had lower quality of life scores from physical ability (-8.6  points; p = 0.01) and bodily pain/discomfort (+8.2 points; p < 0.05). In  addition, health-related quality of life was lower in those who had more  healthcare providers and prescribed medications. In older children,  health-related quality of life was lower if they had prescribed medications,  emergency department visits, or hospital readmission. 

CONCLUSIONS: Children  recovering from acute respiratory failure have ongoing healthcare resource use.  Yet, lower income children use less in-home and outpatient services and use more  hospital resources. Continued follow-up care, especially in lower income  children, may help identify those in need of ongoing healthcare resources and  those at-risk for decreased health-related quality of life.

## 社会经济状况与出院后儿科资源利用和生活质量的相关性。

目的：社会经济因素可能影响医疗保健资源的使用和健康相关生活质量，但其与危重病后的相关性  结局未知。本研究考察了社会经济与  儿童队列中的状态、资源利用和健康相关生活质量  急性呼吸衰竭好转。

设计：数据的次要分析  来自针对呼吸衰竭的镇静滴定随机评估  临床试验。

设置：31个PICU。

患者：急性儿童  呼吸衰竭入组，其父母/监护人同意进行随访。

测量和主要结果：资源使用包括家庭护理，  医疗保健提供者、处方药、家庭医疗设备、急救  科室访视和再次入院。估计社会经济状况  将居住地址与基于人口普查示踪的收入中位数相匹配。使用基于年龄的父母报告测量健康相关生活质量  仪器。资源利用访谈匹配的人口普查道数据(n = 958)和  评估了健康相关生活质量问卷(n = 750/958)。与高收入儿童相比，低收入儿童获得的护理更少  类型的医疗保健提供者(? =-0.4；p = 0.004)，使用较少的新处方  医疗设备（比值比 = 0.4；p < 0.001），急诊次数更多  科室访视(43%vs 33%；p = 0.04)。最年轻队列（< 2岁），  低收入儿童的体能生活质量评分较低(-8.6)  评分；p = 0.01）和身体疼痛/不适（+ 8.2分；p < 0.05）。In  此外，健康相关生活质量较低的患者  医疗保健提供者和处方药物。在大龄儿童中，  如果他们接受过处方药物治疗，则健康相关生活质量较低，  急诊科就诊或再次入院。

结论：儿童  正在从急性呼吸衰竭中恢复，持续使用医疗保健资源。然而，收入较低的儿童使用较少的家庭和门诊服务，使用较多  医院资源。继续进行随访护理，尤其是在低收入人群中  儿童，可能有助于确定需要持续医疗资源的人群和  存在健康相关生活质量下降风险的患者。
关键词：Humans; Female; Male; Child; Infant; Child, Preschool; Patient Discharge/statistics & numerical data; *Social Class; Health Resources/standards/statistics & numerical data/*supply & distribution; Intensive Care Units, Pediatric/organization & administration/statistics & numerical data; Patient Acceptance of Health Care/*statistics & numerical data; Quality of Life/*psychology

--------
--------

## Fluid Balance and Ventilator-Associated Events Among Patients Admitted to ICUs in China: A Nested Case-Control Study.

2:307-316. DOI:10.1097/CCM.0000000000005227

Abstract: 

OBJECTIVES: Fluid therapy is an important component of intensive care management, however, optimal fluid management is unknown. The relationship between fluid  balance and ventilator-associated events has not been well established. This  study investigated the dose-response relationship between fluid balance and  ventilator-associated events. 

DESIGN: Nested case-control study. 

SETTING: The  study was based on a well-established, research-oriented registry of  healthcare-associated infections at ICUs of West China Hospital system (Chengdu,  China). 

PATIENTS: A total of 1,528 ventilator-associated event cases with 3,038  matched controls, who consistently underwent mechanical ventilation for at least  4 days from April 1, 2015, to December 31, 2018, were included. 

INTERVENTIONS:  None. 

MEASUREMENTS AND MAIN RESULTS: We calculated cumulative fluid balance  within 4 days prior to ventilator-associated event occurrence. A weighted Cox  proportional hazards model with restricted cubic splines was used to evaluate the  dose-response relationship. A nonlinear relationship between fluid balance and  all three tiers of ventilator-associated events, patients with fluid balance  between -1 and 0 L had the lowest risk (p < 0.05 for nonlinear test). The risk of  ventilator-associated event was significantly higher in patients with positive  fluid balance (4 d cumulative fluid balance: 1 L: 1.19; 3 L: 1.92; 5 L: 2.58; 7  L: 3.24), but not in those with negative fluid balance (-5 L: 1.34; -3 L: 1.14;  -1 L: 0.98). 

CONCLUSIONS: There was nonlinear relationship between fluid balance  and all three tiers of ventilator-associated event, with an fluid balance between  -1 and 0 L corresponding to the lowest risk. Positive but not negative fluid  balance increased the risk of ventilator-associated events, with higher positive  fluid balance more likely to lead to ventilator-associated events.

## 中国ICU患者的液体平衡和呼吸机相关事件：一项巢式病例对照研究。

目的：液体治疗是重症监护管理的重要组成部分，但是，尚不清楚最佳的液体管理。液体之间的关系  尚未充分确定平衡和呼吸机相关事件。此  研究调查了液体平衡和以下之间的剂量-反应关系  呼吸机相关事件。

设计：巢式病例对照研究。

设置：  研究基于一项完善的以研究为导向的登记研究  华西医院（成都，  中国）。

患者：共计1,528例呼吸机相关事件病例，3,038例  匹配的对照，持续接受机械通气至少  2015年4月1日至2018年12月31日，共4天。

干预：  无。

测量和主要结果：我们计算了累积液体平衡  呼吸机相关事件发生前4天内。加权Cox  使用限制三次样条的比例风险模型评估  剂量-反应关系。液体平衡与  所有三级呼吸机相关事件、体液平衡患者  between -1和0 L之间的风险最低（非线性检验p < 0.05）。下列风险  呼吸机相关事件在阳性  液体平衡（4天累积液体平衡：1 L：1.19；3 L：1.92；5 L：2.58；7  L：3.24），但液体负平衡者（-5l：1.34；-3l：1.14；  -1 L: 0.98).结论：液体平衡之间存在非线性关系  和所有三层呼吸机相关事件，液体平衡介于  -1和0 L对应于最低风险。阳性但非阴性液体  平衡增加了呼吸机相关事件的风险，正性更高  体液平衡更可能导致呼吸机相关事件。
关键词：Humans; Female; Male; Middle Aged; Aged; Case-Control Studies; China/epidemiology; Intensive Care Units/organization & administration/statistics & numerical data; Fluid Therapy/adverse effects/methods/statistics & numerical data; Respiration, Artificial/*adverse effects/instrumentation; Ventilators, Mechanical/*adverse effects/statistics & numerical data; Water-Electrolyte Balance/drug effects/*physiology

--------
--------

## Long-Term Acute Care Hospital Outcomes of Mechanically Ventilated Patients With Coronavirus Disease 2019., Saad, Marina

2:256-263. DOI:10.1097/CCM.0000000000005193

Abstract: 

OBJECTIVES: To describe the clinical characteristics and outcomes of adult patients with coronavirus disease 2019 requiring weaning from prolonged  mechanical ventilation. 

DESIGN: Observational cohort study of patients admitted  to two long-term acute care hospitals from April 1, 2020, to March 31, 2021.  

SETTING: Two long-term acute care hospitals specialized in weaning from prolonged  mechanical ventilation in the Chicagoland area, Illinois, United States.  

PATIENTS: Adult (?‰? 18 yr old) ICU survivors of respiratory failure caused by  severe acute respiratory syndrome coronavirus 2 pneumonia receiving prolonged  mechanical ventilation. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS:  During the study period, 158 consecutive patients were transferred to the  long-term acute care hospitals for weaning from prolonged ventilation.  Demographic, clinical, and laboratory data were collected and analyzed. Final  date of follow-up was June 1, 2021. Prior to long-term acute care hospital  transfer, median length of stay at the acute care hospital was 41.0 days and  median number of ventilator days was 35. Median age was 60.0 years, 34.8% of  patients were women, 91.8% had a least one comorbidity, most commonly  hypertension (65.8%) and diabetes (53.2%). The percentage of weaning success was  70.9%. The median duration of successful weaning was 8 days. Mortality was 9.6%.  As of June 1, 2021, 19.0% of patients had been discharged home, 70.3% had been  discharged to other facilities, and 1.3% were still in the long-term acute care  hospitals. 

CONCLUSIONS: Most patients with coronavirus disease 2019 transferred  to two Chicago-area long-term acute care hospitals successfully weaned from  prolonged mechanical ventilation.

## 2019年机械通气的冠状病毒病患者长期急性护理医院结局。

目的：描述2019年需要长期停药的冠状病毒病成人患者的临床特征和结局  机械通气。

设计：入院患者的观察性队列研究  至2020年4月1日至2021年3月31日的两家长期急症护理医院。

背景：两家长期专门从事戒断治疗的长期急症治疗医院  美国伊利诺斯州奇拉戈兰地区的机械通风。

患者：因下列原因导致呼吸衰竭的ICU成人（ ≥ 18岁）生存者  严重急性呼吸综合征冠状病毒2型肺炎接受长期治疗  机械通气。

干预：无。

测量和主要结果：  在研究期间，158例连续患者转入  长期急性护理医院，用于从长期通气断开。收集并分析人口统计学、临床和实验室数据。最终  随访日期为2021年6月1日。在长期急症医院之前  转入急诊医院时，中位住院时间为41.0天  呼吸机使用天数中位数为35天。中位年龄为60.0岁，  患者为女性，91.8%至少有一种合并症，最常见  高血压(65.8%)和糖尿病(53.2%)。断奶成功的百分比为  70.9%.成功断奶的中位持续时间为8天。死亡率为9.6%。截至2021年6月1日，19.0%的患者已出院回家，70.3%的患者已  出院后转至其他机构，1.3%的患者仍在接受长期紧急治疗  医院。

结论：2019年大部分冠状病毒病患者转  成功脱离芝加哥地区的两家长期急症护理医院  长时间机械通气。
关键词：Humans; Treatment Outcome; Female; Male; Middle Aged; Aged; Length of Stay; Cohort Studies; *SARS-CoV-2; Patient Discharge; *Ventilator Weaning; *Respiration, Artificial; Patient Transfer; COVID-19/complications/*therapy; *Hospitals, Special; Chicago/epidemiology; Respiratory Insufficiency/etiology/*therapy

--------
--------

## Comparison of Machine Learning Methods for Predicting Outcomes After In-Hospital Cardiac Arrest.

2:e162-e172. DOI:10.1097/CCM.0000000000005286

Abstract: 

OBJECTIVES: Prognostication of neurologic status among survivors of in-hospital cardiac arrests remains a challenging task for physicians. Although models such  as the Cardiac Arrest Survival Post-Resuscitation In-hospital score are useful  for predicting neurologic outcomes, they were developed using traditional  statistical techniques. In this study, we derive and compare the performance of  several machine learning models with each other and with the Cardiac Arrest  Survival Post-Resuscitation In-hospital score for predicting the likelihood of  favorable neurologic outcomes among survivors of resuscitation. 

DESIGN: Analysis  of the Get With The Guidelines-Resuscitation registry. 

SETTING: Seven-hundred  fifty-five hospitals participating in Get With The Guidelines-Resuscitation from  January 1, 2001, to January 28, 2017. 

PATIENTS: Adult in-hospital cardiac arrest  survivors. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Of 117,674  patients in our cohort, 28,409 (24%) had a favorable neurologic outcome, as  defined as survival with a Cerebral Performance Category score of less than or  equal to 2 at discharge. Using patient characteristics, pre-existing conditions,  prearrest interventions, and periarrest variables, we constructed logistic  regression, support vector machines, random forests, gradient boosted machines,  and neural network machine learning models to predict favorable neurologic  outcome. Events prior to October 20, 2009, were used for model derivation, and  all subsequent events were used for validation. The gradient boosted machine  predicted favorable neurologic status at discharge significantly better than the  Cardiac Arrest Survival Post-Resuscitation In-hospital score (C-statistic: 0.81  vs 0.73; p < 0.001) and outperformed all other machine learning models in terms  of discrimination, calibration, and accuracy measures. Variables that were  consistently most important for prediction across all models were duration of  arrest, initial cardiac arrest rhythm, admission Cerebral Performance Category  score, and age. 

CONCLUSIONS: The gradient boosted machine algorithm was the most  accurate for predicting favorable neurologic outcomes in in-hospital cardiac  arrest survivors. Our results highlight the utility of machine learning for  predicting neurologic outcomes in resuscitated patients.

## 预测院内心脏骤停后结局的学习机方法比较。

目的：对于医生而言，院内心脏骤停幸存者的神经系统状态预后仍然是一项具有挑战性的任务。尽管模型如下  因为心脏骤停存活率院内复苏后评分有用  为了预测神经系统结局，使用传统方法  统计技术。在本研究中，我们推导并比较了  几个相互关联的机器学习模型和心搏骤停模型  复苏后生存院内评分用于预测以下可能性  复苏幸存者的良好神经系统结局。

设计：分析  指南的获取-复苏注册。

设置：700  参与指南获取的55家医院-复苏来自  2001年1月1日至2017年1月28日。

患者：院内心脏骤停成人  存活者。

干预：无。

测量和主要结果：117,674  在我们的队列中，28,409例(24%)患者具有良好的神经系统结局，因为  定义为脑功能分级评分小于或等于1分的生存期  出院时等于2。使用患者特征、既存疾病，  停搏前干预和停搏期间变量，我们构建了逻辑  回归，支持向量机，随机图像，梯度增强机器，  和用于预测有利神经系统的神经学模型  结局。将2009年10月20日之前的事件用于模型推导，并且  所有后续事件均用于验证。梯度增强机器  出院时预测的良好神经系统状态显著优于  院内复苏后心脏骤停存活率评分（C统计量：0.81）  vs 0.73；p < 0.001），在性能方面优于所有其他机器学习模型  的鉴别、校准和准确度测量。变量  在所有模型中对预测始终最重要的是  停搏，初期心脏骤停节律，入院脑功能分类  评分和年龄。

结论：梯度增强的机器算法是最  准确预测院内心脏手术良好的神经系统结局  逮捕幸存者。我们的结果强调了机器学习对于  预测复苏患者的神经系统结局。
关键词：Humans; Female; Male; Middle Aged; Prognosis; Aged; Cohort Studies; ROC Curve; Outcome Assessment, Health Care/methods/*statistics & numerical data; Area Under Curve; Survivors/statistics & numerical data; Forecasting/*methods; Heart Arrest/*complications/epidemiology/mortality; Machine Learning/*standards/statistics & numerical data

--------
--------

## A Systematic Review and Pooled Prevalence of Delirium in Critically Ill Children.

2:317-328. DOI:10.1097/CCM.0000000000005260

Abstract: 

OBJECTIVES: Pediatric delirium is a neuropsychiatric disorder with disrupted cerebral functioning due to underlying disease and/or critical care treatment.  Pediatric delirium can be classified as hypoactive, hyperactive, and mixed. This  systematic review was conducted to estimate the pooled prevalence of pediatric  delirium using validated assessment tools in children (Cornell Assessment of  Pediatric Delirium, Pediatric Confusion Assessment Method for the ICU, PreSchool  Confusion Assessment Method for the ICU, Pediatric Confusion Assessment Method  for the ICU Severity Scale, and Sophia Observation Withdrawal Symptoms Pediatric  Delirium scale), identify modifiable and nonmodifiable risk factors, and explore  the association of pediatric delirium with clinical outcomes. 

DATA SOURCES: A  systematic search of PubMed, EMBASE, and CINAHL databases was undertaken for full  articles pertaining to pediatric delirium prevalence. 

STUDY SELECTION: No  language or date barriers were set. 

Studies were included where the following  eligibility criteria were met: study design aimed to estimate pediatric delirium  prevalence arising from treatment in the intensive care setting, using a  validated tool. Only randomized controlled trials, cross-sectional studies, or  cohort studies allowing an estimate of the prevalence of pediatric delirium were  included. 

DATA EXTRACTION: Data were extracted by the primary researcher (D.S.)  and accuracy checked by coauthors. 

DATA SYNTHESIS: A narrative synthesis and  pooled prevalence meta-analysis were undertaken. 

CONCLUSIONS: Pediatric delirium,  as determined by the Cornell Assessment of Pediatric Delirium score, is estimated  to occur in 34% of critical care admissions. Eight of 11 studies reporting on  subtype identified hypoactive delirium as most prevalent (46-81%) with each of  the three remaining reporting either hyperactive (44%), mixed (57%), or equal  percentages of hypoactive and mixed delirium (43%) as most prevalent. The  development of pediatric delirium is associated with cumulative doses of  benzodiazepines, opioids, the number of sedative classes used, deep sedation, and  cardiothoracic surgery. Increased time mechanically ventilated, length of stay,  mortality, healthcare costs, and associations with decreased quality of life  after discharge were also found. Multi-institutional and longitudinal studies are  required to better determine the natural history, true prevalence, long-term  outcomes, management strategies, and financial implications of pediatric  delirium.

## 危重病儿童中谵妄的系统审查和汇总患病率。

目的：儿科谵妄是一种神经精神疾病，由于基础疾病和/或重症监护治疗而导致脑功能破坏。儿童谵妄可分为活动减退型、活动过度型和混合型。此  进行了系统性审查，以估计儿科患者的汇总患病率  使用经验证的儿童谵妄评估工具（Cornell评估  儿科谵妄，ICU儿科意识模糊评估方法，学前  ICU意识模糊评估方法，儿童意识模糊评估方法  ICU严重程度量表和Sophia观察儿童戒断症状  谵妄量表），确定可改变和不可改变的风险因素，并探索  儿科谵妄与临床结局的相关性。

数据来源：A  全面检索PubMed、EMBASE和CINAHL数据库  与儿童谵妄患病率相关的文章。

研究选择：否  设置语言或日期障碍。纳入了以下研究  符合合格性标准：旨在估计儿童谵妄的研究设计  在重症监护条件下使用  经验证的工具。仅随机对照试验、横断面研究或  允许估计儿童谵妄患病率的队列研究包括：  包括。

数据提取：由主要研究者(D.S.)提取数据。  并由共同作者检查准确度。

数据综合：叙述综合和  进行汇总患病率荟萃分析。

结论：儿童谵妄，  根据儿科谵妄评分的Cornell评估，估计  在34%的重症监护住院患者中发生。11项研究中的8项报告了  亚型确定活动减退性谵妄为最常见(46-81%)，  其余3例报告活动过度(44%)、混合(57%)或相等  活动减退和混合性谵妄(43%)的百分比最常见。事件  儿童谵妄的发生与以下药物的累积剂量相关：  苯二氮卓类、阿片类、使用的镇静类别数量、深度镇静和  胸心外科。机械通气时间、住院时间延长，  死亡率、医疗费用以及与生活质量下降的相关性  还发现出院后。多机构和纵向研究为  需要更好地确定自然史、真实患病率、长期  儿科结局、管理策略和财务影响  谵妄。
关键词：Humans; Risk Factors; *Prevalence; Critical Illness/*classification/epidemiology; Delirium/*diagnosis/epidemiology/etiology

--------
--------

## Unassisted Return of Spontaneous Circulation Following Withdrawal of Life-Sustaining Therapy During Donation After Circulatory Determination of Death  in a Child., Zier, Judith L.

2:e183-e188. DOI:10.1097/CCM.0000000000005273

Abstract: 

OBJECTIVES: To describe the unassisted return of spontaneous circulation following withdrawal of life-sustaining treatment in a child. 

DESIGN: Case report  based on clinical observation and medical record review. 

SETTING: Community  Children's Hospital. 

PATIENT: Two-year old child. 

INTERVENTIONS: Following  hypoxic-ischemic brain injury, the child was taken to the operating room for  withdrawal of life-sustaining treatment during controlled donation after  circulatory determination of death. 

MEASUREMENTS AND MAIN RESULTS: In addition to  direct observation by experienced pediatric critical care providers, the child  was monitored with electrocardiography, pulse oximetry, and invasive blood  pressure via femoral arterial catheter in addition to direct observation by  experienced pediatric critical care providers. Unassisted return of spontaneous  circulation occurred greater than 2 minutes following circulatory arrest and was  accompanied by return of respiration. 

CONCLUSIONS: We provide the first report of  unassisted return of spontaneous circulation following withdrawal of  life-sustaining treatment in a child. In our case, return of spontaneous  circulation occurred in the setting of controlled donation after circulatory  determination of death and was accompanied by return of respiration. Return of  spontaneous circulation greater than 2 minutes following circulatory arrest in  our patient indicates that 2 minutes of observation is insufficient to ensure  that cessation of circulation is permanent after withdrawal of life-sustaining  treatment in a child.

## 确定循环死亡后捐献期间停止维持生命治疗后自发循环的无辅助恢复  儿童。

目的：描述儿童生命维持治疗停止后自主循环的无辅助恢复。

设计：病例报告  基于临床观察和病历审查。

设置：社区  儿童医院。

患者：2岁儿童。

干预：如下  缺氧缺血性脑损伤，患儿被送入手术室  控制献血后，停止维持生命的治疗  循环确定死亡。

测量和主要结果：除  由有经验的儿科重症监护医生直接观察，  通过心电图、脉搏血氧饱和度和侵入性血液监测  除直接观察外，通过股动脉导管测量血压  经验丰富的儿科重症监护医生。无协助自主返回  循环在停循环后超过2 min发生，  伴随呼吸恢复。

结论：我们提供了第一份报告  撤药后自主循环的无辅助恢复  儿童维持生命的治疗。在我们的病例中，自发恢复  在循环后控制献血的情况下进行循环  确定死亡，伴随呼吸恢复。返还  循环骤停后超过2 min的自主循环  我们的患者表示观察2 min不足以确保  在停止维持生命的治疗后，循环永久性停止  儿童治疗。
关键词：Humans; Male; Child, Preschool; *Withholding Treatment; Brain Death/physiopathology; Life Support Care/*methods; Pediatrics/methods/standards; Return of Spontaneous Circulation/*physiology; Shock/complications/*therapy

--------
--------

## The Intriguing, Still Undercovered, Clinical Role of Echocardiography in Critically Ill Coronavirus Disease Patients., Lazzeri, Chiara

2:e212-e213. DOI:10.1097/CCM.0000000000005290

## 超声心动图在危重症冠状病毒病患者中的重要临床作用，目前仍未阐明。
关键词：Humans; Echocardiography; *COVID-19; *Critical Illness

--------
--------

## The Role of the Long-Term Acute Care Hospital Following Critical Illness-Has the Coronavirus Disease 2019 Pandemic Demonstrated Their Usefulness or Emphasized  Their Downside?

2:341-343. DOI:10.1097/CCM.0000000000005206

## 危重病后长期急性护理医院的作用-冠状病毒病2019年流行病证实了其有用性或重要性  它们的缺点？
关键词：Humans; *COVID-19; SARS-CoV-2; Hospitals; *Pandemics; Critical Illness/epidemiology

--------
--------

## Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges., Auld, Sara C.

2:245-255. DOI:10.1097/CCM.0000000000005185

Abstract: 

OBJECTIVES: To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019.  

DESIGN: Observational cohort study from March 6, 2020, to January 31, 2021.  

SETTING: ICUs at four hospitals within an academic health center network in  Atlanta, GA. 

PATIENTS: Adults greater than or equal to 18 years with coronavirus  disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to  April, Lull 1: May to June, Surge 2: July to August, Lull 2: September to  November, Surge 3: December to January). 

MEASUREMENTS AND MAIN RESULTS: Among  1,686 patients with coronavirus disease 2019 admitted to an ICU during the study  period, all-cause hospital mortality was 29.7%. 

Mortality differed significantly  over time: 28.7% in Surge 1, 21.3% in Lull 1, 25.2% in Surge 2, 30.2% in Lull 2,  34.7% in Surge 3 (p = 0.007). Mortality was significantly associated with 1)  preexisting risk factors (older age, race, ethnicity, lower body mass index,  higher Elixhauser Comorbidity Index, admission from a nursing home); 2) clinical  status at ICU admission (higher Sequential Organ Failure Assessment score, higher  d-dimer, higher C-reactive protein); and 3) ICU interventions (receipt of  mechanical ventilation, vasopressors, renal replacement therapy, inhaled  vasodilators). After adjusting for baseline and clinical variables, there was a  significantly increased risk of mortality associated with admission during Lull 2  (relative risk, 1.37 [95% CI = 1.03-1.81]) and Surge 3 (relative risk, 1.35 [95%  CI = 1.04-1.77]) as compared to Surge 1. 

CONCLUSIONS: Despite increased  experience and evidence-based treatments, the risk of death for patients admitted  to the ICU with coronavirus disease 2019 was highest during the fall and winter  of 2020. Reasons for this increased mortality are not clear.

## 2019年冠状病毒病ICU死亡率的趋势：三次高峰。

目的：确定2019年冠状病毒病重症成人患者住院时间段与住院死亡率之间的相关性。

设计：观察性队列研究，2020年3月6日至2021年1月31日。

地点：美国国立卫生研究院学术中心网络内的4家医院的ICU  佐治亚州亚特兰大。

患者：18岁及以上伴有冠状病毒的成人  2019年疾病在研究期间入住ICU（即，Surge 1：3月至  4月，拉1：5月至6月，波动2：7月至8月，拉2：9月至  11月，波动3：12月至1月）。

测量和主要结果：其中  1,686例冠状病毒病患者2019例在研究期间入住ICU  期间，全因死亡率为29.7%。死亡率差异显著  随时间推移：Surge 1为28.7%，Lull 1为21.3%，Surge 2为25.2%，Lull 2为30.2%，  浪涌3中为34.7%(p = 0.007)。死亡率与1）显著相关  既存风险因素（年龄较大、人种、种族、体重指数较低、  Elixhauser合并症指数较高，入住养老院）；2）临床  ICU入院时的状态（序贯器官衰竭评估评分较高，较高  d-二聚体，C反应蛋白较高）；和3）ICU干预（接受  机械通气、血管加压药、肾脏替代治疗、吸入  血管扩张剂）。校正基线和临床变量后，  与Lull 2期间入院相关的死亡风险显著增加  （相对风险，1.37[95%CI = 1.03-1.81]）和浪涌3（相对风险，1.35 [95%  CI = 1.04-1.77]），相比浪涌1.结论：尽管增加  经验和循证治疗，入院患者的死亡风险  2019年秋冬季节冠状病毒病入住ICU的比例最高  of 2020.死亡率增加的原因尚不清楚。
关键词：Humans; Female; Male; Middle Aged; Time Factors; Aged; Critical Illness; Cohort Studies; Academic Medical Centers; *SARS-CoV-2; COVID-19/*mortality; Hospital Mortality/*trends; Hospitalization/*trends; Intensive Care Units/*trends

--------
--------

## Use of the Molecular Adsorbent Recirculating System in Acute Liver Failure: Results of a Multicenter Propensity Score-Matched Study., MacDonald, Andrew J.

2:286-295. DOI:10.1097/CCM.0000000000005194

Abstract: 

OBJECTIVES: The molecular adsorbent recirculating system removes water-soluble and albumin-bound toxins and may be beneficial for acute liver failure patients.  We compared the rates of 21-day transplant-free survival in acute liver failure  patients receiving molecular adsorbent recirculating system therapy and patients  receiving standard medical therapy. 

DESIGN: Propensity score-matched  retrospective cohort analysis. 

SETTING: Tertiary North American liver transplant  centers. 

PATIENTS: Acute liver failure patients receiving molecular adsorbent  recirculating system at three transplantation centers (n = 104; January  2009-2019) and controls from the U.S. Acute Liver Failure Study Group registry.  

INTERVENTIONS: Molecular adsorbent recirculating system treatment versus standard  medical therapy (control). 

MEASUREMENTS AND MAIN RESULTS: One-hundred four  molecular adsorbent recirculating system patients were propensity score-matched  (4:1) to 416 controls. Using multivariable conditional logistic regression  adjusting for acute liver failure etiology (acetaminophen: n = 248; vs  nonacetaminophen: n = 272), age, vasopressor support, international normalized  ratio, King's College Criteria, and propensity score (main model), molecular  adsorbent recirculating system was significantly associated with increased 21-day  transplant-free survival (odds ratio, 1.90; 95% CI, 1.07-3.39; p = 0.030). This  association remained significant in several sensitivity analyses, including  adjustment for acute liver failure etiology and propensity score alone ("model  2"; molecular adsorbent recirculating system odds ratio, 1.86; 95% CI, 1.05-3.31;  p = 0.033), and further adjustment of the "main model" for mechanical  ventilation, and grade 3/4 hepatic encephalopathy ("model 3"; molecular adsorbent  recirculating system odds ratio, 1.91; 95% CI, 1.07-3.41; p = 0.029). In  acetaminophen-acute liver failure (n = 51), molecular adsorbent recirculating  system was associated with significant improvements (post vs pre) in mean  arterial pressure (92.0 vs 78.0 mm Hg), creatinine (77.0 vs 128.2 ??mol/L),  lactate (2.3 vs 4.3 mmol/L), and ammonia (98.0 vs 136.0 ??mol/L; p ?‰¤ 0.002 for  all). In nonacetaminophen acute liver failure (n = 53), molecular adsorbent  recirculating system was associated with significant improvements in bilirubin  (205.2 vs 251.4 ??mol/L), creatinine (83.1 vs 133.5 ??mol/L), and ammonia (111.5 vs  140.0 ??mol/L; p ?‰¤ 0.022 for all). 

CONCLUSIONS: Treatment with molecular adsorbent  recirculating system is associated with increased 21-day transplant-free survival  in acute liver failure and improves biochemical variables and hemodynamics,  particularly in acetaminophen-acute liver failure.

## 分子吸附再循环系统在急性肝衰竭中的应用：一项多中心倾向评分匹配研究的结果。

目的：分子吸附再循环系统可去除水溶性和与白蛋白结合的毒素，可能对急性肝衰竭患者有益。我们比较了急性肝衰竭患者的21天无移植生存率  接受分子吸附再循环系统治疗的患者和  接受标准药物治疗。

设计：倾向得分匹配  回顾性队列分析。

背景：第三期北美肝移植  研究中心。

患者：接受分子吸附治疗的急性肝衰竭患者  3个移植中心的再循环系统（n = 104；1月  2009-2019）以及来自美国急性肝衰竭研究组登记研究的对照组。

干预：分子吸附再循环系统治疗vs.标准治疗  药物治疗（对照）。

测量和主要结果：104例  分子吸附再循环系统患者倾向得分匹配  (4:1)至416例对照。使用多变量条件性logistic回归  校正急性肝衰竭病因（对乙酰氨基酚：n = 248；vs  非对乙酰氨基酚：n = 272），年龄，血管加压药支持，国际标准化  比值、King's College标准和倾向评分（主要模型），分子学  吸附再循环系统与21天增加显著相关  无移植生存期（比值比，1.90；95%CI，1.07-3.39；p = 0.030）。此  在几项敏感性分析中，包括  仅根据急性肝衰竭病因和倾向评分进行调整（“模型  2"；分子吸附再循环系统比值比，1.86；95%CI，1.05-3.31；  p = 0.033），并且进一步调整了机械  通风，和3/4级肝性脑病（“模型3”；分子吸附剂  再循环系统比值比，1.91；95%CI，1.07-3.41；p = 0.029）。In  对乙酰氨基酚-急性肝衰竭(n = 51)，分子吸附再循环  系统与平均值的显著改善（术后vs术前）相关  动脉压(92.0 vs 78.0 mmHg)、肌酐(77.0 vs 128.2 μmol/L)，  乳酸盐(2.3 vs 4.3 mmol/L)和氨（98.0 vs 136.0 μmol/L；p?‰?0.002，  所有）。在非对乙酰氨基酚急性肝衰竭(n = 53)中，使用分子吸附剂  循环系统与胆红素的显著改善相关  （205.2对比251.4?mol/L）、肌酐（83.1对比133.5?mol/L）和氨（111.5对比251.4?mol/L）。  140.0 μmol/L；所有p?‰?0.022）。

结论：分子吸附剂治疗  再循环系统可提高21天无移植生存率  在急性肝衰竭中，改善生化变量和血液动力学，  尤其是对乙酰氨基酚-急性肝衰竭。
关键词：Humans; Female; Male; Middle Aged; Adult; Cohort Studies; Propensity Score; Retrospective Studies; Logistic Models; Alberta/epidemiology; Tertiary Care Centers/organization & administration/statistics & numerical data; Liver Failure, Acute/epidemiology/*etiology/therapy; Liver Transplantation/methods/*statistics & numerical data; Models, Molecular

--------
--------

## Prone-Positioning for Severe Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation., Petit, Matthieu

2:264-274. DOI:10.1097/CCM.0000000000005145

Abstract: 

OBJECTIVES: To determine the characteristics and outcomes of patients prone-positioned during extracorporeal membrane oxygenation for severe acute  respiratory distress syndrome and lung CT pattern associated with improved  respiratory system static compliance after that intervention. 

DESIGN:  Retrospective, single-center study over 8 years. 

SETTINGS: Twenty-six bed ICU in  a tertiary center. 

MEASUREMENTS AND MAIN RESULTS: A propensity score-matched  analysis compared patients with prone-positioning during extracorporeal membrane  oxygenation and those without. An increase of the static compliance greater than  or equal to 3 mL/cm H2O after 16 hours of prone-positioning defined  prone-positioning responders. The primary outcome was the time to successful  extracorporeal membrane oxygenation weaning within 90 days of postextracorporeal  membrane oxygenation start, with death as a competing risk. Among 298 venovenous  extracorporeal membrane oxygenation-treated adults with severe acute respiratory  distress syndrome, 64 were prone-positioning extracorporeal membrane oxygenation.  Although both propensity score-matched groups had similar extracorporeal membrane  oxygenation durations, prone-positioning extracorporeal membrane oxygenation  patients' 90-day probability of being weaned-off extracorporeal membrane  oxygenation and alive was higher (0.75 vs 0.54, p = 0.03; subdistribution hazard  ratio [95% CI], 1.54 [1.05-2.58]) and 90-day mortality was lower (20% vs 42%, p <  0.01) than that for no prone-positioning extracorporeal membrane oxygenation  patients. Extracorporeal membrane oxygenation-related complications were  comparable for the two groups. Patients without improved static compliance had  higher percentages of nonaerated or poorly aerated ventral and medial-ventral  lung regions (p = 0.047). 

CONCLUSIONS: Prone-positioning during venovenous  extracorporeal membrane oxygenation was safe and effective and was associated  with a higher probability of surviving and being weaned-off extracorporeal  membrane oxygenation at 90 days. Patients with greater normally aerated lung  tissue in the ventral and medial-ventral regions on quantitative lung CT-scan  performed before prone-positioning are more likely to improve their static  compliance after that procedure during extracorporeal membrane oxygenation.

## 需要体外膜肺氧合的重度急性呼吸窘迫综合征的俯卧位。

目的：确定重度急性呼吸窘迫综合征和肺CT模式（与干预后呼吸系统静态顺应性改善相关）体外膜肺氧合期间患者体位的特征和结局。

设计：8年的回顾性、单中心研究。

背景：三级中心ICU的26张病床。

测量值和主要结果：倾向性评分匹配分析比较了体外膜肺氧合过程中俯卧位患者和无俯卧位患者。16小时仰卧位后静态顺应性增加≥3 mL/cm H2O定义为仰卧位应答者。主要结局为体外膜肺氧合开始后90天内至成功体外膜肺氧合撤机的时间，死亡为竞争风险。在298例静脉-静脉体外膜肺氧合治疗的成人重度急性呼吸窘迫综合征患者中，64例为仰卧位体外膜肺氧合。尽管两个倾向性评分匹配组的体外膜氧合持续时间相似，但是单独定位体外膜氧合患者90天后脱离体外膜氧合和存活的概率更高（0.75 vs 0.54，p = 0.03；亚分布风险比[95%CI]，1.54[1.05-2.58]），90天死亡率(20%vs 42%，p < 0.01)低于无体位体外膜肺氧合患者。两组的体外膜肺氧合相关并发症相当。无改善静态依从性的患者无通气或通气不良的腹侧和中-腹侧肺区百分比较高(p = 0.047)。

结论：静脉-静脉体外膜氧合过程中的俯卧位安全有效，与90天时存活和脱离体外膜氧合的概率较高相关。在仰卧位前进行的定量肺CT扫描中，腹侧和中-腹侧区域通常充气肺组织较大的患者在体外膜肺氧合期间更可能改善该操作后的静态顺应性。
关键词：Humans; Female; Male; Middle Aged; Adult; Retrospective Studies; Intensive Care Units/organization & administration/statistics & numerical data; Proportional Hazards Models; *Prone Position; Extracorporeal Membrane Oxygenation/methods/*standards/statistics & numerical data; Paris/epidemiology; Patient Positioning/methods; Respiratory Distress Syndrome/epidemiology/*therapy

--------
--------

## Phospholipid Screening Postcardiac Arrest Detects Decreased Plasma Lysophosphatidylcholine: Supplementation as a New Therapeutic Approach.

2:e199-e208. DOI:10.1097/CCM.0000000000005180

Abstract: 

OBJECTIVES: Cardiac arrest and subsequent resuscitation have been shown to deplete plasma phospholipids. This depletion of phospholipids in circulating  plasma may contribute to organ damage postresuscitation. Our aim was to identify  the diminishment of essential phospholipids in postresuscitation plasma and  develop a novel therapeutic approach of supplementing these depleted  phospholipids that are required to prevent organ dysfunction postcardiac arrest,  which may lead to improved survival. 

DESIGN: Clinical case control study followed  by translational laboratory study. 

SETTING: Research institution.  PATIENTS/SUBJECTS: Adult cardiac arrest patients and male Sprague-Dawley rats.  

INTERVENTIONS: Resuscitated rats after 10-minute asphyxial cardiac arrest were  randomized to be treated with lysophosphatidylcholine specie or vehicle.  

MEASUREMENTS AND MAIN RESULTS: We first performed a phospholipid survey on human  cardiac arrest and control plasma. Using mass spectrometry analysis followed by  multivariable regression analyses, we found that plasma lysophosphatidylcholine  levels were an independent discriminator of cardiac arrest. We also found that  decreased plasma lysophosphatidylcholine was associated with poor patient  outcomes. A similar association was observed in our rat model, with significantly  greater depletion of plasma lysophosphatidylcholine with increased cardiac arrest  time, suggesting an association of lysophosphatidylcholine levels with injury  severity. Using a 10-minute cardiac arrest rat model, we tested supplementation  of depleted lysophosphatidylcholine species, lysophosphatidylcholine(18:1), and  lysophosphatidylcholine(22:6), which resulted in significantly increased survival  compared with control. Furthermore, the survived rats treated with these  lysophosphatidylcholine species exhibited significantly improved brain function.  However, supplementing lysophosphatidylcholine(18:0), which did not decrease in  the plasma after 10-minute cardiac arrest, had no beneficial effect. 

CONCLUSIONS:  Our data suggest that decreased plasma lysophosphatidylcholine is a major  contributor to mortality and brain damage postcardiac arrest, and its  supplementation may be a novel therapeutic approach.

## 心脏骤停后磷脂筛查检测血浆溶血磷脂酰胆碱降低：补充溶血磷脂酰胆碱作为一种新的治疗方法。

目的：已证实心脏骤停和随后的复苏可减少血浆磷脂。循环血浆中磷脂的耗竭可能导致复苏后器官损伤。我们的目的是确定复苏后血浆中必需磷脂的减少，并开发一种新的治疗方法，补充这些耗尽的磷脂，以预防心脏骤停后器官功能障碍（可能导致生存率改善）。

设计：临床病例对照研究后进行转化实验室研究。

单位：研究单位。患者/受试者：成年心脏骤停患者和雄性Sprague-Dawley大鼠。

干预：将10 min窒息性心脏骤停后复苏的大鼠随机分配至溶血磷脂酰胆碱组或溶媒组。

测量和主要结果：我们首先对人心脏骤停和对照血浆进行了磷脂调查。使用质谱分析后进行多变量回归分析，我们发现血浆溶血卵磷脂水平是心脏骤停的独立鉴别器。我们还发现血浆溶血磷脂酰胆碱降低与患者结局较差相关。在我们的大鼠模型中观察到了类似的关联，血浆溶血卵磷脂耗竭程度显著更大，心脏骤停时间增加，表明溶血卵磷脂水平与损伤严重程度相关。采用10 min心脏骤停大鼠模型，我们测试了补充耗尽的溶血磷脂酰胆碱、溶血磷脂酰胆碱(18:1)和溶血磷脂酰胆碱(22:6)，与对照组相比，其导致存活率显著增加。此外，接受这些溶血卵磷脂物种治疗的存活大鼠表现出脑功能显著改善。然而，补充溶血卵磷脂(18:0)（心脏骤停10 min后血浆中未减少）没有产生有益作用。

结论：我们的数据表明，血浆溶血磷脂酰胆碱降低是心脏骤停后死亡率和脑损伤的主要因素，补充溶血磷脂酰胆碱可能是一种新的治疗方法。
关键词：Humans; Female; Male; Aged; Aged, 80 and over; Animals; Rats, Sprague-Dawley; Severity of Illness Index; Rats; Heart Arrest/blood/complications/*metabolism; Lysophosphatidylcholines/*analysis/blood; Mass Screening/methods/*standards/statistics & numerical data; Phospholipids/*analysis/blood

--------
--------

## Viral Micro-RNAs Are Detected in the Early Systemic Response to Injury and Are Associated With Outcomes in Polytrauma Patients., Vicente, Diego

2:296-306. DOI:10.1097/CCM.0000000000005181

Abstract: 

OBJECTIVES: To evaluate early activation of latent viruses in polytrauma patients and consider prognostic value of viral micro-RNAs in these patients. 

DESIGN: This  was a subset analysis from a prospectively collected multicenter trauma database.  Blood samples were obtained upon admission to the trauma bay (T0), and trauma  metrics and recovery data were collected. 

SETTING: Two civilian Level 1 Trauma  Centers and one Military Treatment Facility. 

PATIENTS: Adult polytrauma patients  with Injury Severity Scores greater than or equal to 16 and available T0 plasma  samples were included in this study. Patients with ICU admission greater than 14  days, mechanical ventilation greater than 7 days, or mortality within 28 days  were considered to have a complicated recovery. 

INTERVENTIONS: None. 

MEASUREMENTS  AND MAIN RESULTS: Polytrauma patients (n = 180) were identified, and complicated  recovery was noted in 33%. Plasma samples from T0 underwent reverse  transcriptase-quantitative polymerase chain reaction analysis for Kaposi's  sarcoma-associated herpesvirus micro-RNAs (miR-K12_10b and miRK-12-12) and  Epstein-Barr virus-associated micro-RNA (miR-BHRF-1), as well as Luminex  multiplex array analysis for established mediators of inflammation. Ninety-eight  percent of polytrauma patients were found to have detectable Kaposi's  sarcoma-associated herpesvirus and Epstein-Barr virus micro-RNAs at T0, whereas  healthy controls demonstrated 0% and 100% detection rate for Kaposi's  sarcoma-associated herpesvirus and Epstein-Barr virus, respectively. Univariate  analysis revealed associations between viral micro-RNAs and polytrauma patients'  age, race, and postinjury complications. Multivariate least absolute shrinkage  and selection operator analysis of clinical variables and systemic biomarkers at  T0 revealed that interleukin-10 was the strongest predictor of all viral  micro-RNAs. Multivariate least absolute shrinkage and selection operator analysis  of systemic biomarkers as predictors of complicated recovery at T0 demonstrated  that miR-BHRF-1, miR-K12-12, monocyte chemoattractant protein-1, and hepatocyte  growth factor were independent predictors of complicated recovery with a model  complicated recovery prediction area under the curve of 0.81. 

CONCLUSIONS: Viral  micro-RNAs were detected within hours of injury and correlated with poor outcomes  in polytrauma patients. Our findings suggest that transcription of viral  micro-RNAs occurs early in the response to trauma and may be associated with the  biological processes involved in polytrauma-induced complicated recovery.

## 在对损伤的早期系统反应中检测到病毒microrna，并与多发性创伤患者的结局相关。

目的：评估多创伤患者中潜伏病毒的早期激活，并考虑病毒microrna在这些患者中的预后价值。

设计：这是前瞻性收集的多中心创伤数据库的子集分析。在入住创伤室时(T0)采集血样，并收集创伤指标和恢复数据。

地点：两个一级二级二级二级创伤中心和一个军事治疗设施。

患者：损伤严重程度评分大于或等于16分的成人多发伤患者和可用的T0血浆样本纳入本研究。入住ICU超过14天、机械通气超过7天或28天内死亡的患者视为复杂的恢复。

干预：无。

测量和主要结果：确定了多发伤患者(n = 180)，33%的患者伴有并发症。从T0开始，对血浆样本进行Kaposi肉瘤相关疱疹病毒微RNA（ΛK12_10b和ΛK-12-12）和eb病毒相关微RNA(ΛBHRF-1)的逆转录酶定量聚合酶链反应分析，以及建立炎症介质的Luminex多重阵列分析。发现98%的多发性创伤患者在T0时可检测到卡波西肉瘤相关疱疹病毒和eb病毒微RNA，而健康对照显示对卡波西肉瘤相关疱疹病毒和eb病毒的检出率分别为0%和100%。单变量分析显示病毒microrna与多发伤患者的年龄、人种和损伤后并发症之间存在相关性。T0时临床变量和系统生物标志物的多变量最小绝对收缩和选择运算符分析显示，白介素-10是所有病毒microrna的最强预测因子。在T0时，系统生物标志物作为复杂恢复预测因子的多变量最小绝对收缩和选择算子分析证明，综上所述，肝细胞生长因子是复杂恢复的独立预测因子，模型复杂恢复预测曲线下面积为0.81。

结论：在受伤数小时内检测到病毒microrna，并与多发伤患者的不良结局相关。我们的研究结果表明，病毒microrna的转录发生在创伤反应早期，可能与多种创伤诱导的复杂恢复相关的生物学过程有关。
关键词：Humans; Female; Male; Middle Aged; Adult; Herpesvirus 4, Human/genetics/isolation & purification; Herpesvirus 8, Human/genetics/isolation & purification; MicroRNAs/*analysis/blood/genetics; Multiple Trauma/*immunology/*virology; Reverse Transcriptase Polymerase Chain Reaction/methods/statistics & numerical data; RNA, Viral/*analysis/blood/genetics

--------
--------

## Insights on Blood Product Transfusions on ICU-Acquired Infections in Septic Shock.

1:e102. DOI:10.1097/CCM.0000000000005254

## 对败血症性休克中ICU获得性感染血液制品输注的见解。
关键词：Humans; Intensive Care Units; Blood Transfusion; *Shock, Septic/therapy

--------
--------

## Bayesian Models for Therapeutic Monitoring of Vancomycin in the Critically Ill: What Should They Predict?, Briassoulis, Panagiotis

1:e100-e101. DOI:10.1097/CCM.0000000000005228

## 危重病患者中万古霉素治疗监测的贝叶斯模型：应预测什么？
关键词：Humans; Anti-Bacterial Agents/therapeutic use; *Vancomycin; *Critical Illness; Bayes Theorem; Drug Monitoring

--------
--------

## Hyperoxia on Venoarterial Extracorporeal Membrane Oxygenation: A Modifiable Risk?, Joyce, Christopher J.

1:e99-e100. DOI:10.1097/CCM.0000000000005252

## 静脉动脉体外膜氧合的高氧血症：可改变的风险？
关键词：Humans; Risk Factors; Retrospective Studies; *Hyperoxia; *Extracorporeal Membrane Oxygenation

--------
--------

## Possible Underestimation of Cerebral Hyperoxia in Patients With Left Ventricular Output Encountering With Extracorporeal Membrane Oxygenation Flow at the Aortic  Arch.

1:e98-e99. DOI:10.1097/CCM.0000000000005249

## 伴有左室输出且主动脉弓处有体外膜肺氧合血流的患者，其脑氧饱和度可能被低估。
关键词：Humans; *Hyperoxia; *Extracorporeal Membrane Oxygenation; Heart Ventricles; Aorta, Thoracic/diagnostic imaging

--------
--------

## Potential Confounders in Evaluating the Impact of Hyperoxia on Neurological Outcomes in Patients Receiving Extracorporeal Membrane Oxygenation., Ishii, Junki

1:e97-e98. DOI:10.1097/CCM.0000000000005239

## 评价高氧血症对体外膜肺氧合患者神经系统结局影响的潜在混杂因素。
关键词：Humans; Retrospective Studies; *Hyperoxia; *Extracorporeal Membrane Oxygenation; *Cardiopulmonary Resuscitation

--------
--------

## The authors reply.

1:e91-e92. DOI:10.1097/CCM.0000000000005329

## 作者回复。

--------
--------

## Sedation, Neuromuscular Blockade, and Mortality in Acute Respiratory Distress Syndrome: Important Questions Remain., Train, Sarah E.

1:e89-e90. DOI:10.1097/CCM.0000000000005258

## 急性呼吸窘迫综合征中的镇静、神经肌肉阻滞和死亡率：仍然是重要的问题。
关键词：Humans; *Anesthetics; *Neuromuscular Blockade; *Anesthesia; *Neuromuscular Blocking Agents; *Respiratory Distress Syndrome/drug therapy

--------
--------

## The authors reply., Taylor, Stephanie Parks

1:e88-e89. DOI:10.1097/CCM.0000000000005339

## 作者回复。

--------
--------

## Concerning the Association Between Delayed Administration of Antibiotics and Mortality in Patients With Suspected Sepsis.

1:e87-e88. DOI:10.1097/CCM.0000000000005255

## 关于疑似败血症患者延迟抗生素给药与死亡率之间的相关性。
关键词：Humans; Anti-Bacterial Agents/therapeutic use; *Shock, Septic/drug therapy; *Sepsis/drug therapy

--------
--------

## Is Time-of-Flight Ready for Take Off to Measure Patient Self-Inflicted Lung Injury?, Kouch, Michael

1:168-170. DOI:10.1097/CCM.0000000000005237

## 准备好飞行时间测量患者自残肺损伤了吗？
关键词：Humans; Lung; *Lung Injury

--------
--------

## The Challenge of Conducting Research in the Neonatal and Pediatric Age and of Translating Results Into Clinical Practice., Marraro, Giuseppe A.

1:165-168. DOI:10.1097/CCM.0000000000005192

## 开展新生儿和儿科研究以及将结果转化为临床实践的挑战。
关键词：Humans; Child; Infant, Newborn; *Translating

--------
--------

## The ICU Liberation ABCDEF Bundle: Utilization Among Critically Ill Little Adults.

1:163-165. DOI:10.1097/CCM.0000000000005214

## ICU自由ABCDEF束：在危重小成人中的应用。
关键词：Humans; Adult; Critical Care; *Intensive Care Units; *Critical Illness

--------
--------

## Why Predict What Time Will Tell? A Strategic Rationale for Predicting Prolonged Mechanical Ventilation After Subarachnoid Hemorrhage., Maas, Matthew B.

1:160-162. DOI:10.1097/CCM.0000000000005250

## 为什么预测什么时间会有结果？预测蛛网膜下腔出血后机械通气延长的策略原理。
关键词：Humans; Time Factors; Respiration, Artificial; *Subarachnoid Hemorrhage/therapy

--------
--------

## Chimeric Antigen Receptor T Cells, the Shock of the New.

1:157-160. DOI:10.1097/CCM.0000000000005153

## 嵌合抗原受体T细胞，新的休克。
关键词：T-Lymphocytes; *Receptors, Chimeric Antigen; Immunotherapy, Adoptive; Receptors, Antigen, T-Cell

--------
--------

## Renin Kinetics and Mortality-Same, Same But Different?, Khanna, Ashish K.

1:153-157. DOI:10.1097/CCM.0000000000005157

## 肾素动力学和死亡率-相同、相同但不同？
关键词：*Renin; Kinetics

--------
--------

## Preserving Equity and Quality in the Push to Increase Access to Critical Care Services.

1:150-153. DOI:10.1097/CCM.0000000000005161

## 在推动增加重症监护服务的准入方面，维护公平和质量。
关键词：Humans; Critical Care/*organization & administration/standards; Efficiency, Organizational; Health Equity/*organization & administration; Health Facility Planning/*organization & administration; Health Services Accessibility/*organization & administration; Quality of Health Care/*organization & administration/standards

--------
--------

## Sepsis Definitions: I Know It When I See It., Parker, Margaret M.

1:148-150. DOI:10.1097/CCM.0000000000005350

## 败血症定义：我看到时就知道了。
关键词：Humans; *Shock, Septic; *Sepsis/diagnosis

--------
--------

## Time for a New Approach Investigating and Eliminating Racial Inequities in the ICU.

1:144-147. DOI:10.1097/CCM.0000000000005280

## 在ICU探索和消除人种偏见的新方法的时机。
关键词：Humans; Intensive Care Units; *Racial Groups; *Racism

--------
--------

## Racial Disparities in ICU Outcomes: A Systematic Review.

1:1-20. DOI:10.1097/CCM.0000000000005269

Abstract: 

OBJECTIVES: Racial disparities in the United States healthcare system are well described across a variety of clinical settings. The ICU is a clinical  environment with a higher acuity and mortality rate, potentially compounding the  impact of disparities on patients. We sought to systematically analyze the  literature to assess the prevalence of racial disparities in the ICU. 

DATA  SOURCES: We conducted a comprehensive search of PubMed/MEDLINE, Scopus, CINAHL,  and the Cochrane Library. 

STUDY SELECTION: We identified articles that evaluated  racial differences on outcomes among ICU patients in the United States. Two  authors independently screened and selected articles for inclusion. 

DATA  EXTRACTION: We dual-extracted study characteristics and outcomes that assessed  for disparities in care (e.g., in-hospital mortality, ICU length of stay).  Studies were assessed for bias using the Newcastle-Ottawa Scale. 

DATA SYNTHESIS:  Of 1,325 articles screened, 25 articles were included (n = 751,796 patients).  Studies demonstrated race-based differences in outcomes, including higher  mortality rates for Black patients when compared with White patients. However,  when controlling for confounding variables, such as severity of illness and  hospital type, mortality differences based on race were no longer observed.  Additionally, results revealed that Black patients experienced greater financial  impacts during an ICU admission, were less likely to receive early tracheostomy,  and were less likely to receive timely antibiotics than White patients. Many  studies also observed differences in patients' end-of-life care, including lower  rates on the quality of dying, less advanced care planning, and higher intensity  of interventions at the end of life for Black patients. 

CONCLUSIONS: This  systematic review found significant differences in the care and outcomes among  ICU patients of different races. Mortality differences were largely explained by  accompanying demographic and patient factors, highlighting the effect of  structural inequalities on racial differences in mortality in the ICU. This  systematic review provides evidence that structural inequalities in care persist  in the ICU, which contribute to racial disparities in care. Future research  should evaluate interventions to address inequality in the ICU.

## ICU结局中的种族差异：一项系统性综述。

目的：美国医疗保健系统中的人种差异在各种临床背景中均有很好的描述。ICU是具有较高急性和死亡率的临床环境，可能加剧差异对患者的影响。我们试图系统分析文献，以评估ICU中人种差异的患病率。

数据来源：我们对PubMed/MEDLINE、Scopus、CINAHL和Cochrane Library进行了全面检索。

研究选择：我们确定了评价美国ICU患者结局的人种差异的文章。两位作者独立筛选并选择文章纳入。

数据提取：我们双重提取了研究特征和结局，评估护理差异（例如，住院死亡率、ICU住院时间）。使用Newcastle-Ottawa量表评估研究的偏倚。

资料综合：在筛选的1325篇文献中，纳入25篇文献（n = 751796例患者）。研究表明结局存在基于人种的差异，包括与白人患者相比，黑人患者的死亡率更高。但是，当控制混杂变量时，如疾病严重程度和医院类型，不再观察到基于人种的死亡率差异。此外，结果显示，与白人患者相比，黑人患者在入住ICU期间经历了更大的经济影响，不太可能接受早期气管造口术，也不太可能及时接受抗生素治疗。许多研究还观察到患者的临终关怀存在差异，包括黑人患者的死亡质量率较低、晚期护理计划较少和临终关怀干预强度较高。

结论：本系统综述发现不同人种ICU患者的护理和结局存在显著差异。死亡率差异在很大程度上可通过伴随的人口统计学和患者因素来解释，突出了结构性不平等对ICU中死亡率的人种差异的影响。这项系统性审查提供的证据表明，ICU中护理的结构性不平等持续存在，这导致护理中的人种差异。未来的研究应评估干预措施，以解决ICU中的不均一性。
关键词：Humans; Length of Stay; United States; Patient Acuity; Intensive Care Units/*statistics & numerical data; Healthcare Disparities/*ethnology; Hospital Mortality/ethnology; Terminal Care/standards

--------
--------

## Criteria for Pediatric Sepsis-A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce., Menon, Kusum

1:21-36. DOI:10.1097/CCM.0000000000005294

Abstract: 

OBJECTIVE: To determine the associations of demographic, clinical, laboratory, organ dysfunction, and illness severity variable values with: 1) sepsis, severe  sepsis, or septic shock in children with infection and 2) multiple organ  dysfunction or death in children with sepsis, severe sepsis, or septic shock.  

DATA SOURCES: MEDLINE, Embase, and the Cochrane Central Register of Controlled  Trials were searched from January 1, 2004, and November 16, 2020. 

STUDY  SELECTION: Case-control studies, cohort studies, and randomized controlled trials  in children greater than or equal to 37-week-old postconception to 18 years with  suspected or confirmed infection, which included the terms "sepsis,"  "septicemia," or "septic shock" in the title or abstract. 

DATA EXTRACTION: Study  characteristics, patient demographics, clinical signs or interventions,  laboratory values, organ dysfunction measures, and illness severity scores were  extracted from eligible articles. Random-effects meta-analysis was performed.  

DATA SYNTHESIS: One hundred and six studies met eligibility criteria of which 81  were included in the meta-analysis. Sixteen studies (9,629 patients) provided  data for the sepsis, severe sepsis, or septic shock outcome and 71 studies  (154,674 patients) for the mortality outcome. In children with infection,  decreased level of consciousness and higher Pediatric Risk of Mortality scores  were associated with sepsis/severe sepsis. In children with sepsis/severe  sepsis/septic shock, chronic conditions, oncologic diagnosis, use of  vasoactive/inotropic agents, mechanical ventilation, serum lactate, platelet  count, fibrinogen, procalcitonin, multi-organ dysfunction syndrome, Pediatric  Logistic Organ Dysfunction score, Pediatric Index of Mortality-3, and Pediatric  Risk of Mortality score each demonstrated significant and consistent associations  with mortality. Pooled mortality rates varied among high-, upper middle-, and  lower middle-income countries for patients with sepsis, severe sepsis, and septic  shock (p < 0.0001). 

CONCLUSIONS: Strong associations of several markers of organ  dysfunction with the outcomes of interest among infected and septic children  support their inclusion in the data validation phase of the Pediatric Sepsis  Definition Taskforce.

## 儿科败血症标准-儿科败血症定义Taskforce的系统审查和荟萃分析。

目的：确定人口统计学、临床、实验室、器官功能障碍和疾病严重程度变量值与以下指标的相关性：1）感染儿童中的败血症、重度败血症或感染性休克，和2）败血症、重度败血症或感染性休克儿童中的多器官功能障碍或死亡。

资料来源：检索2004年1月1日至2020年11月16日MEDLINE、Embase和Cochrane临床对照试验中心注册数据库。

研究选择：在受孕后≥37周、至18岁疑似或确诊感染的儿童中进行的病例对照研究、队列研究和随机对照试验，在标题或摘要中纳入术语“败血症”、“败血症”或“感染性休克”。

数据提取：从合格文献中提取研究特征、患者人口统计学、临床体征或干预、实验室检查值、器官功能障碍指标和疾病严重程度评分。进行了随机效应荟萃分析。

数据综合：106项研究符合合格标准，其中81项被纳入荟萃分析。16项研究（9629例患者）提供了败血症、重度败血症或感染性休克结局数据，71项研究（154674例患者）提供了死亡结局数据。在感染儿童中，意识水平下降和较高的儿科死亡风险评分与败血症/重度败血症相关。在伴有败血症/重度败血症/感染性休克、慢性疾病、肿瘤诊断、使用血管活性/正性肌力药、机械通气、血清乳酸盐、血小板计数、纤维蛋白原、降钙素原、多器官功能障碍综合征的儿童中，儿童Logistic器官功能障碍评分、儿童死亡率指数-3，儿科死亡风险评分均显示与死亡率显著且一致的相关性。对于脓毒症、重度脓毒症和脓毒性休克患者，不同高、中上、中下收入国家的汇总死亡率不同(p < 0.0001)。

结论：在感染和败血症儿童中，器官功能障碍的几个标志物与关注结局的强相关性支持将其纳入儿科败血症定义工作组的数据验证阶段。
关键词：Humans; Female; Male; Respiration, Artificial; Adolescent; Child; Infant; Infant, Newborn; Child, Preschool; Patient Acuity; Organ Dysfunction Scores; Clinical Laboratory Techniques; Consciousness; Global Health; Sepsis/*epidemiology/mortality/*physiopathology; Shock, Septic/epidemiology/physiopathology; Sociodemographic Factors

--------
--------

## The authors reply.

1:e94-e95. DOI:10.1097/CCM.0000000000005371

## 作者回复。

--------
--------

## Thrombocytopenia After Coronavirus Disease 2019 Vaccination: Remember to Put the Blame on Others Too., De Bruyne, Sander

1:e92-e93. DOI:10.1097/CCM.0000000000005327

## 2019年接种冠状病毒病疫苗后发生血小板减少症：记住也要责备其他人。
关键词：Humans; *COVID-19; SARS-CoV-2; *Leukopenia; *Thrombocytopenia; Vaccination/adverse effects

--------
--------

## Physiological Assessment of Delirium Severity: The Electroencephalographic Confusion Assessment Method Severity Score (E-CAM-S)., van Sleuwen, Meike

1:e11-e19. DOI:10.1097/CCM.0000000000005224

Abstract: 

OBJECTIVES: Delirium is a common and frequently underdiagnosed complication in acutely hospitalized patients, and its severity is associated with worse clinical  outcomes. 

We propose a physiologically based method to quantify delirium severity  as a tool that can help close this diagnostic gap: the Electroencephalographic  Confusion Assessment Method Severity Score (E-CAM-S). 

DESIGN: Retrospective  cohort study. 

SETTING: Single-center tertiary academic medical center. 

PATIENTS:  Three-hundred seventy-three adult patients undergoing electroencephalography to  evaluate altered mental status between August 2015 and December 2019.  

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: We developed the E-CAM-S  based on a learning-to-rank machine learning model of forehead  electroencephalography signals. Clinical delirium severity was assessed using the  Confusion Assessment Method Severity (CAM-S). We compared associations of E-CAM-S  and CAM-S with hospital length of stay and inhospital mortality. E-CAM-S  correlated with clinical CAM-S (R = 0.67; p < 0.0001). For the overall cohort,  E-CAM-S and CAM-S were similar in their strength of association with hospital  length of stay (correlation = 0.31 vs 0.41, respectively; p = 0.082) and  inhospital mortality (area under the curve = 0.77 vs 0.81; p = 0.310). Even when  restricted to noncomatose patients, E-CAM-S remained statistically similar to  CAM-S in its association with length of stay (correlation = 0.37 vs 0.42,  respectively; p = 0.188) and inhospital mortality (area under the curve = 0.83 vs  0.74; p = 0.112). In addition to previously appreciated spectral features, the  machine learning framework identified variability in multiple measures over time  as important features in electroencephalography-based prediction of delirium  severity. 

CONCLUSIONS: The E-CAM-S is an automated, physiologic measure of  delirium severity that predicts clinical outcomes with a level of performance  comparable to conventional interview-based clinical assessment.

## 谵妄严重程度的生理学评估：脑电图意识模糊评估方法严重程度评分(E-CAM-S)。

目的：谵妄是急性住院患者中一种常见且经常被漏诊的并发症，其严重程度与较差的临床结局相关。我们提出一种基于生理学的方法，对谵妄严重程度进行定量，作为一种能够帮助填补该诊断空白的工具：脑电图意识模糊评估方法严重程度评分(E-CAM-S)。

设计：回顾性队列研究。

单位：单中心三级学术医学中心。

患者：2015年8月至2019年12月，373例接受脑电图检查以评价精神状态改变的成人患者。

干预：无。

测量和主要结果：我们基于前额脑电图信号的学习秩机器学习模型开发了E-CAM-S。采用意识模糊评估方法严重程度(CAM-S)评估临床谵妄严重程度。我们比较了E-CAM-S和CAM-S与住院时间和住院死亡率的相关性。E-CAM-S与临床CAM-S相关(R = 0.67；p < 0.0001)。对于总体队列，E-CAM-S和CAM-S与住院时间（相关性分别为0.31 vs 0.41；p = 0.082）和住院死亡率（曲线下面积 = 0.77 vs 0.81；p = 0.310）的相关性强度相似。即使仅限于非昏迷患者，E-CAM-S与CAM-S在住院时间（相关性分别为0.37 vs 0.42；p = 0.188）和住院死亡率（曲线下面积 = 0.83 vs 0.74；p = 0.112）方面仍然具有统计学相似性。除了以前认可的光谱特征外，机器学习框架还识别了多个指标随时间变化的变异性，作为基于脑电图预测谵妄严重程度的重要特征。

结论：E-CAM-S是一种对谵妄严重程度的自动化、生理学测量，可预测临床结局，其性能水平与基于常规访谈的临床评估相当。
关键词：Humans; Female; Male; Middle Aged; Prognosis; Aged; Adult; Retrospective Studies; Severity of Illness Index; Comorbidity; Patient Acuity; Length of Stay/statistics & numerical data; *Machine Learning; Academic Medical Centers/statistics & numerical data; Confusion/*diagnosis; Delirium/*diagnosis; Electroencephalography/*methods; Hospital Mortality/trends; Hospitals/statistics & numerical data; Image Processing, Computer-Assisted/*methods

--------
--------

## Molar Sodium Lactate Attenuates the Severity of Postcardiac Arrest Syndrome: A Preclinical Study., Stevic, Neven

1:e71-e79. DOI:10.1097/CCM.0000000000005233

Abstract: 

OBJECTIVES: To determine whether continuous IV infusion of molar sodium lactate would limit cardiac arrest-induced neurologic injury and cardiovascular failure.  

DESIGN: Randomized blinded study (animal model). 

SETTING: University animal  research facility. 

SUBJECTS: Twenty-four adult male "New Zealand White" rabbits.  

INTERVENTIONS: Anesthetized rabbits underwent 12.5 minutes of asphyxial cardiac  arrest and were randomized to receive either normal saline (control group, n =  12) or molar sodium lactate (molar sodium lactate group, n = 12) at a rate of  5 mL/kg/hr during the whole 120-minute reperfusion period. 

MEASUREMENTS AND MAIN  RESULTS: Pupillary reactivity (primary outcome), levels of S100?? protein, in  vitro brain mitochondria functions, cardiovascular function, and fluid balance  were assessed. Molar sodium lactate reduced brain injury, with a higher  proportion of animals exhibiting pupillary reactivity to light (83% vs 25% in the  CTRL group, p = 0.01) and lower S100?? protein levels (189 ?± 42 vs 412 ?± 63 pg/mL,  p < 0.01) at the end of the protocol. Molar sodium lactate significantly  prevented cardiac arrest-induced decrease in oxidative phosphorylation and  mitochondrial calcium-retention capacity compared with controls. At 120 minutes  of reperfusion, survival did not significantly differ between the groups (10/12,  83% in the molar sodium lactate group vs nine of 12, 75% in the control group; p  > 0.99), but hemodynamics were significantly improved in the molar sodium lactate  group compared with the control group (higher mean arterial pressure [49 ?± 2 vs  29 ?± 3 mm Hg; p < 0.05], higher cardiac output [108 ?± 4 vs 58 ?± 9 mL/min; p <  0.05], higher left ventricle surface shortening fraction [38% ?± 3% vs 19% ?± 3%; p  < 0.05], and lower left ventricular end-diastolic pressure [3 ?± 1 vs 8 ?± 2 mm Hg;  p < 0.01]). While fluid intake was similar in both groups, fluid balance was  higher in control animals (11 ?± 1 mL/kg) than that in molar sodium  lactate-treated rabbits (1 ?± 3 mL/kg; p < 0.01) due to lower diuresis.  

CONCLUSIONS: Molar sodium lactate was effective in limiting the severity of the  postcardiac arrest syndrome. This preclinical study opens up new perspectives for  the treatment of cardiac arrest.

## 乳酸钠摩尔降低心后停搏综合征的严重程度：一项临床前研究。

目的：确定持续IV输注摩尔乳酸钠是否会限制心脏骤停诱导的神经损伤和心血管衰竭。

设计：随机盲法研究（动物模型）。

单位：大学动物研究机构。

受试者：24只成年雄性“新西兰白兔”。

干预：麻醉家兔经历了12.5 min的窒息性心脏骤停，并在整个120 min再灌注期间随机接受生理盐水（对照组，n = 12）或摩尔乳酸钠（摩尔乳酸钠组，n = 12），速率为5 mL/kg/hr。

测量和主要结果：评估瞳孔反应性（主要结局）、S100?蛋白水平、体外脑线粒体功能、心血管功能和体液平衡。摩尔乳酸钠减少了脑损伤，在方案结束时，更高比例的动物表现出瞳孔对光的反应性（83%vs CTRL组的25%，p = 0.01），并且s100nct014?蛋白水平较低(189?±42 vs 412Μ±63 pg/mL，p < 0.01)。与对照组相比，摩尔乳酸钠显著预防了心脏骤停诱导的氧化磷酸化和线粒体钙潴留能力下降。再灌注120 min时，各组间存活率无显著差异（10/12，摩尔乳酸钠组83%vs对照组9/12，75%；p > 0.99），但与对照组相比，摩尔乳酸钠组的血流动力学显著改善（平均动脉压较高[49?±2 vs 29?±3 mmHg；p < 0.05]、心输出量较高[108?±4 vs 58?±9 mL/min；p < 0.05]、左心室表面缩短分数较高[38%?±3%vs 19%?±3%；p < 0.05]，左室舒张末期压较低([mür±1 vs mür±2 mmHg；p < 0.01])。虽然两组的液体摄入量相似，但由于较低的利尿作用，对照动物(11?±1 mL/kg)的液体平衡高于摩尔乳酸钠处理的家兔(1?±3 mL/kg；p < 0.01)。

结论：摩尔乳酸钠可有效限制心脏骤停后综合征的严重程度。本临床前研究为心脏骤停的治疗开辟了新的视角。
关键词：Male; Animals; Disease Models, Animal; Random Allocation; Rabbits; Brain/drug effects; Hemodynamics/*drug effects; Post-Cardiac Arrest Syndrome/*physiopathology; Sodium Lactate/*pharmacology

--------
--------

## Components of Health-Related Quality of Life Most Affected Following Pediatric Critical Illness., Killien, Elizabeth Y.

1:e20-e30. DOI:10.1097/CCM.0000000000005230

Abstract: 

OBJECTIVES: To evaluate which individual elements of health-related quality of life contribute most to decline in overall health-related quality of life status  following pediatric critical care. 

DESIGN: Retrospective cohort study. 

SETTING:  Seattle Children's Hospital. 

PATIENTS: ICU patients age 1 month to 18 years  admitted between December 2011 and February 2017. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: We assessed health-relatedquality of life decline  from baseline to postdischarge (median, 6 wk) and determined the individual items  of the Pediatric Quality of Life Inventory Infant Scales (< 2 yr) and Generic  Core Scales (2-18 yr) with the highest prevalence of decline. We used  multivariable regression to estimate the risk of decline in each of seven  thematic categories by patient age, baseline health status, diagnosis, Pediatric  Risk of Mortality score, and ICU length of stay. Decline from baseline  health-related quality of life occurred in 22.5% of 539 patients. Items most  commonly affected for infants less than 2 years were primarily emotional  (cranky/crying, sleep, and self-soothing). Children 2-18 years most commonly  experienced declines in physical functioning (play/exercise, lifting, and pain).  Across the entire cohort, declines in categories of energy (31.5%), activity  (31.0%), sleep (28.0%), and fear (24.7%) were most commonly endorsed. Risk of  decline in each category varied with patient age, medical complexity, and  diagnosis. 

CONCLUSIONS: Deconditioning, sleep, fear, and pain are important  targets for intervention to improve health-related quality of life outcomes for  critically ill children.

## 健康相关生活质量的组分在儿童危重疾病后受影响最大。

目的：评价在儿科重症监护后，健康相关生活质量的个体因素对总体健康相关生活质量状态下降的贡献最大。

设计：回顾性队列研究。

单位：西雅图儿童医院。

患者：2011年12月至2017年2月期间收治的1月龄至18岁的ICU患者。

干预：无。

测量和主要结果：我们评估了出院后健康相关生活质量自基线（中位数，6周）的下降，并确定了下降患病率最高的儿科生活质量调查表婴儿量表（< 2年）和通用核心量表（2-18年）的单项。我们使用多变量回归来估计按患者年龄、基线健康状况、诊断、儿科死亡风险评分和ICU住院时间划分的7个主题类别中每一个类别的下降风险。539例患者中，22.5%的患者的健康相关生活质量较基线下降。2岁以下婴儿最常受累的项目主要为情绪（烦躁/哭闹、睡眠和自我舒缓）。2-18岁儿童最常发生身体功能下降（游戏/运动、举起和疼痛）。在整个队列中，能量(31.5%)、活动(31.0%)、睡眠(28.0%)和恐惧(24.7%)类别下降最常见。各类别中的下降风险因患者年龄、医学复杂性和诊断而异。

结论：失调、睡眠、恐惧和疼痛是改善危重儿童健康相关生活质量结局的重要干预目标。
关键词：Humans; Female; Male; Length of Stay; Adolescent; Retrospective Studies; Child; Infant; Severity of Illness Index; Child, Preschool; Exercise; Age Factors; *Quality of Life; *Critical Illness; *Intensive Care Units, Pediatric; Health Status; Hospitals, Pediatric; Play and Playthings; Sleep Quality; Surveys and Questionnaires/*standards

--------
--------

## Coronavirus Disease-Induced Blurred Judgment.

1:e95-e96. DOI:10.1097/CCM.0000000000005248

## 冠状病毒病引起的判断模糊。
关键词：Humans; *Coronavirus; *Coronavirus Infections; Diagnostic Tests, Routine; Judgment

--------
--------

## Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness  Universal Study (Coronavirus Disease 2019) Registry., Bhalala, Utpal S.

1:e40-e51. DOI:10.1097/CCM.0000000000005232

Abstract: 

OBJECTIVES: Multicenter data on the characteristics and outcomes of children hospitalized with coronavirus disease 2019 are limited. Our objective was to  describe the characteristics, ICU admissions, and outcomes among children  hospitalized with coronavirus disease 2019 using Society of Critical Care  Medicine Discovery Viral Infection and Respiratory Illness Universal Study:  Coronavirus Disease 2019 registry. 

DESIGN: Retrospective study. 

SETTING: Society  of Critical Care Medicine Viral Infection and Respiratory Illness Universal Study  (Coronavirus Disease 2019) registry. 

PATIENTS: Children (< 18 yr) hospitalized  with coronavirus disease 2019 at participating hospitals from February 2020 to  January 2021. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: The primary  outcome was ICU admission. Secondary outcomes included hospital and ICU duration  of stay and ICU, hospital, and 28-day mortality. A total of 874 children with  coronavirus disease 2019 were reported to Viral Infection and Respiratory Illness  Universal Study registry from 51 participating centers, majority in the United  States. Median age was 8 years (interquartile range, 1.25-14 yr) with a  male:female ratio of 1:2. A majority were non-Hispanic (492/874; 62.9%). Median  body mass index (n = 817) was 19.4 kg/m2 (16-25.8 kg/m2), with 110 (13.4%)  overweight and 300 (36.6%) obese. A majority (67%) presented with fever, and  43.2% had comorbidities. A total of 238 of 838 (28.2%) met the Centers for  Disease Control and Prevention criteria for multisystem inflammatory syndrome in  children, and 404 of 874 (46.2%) were admitted to the ICU. In multivariate  logistic regression, age, fever, multisystem inflammatory syndrome in children,  and pre-existing seizure disorder were independently associated with a greater  odds of ICU admission. Hospital mortality was 16 of 874 (1.8%). Median  (interquartile range) duration of ICU (n = 379) and hospital (n = 857) stay were  3.9 days (2-7.7 d) and 4 days (1.9-7.5 d), respectively. For patients with 28-day  data, survival was 679 of 787, 86.3% with 13.4% lost to follow-up, and 0.3%  deceased. 

CONCLUSIONS: In this observational, multicenter registry of children  with coronavirus disease 2019, ICU admission was common. Older age, fever,  multisystem inflammatory syndrome in children, and seizure disorder were  independently associated with ICU admission, and mortality was lower among  children than mortality reported in adults.

## 2019年冠状病毒病住院儿童的特征和结局：一项多中心、病毒感染和呼吸系统疾病的报告  通用研究(Coronavirus Disease 2019)登记研究。

目的：有关2019年因冠状病毒病住院的儿童的特征和结局的多中心数据有限。我们的目标是  描述儿童的特征、ICU收治和结局  2019年重症协会评估的冠状病毒病导致住院  医学发现病毒感染和呼吸系统疾病的普遍研究：  2019年冠状病毒病登记研究。

设计：回顾性研究。

单位：学会  重症医学病毒感染与呼吸系统疾病的普遍研究  (Coronavirus Disease 2019)登记研究。

患者：儿童（< 18岁）住院  伴随冠状病毒病2019年2020年2月2月在参与医院  2021年1月。

干预：无。

测量和主要结果：主要  结局为入住ICU。次要结局包括住院和ICU持续时间  住院和ICU、住院和28天死亡率。共有874例儿童发生  2019年将冠状病毒病报告至病毒感染和呼吸系统疾病  来自51家参与研究中心的通用研究登记，大多数在美国  状态。中位年龄为8岁（四分位距：1.25-14岁），  男性：女性比例为1:2。大多数为非西班牙裔(492/874；62.9%)。中位数  体重指数(n = 817)为19.4 kg/m2(16-25.8 kg/m2)，其中110(13.4%)  超重和肥胖患者300例(36.6%)。大多数(67%)表现为发热，以及  43.2%有合并症。共计238/838名患者(28.2%)符合  我国多系统炎症综合征的疾病防治标准  儿童，404/874(46.2%)例患者进入ICU。多变量  logistic回归、年龄、发热、儿童多系统炎症综合征，  既存癫痫发作性疾病与以下因素独立相关：  入住ICU的几率。住院死亡率为874例中的16例(1.8%)。中位数  （四分位距）ICU(n = 379)和住院(n = 857)时间  3.9天（2-7.7天）和4天（1.9-7.5 d）。对于28天患者  数据，生存率为679/787，86.3%，13.4%失访，0.3%  死亡。

结论：在这项观察性、儿童多中心登记研究中  2019年，患者因冠状病毒病入住ICU。高龄、发热、  儿童多系统炎症综合征和癫痫发作  与入住ICU独立相关，且死亡率较低  儿童死亡率高于成人死亡率。
关键词：Humans; Female; Male; Adolescent; Retrospective Studies; Child; Infant; Child, Preschool; Age Factors; Comorbidity; SARS-CoV-2; Intensive Care Units/statistics & numerical data; Body Mass Index; Logistic Models; Hospital Mortality/trends; Child, Hospitalized/*statistics & numerical data; COVID-19/*complications/*epidemiology/mortality/*physiopathology; Systemic Inflammatory Response Syndrome/*epidemiology/mortality/*physiopathology

--------
--------

## Mortality Among Noncoronavirus Disease 2019 Critically Ill Patients Attributable to the Pandemic in France.

1:138-143. DOI:10.1097/CCM.0000000000005215

Abstract: 

OBJECTIVES: We investigated whether the risk of death among noncoronavirus disease 2019 critically ill patients increased when numerous coronavirus disease  2019 cases were admitted concomitantly to the same hospital units. 

DESIGN: We  performed a nationwide observational study based on the medical information  system from all public and private hospitals in France. 

SETTING: Information  pertaining to every adult admitted to ICUs or intermediate care units from 641  hospitals between January 1, 2020, and June 30, 2020 was analyzed. 

PATIENTS: A  total of 454,502 patients (428,687 noncoronavirus disease 2019 and 25,815  coronavirus disease 2019 patients) were included. 

INTERVENTIONS: For each  noncoronavirus disease 2019 patient, pandemic exposure during their stay was  calculated per day using the proportion of coronavirus disease 2019 patients  among all patients treated in ICU. 

MEASUREMENTS AND MAIN RESULTS: We computed a  multivariable logistic regression model to estimate the influence of pandemic  exposure (low, moderate, and high exposure) on noncoronavirus disease 2019  patient mortality during ICU stay. We adjusted on patient and hospital  confounders. The risk of death among noncoronavirus disease 2019 critically ill  patients increased in case of moderate (adjusted odds ratio, 1.12; 95% CI,  1.05-1.19; p < 0.001) and high pandemic exposures (1.52; 95% CI, 1.33-1.74; p <  0.001). 

CONCLUSIONS: In hospital units with moderate or high levels of  coronavirus disease 2019 critically ill patients, noncoronavirus disease deaths  were at higher levels.

## 2019年法国大流行导致的非冠状病毒疾病危重患者的死亡率

目的：我们研究了在2019例重症患者中，当许多冠状病毒疾病发生时，非冠状病毒疾病的死亡风险是否升高  2019例病例在同一医院住院。

设计：我们  基于医学信息开展一项全国观察性研究  来自法国所有公立和私立医院的系统。

设置：信息  与641年入住ICU或中间监护病房的每一位成人有关  分析了2020年1月1日至2020年6月30日期间的医院。

患者：A  共454,502例患者（428,687例非冠状病毒病2019和25,815例）  冠状病毒病2019例患者）。

干预：针对每种  非冠状病毒病2019例患者，住院期间大流行暴露  使用2019例患者中的冠状病毒病比例计算  ICU治疗的所有患者中。

测量和主要结果：我们计算了  用于估计大流行影响的多变量logistic回归模型  2019年非冠状病毒疾病暴露（低、中、高暴露）  患者在ICU住院期间的死亡率。我们根据患者和医院进行了调整  混杂因素。2019年重症非冠状病毒病死亡风险分析  中度患者增加（调整比值比，1.12；95%CI，  1.05-1.19；p < 0.001）和大流行暴露（1.52；95%CI，1.33-1.74；p <  0.001).结论：在医院病房中，中度或高度  冠状病毒病2019例重症患者，非冠状病毒病死亡  均处于较高水平。
关键词：Humans; Female; Male; Middle Aged; Aged; Aged, 80 and over; Pandemics; SARS-CoV-2; Logistic Models; COVID-19/*epidemiology; Intensive Care Units/*statistics & numerical data; Critical Illness/*mortality; France/epidemiology; Mortality/*trends

--------
--------

## Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients.

1:e1-e10. DOI:10.1097/CCM.0000000000005216

Abstract: 

OBJECTIVES: Obesity is a risk factor for severe coronavirus disease 2019 and might play a role in its pathophysiology. It is unknown whether body mass index  is related to clinical outcome following ICU admission, as observed in various  other categories of critically ill patients. We investigated the relationship  between body mass index and inhospital mortality in critically ill coronavirus  disease 2019 patients and in cohorts of ICU patients with non-severe acute  respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and  multiple trauma. 

DESIGN: Multicenter observational cohort study. 

SETTING:  Eighty-two Dutch ICUs participating in the Dutch National Intensive Care  Evaluation quality registry. 

PATIENTS: Thirty-five-thousand five-hundred six  critically ill patients. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS:  Patient characteristics and clinical outcomes were compared between four cohorts  (coronavirus disease 2019, nonsevere acute respiratory syndrome coronavirus 2  viral pneumonia, bacterial pneumonia, and multiple trauma patients) and between  body mass index categories within cohorts. Adjusted analyses of the relationship  between body mass index and inhospital mortality within each cohort were  performed using multivariable logistic regression. Coronavirus disease 2019  patients were more likely male, had a higher body mass index, lower Pao2/Fio2  ratio, and were more likely mechanically ventilated during the first 24 hours in  the ICU compared with the other cohorts. Coronavirus disease 2019 patients had  longer ICU and hospital length of stay, and higher inhospital mortality. Odds  ratios for inhospital mortality for patients with body mass index greater than or  equal to 35 kg/m2 compared with normal weight in the coronavirus disease 2019,  nonsevere acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial  pneumonia, and trauma cohorts were 1.15 (0.79-1.67), 0.64 (0.43-0.95), 0.73  (0.61-0.87), and 0.81 (0.57-1.15), respectively. 

CONCLUSIONS: The obesity  paradox, which is the inverse association between body mass index and mortality  in critically ill patients, is not present in ICU patients with coronavirus  disease 2019-related respiratory failure, in contrast to nonsevere acute  respiratory syndrome coronavirus 2 viral and bacterial respiratory infections.

## 2019年冠状病毒病和其他疾病患者的体重指数和死亡率：一项纳入35,506例ICU患者的队列研究。

目的：肥胖是2019年严重冠状病毒疾病的风险因素，可能在其病理生理学中发挥作用。体重指数是否未知  与ICU入院后的临床结局相关，如在各种  其他类别的重症患者。我们研究了关系  危重冠状病毒患者体重指数与住院死亡率的关系  2019例患者和ICU非重度急性发作患者队列  呼吸道综合征冠状病毒2型病毒性肺炎、细菌性肺炎和  多发性创伤。

设计：多中心观察性队列研究。

设置：  82间荷兰ICU参与荷兰国家重症监护  评价质量登记。

患者：355006  重症患者。

干预：无。

测量和主要结果：  比较了4个队列之间的患者特征和临床结局  （冠状病毒病2019、非严重急性呼吸综合征冠状病毒2  病毒性肺炎、细菌性肺炎和多发性创伤患者）以及  队列内的体重指数类别。相关性的校正分析  每个队列中体重指数与住院死亡率之间的关系为  使用多变量logistic回归进行。冠状病毒病2019  患者更可能为男性，体重指数更高，Pao2/Fio2更低  比值，并且更可能在入组后24小时内进行机械通气  ICU与其他队列相比。冠状病毒病2019例患者  ICU和住院时间更长，住院死亡率更高。几率  体重指数大于或等于  在2019年，与正常体重相比，等于35 kg/m2，  非严重急性呼吸综合征冠状病毒2型细菌性病毒性肺炎  肺炎和创伤队列分别为1.15(0.79-1.67)、0.64(0.43-0.95)和0.73  (0.61-0.87),和0.81（0.57-1.15）。

结论：肥胖  反常，即体重指数与死亡率之间的负相关  重症患者中，ICU患者中不存在冠状病毒  2019年相关疾病呼吸衰竭，与非重度急性相反  呼吸道综合征冠状病毒2型病毒性和细菌性呼吸道感染。
关键词：Humans; Female; Male; Middle Aged; Aged; Critical Illness; Intensive Care Units; Length of Stay; SARS-CoV-2; Netherlands/epidemiology; Patient Acuity; Hospital Mortality/*trends; *Body Mass Index; COVID-19/*epidemiology/mortality; Multiple Trauma/epidemiology; Obesity/*epidemiology; Pneumonia, Bacterial/epidemiology

--------
--------

## Dielectric Blood Coagulometry for the Early Detection of Sepsis-Induced Disseminated Intravascular Coagulation: A Prospective Observational Study., Takayama, Wataru

1:e31-e39. DOI:10.1097/CCM.0000000000005231

Abstract: 

OBJECTIVES: To evaluate the utility of dielectric blood coagulometry for early sepsis-induced disseminated intravascular coagulation diagnosis. 

DESIGN:  Single-center, prospective observational study. 

SETTING: Patients with sepsis or  septic shock at the Tokyo Medical and Dental University Hospital of Medicine  between September 2019 and September 2020. 

PATIENTS: The patients were divided  into three groups according to the timing of disseminated intravascular  coagulation diagnosis based on the Disseminated Intravascular Coagulation score  by the Japanese Association for Acute Medicine: 1) no disseminated intravascular  coagulation group, 2) late-diagnosed disseminated intravascular coagulation  group: not diagnosed with disseminated intravascular coagulation on day 1 but  diagnosed within 48 hours after admission, and 3) disseminated intravascular  coagulation group: diagnosed with disseminated intravascular coagulation on day  1. The study evaluated 80 patients (no disseminated intravascular coagulation, 31  [38.8%]; late-diagnosed disseminated intravascular coagulation, 34 (42.5%);  disseminated intravascular coagulation, 15 [18.8%]). 

MEASUREMENTS AND MAIN  RESULTS: We compared the clinical severity scores and mortality of the groups and  assessed the correlation between the dielectric blood coagulometry-derived  coagulation marker, thrombin levels, and Disseminated Intravascular Coagulation  score using Spearman rank correlation. The mortality rate was 0% (0/31) in the no  disseminated intravascular coagulation group, 35.3% (12/34) in the late-diagnosed  disseminated intravascular coagulation group, and 33.3% (5/15) in the  disseminated intravascular coagulation group. Although the Disseminated  Intravascular Coagulation score on day 1 did not reflect disseminated  intravascular coagulation in approximately 70% of patients who developed  disseminated intravascular coagulation by day 2, dielectric clot strength  measured by dielectric blood coagulometry on day 1 strongly correlated with  disseminated intravascular coagulation development by day 2 (Spearman ?? = 0.824;  p < 0.05) and with thrombin level on day 1 (Spearman ?? = 0.844; p < 0.05).  

CONCLUSIONS: Dielectric blood coagulometry can be used to detect early-phase  disseminated intravascular coagulation in patients with sepsis and is strongly  correlated with thrombin levels. Larger studies are needed to verify our results  for developing clinical applications.

## 使用电介质血液凝固法早期检测败血症诱导的弥散性血管内凝血：一项前瞻性观察性研究。

目的：评价电介质血液凝固法用于早期败血症诱导的弥散性血管内凝血的诊断。

设计：  单中心、前瞻性观察性研究。

设置：脓毒症或  东京医科齿科大学医学院脓毒性休克  2019年9月至2020年9月。

患者：将患者分为  根据弥散性血管内  基于弥散性血管内凝血评分的凝血诊断  日本急性医学协会：1）无弥漫性血管内  凝血组，2）晚期确诊的弥漫性血管内凝血  组：第1天未诊断为弥散性血管内凝血，但  入院后48小时内确诊，和3）弥散性血管内  凝血组：当天确诊弥散性血管内凝血  1.研究评估了80名患者（无弥散性血管内凝血，31  [38.8%]；晚期诊断的弥散性血管内凝血，34(42.5%)；  弥散性血管内凝血，15[18.8%]）。测量和主要  结果：我们比较了各组的临床严重程度评分和死亡率  评估了电介质血凝仪测得的  凝血标志物、凝血酶水平和弥散性血管内凝血  使用Spearman等级相关进行评分。无并发症组的死亡率为0%(0/31)  弥散性血管内凝血组，晚期诊断患者中35.3%(12/34)  弥散性血管内凝血组，33.3%(5/15)  弥散性血管内凝血组。尽管已传播  第1天血管内凝血评分未反映弥散性  约70%发生血管内凝血的患者  第2天弥散性血管内凝血，电介质凝块强度  第1天通过电介质血凝测定法测量的结果与  第2天出现弥散性血管内凝血（Spearman<unk><unk>=0.824；  p<0.05），第1天的凝血酶水平(Spearman<unk><unk>=0.844；p<0.05)。

结论：介电血凝仪可用于检测早期  脓毒症患者弥散性血管内凝血，强烈  与凝血酶水平相关。需要更大规模的研究来验证我们的结果  用于开发临床应用。
关键词：Humans; Female; Male; Middle Aged; Prospective Studies; Aged; Aged, 80 and over; Early Diagnosis; Patient Acuity; Blood Coagulation Tests/*methods; Disseminated Intravascular Coagulation/*diagnosis/*etiology; Sepsis/*complications/mortality; Shock, Septic/complications/mortality

--------
--------

## Cardiac Output Measurement in Neonates and Children Using Noninvasive Electrical Bioimpedance Compared With Standard Methods: A Systematic Review and  Meta-Analysis., Mansfield, Roshni C.

1:126-137. DOI:10.1097/CCM.0000000000005144

Abstract: 

OBJECTIVE: To systematically review and meta-analyze the validity of electrical bioimpedance-based noninvasive cardiac output monitoring in pediatrics compared  with standard methods such as thermodilution and echocardiography. 

DATA SOURCES:  Systematic searches were conducted in MEDLINE and EMBASE (2000-2019). 

STUDY  SELECTION: Method-comparison studies of transthoracic electrical velocimetry or  whole body electrical bioimpedance versus standard cardiac output monitoring  methods in children (0-18 yr old) were included. 

DATA EXTRACTION: Two reviewers  independently performed study selection, data extraction, and risk of bias  assessment. Mean differences of cardiac output, stroke volume, or cardiac index  measurements were pooled using a random-effects model (R Core Team, R Foundation  for Statistical Computing, Vienna, Austria, 2019). Bland-Altman statistics  assessing agreement between devices and author conclusions about  inferiority/noninferiority were extracted. 

DATA SYNTHESIS: Twenty-nine of 649  identified studies were included in the qualitative analysis, and 25 studies in  the meta-analyses. No significant difference was found between means of cardiac  output, stroke volume, and cardiac index measurements, except in exclusively  neonatal/infant studies reporting stroke volume (mean difference, 1.00 mL; 95%  CI, 0.23-1.77). Median percentage error in child/adolescent studies approached  acceptability (percentage error less than or equal to 30%) for cardiac output in  L/min (31%; range, 13-158%) and stroke volume in mL (26%; range, 14-27%), but not  in neonatal/infant studies (45%; range, 29-53% and 45%; range, 28-70%,  respectively). Twenty of 29 studies concluded that transthoracic electrical  velocimetry/whole body electrical bioimpedance was noninferior. Transthoracic  electrical velocimetry was considered inferior in six of nine studies with  heterogeneous congenital heart disease populations. 

CONCLUSIONS: The  meta-analyses demonstrated no significant difference between means of compared  devices (except in neonatal stroke volume studies). The wide range of percentage  error reported may be due to heterogeneity of study designs, devices, and  populations included. Transthoracic electrical velocimetry/whole body electrical  bioimpedance may be acceptable for use in child/adolescent populations, but  validity in neonates and congenital heart disease patients remains uncertain.  Larger studies in specific clinical contexts with standardized methodologies are  required.

## 无创生物电阻抗法测量新生儿和儿童心输出量与标准方法的比较：一项系统回顾和  荟萃分析。

目的：对基于电生物阻抗的无创心输出量监测在儿科中应用的有效性进行系统回顾和荟萃分析  使用标准方法，如热稀释法和超声心动图。

数据来源：  在MEDLINE和EMBASE(2000-2019)中进行了系统检索。研究  选择：经胸廓电测速或  全身电生物阻抗与标准心输出量监测  纳入儿童（0-18岁）方法。

数据提取：两名审查员  独立进行研究选择、数据提取和偏倚风险  评估。心输出量、每搏输出量或心脏指数的平均差异  使用随机效应模型(R Core Team,R Foundation)汇总测量值  统计计算，Vienna,Austria,2019）。Bland-Altman统计量  评估器械之间的一致性以及作者的结论  提取劣效性/非劣效性。

数据综合：29/649  确定的研究纳入定性分析，25项研究纳入  荟萃分析。心脏参数平均值之间无显著差异  输出量、每搏输出量和心脏指数测量值，除外  报告每搏输出量的新生儿/婴儿研究（平均差异，1.00 mL；95%  CI, 0.23-1.77).接近儿童/青少年研究的中位误差百分比  心输出量的可接受性（误差百分比≤30%）  L/min（31%；范围：13-158%）和每搏输出量(mL)（26%；范围：14-27%），但不是  新生儿/婴儿研究（45%；范围：29-53%和45%；范围：28-70%，  分别）。29项研究中有20项得出的结论是，经胸廓电  速度测量/全身电生物阻抗非劣效。经胸  在9项研究的6项中，电测速被认为劣于  异质性先天性心脏病人群。

结论：  荟萃分析显示，比较的平均值之间无显著差异  器械（新生儿每搏输出量研究除外）。百分比范围宽  报告的错误可能是由于研究设计、器械和  纳入的人群。经胸廓电测速/全身电  生物阻抗可用于儿童/青少年人群，但  在新生儿和先天性心脏病患者中的有效性仍不确定。在特定临床背景中使用标准化方法的更大型研究为  要求。
关键词：Humans; Female; Male; Adolescent; Child; Infant; Infant, Newborn; Child, Preschool; Cardiac Output/*physiology; Cardiography, Impedance/*standards; Echocardiography/standards; Monitoring, Physiologic/*methods; Stroke Volume/physiology; Thermodilution/standards

--------
--------

## Noninvasive Tidal Volume Measurements, Using a Time-of-Flight Camera, Under High-Flow Nasal Cannula-A Physiological Evaluation, in Healthy Volunteers., Le Moigne, Guillaume

1:e61-e70. DOI:10.1097/CCM.0000000000005183

Abstract: 

OBJECTIVES: The mechanisms of high-flow nasal cannula are still debated but may be mediated by the generation of low positive end-expiratory pressure and a  washout of the airway dead space. The aims of this study were to assess the  effects of high-flow nasal cannula on tidal volume using a noninvasive method  using a time-of-flight camera, under various conditions. 

DESIGN: A physiologic  evaluation in healthy volunteers. 

SETTING: An university hospital ICU. 

SUBJECTS:  Ten healthy volunteers were included in a physiologic study (CamOpt study,  ClinicalTrials.gov identifier: NCT04096183). 

INTERVENTIONS: All volunteers were  submitted to 12 different conditions (i.e., gas flow [baseline = 0; 30-60 L/min];  mouth [open/closed]; respiratory rate [baseline; baseline + 10 breaths/min]).  Tidal volume measurements were performed every minute, during a 6-minute  recording period. In all combinations, reference respiratory rate was measured by  using chronometric evaluation, over a 30-second period (RRREF), and by using the  time-of-flight camera (RRTOF). 

MEASUREMENTS AND MAIN RESULTS: Tidal volume  increased while increasing gas flow whatever the respiratory rate and mouth  condition (p < 0.001). Similar results were observed whatever the experimental  conditions (p < 0.01), except one (baseline respiratory rate + 10 breaths/min and  mouth closed). Tidal volume increased while decreasing respiratory rate (p <  0.001) and mouth closing (p < 0.05). Proportion of tidal volume greater than 10,  15, and 20 mL/kg changed while increasing the flow. RRTOF was in agreement with  RRREF (intraclass correlation coefficient, 0.96), with a low mean bias (0.55  breaths/min) and acceptable deviation. 

CONCLUSIONS: Time-of-flight enables to  detect tidal volume changes under various conditions of high-flow nasal cannula  application. Tidal volume increased significantly while increasing gas flow and  mouth closing. Such technique might be useful to monitor the risk of patient  self-inflicted lung injury or under assistance.

## 在健康志愿者中，使用飞行时间相机在高流量鼻插管-a生理评估下进行非侵入性潮气量测量。

目的：高流量鼻插管的机制仍有争议，但可能是通过产生低呼气末正压和  冲洗气道死腔。本研究的目的是评估  非侵入性方法评价高流量鼻导管对潮气量的影响  在各种条件下使用飞行时间相机。

设计：生理学  在健康志愿者中的评价。

单位：大学医院ICU。

受试者：  10例健康志愿者被纳入一项生理学研究（CamOpt研究，  临床试验。gov标识符：NCT04096183）。

干预：所有志愿者均为  提交至12种不同的条件（即，气体流量[基线 = 0；30-60 L/min]；  口腔[打开/关闭]；呼吸率[基线；基线 + 10次/分]）。6 min内，每分钟进行一次潮气量测量  记录周期。在所有组合中，参考呼吸率通过以下指标测量  使用时间计时评估，在30秒期间(RRREF)，并通过使用  飞行时间相机(RRTOF)。

测量和主要结果：潮气量  无论呼吸频率和口腔如何，随着气体流量增加而增加  条件(p < 0.001)。无论实验结果如何，均观察到相似结果  疾病(p < 0.01)，除了1项（基线呼吸速率 + 10次/分钟和  闭口）。潮气量随呼吸频率降低而增加（p <  0.001）和闭口(p < 0.05)。潮气量大于10的比例，  15和20 mL/kg随流速增加而变化。RRTOF与  RRREF（组内相关系数，0.96），平均偏倚较低(0.55)  次/分）和可接受的偏差。

结论：飞行时间能够  检测高流量鼻导管不同条件下的潮气量变化  申请。潮气量随着气体流量增加而显著增加，  闭口。这种技术可能有助于监测患者自身造成的肺损伤风险或辅助治疗。
关键词：Humans; Female; Male; Time Factors; Intensive Care Units; Adult; Healthy Volunteers; *Cannula; Oxygen Inhalation Therapy/*methods; Tidal Volume/*physiology

--------
--------

## Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.

1:e80-e86. DOI:10.1097/CCM.0000000000005211

Abstract: 

OBJECTIVES: Vaccine-induced immune thrombotic thrombocytopenia is an unexpected consequence of the coronavirus disease 2019 pandemic era. We reviewed the  pathogenesis, clinical presentation, diagnosis, and treatment of this rare side  effect. 

DATA SOURCES: Online search of published medical literature through  PubMed, Scopus, Web of Science, and Google Scholar using the terms "COVID-19,"  "vaccine," "thrombosis" was performed. 

STUDY SELECTION: Articles were chosen for  inclusion based on their relevance to coronavirus disease 2019, vaccine, and  thrombosis. 

DATA SYNTHESIS: Vaccine-induced immune thrombotic thrombocytopenia  manifests most often as unusual thromboses (cerebral venous sinus thrombosis,  splanchnic vein thrombosis) but sometimes also "usual" thromboses (arterial  stroke, pulmonary embolism, deep-vein thrombosis), with oftentimes severe  thrombocytopenia, that becomes clinically evident 5-30 days after  adenovirus-vectored coronavirus disease 2019 vaccine administration. Most  patients have disseminated intravascular coagulation. These features are the  result of vaccine-triggered formation of anti-platelet factor 4 immunoglobulin G  that activate platelets, clinically mimicking autoimmune heparin-induced  thrombocytopenia. Early recognition based on thrombosis (sometimes, hemorrhage),  thrombocytopenia, and d-dimer elevation within the day 5-30 postvaccine "window"  is important given treatment with high-dose IV immunoglobulin plus nonheparin  anticoagulation. 

CONCLUSIONS: Vaccine-induced immune thrombotic thrombocytopenia  is a serious complication of vaccination that is not feasible to anticipate or  prevent. When the patient presents with sustained headache, neurologic  symptoms/signs, abdominal pain, dyspnea, or limb pain/swelling beginning 5-30  days post vaccination, platelet count and d-dimer must be measured, and imaging  for thrombosis performed. Confirmation of vaccine-induced immune thrombotic  thrombocytopenia diagnosis should be ordered (platelet factor 4/polyanion  enzyme-linked immunosorbent assay; platelet factor 4-enhanced platelet activation  testing) as treatment is initiated (nonheparin anticoagulation, IV  immunoglobulin).

## 认识疫苗诱导的免疫性血栓性血小板减少症。

目的：疫苗诱导的免疫血栓性血小板减少症是2019年冠状病毒病大流行时代的非预期结果。我们对这种罕见副作用的发病机制、临床表现、诊断和治疗进行了综述。

数据来源：使用术语“COVID-19”、“疫苗”、“血栓形成”在线检索PubMed、Scopus、Web of Science和Google Scholar中已发表的医学文献。

研究选择：根据文章与2019年冠状病毒疾病、疫苗和血栓形成的相关性选择文章纳入。

资料综合：疫苗诱导的免疫性血栓性血小板减少症最常表现为不寻常的血栓形成（脑静脉窦血栓形成、内脏静脉血栓形成），但有时也表现为“常见”血栓形成（动脉卒中、肺栓塞、深静脉血栓形成），通常伴有重度血小板减少症，在2019年腺病毒载体冠状病毒病疫苗接种后5-30天出现临床症状。大多数患者有弥散性血管内凝血。这些特征是疫苗触发的活化血小板的抗血小板因子4免疫球蛋白G形成的结果，临床上类似自身免疫性肝素诱导的血小板减少症。在疫苗接种后第5-30天的“窗口期”内，根据血栓形成（有时是出血）、血小板减少症和d-二聚体升高进行早期识别很重要，给予高剂量IV免疫球蛋白加非肝素抗凝治疗。

结论：疫苗诱导的免疫性血栓性血小板减少症是疫苗接种的一种严重并发症，不能进行预测或预防。疫苗接种后5-30天，患者出现持续性头痛、神经系统症状/体征、腹痛、呼吸困难或肢体疼痛/肿胀时，必须测量血小板计数和d-二聚体，并对血栓形成进行影像学检查。随着治疗的开始（非肝素抗凝，IV免疫球蛋白），应进行疫苗诱导的免疫性血栓形成性血小板减少症的确诊（血小板因子4/聚阴离子酶联免疫吸附试验；血小板因子4增强的血小板活化试验）。
关键词：Humans; Age Factors; Sex Factors; SARS-CoV-2; COVID-19 Vaccines/administration & dosage/*adverse effects; COVID-19/prevention & control; Enzyme-Linked Immunosorbent Assay; Thrombocytopenia/*chemically induced/immunology; Thrombosis/*chemically induced/immunology

--------
--------

## ABCDEF Bundle Practices for Critically Ill Children: An International Survey of 161 PICUs in 18 Countries., Ista, Erwin

1:114-125. DOI:10.1097/CCM.0000000000005168

Abstract: 

OBJECTIVES: To evaluate current international practice in PICUs regarding components of the "Assessing Pain, Both Spontaneous Awakening and Breathing  Trials, Choice of Sedation, Delirium Monitoring/Management, Early  Exercise/Mobility, and Family Engagement/Empowerment" (ABCDEF) bundle. 

DESIGN:  Online surveys conducted between 2017 and 2019. 

SETTING: One-hundred sixty-one  PICUs across the United States (n = 82), Canada (n = 14), Brazil (n = 27), and  Europe (n = 38) participating in the Prevalence of Acute Rehabilitation for Kids  in the PICU study. 

INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Of the 161  participating PICUs, 83% were in academic teaching hospitals and 42% were in  free-standing children's hospitals. Median size was 16 beds (interquartile range,  10-24 beds). Only 15 PICUs (9%) had incorporated all six ABCDEF bundle components  into routine practice. Standardized pain assessment (A) was the most common  (91%), followed by family engagement (F, 88%) and routine sedation assessment (C)  with validated scales (84%). Protocols for testing extubation readiness or  conducting spontaneous breathing trials (B) were reported in 57%, with 34%  reporting a ventilator weaning protocol. Routine delirium monitoring with a  validated screening tool (D) was reported by 44% of PICUs, and 26% had a  guideline, protocol, or policy for early exercise/mobility (E). Practices for  spontaneous breathing trials were variable in 29% of Canadian PICUs versus  greater than 50% in the other regions. Delirium monitoring was lowest in  Brazilian PICUs (18%) versus greater than 40% in other regions, and family  engagement was reported in 55% of European PICUs versus greater than 90% in other  regions. 

CONCLUSIONS: ABCDEF bundle components have been adopted with substantial  variability across regions. Additional research must rigorously evaluate the  efficacy of specific elements with a focus on B, D, E, and full ABCDEF bundle  implementation. Implementation science is needed to facilitate an understanding  of the barriers to ABCDEF implementation and sustainability with a focus on  specific cultural and regional differences.

## ABCDEF危重儿童捆绑措施：18个国家161家PICU的国际调查。

目的：评价PICU中有关“评估疼痛、自发觉醒和呼吸试验、镇静选择、谵妄监测/管理、早期运动/活动和家庭参与/增强”(ABCDEF)组合组成部分的当前国际实践。

设计：2017年至2019年进行在线调查。

设置：美国(n = 82)、加拿大(n = 14)、巴西(n = 27)和欧洲(n = 38)的161家PICU参与了PICU研究中儿童急性康复的患病率。

干预：无。

测量和主要结果：在161家参与的PICU中，83%在教学医院，42%在独立儿童医院。中位尺寸为16个床位（四分位距，10-24个床位）。仅15家PICU(9%)将ABCDEF束支所有6个组成部分整合到常规实践中。标准化疼痛评估(A)最常见(91%)，其次是家庭参与(F，88%)和使用经验证的量表进行的常规镇静评估(C)(84%)。57%报告了测试拔管准备或进行自主呼吸试验(B)的方案，34%报告了呼吸机撤机方案。44%的PICU报告了采用经验证的筛选工具(D)进行的常规谵妄监测，26%的PICU有指南、方案或早期运动/运动(E)政策。29%的加拿大PICU患者的自主呼吸试验实践不同，而其他地区则超过50%。谵妄监测在巴西PICU中最低(18%)，在其他地区高于40%，55%的欧洲PICU报告了家庭参与，在其他地区高于90%。

结论：采用了ABCDEF束支成分，不同地区存在相当大的变异性。额外的研究必须严格评价特定要素的疗效，重点是B、D、E和完整的ABCDEF集束化实施。需要实施科学来促进理解ABCDEF实施和可持续性的障碍，重点关注特定的文化和地区差异。
关键词：Humans; Clinical Protocols; Critical Illness/*therapy; Anesthesia/standards; Delirium/diagnosis/prevention & control/therapy; Family; Intensive Care Units, Pediatric/standards/*statistics & numerical data; Pain Measurement/standards/statistics & numerical data; Patient Care Bundles/standards/*statistics & numerical data; Ventilator Weaning/standards

--------
--------

## Regionalization of Critical Care in the United States: Current State and Proposed Framework From the Academic Leaders in Critical Care Medicine Task Force of the  Society of Critical Care Medicine., Leung, Sharon

1:37-49. DOI:10.1097/CCM.0000000000005147

Abstract: 

OBJECTIVES: The Society of Critical Care Medicine convened its Academic Leaders in Critical Care Medicine taskforce on February 22, 2016, during the 45th  Critical Care Congress to develop a series of consensus papers with toolkits for  advancing critical care organizations in North America. The goal of this article  is to propose a framework based on the expert opinions of critical care  organization leaders and their responses to a survey, for current and future  critical care organizations, and their leadership in the health system to design  and implement successful regionalization for critical care in their regions. 

DATA  SOURCES AND STUDY SELECTION: Members of the workgroup convened monthly via  teleconference with the following objectives: to 1) develop and analyze a  regionalization survey tool for 23 identified critical care organizations in the  United States, 2) assemble relevant medical literature accessed using Medline  search, 3) use a consensus of expert opinions to propose the framework, and 4)  create groups to write the subsections and assemble the final product. 

DATA  EXTRACTION AND SYNTHESIS: The most prevalent challenges for regionalization in  critical care organizations remain a lack of a strong central authority to  regulate and manage the system as well as a lack of necessary infrastructure, as  described more than a decade ago. We provide a framework and outline a  nontechnical approach that the health system and their critical care medicine  leadership can adopt after considering their own structure, complexity, business  operations, culture, and the relationships among their individual hospitals.  Transforming the current state of regionalization into a coordinated, accountable  system requires a critical assessment of administrative and clinical challenges  and barriers. Systems thinking, business planning and control, and essential  infrastructure development are critical for assisting critical care  organizations. 

CONCLUSIONS: Under the value-based paradigm, the goals are  operational efficiency and patient outcomes. Health systems that can align  strategy and operations to assist the referral hospitals with implementing  regionalization will be better positioned to regionalize critical care  effectively.

## 美国重症监护的区域化：重症医学协会重症医学学术领袖工作组的当前状态和拟定框架。

目的：2016年2月22日，在第45届重症监护大会期间，重症监护医学协会召集了其重症监护医学学术领袖工作组，使用工具包开发了一系列共识文件，以推进北美的重症监护组织。本文的目的是根据重症监护组织领导的专家意见及其对调查的答复，为当前和未来的重症监护组织及其在卫生系统的领导设计并实施其所在地区成功的重症监护区域化，提出一个框架。

数据来源和研究选择：工作组成员每月通过电话会议召开会议，目的如下：1）为美国确定的23家重症监护组织开发和分析区域化调查工具，2）收集使用Medline检索访问的相关医学文献，3）运用专家共识意见提出框架，4）创建小组撰写小节汇编最终产品。

数据提取和综合：正如10多年前所描述的，重症监护组织中区域化最普遍的挑战仍然是缺乏监管和管理系统的强大中央权力机构以及缺乏必要的基础设施。我们提供了一个框架，概述了卫生系统及其重症监护医学领导在考虑了自身结构、复杂性、业务运营、文化及其个体医院之间的关系后可以采用的非技术方法。将目前的区域化状态转变为一个协调、负责的系统，需要对行政和临床挑战和障碍进行严格评估。系统思考、业务规划和控制以及基本基础设施开发对于帮助重症监护组织至关重要。

结论：在基于价值的模式下，目标是操作效率和患者结局。卫生系统可以使战略和运作一致，以帮助转诊医院实施区域化，将更好地定位，以有效地对重症监护进行区域化。
关键词：Humans; Treatment Outcome; United States; Efficiency, Organizational; Health Facility Planning/*organization & administration; Critical Care/*organization & administration; Leadership; Referral and Consultation/organization & administration; Systems Analysis; Telemedicine/organization & administration

--------
--------

## Left Ventricular Function Changes Induced by Moderate Hypothermia Are Rapidly Reversed After Rewarming-A Clinical Study.

1:e52-e60. DOI:10.1097/CCM.0000000000005170

Abstract: 

OBJECTIVES: Targeted temperature management (32-36?°C) is used for neuroprotection in cardiac arrest survivors. The isolated effects of hypothermia on myocardial  function, as used in clinical practice, remain unclear. Based on experimental  results, we hypothesized that hypothermia would reversibly impair diastolic  function with less tolerance to increased heart rate in patients with uninsulted  hearts. 

DESIGN: Prospective clinical study, from June 2015 to May 2018. 

SETTING:  Cardiothoracic surgery operation room, Oslo University Hospital. 

PATIENTS: Twenty  patients with left ventricular ejection fraction greater than 55%, undergoing  ascending aorta graft-replacement connected to cardiopulmonary bypass were  included. 

INTERVENTIONS: Left ventricular function was assessed during reduced  cardiopulmonary bypass support at 36?°C, 32?°C prior to graft-replacement, and at  36?°C postsurgery. Electrocardiogram, hemodynamic, and echocardiographic  recordings were made at spontaneous heart rate and 90 beats per minute at  comparable loading conditions. 

MEASUREMENTS AND MAIN RESULTS: Hypothermia  decreased spontaneous heart rate, and R-R interval was prolonged (862 ?± 170 to  1,156 ?± 254 ms, p < 0.001). Although systolic and diastolic fractions of R-R  interval were preserved (0.43 ?± 0.07 and 0.57 ?± 0.07), isovolumic relaxation time  increased and diastolic filling time was shortened. Filling pattern changed from  early to late filling. Systolic function was preserved with unchanged myocardial  strain and stroke volume index, but cardiac index was reduced with maintained  mixed venous oxygen saturation. At increased heart rate, systolic fraction  exceeded diastolic fraction (0.53 ?± 0.05 and 0.47 ?± 0.05) with diastolic  impairment. Strain and stroke volume index were reduced, the latter to 65% of  stroke volume index at spontaneous heart rate. Cardiac index decreased, but mixed  venous oxygen saturation was maintained. After rewarming, myocardial function was  restored. 

CONCLUSIONS: In patients with normal left ventricular function,  hypothermia impaired diastolic function. At increased heart rate, systolic  function was subsequently reduced due to impeded filling. Changes in left  ventricular function were rapidly reversed after rewarming.

## 中度低温诱导的左心室功能变化在再次提醒后迅速逆转-一项临床研究。

目的：目标温度管理(32-36 ℃)用于心脏骤停幸存者的神经保护。临床实践中使用的低温对心肌功能的孤立效应尚不清楚。根据实验结果，我们假设低体温可逆性损害心脏舒张功能，对未受损心脏患者心率增加的耐受性较低。

设计：前瞻性临床研究，2015年6月至2018年5月。

单位：奥斯陆大学医院心胸外科手术室。

患者：20例左室射血分数大于55%，接受与心肺转流相连的升主动脉移植物置换的患者被纳入。

干预：在移植物置换前和术后36 ℃下，在减少心肺转流支持期间评估左心室功能。在相当负荷条件下，以自主心率和每分钟90次搏动记录心电图、血液动力学和超声心动图。

测量值和主要结果：低温降低了自发性心率，并且R-R间期延长（862?±170至1,156?±254 ms，p < 0.001）。虽然R-R间期的收缩和舒张分数保持不变（0.43?±0.07和0.57?±0.07），但等容舒张时间延长，舒张充盈时间缩短。灌装模式从早期变更为晚期灌装。在心肌应变和每搏量指数不变的情况下，保留了收缩功能，但在维持混合静脉血氧饱和度的情况下，心脏指数降低。心率增加时，收缩分数超过舒张分数（0.53?±0.05和0.47?±0.05），出现舒张损害。应变和每搏量指数降低，后者降至自主心率时每搏量指数的65%。心脏指数下降，但混合静脉血氧饱和度保持不变。复温后心肌功能恢复。

结论：在左心室功能正常的患者中，低温会损害舒张功能。心率加快时，由于充盈受阻，收缩功能随后降低。复温后左心室功能变化迅速逆转。
关键词：Hemodynamics; Humans; Female; Male; Middle Aged; Prospective Studies; Aged; *Rewarming; Electrocardiography; Heart Arrest/*therapy; Hypothermia, Induced/*methods; Hypothermia/*physiopathology; Ventricular Function, Left/*physiology

--------
--------

## Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study., Gutierrez, Cristina

1:81-92. DOI:10.1097/CCM.0000000000005149

Abstract: 

OBJECTIVES: To report the epidemiology, treatments, and outcomes of adult patients admitted to the ICU after cytokine release syndrome or immune effector  cell-associated neurotoxicity syndrome. 

DESIGN: Retrospective cohort study.  

SETTING: Nine centers across the U.S. part of the chimeric antigen receptor-ICU  initiative. 

PATIENTS: Adult patients treated with chimeric antigen receptor  T-cell therapy who required ICU admission between November 2017 and May 2019.  

INTERVENTIONS: Demographics, toxicities, specific interventions, and outcomes  were collected. 

RESULTS: One-hundred five patients treated with axicabtagene  ciloleucel required ICU admission for cytokine release syndrome or immune  effector cell-associated neurotoxicity syndrome during the study period. At the  time of ICU admission, the majority of patients had grade 3-4 toxicities (66.7%);  15.2% had grade 3-4 cytokine release syndrome and 64% grade 3-4 immune effector  cell-associated neurotoxicity syndrome. During ICU stay, cytokine release  syndrome was observed in 77.1% patients and immune effector cell-associated  neurotoxicity syndrome in 84.8% of patients; 61.9% patients experienced both  toxicities. Seventy-nine percent of patients developed greater than or equal to  grade 3 toxicities during ICU stay, however, need for vasopressors (18.1%),  mechanical ventilation (10.5%), and dialysis (2.9%) was uncommon. Immune Effector  Cell-Associated Encephalopathy score less than 3 (69.7%), seizures (20.2%),  status epilepticus (5.7%), motor deficits (12.4%), and cerebral edema (7.9%) were  more prevalent. ICU mortality was 8.6%, with only three deaths related to  cytokine release syndrome or immune effector cell-associated neurotoxicity  syndrome. Median overall survival time was 10.4 months (95% CI, 6.64-not  available mo). Toxicity grade or organ support had no impact on overall survival;  higher cumulative corticosteroid doses were associated to decreased overall and  progression-free survival. 

CONCLUSIONS: This is the first study to describe a  multicenter cohort of patients requiring ICU admission with cytokine release  syndrome or immune effector cell-associated neurotoxicity syndrome after chimeric  antigen receptor T-cell therapy. Despite severe toxicities, organ support and  in-hospital mortality were low in this patient population.

## 治疗嵌合抗原受体相关毒性的危重患者：一项多中心研究。

目的：报告细胞因子释放综合征或免疫效应细胞相关神经毒性综合征后入住ICU的成人患者的流行病学、治疗和结局。

设计：回顾性队列研究。

设置：美国嵌合抗原受体ICU倡议的9个中心。

患者：2017年11月至2019年5月期间需要入住ICU接受嵌合抗原受体T细胞治疗的成人患者。

干预：收集人口统计学、毒性、特殊干预和结局数据。

结果：105例接受axicabtagene ciloleucel治疗的患者在研究期间因细胞因子释放综合征或免疫效应细胞相关神经毒性综合征需要入住ICU。入住ICU时，大多数患者发生3-4级毒性(66.7%)；15.2%发生3-4级细胞因子释放综合征，64%发生3-4级免疫效应细胞相关神经毒性综合征。在ICU住院期间，77.1%的患者观察到细胞因子释放综合征，84.8%的患者观察到免疫效应细胞相关神经毒性综合征；61.9%的患者发生两种毒性。79%的患者在ICU住院期间发生≥3级毒性，然而，血管加压素(18.1%)、机械通气(10.5%)和透析(2.9%)的需求并不常见。免疫效应细胞相关性脑病评分小于3(69.7%)、癫痫发作(20.2%)、癫痫持续状态(5.7%)、运动缺陷(12.4%)和脑水肿(7.9%)更常见。ICU死亡率为8.6%，仅3例死亡与细胞因子释放综合征或免疫效应细胞相关的神经毒性综合征相关。中位总生存时间为10.4个月（95%CI，6.64-不可用月）。毒性分级或器官支持对总生存期无影响；更高的糖皮质激素累积剂量与总生存期和无进展生存期下降相关。

结论：这是首次描述一个多中心队列患者的研究，该队列患者在接受嵌合抗原受体T细胞治疗后出现细胞因子释放综合征或免疫效应细胞相关神经毒性综合征，需要入住ICU。尽管存在重度毒性，但该患者人群的器官支持和住院死亡率较低。
关键词：Humans; Female; Male; Middle Aged; Aged; Adult; Retrospective Studies; Comorbidity; United States; Intensive Care Units/statistics & numerical data; *Critical Illness; Patient Acuity; *Receptors, Chimeric Antigen; Sociodemographic Factors; Biological Products/*toxicity; Cytokine Release Syndrome/*chemically induced/mortality/therapy; Immunotherapy, Adoptive/*adverse effects; Neurotoxicity Syndromes/*etiology/mortality/therapy

--------
--------

## Factors Associated With Prolonged Mechanical Ventilation in Patients With Subarachnoid Hemorrhage-The RAISE Score., Rass, Verena

1:103-113. DOI:10.1097/CCM.0000000000005189

Abstract: 

OBJECTIVES: Patients suffering from spontaneous subarachnoid hemorrhage frequently require mechanical ventilation. Here, we aimed to identify factors  associated with prolonged mechanical ventilation in subarachnoid hemorrhage  patients and to create a new predictive score for prolonged mechanical  ventilation. 

DESIGN: Prospective cohort study with retrospective data analysis.  

SETTING: Neurocritical care unit at a tertiary academic medical center. 

PATIENTS:  Two hundred ninety-seven consecutive nontraumatic adult subarachnoid hemorrhage  patients. 

METHODS: In patients with mechanical ventilation, we identified factors  associated with mechanical ventilation greater than 48 hours, greater than 7  days, and greater than 14 days compared with mechanical ventilation less than or  equal to 48 hours, less than or equal to 7 days, or less than or equal to 14 days  in multivariable generalized linear models. Ventilated patients who died before  48 hours, 7 days, or 14 days and those never ventilated were excluded from the  respective analysis. We incorporated those factors into a new prognostic score  (the RAISE score) to predict prolonged mechanical ventilation greater than 7  days. The calculation was based on a random dataset of 60% of subarachnoid  hemorrhage patients and was internally validated. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: Patients were 57 years old (interquartile range,  47-68 yr) and presented with a median Hunt and Hess grade of 3 (1-5). Two hundred  forty-two patients (82%) required mechanical ventilation for 9 days (2-20 d). In  multivariable analysis, a higher Acute Physiology Score was associated with  mechanical ventilation greater than 48 hours, greater than 7 days, and greater  than 14 days, a higher Hunt and Hess grade with greater than 7 days and greater  than 14 days. Early neuroimaging findings were associated with mechanical  ventilation greater than 48 hours (hydrocephalus; high-grade Subarachnoid  Hemorrhage Early Brain Edema Score), greater than 7 days (high-grade Subarachnoid  Hemorrhage Early Brain Edema Score, co-occurrence of intracerebral bleeding) but  not with prolonged mechanical ventilation greater than 14 days. The RAISE score,  including age, Acute Physiology Score, Hunt and Hess grade, Subarachnoid  Hemorrhage Early Brain Edema Score, and the co-occurrence of intracerebral  hemorrhage accurately stratified patients by prolonged mechanical ventilation  greater than 7 days (C-statistic 0.932). A RAISE score of 12 predicted 60%  likelihood of mechanical ventilation greater than 7 days. 

CONCLUSIONS: Initial  disease severity and neuroimaging findings detected within 24 hours after ICU  admission were associated with the need for prolonged mechanical ventilation in  patients with subarachnoid hemorrhage. These results may be helpful for patient  families and caregivers to better anticipate the course of therapy.

## 蛛网膜下腔出血患者机械通气延长的相关因素-RAISE评分。

目的：自发性蛛网膜下腔出血患者经常需要机械通气。在此，我们旨在确定蛛网膜下腔出血患者中与长期机械通气相关的因素，并创建一个新的长期机械通气预测评分。

设计：回顾性数据分析的前瞻性队列研究。

设置：三级学术医学中心的神经重症监护室。

患者：297例连续非创伤性成人蛛网膜下腔出血患者。

方法：在机械通气患者中，与小于或等于48小时，小于或等于7天的机械通气相比，我们确定了大于48小时，大于7天，大于14天的机械通气相关因素。或在多变量广义线性模型中≤14天。在48小时、7天或14天前死亡的通气患者以及从未通气的患者被排除在各自的分析之外。我们将这些因素纳入新的预后评分（RAISE评分），以预测超过7天的长期机械通气。该计算基于60%蛛网膜下腔出血患者的随机数据集，并进行了内部验证。

干预：无。

测量和主要结果：患者57岁（四分位距，47-68岁），中位Hunt和Hess分级为3级(1-5)。242例患者(82%)需要机械通气9天（2-20天）。在多变量分析中，较高的急性生理学评分与超过48小时、超过7天和超过14天的机械通气、超过7天和超过14天的Hunt and Hess分级较高相关。早期神经影像学检查结果与大于48小时（脑积水；高级别蛛网膜下腔出血早期脑水肿评分）、大于7天（高级别蛛网膜下腔出血早期脑水肿评分，同时发生脑出血）的机械通气相关，但与超过14天的机械通气不相关。RAISE评分，包括年龄、急性生理学评分、Hunt and Hess分级、蛛网膜下腔出血早期脑水肿评分和同时发生脑出血通过长期机械通气大于7天对患者进行准确分层（C-统计量0.932）。12分的RAISE评分预测机械通气超过7天的可能性为60%。

结论：入ICU 24小时内检测到的初始疾病严重程度和神经影像学结果与蛛网膜下腔出血患者需要延长机械通气相关。这些结果可能有助于患者家属和护理人员更好地预测治疗过程。
关键词：Humans; Female; Male; Middle Aged; Prognosis; Time Factors; Aged; APACHE; Adult; Retrospective Studies; Severity of Illness Index; Comorbidity; Academic Medical Centers/statistics & numerical data; Brain Edema/etiology; Respiration, Artificial/*statistics & numerical data; Subarachnoid Hemorrhage/complications/*therapy

--------
--------

## Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients.

1:50-60. DOI:10.1097/CCM.0000000000005143

Abstract: 

OBJECTIVES: Whole blood lactate concentration is widely used in shock states to assess perfusion. We aimed to determine if the change in plasma renin  concentration over time would be superior to the change in lactate concentration  for predicting in-hospital mortality in hypotensive patients on vasopressors.  

DESIGN: Prospective, observational cohort study. 

SETTING: Tertiary academic ICU.  

PATIENTS: Adult patients on vasopressors for greater than 6 hours to maintain a  mean arterial pressure greater than or equal to 65 mm Hg during January 2020.  

INTERVENTIONS: Plasma renin concentrations were measured at enrollment and at 24,  48, and 72 hours. Whole blood lactate measurements were performed according to  normal standard of care. Logistic regression was performed to evaluate whether  the change in renin or lactate concentration could predict in-hospital mortality.  Generalized estimating equations were used to analyze the association between  renin and lactate concentration and in-hospital mortality. The area under the  receiver operating characteristics curve was performed to measure the  discriminative ability of initial and peak renin and lactate concentration to  predict mortality. The association between renin and lactate concentration above  the upper limit of normal at each timepoint with in-hospital mortality was also  examined. 

MEASUREMENTS AND MAIN RESULTS: The study included 197 renin and 148  lactate samples obtained from 53 patients. The slope of the natural log (ln) of  renin concentration was independently associated with mortality (adjusted odds  ratio, 10.35; 95% CI, 1.40-76.34; p = 0.022), but the slope of ln-lactate  concentration was not (adjusted odds ratio, 4.78; 95% CI, 0.03-772.64; p = 0.55).  The generalized estimating equation models found that both ln-renin (adjusted  odds ratio, 1.18; 95% CI, 1.02-1.37; p = 0.025) and ln-lactate (adjusted odds  ratio, 2.38; 95% CI, 1.05-5.37; p = 0.037) were associated with mortality. Area  under the receiver operating characteristics curve analysis demonstrated that  initial renin could predict in-hospital mortality with fair discrimination (area  under the receiver operating characteristics curve, 0.682; 95% CI, 0.503-0.836; p  = 0.05), but initial lactate could not (area under the receiver operating  characteristics curve, 0.615; 95% CI, 0.413-0.803; p = 0.27). Peak renin (area  under the receiver operating characteristics curve, 0.728; 95% CI, 0.547-0.888; p  = 0.01) and peak lactate (area under the receiver operating characteristics  curve, 0.746; 95% CI, 0.584-0.876; p = 0.01) demonstrated moderate  discrimination. There was no significant difference in discriminative ability  between initial or peak renin and lactate concentration. At each study time  point, a higher proportion of renin values exceeded the threshold of normal (40  pg/mL) in nonsurvivors than in survivors, but this association was not  significant for lactate. 

CONCLUSIONS: Although there was no significant  difference in the performance of renin and lactate when examining the absolute  values of each laboratory, a positive rate of change in renin concentration, but  not lactate concentration, over 72 hours was associated with in-hospital  mortality. For each one-unit increase in the slope of ln-renin, the odds of  mortality increased 10-fold. Renin levels greater than 40 pg/mL, but not lactate  levels greater than 2 mmol/L, were associated with in-hospital mortality. These  findings suggest that plasma renin kinetics may be superior to lactate kinetics  in predicting mortality of hypotensive, critically ill patients.

## 肾素动力学在预测低血压危重患者院内死亡率方面优于乳酸盐动力学。

目的：全血乳酸盐浓度被广泛用于休克状态，以评估灌注。我们的目的是确定在预测接受血管加压药的低血压患者住院期间死亡率时，血浆肾素浓度随时间的变化是否优于乳酸盐浓度的变化。

设计：前瞻性、观察性队列研究。

单位：三级学术ICU。

患者：2020年1月期间，接受血管加压药治疗6小时以上，以维持平均动脉压≥65 mmHg的成人患者。

干预：在入组时和24、48和72小时测量血浆肾素浓度。根据正常护理标准进行全血乳酸盐测量。进行Logistic回归，以评价肾素或乳酸盐浓度的变化是否可预测住院死亡率。使用广义估计方程分析肾素和乳酸盐浓度与住院死亡率之间的相关性。受试者工作特征曲线下面积用于测量初始和峰值肾素和乳酸盐浓度预测死亡率的鉴别能力。还检查了每个时间点高于正常上限的肾素和乳酸盐浓度与住院死亡率之间的相关性。

测量和主要结果：研究包括从53例患者中获得的197份肾素和148份乳酸盐样本。肾素浓度的自然对数(ln)斜率与死亡率独立相关（校正后比值比为10.35；95%CI，1.40-76.34；p = 0.022），但ln-乳酸盐浓度的斜率则与死亡率不相关（校正后比值比为4.78；95%CI，0.03-772.64；p = 0.55）。广义估计方程模型发现，肾素（校正比值比，1.18；95%CI，1.02-1.37；p = 0.025）和乳酸（校正比值比，2.38；95%CI，1.05-5.37；p = 0.037）均与死亡率相关。受试者工作特征曲线下面积分析表明，初始肾素可以在公平判别下预测住院死亡率（受试者工作特征曲线下面积，0.682；95%CI，0.503-0.836；p = 0.05），但初始乳酸盐不能（受试者工作特征曲线下面积，0.615；95%CI，0.413-0.803；p = 0.27）。肾素峰值（受试者工作特征曲线下面积，0.728；95%CI，0.547-0.888；p = 0.01）和乳酸盐峰值（受试者工作特征曲线下面积，0.746；95%CI，0.584-0.876；p = 0.01）表现出中度区分度。初始或峰值肾素和乳酸盐浓度之间的区分能力无显著差异。在每个研究时间点，非存活者中肾素值超过正常阈值(40 pg/mL)的比例高于存活者，但乳酸盐的这种相关性不显著。

结论：尽管在检查每个实验室的绝对值时，肾素和乳酸盐的性能没有显著差异，但是72小时内肾素浓度（而不是乳酸盐浓度）变化的阳性率与住院死亡率相关。肾素斜率每增加1个单位，死亡率增加10倍。肾素水平大于40 pg/mL，但乳酸盐水平不大于2 mmol/L与住院死亡率相关。这些结果表明，在预测低血压重症患者的死亡率方面，血浆肾素动力学可能优于乳酸盐动力学。
关键词：Humans; Female; Male; Middle Aged; Prospective Studies; Aged; Adult; Retrospective Studies; Academic Medical Centers; ROC Curve; Intensive Care Units/statistics & numerical data; Critical Illness/*mortality; Hospital Mortality/*trends; Hypotension/*mortality; Lactic Acid/*blood/metabolism; Renin/*blood/metabolism

--------
--------

## Association of Proximity to a Long-Term Acute Care Hospital With Hospital Tracheostomy Practices., Mehta, Anuj B.

1:93-102. DOI:10.1097/CCM.0000000000005146

Abstract: 

OBJECTIVES: Availability of long-term acute care hospitals has been associated with hospital discharge practices. It is unclear if long-term acute care hospital  availability can influence patient care decisions. We sought to determine the  association of long-term acute care hospital availability at different hospitals  with the likelihood of tracheostomy. 

DESIGN: Retrospective cohort study. 

SETTING:  California Patient Discharge Database, 2016-2018. 

PATIENTS: Adult patients  receiving mechanical ventilation for respiratory failure. 

INTERVENTIONS: None.  

MEASUREMENTS AND MAIN RESULTS: Using the California Patient Discharge Database  2016-2018, we identified all mechanically ventilated patients and those who  received tracheostomy. We determine the association between tracheostomy and the  distance between each hospital and the nearest long-term acute care hospital and  the number of long-term acute care hospital beds within 20 miles of each  hospital. Among 281,502 hospitalizations where a patient received mechanical  ventilation, 22,899 (8.1%) received a tracheostomy. Patients admitted to a  hospital closer to a long-term acute care hospital compared with those furthest  from a long-term acute care hospital had 38.9% (95% CI, 33.3-44.6%) higher odds  of tracheostomy (closest hospitals 8.7% vs furthest hospitals 6.3%, adjusted odds  ratio = 1.65; 95% CI, 1.40-1.95). Patients had a 32.4% (95% CI, 27.6-37.3%)  higher risk of tracheostomy when admitted to a hospital with more long-term acute  care hospital beds in the immediate vicinity (most long-term acute care hospital  beds within 20 miles 8.9% vs fewest long-term acute care hospital beds 6.7%,  adjusted odds ratio = 1.54; 95% CI, 1.31-1.80). Distance to the nearest long-term  acute care hospital was inversely correlated with hospital risk-adjusted  tracheostomy rates (?? = -0.25; p < 0.0001). The number of long-term acute care  hospital beds within 20 miles was positively correlated with hospital  risk-adjusted tracheostomy rates (?? = 0.22; p < 0.0001). 

CONCLUSIONS: Proximity  and availability of long-term acute care hospital beds were associated with  patient odds of tracheostomy and hospital tracheostomy practices. These findings  suggest a hospital effect on tracheostomy decision-making over and above patient  case-mix. Future studies focusing on shared decision-making for tracheostomy are  needed to ensure goal-concordant care for prolonged mechanical ventilation.

## 长期急症医院与医院气管造口术实践的关联。

目的：长期急症护理医院的可用性与出院实践相关。目前尚不清楚长期急症护理医院的可用性是否会影响患者的护理决策。我们试图确定不同医院的长期急症护理医院可用性与气管造口术可能性的相关性。

设计：回顾性队列研究。

设置：加利福尼亚州患者出院数据库，2016-2018。

患者：接受机械通气治疗呼吸衰竭的成人患者。

干预：无。

测量和主要结果：使用加利福尼亚州患者出院数据库2016-2018，我们确定了所有机械通气患者和接受气管造口术的患者。我们确定了气管造口术与每家医院与最近的长期急症医院之间的距离以及每家医院20英里内长期急症医院床位数量之间的相关性。在281,502例接受机械通气的住院患者中，22,899例(8.1%)接受了气管造口术。与长期急症医院距离最远的患者相比，入住距离长期急症医院较近的医院的患者接受气管造口术的几率高38.9%(95%CI，33.3-44.6%)（距离最近的医院8.7%vs距离最远的医院6.3%，调整后的比值比 = 1.65；95%CI，1.40-1.95）。当患者入住附近有较多长期急症护理医院床位的医院时，气管造口术的风险高32.4%(95%CI，27.6-37.3%)（大部分长期急症护理医院床位在20英里内为8.9%vs长期急症护理医院床位最少为6.7%，调整后比值比 = 1.54；95%CI，1.31-1.80）。距离最近的长期急症护理医院的距离与医院风险调整的气管切开率呈负相关(<unk><unk>=-0.25；p<0.0001)。20英里内的长期急症护理医院床位数量与医院风险调整的气管切开率呈正相关(<unk><unk>=0.22；p<0.0001)。

结论：长期急症护理医院床位的接近和可用性与气管造口术和医院气管造口术实践的患者几率相关。这些结果表明，在患者病例组合中以上，医院对气管造口术的决策有影响。需要重点关注气管造口术共同决策制定的未来研究，以确保长时间机械通气的目标一致护理。
关键词：Humans; Female; Male; Middle Aged; Aged; Adult; Aged, 80 and over; Retrospective Studies; Hospital Mortality; Comorbidity; Sociodemographic Factors; Respiration, Artificial/*statistics & numerical data; California; Hospitals/*statistics & numerical data/*supply & distribution; Long-Term Care/statistics & numerical data; Respiratory Insufficiency/*therapy; Tracheostomy/*statistics & numerical data; Transportation

--------
--------

## Long-Term Functional Outcome and Quality of Life Following In-Hospital Cardiac Arrest-A Longitudinal Cohort Study.

1:61-71. DOI:10.1097/CCM.0000000000005118

Abstract: 

OBJECTIVES: To evaluate the functional outcome and health-related quality of life of in-hospital cardiac arrest survivors at 6 and 12 months. 

DESIGN: A  longitudinal cohort study. 

SETTING: Seven metropolitan hospitals in Australia.  

PATIENTS: Data were collected for hospitalized adults (?‰? 18 yr) who experienced  in-hospital cardiac arrest, defined as "a period of unresponsiveness, with no  observed respiratory effort and the commencement of external cardiac  compressions." INTERVENTIONS: None. 

MEASUREMENTS AND MAIN RESULTS: Prior to  hospital discharge, patients were approached for consent to participate in  6-month and 12-month telephone interviews. Outcomes included the modified Rankin  Scale, Barthel Index, Euro-Quality of Life 5 Dimension 5 Level, return to work  and hospital readmissions. Forty-eight patients (80%) consented to follow-up  interviews. The mean age of participants was 67.2 (?± 15.3) years, and 33 of 48  (68.8%) were male. Good functional outcome (modified Rankin Scale score ?‰¤ 3) was  reported by 31 of 37 participants (83.8%) at 6 months and 30 of 33 (90.9%) at 12  months. The median Euro-Quality of Life-5D index value was 0.73 (0.33-0.84) at 6  months and 0.76 (0.47-0.88) at 12 months. The median Euro-Quality of Life-Visual  Analogue Scale score at 6 months was 70 (55-80) and 75 (50-87.5) at 12 months.  Problems in all Euro-Quality of Life-5D-5 L dimension were reported frequently at  both time points. Hospital readmission was reported by 23 of 37 patients (62.2%)  at 6 months and 16 of 33 (48.5%) at 12 months. Less than half of previously  working participants had returned to work by 12 months. 

CONCLUSIONS: The majority  of in-hospital cardiac arrest survivors had a good functional outcome and  health-related quality of life at 6 months, and this was largely unchanged at 12  months. Despite this, many reported problems with mobility, self-care, usual  activities, pain, and anxiety/depression. Return to work rates was low, and  hospital readmissions were common.

## 院内心脏骤停后的长期功能结局和生活质量-一项纵向队列研究。

目的：评价6个月和12个月时院内心脏骤停幸存者的功能结局和健康相关生活质量。

设计：纵向队列研究。

设置：澳大利亚的7家大都市医院。

患者：收集发生院内心脏骤停的成年住院患者（ ≥ 18岁）的数据，定义为“无反应，没有观察到呼吸努力，开始外部心脏按压的时间段”。

干预：无。

测量和主要结果：在出院前，患者被要求同意参加6个月和12个月的电话访谈。结局包括改良Rankin量表、Barthel指数、欧洲生活质量5维度5水平、恢复工作和再次入院。48例患者(80%)同意进行随访访谈。受试者的平均年龄为67.2(?±15.3)岁，48例受试者中33例(68.8%)为男性。在6个月时37名参与者中有31名(83.8%)报告了良好的功能结局（改良Rankin量表评分?‰?3），在12个月时33名参与者中有30名(90.9%)报告了良好的功能结局。6个月时中位欧洲生活质量-5D指数值为0.73(0.33-0.84)，12个月时为0.76(0.47-0.88)。6个月时的中位欧洲生活质量-视觉模拟量表评分为70(55-80)，12个月时为75(50-87.5)。在两个时间点频繁报告了所有欧洲生活质量-5D-5l维度的问题。在6个月时37例患者中的23例(62.2%)和12个月时33例患者中的16例(48.5%)报告了再次入院。之前参加工作的受试者中不到一半在12个月内返回工作。

结论：6个月时，大多数院内心脏骤停幸存者的功能结局和健康相关生活质量良好，12个月时基本没有变化。尽管如此，许多报告了运动、自理、日常活动、疼痛和焦虑/抑郁问题。恢复工作的比率较低，再次入院很常见。
关键词：Humans; Female; Male; Middle Aged; Aged; Aged, 80 and over; Activities of Daily Living; *Quality of Life; Survivors/*statistics & numerical data; *Functional Status; Heart Arrest/*epidemiology; Patient Readmission/statistics & numerical data; Return to Work/statistics & numerical data

--------
--------

## Trends in Endotracheal Intubation During In-Hospital Cardiac Arrests: 2001-2018., Schwab, Kristin

1:72-80. DOI:10.1097/CCM.0000000000005120

Abstract: 

OBJECTIVES: Airway management during in-hospital cardiac arrest represents a fundamental component of resuscitative efforts, yet little is known about  temporal trends in intubation during in-hospital cardiac arrest. Our objective  was to investigate changes in in-hospital cardiac arrest airway management over  time and in response to national guideline updates. 

DESIGN: Observational cohort  study of a prospectively collected database. 

SETTING: Multicenter study of  hospitals participating in the "Get With The Guidelines-Resuscitation" registry  from January 1, 2001, to December 31, 2018. 

SUBJECTS: Adult patients who  experienced an in-hospital cardiac arrest and did not have an invasive airway in  place prior to the arrest. 

INTERVENTIONS: The primary outcome was the rate of  intra-arrest intubation from 2001 to 2018. We constructed multivariable  regression models with generalized estimating equations to determine the annual  adjusted odds of intubation. We also assessed the timing of intubation relative  to the onset of pulselessness and other arrest measures. We used an interrupted  time-series analysis to assess the association between the 2010 Advanced Cardiac  Life Support guideline update and intubation rates. 

MEASUREMENTS AND MAIN  RESULTS: One thousand sixty-six eight hundred patients from 797 hospitals were  included. From 2001 to 2018, the percentage of patients intubated during an  arrest decreased from 69% to 55% for all rhythms, 73% to 60% for nonshockable  rhythms, and 58% to 36% for shockable rhythms (p < 0.001 for trend for all 3  groups). The median time from onset of pulselessness to intubation increased from  5 minutes in 2001 (interquartile range, 2-8 min) to 6 minutes in 2018  (interquartile range, 4-10 min) (p < 0.001 for trend). Following the 2010  guideline update, there was a downward step change and a steeper decrease over  time in the rate of intubation as compared to the preintervention period (p <  0.001). 

CONCLUSIONS: Endotracheal intubation rates during in-hospital cardiac  arrest have decreased significantly over time, with a more substantial decline  following the updated 2010 guideline that prioritized chest compressions over  airway management.

## 院内心脏骤停期间气管插管的趋势：2001-2018。

目的：院内心脏骤停期间的气道管理是复苏努力的基本组成部分，但对于院内心脏骤停期间插管的时间趋势知之甚少。我们的目的是调查院内心脏骤停气道管理随时间推移的变化，并对国家指南更新作出回应。

设计：前瞻性收集数据库的观察性队列研究。

设置：从2001年1月1日至2018年12月31日，参加“遵循指南-复苏”登记的医院的多中心研究。

受试者：发生院内心脏骤停且在心脏骤停前未放置侵入性气道的成人患者。

干预：主要结局是2001年至2018年的停搏内插管率。我们用广义估计方程构建了多变量回归模型，以确定每年调整的插管几率。我们还评估了相对于无脉性发作和其他停搏措施的插管时间。我们使用了间断时间序列分析来评估2010年高级心脏生命支持指南更新和插管率之间的相关性。

测量和主要结果：797家医院的166800名患者被纳入。从2001年至2018年，所有节律时心脏骤停期间插管的患者百分比从69%降至55%，不可电击节律时从73%降至60%，可电击节律时从58%降至36%（所有3组趋势p < 0.001）。从出现无脉症到插管的中位时间从2001年的5 min（四分位距，2-8 min）增加到2018年的6 min（四分位距，4-10 min）（趋势p < 0.001）。2010年指南更新后，与干预前阶段相比，插管率随时间推移发生了向下的阶跃变化，并且下降幅度更大(p < 0.001)。

结论：院内心脏骤停期间的气管插管率随时间推移显著下降，在2010年更新指南中将胸外按压优先于气道管理后，气管插管率显著下降。
关键词：Humans; Female; Male; Middle Aged; Prospective Studies; Time Factors; Aged; Aged, 80 and over; Heart Arrest/*therapy; Cardiopulmonary Resuscitation/statistics & numerical data; Hospitals/*statistics & numerical data; Interrupted Time Series Analysis; Intubation, Intratracheal/*statistics & numerical data

--------
--------

